0000950170-22-016942.txt : 20220811 0000950170-22-016942.hdr.sgml : 20220811 20220811170918 ACCESSION NUMBER: 0000950170-22-016942 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 83 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220811 DATE AS OF CHANGE: 20220811 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Arcadia Biosciences, Inc. CENTRAL INDEX KEY: 0001469443 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100] IRS NUMBER: 810571538 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37383 FILM NUMBER: 221156872 BUSINESS ADDRESS: STREET 1: 202 COUSTEAU PLACE STREET 2: SUITE 105 CITY: DAVIS STATE: X1 ZIP: 95618 BUSINESS PHONE: 530-756-7077 MAIL ADDRESS: STREET 1: 202 COUSTEAU PLACE STREET 2: SUITE 105 CITY: DAVIS STATE: CA ZIP: 95618 10-Q 1 rkda-20220630.htm 10-Q 10-Q
0001469443--12-31P1YfalseQ2one yearP2Y6M2005-06-30http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member0001469443us-gaap:TrademarksAndTradeNamesMember2022-06-300001469443us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001469443us-gaap:EmployeeStockMember2021-04-012021-06-3000014694432022-03-310001469443rkda:April2019ServiceAndPerformanceWarrantsMember2021-12-3100014694432022-06-300001469443us-gaap:EmployeeStockMember2022-06-300001469443us-gaap:LeaseholdImprovementsMember2022-06-300001469443rkda:ArcadiaWellnessLimitedLiabilityCompanyMember2021-05-172021-05-170001469443us-gaap:RetainedEarningsMember2022-04-012022-06-300001469443rkda:JuneTwoThousandEighteenPurchaseAgreementMember2018-06-012018-06-300001469443us-gaap:WarrantMemberrkda:JuneTwoThousandNineteenSecuritiesPurchaseAgreementMemberrkda:JuneTwoThousandNineteenPlacementAgentWarrantsMember2019-06-012019-06-300001469443us-gaap:ProductMember2022-01-012022-06-300001469443us-gaap:EmployeeStockOptionMember2022-01-012022-06-300001469443us-gaap:WarrantMemberrkda:DecemberTwoThousandTwentyPlacementAgentWarrantsMemberrkda:DecemberTwoThousandAndTwentyPurchaseAgreementMember2020-12-012020-12-310001469443us-gaap:EmployeeStockOptionMember2021-04-012021-06-300001469443rkda:LaboratoryEquipmentMember2021-12-310001469443us-gaap:WarrantMemberrkda:SeptemberTwoThousandNineteenPurchaseAgreementMemberrkda:SeptemberTwoThousandNineteenPlacementAgentWarrantMember2019-09-300001469443us-gaap:WarrantMemberrkda:DecemberTwoThousandAndTwentyPurchaseAgreementMember2020-12-310001469443rkda:IntellectualPropertyAndCustomerListsMembersrt:MinimumMember2022-01-012022-06-300001469443rkda:April2019ServiceAndPerformanceWarrantsMember2022-01-012022-06-300001469443us-gaap:AdditionalPaidInCapitalMemberrkda:JanuaryTwoThousandAndTwentyOnePIPEMember2021-01-012021-03-310001469443us-gaap:CustomerListsMember2021-12-3100014694432020-12-310001469443us-gaap:EmployeeStockOptionMember2021-01-012021-06-300001469443us-gaap:NoncontrollingInterestMember2022-04-012022-06-300001469443rkda:JanuaryTwoThousandTwentyOnePlacementAgentWarrantsMember2022-06-300001469443rkda:September2019PlacementAgentWarrantsMember2022-06-3000014694432022-05-012022-05-310001469443rkda:JanuaryTwoThousandTwentyOnePlacementAgentWarrantsMember2021-12-310001469443us-gaap:MoneyMarketFundsMemberus-gaap:CashEquivalentsMember2022-06-300001469443rkda:February122020ServiceAndPerformanceWarrantsMember2022-06-300001469443us-gaap:CommonStockMember2021-12-310001469443rkda:IntellectualPropertyAndCustomerListsMembersrt:MaximumMember2022-01-012022-06-300001469443us-gaap:CommonStockMember2021-01-012021-03-310001469443rkda:JuneTwoThousandEighteenPlacementAgentWarrantsMember2022-06-300001469443rkda:FormulationsMemberrkda:ArcadiaWellnessLimitedLiabilityCompanyMember2021-05-170001469443rkda:July2020PlacementAgentWarrantsMember2022-01-012022-06-300001469443us-gaap:CommonStockMember2021-06-300001469443us-gaap:FurnitureAndFixturesMember2022-06-300001469443us-gaap:SellingGeneralAndAdministrativeExpensesMemberrkda:SeparationAgreementMember2021-01-012021-12-310001469443us-gaap:MachineryAndEquipmentMember2021-12-310001469443us-gaap:WarrantMember2021-01-012021-06-300001469443us-gaap:RoyaltyMember2021-04-012021-06-300001469443rkda:SoftwareAndComputerEquipmentMember2021-12-310001469443rkda:ArcadiaWellnessLimitedLiabilityCompanyMember2021-05-172021-12-310001469443us-gaap:ResearchAndDevelopmentExpenseMember2021-04-012021-06-300001469443rkda:SeptemberTwoThousandNineteenWarrantsMember2022-01-012022-06-3000014694432021-03-310001469443us-gaap:AdditionalPaidInCapitalMember2021-06-300001469443us-gaap:FairValueInputsLevel3Memberus-gaap:AccountingStandardsUpdate202006Member2022-01-012022-06-300001469443rkda:RadianceBeautyLicensingAgreementMember2022-01-012022-06-300001469443us-gaap:NoncontrollingInterestMember2022-06-300001469443rkda:July2020PlacementAgentWarrantsMember2022-06-300001469443rkda:JanuaryTwoThousandTwentyOneWarrantsMember2022-06-300001469443us-gaap:FairValueInputsLevel3Member2021-12-310001469443us-gaap:ProductMember2021-01-012021-06-300001469443rkda:DecemberTwoThousandTwentyPlacementAgentWarrantsMember2021-12-310001469443rkda:JanuaryTwoThousandTwentyOneWarrantsMember2022-01-012022-06-300001469443rkda:LegacyVenturesHawaiiLLCMemberrkda:ArchipelagoVenturesHawaiiLLCMember2019-08-092019-08-090001469443rkda:JanuaryTwoThousandAndTwentyOnePIPEMember2021-01-012021-03-310001469443rkda:AmendmentMembersrt:BoardOfDirectorsChairmanMember2020-04-012020-04-300001469443us-gaap:WarrantMemberrkda:DecemberTwoThousandAndTwentyPurchaseAgreementMember2020-12-012020-12-310001469443us-gaap:EmployeeStockMember2015-05-140001469443rkda:InducementStockOptionMember2022-06-300001469443us-gaap:FairValueInputsLevel3Memberrkda:ContingentLiabilitiesMember2022-06-300001469443us-gaap:CommonStockMemberrkda:ArcadiaWellnessLimitedLiabilityCompanyMember2021-04-012021-06-300001469443rkda:JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMemberrkda:JanuaryTwoThousandTwentyOnePrivatePlacementMember2021-01-012021-01-310001469443us-gaap:AccountingStandardsUpdate202006Member2022-01-012022-06-300001469443us-gaap:CommonStockMemberrkda:ArcadiaWellnessLimitedLiabilityCompanyMember2021-05-182021-05-310001469443rkda:IndustrialSeedInnovationsMember2022-01-012022-03-310001469443rkda:VerdecaLLCMember2022-01-012022-06-300001469443srt:BoardOfDirectorsChairmanMember2019-02-280001469443us-gaap:WarrantMemberrkda:JuneTwoThousandNineteenSecuritiesPurchaseAgreementMember2019-06-300001469443us-gaap:CommonStockMember2022-06-300001469443rkda:February32020ServiceAndPerformanceWarrantsMember2022-06-300001469443us-gaap:WarrantMemberrkda:JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMemberrkda:JanuaryTwoThousandTwentyOnePrivatePlacementMember2021-01-012021-01-310001469443us-gaap:EmployeeStockMember2022-04-012022-06-300001469443us-gaap:CommonStockMember2022-01-012022-03-310001469443rkda:February32020ServiceAndPerformanceWarrantsMember2021-12-310001469443rkda:JohnSperlingFoundationMember2022-06-300001469443srt:BoardOfDirectorsChairmanMember2019-02-012019-02-280001469443us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-06-300001469443us-gaap:RoyaltyMember2021-01-012021-06-300001469443srt:MaximumMember2022-01-012022-06-300001469443rkda:ArcadiaBiosciencesIncorporationMemberrkda:ArchipelagoVenturesHawaiiLLCMember2019-08-092019-08-090001469443us-gaap:AdditionalPaidInCapitalMember2020-12-310001469443rkda:DecemberTwoThousandTwentyWarrantsMember2021-12-310001469443us-gaap:ConstructionInProgressMember2021-12-310001469443rkda:April2019ServiceAndPerformanceWarrantsMember2022-06-300001469443rkda:ArcadiaWellnessLimitedLiabilityCompanyMember2021-01-012021-06-300001469443us-gaap:RetainedEarningsMember2021-12-310001469443us-gaap:TrademarksAndTradeNamesMember2021-12-310001469443rkda:AnawahIncMember2010-12-3100014694432022-01-012022-03-310001469443rkda:SoftwareAndComputerEquipmentMember2022-06-300001469443us-gaap:NoncontrollingInterestMember2021-06-300001469443us-gaap:RoyaltyMember2022-04-012022-06-3000014694432022-01-012022-06-3000014694432022-04-012022-06-300001469443rkda:March2020ServiceAndPerformanceWarrantsMember2022-06-300001469443rkda:DecemberTwoThousandTwentyPlacementAgentWarrantsMember2022-01-012022-06-300001469443rkda:IndustrialSeedInnovationsMember2022-06-300001469443us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-06-300001469443rkda:TwoThousandFifteenOmnibusEquityIncentivePlanMember2021-12-310001469443us-gaap:WarrantMemberrkda:JuneTwoThousandEighteenPurchaseAgreementMemberrkda:JuneTwoThousandEighteenPlacementAgentWarrantsMember2018-06-012018-06-300001469443rkda:DecemberTwoThousandAndTwentyPurchaseAgreementMember2020-12-012020-12-310001469443rkda:IndustrialSeedInnovationsMember2022-04-012022-06-300001469443us-gaap:WarrantMember2022-01-012022-06-300001469443us-gaap:FairValueInputsLevel3Member2022-06-300001469443us-gaap:FairValueInputsLevel3Memberrkda:JuneTwoThousandAndNineteenOfferingMemberrkda:CommonStockWarrantLiabilityMember2021-12-310001469443us-gaap:NoncontrollingInterestMember2021-01-012021-03-310001469443us-gaap:EmployeeStockOptionMember2021-04-012021-06-300001469443rkda:March2018PlacementAgentWarrantsMember2022-06-300001469443rkda:MarchTwoThousandEighteenWarrantsMember2022-06-300001469443us-gaap:CustomerRelationshipsMemberrkda:ArcadiaWellnessLimitedLiabilityCompanyMember2021-05-170001469443rkda:February122020ServiceAndPerformanceWarrantsMember2022-01-012022-06-300001469443us-gaap:LicenseMember2022-01-012022-06-300001469443us-gaap:NoncontrollingInterestMember2020-12-3100014694432021-06-300001469443us-gaap:RetainedEarningsMember2021-01-012021-03-310001469443rkda:JuneTwoThousandNineteenSecuritiesPurchaseAgreementMember2019-06-012019-06-300001469443rkda:AmendmentMembersrt:BoardOfDirectorsChairmanMember2020-03-012020-03-310001469443rkda:JanuaryTwoThousandTwentyOneServiceAndPerformanceWarrantsMember2022-01-012022-06-300001469443rkda:MarchTwoThousandEighteenPrivatePlacementMemberrkda:MarchTwoThousandEighteenSecuritiesPurchaseAgreementMember2018-03-310001469443rkda:SellingGeneralAndAdministrativeAndResearchAndDevelopmentExpensesMember2022-04-012022-06-300001469443rkda:February32020ServiceAndPerformanceWarrantsMember2022-01-012022-06-300001469443rkda:FormulationsMemberrkda:ArcadiaWellnessLimitedLiabilityCompanyMember2021-05-172021-05-170001469443srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMemberus-gaap:FairValueInputsLevel3Memberrkda:CommonStockWarrantLiabilityMemberus-gaap:AccountingStandardsUpdate202006Memberrkda:JanuaryTwoThousandAndTwentyOneOfferingMember2021-12-310001469443us-gaap:VehiclesMember2021-12-3100014694432021-01-012021-03-310001469443us-gaap:EmployeeStockMember2022-01-012022-06-300001469443us-gaap:ProductMember2022-04-012022-06-300001469443us-gaap:WarrantMemberrkda:DecemberTwoThousandTwentyPlacementAgentWarrantsMemberrkda:DecemberTwoThousandAndTwentyPurchaseAgreementMember2020-12-310001469443rkda:JuneTwoThousandEighteenWarrantsMember2022-01-012022-06-300001469443rkda:March2018PlacementAgentWarrantsMember2021-12-310001469443us-gaap:NoncontrollingInterestMember2021-12-310001469443rkda:June2019PlacementAgentWarrantsMember2022-06-300001469443rkda:July2020PlacementAgentWarrantsMember2021-12-310001469443us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-06-300001469443rkda:DecemberTwoThousandTwentyWarrantsMember2022-01-012022-06-300001469443us-gaap:RetainedEarningsMember2021-03-310001469443rkda:IndustrialSeedInnovationsMember2021-01-012021-03-310001469443us-gaap:WarrantMember2022-04-012022-06-300001469443rkda:JuneTwoThousandEighteenPlacementAgentWarrantsMember2021-12-310001469443rkda:JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMemberrkda:JanuaryTwoThousandTwentyOnePrivatePlacementMember2021-01-310001469443rkda:AnawahIncMember2022-06-300001469443us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300001469443rkda:AmendmentMembersrt:BoardOfDirectorsChairmanMember2020-04-300001469443rkda:JuneTwoThousandNineteenWarrantsMember2022-01-012022-06-300001469443us-gaap:PrivatePlacementMemberus-gaap:FairValueInputsLevel3Memberrkda:CommonStockWarrantLiabilityMember2021-12-310001469443rkda:BioceresCropSolutionsMemberrkda:VerdecaLLCMember2020-11-012020-11-300001469443rkda:SeparationAgreementMember2021-12-192021-12-190001469443rkda:AmendmentMembersrt:BoardOfDirectorsChairmanMember2020-03-310001469443srt:MaximumMember2022-06-300001469443us-gaap:RetainedEarningsMember2022-01-012022-03-310001469443us-gaap:CommonStockMember2021-03-310001469443rkda:MarchTwoThousandEighteenSecuritiesPurchaseAgreementMember2018-03-012018-03-310001469443rkda:May2020PlacementAgentWarrantsMember2022-06-300001469443us-gaap:MoneyMarketFundsMember2021-12-310001469443us-gaap:MoneyMarketFundsMemberus-gaap:CashEquivalentsMember2021-12-310001469443rkda:TwoThousandFifteenOmnibusEquityIncentivePlanMember2015-05-192015-05-200001469443us-gaap:WarrantMemberrkda:JuneTwoThousandEighteenPurchaseAgreementMember2018-06-300001469443us-gaap:RetainedEarningsMember2021-04-012021-06-300001469443srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMemberus-gaap:FairValueInputsLevel3Memberrkda:JuneTwoThousandAndNineteenOfferingMemberrkda:CommonStockWarrantLiabilityMemberus-gaap:AccountingStandardsUpdate202006Member2021-12-310001469443rkda:TwoThousandFifteenOmnibusEquityIncentivePlanMember2022-06-300001469443us-gaap:NoncontrollingInterestMember2021-03-310001469443rkda:LaboratoryEquipmentMember2022-06-300001469443rkda:JanuaryTwoThousandTwentyOneServiceAndPerformanceWarrantsMember2022-06-300001469443us-gaap:CommonStockMember2020-12-3100014694432021-12-310001469443rkda:SeptemberTwoThousandAndNineteenOfferingMemberus-gaap:FairValueInputsLevel3Memberrkda:CommonStockWarrantLiabilityMember2021-12-310001469443us-gaap:ProductMember2021-04-012021-06-300001469443us-gaap:AdditionalPaidInCapitalMember2021-03-310001469443rkda:September2019PlacementAgentWarrantsMember2021-12-310001469443us-gaap:MoneyMarketFundsMember2022-06-300001469443rkda:July2020WarrantsMember2022-06-300001469443rkda:TwoThousandSixStockIncentivePlanMember2021-12-310001469443us-gaap:FurnitureAndFixturesMember2021-12-310001469443rkda:DecemberTwoThousandTwentyPlacementAgentWarrantsMember2022-06-300001469443rkda:May2020PlacementAgentWarrantsMember2022-01-012022-06-300001469443us-gaap:RetainedEarningsMember2020-12-310001469443rkda:ArcadiaWellnessLimitedLiabilityCompanyMember2021-05-170001469443rkda:MarchTwoThousandEighteenWarrantsMember2021-12-310001469443us-gaap:WarrantMemberrkda:JuneTwoThousandEighteenPurchaseAgreementMember2018-06-012018-06-300001469443us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2022-06-300001469443rkda:InducementStockOptionMember2021-05-172021-05-170001469443rkda:SeparationAgreementMember2021-12-142021-12-140001469443rkda:TwoThousandFifteenOmnibusEquityIncentivePlanMember2022-01-012022-06-300001469443rkda:JohnSperlingFoundationMember2021-12-310001469443rkda:JanuaryTwoThousandAndTwentyOnePIPESecuritiesPurchaseAgreementMember2021-01-012021-06-300001469443us-gaap:RetainedEarningsMember2021-06-300001469443us-gaap:MachineryAndEquipmentMember2022-06-300001469443us-gaap:WarrantMemberrkda:JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMemberus-gaap:MeasurementInputSharePriceMemberrkda:JanuaryTwoThousandTwentyOnePrivatePlacementMember2021-01-280001469443us-gaap:EmployeeStockOptionMember2022-04-012022-06-300001469443rkda:TwoThousandFifteenOmnibusEquityIncentivePlanMember2019-06-012019-06-300001469443rkda:JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMemberrkda:JanuaryTwoThousandTwentyOnePlacementAgentWarrantsMemberrkda:JanuaryTwoThousandTwentyOnePrivatePlacementMember2021-01-310001469443rkda:AnawahIncMember2022-01-012022-06-300001469443rkda:ArcadiaWellnessAcquisitionMember2022-01-012022-06-300001469443rkda:ArcadiaBiosciencesIncorporationMemberrkda:ArchipelagoVenturesHawaiiLLCMember2022-06-300001469443rkda:SellingGeneralAndAdministrativeAndResearchAndDevelopmentExpensesMember2021-01-012021-06-300001469443us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001469443us-gaap:RoyaltyMember2022-01-012022-06-300001469443rkda:SeptemberTwoThousandAndNineteenOfferingMembersrt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMemberus-gaap:FairValueInputsLevel3Memberrkda:CommonStockWarrantLiabilityMemberus-gaap:AccountingStandardsUpdate202006Member2021-12-310001469443rkda:July2020WarrantsMember2021-12-310001469443rkda:MarchTwoThousandEighteenPrivatePlacementMemberrkda:MarchTwoThousandEighteenSecuritiesPurchaseAgreementMember2018-03-012018-03-310001469443rkda:MarchTwoThousandEighteenSecuritiesPurchaseAgreementMember2018-03-310001469443us-gaap:AccountingStandardsUpdate202006RetrospectiveMember2021-12-310001469443rkda:ArchipelagoVenturesHawaiiLLCMember2021-04-012021-06-300001469443us-gaap:FairValueInputsLevel3Memberrkda:ContingentLiabilitiesMember2021-12-310001469443rkda:February122020ServiceAndPerformanceWarrantsMember2021-12-310001469443rkda:RadianceBeautyLicensingAgreementMember2022-04-012022-06-300001469443us-gaap:CustomerRelationshipsMemberrkda:ArcadiaWellnessLimitedLiabilityCompanyMember2021-05-172021-05-170001469443rkda:RadianceBeautyLicensingAgreementMember2022-06-300001469443srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMemberus-gaap:FairValueInputsLevel3Memberus-gaap:AccountingStandardsUpdate202006Member2021-12-310001469443rkda:SeptemberTwoThousandNineteenWarrantsMember2021-12-310001469443us-gaap:EmployeeStockMember2021-01-012021-06-300001469443us-gaap:IntellectualPropertyMember2022-06-300001469443srt:MaximumMemberrkda:TwoThousandFifteenOmnibusEquityIncentivePlanMember2015-05-192015-05-200001469443us-gaap:RetainedEarningsMember2022-03-310001469443rkda:ArcadiaWellnessLimitedLiabilityCompanyMember2022-01-012022-06-300001469443us-gaap:ConstructionInProgressMember2022-06-300001469443us-gaap:WarrantMemberrkda:JuneTwoThousandNineteenSecuritiesPurchaseAgreementMemberrkda:JuneTwoThousandNineteenPlacementAgentWarrantsMember2019-06-300001469443rkda:JanuaryTwoThousandTwentyOneServiceAndPerformanceWarrantsMember2021-12-310001469443us-gaap:WarrantMemberrkda:SeptemberTwoThousandNineteenPurchaseAgreementMemberrkda:SeptemberTwoThousandNineteenPlacementAgentWarrantMember2019-09-012019-09-300001469443rkda:JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMemberrkda:JanuaryTwoThousandTwentyOnePlacementAgentWarrantsMemberrkda:JanuaryTwoThousandTwentyOnePrivatePlacementMember2021-01-012021-01-310001469443us-gaap:WarrantMemberus-gaap:MeasurementInputRiskFreeInterestRateMemberrkda:JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMemberrkda:JanuaryTwoThousandTwentyOnePrivatePlacementMember2021-01-280001469443us-gaap:NoncontrollingInterestMember2021-04-012021-06-300001469443rkda:ArcadiaWellnessLimitedLiabilityCompanyMember2022-04-012022-06-3000014694432020-04-3000014694432021-04-012021-06-300001469443us-gaap:AdditionalPaidInCapitalMember2021-12-310001469443us-gaap:WarrantMemberrkda:JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMemberrkda:JanuaryTwoThousandTwentyOnePlacementAgentWarrantsMemberrkda:JanuaryTwoThousandTwentyOnePrivatePlacementMember2021-01-310001469443srt:MaximumMemberrkda:BioceresCropSolutionsMemberrkda:VerdecaLLCMember2020-11-012020-11-300001469443us-gaap:AccountingStandardsUpdate202104Member2022-06-300001469443srt:MinimumMember2022-06-300001469443srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMemberus-gaap:PrivatePlacementMemberus-gaap:FairValueInputsLevel3Memberrkda:CommonStockWarrantLiabilityMemberus-gaap:AccountingStandardsUpdate202006Member2021-12-310001469443rkda:September2019PlacementAgentWarrantsMember2022-01-012022-06-300001469443rkda:SeptemberTwoThousandNineteenWarrantsMember2022-06-300001469443us-gaap:FairValueInputsLevel3Memberrkda:CommonStockWarrantLiabilityMemberrkda:JanuaryTwoThousandAndTwentyOneOfferingMember2021-12-310001469443rkda:May2020WarrantsMember2022-06-300001469443us-gaap:FairValueInputsLevel1Member2021-12-310001469443rkda:JuneTwoThousandNineteenWarrantsMember2021-12-310001469443rkda:CollaborativeArrangementsCopromotionMember2017-08-012017-08-310001469443us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001469443rkda:TwoThousandSixStockIncentivePlanMember2022-06-300001469443rkda:SellingGeneralAndAdministrativeAndResearchAndDevelopmentExpensesMember2022-01-012022-06-300001469443rkda:March2020ServiceAndPerformanceWarrantsMember2021-12-310001469443rkda:July2020WarrantsMember2022-01-012022-06-300001469443rkda:JuneTwoThousandEighteenWarrantsMember2022-06-300001469443us-gaap:AdditionalPaidInCapitalMember2022-06-300001469443us-gaap:EmployeeStockOptionMember2022-01-012022-06-300001469443us-gaap:WarrantMemberrkda:SeptemberTwoThousandNineteenPurchaseAgreementMember2019-09-300001469443rkda:ArchipelagoVenturesHawaiiLLCMember2021-01-012021-06-300001469443us-gaap:RetainedEarningsMember2022-06-300001469443us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-04-012021-06-300001469443rkda:LegacyVenturesHawaiiLLCMemberrkda:ArchipelagoVenturesHawaiiLLCMember2022-06-300001469443rkda:TwoThousandFifteenOmnibusEquityIncentivePlanMember2015-05-200001469443us-gaap:WarrantMemberrkda:SeptemberTwoThousandNineteenPurchaseAgreementMember2019-09-012019-09-300001469443us-gaap:EmployeeStockOptionMember2022-04-012022-06-300001469443rkda:March2020ServiceAndPerformanceWarrantsMember2022-01-012022-06-300001469443us-gaap:LicenseMember2022-04-012022-06-300001469443us-gaap:NoncontrollingInterestMember2022-01-012022-03-310001469443rkda:SellingGeneralAndAdministrativeAndResearchAndDevelopmentExpensesMember2021-04-012021-06-300001469443us-gaap:AdditionalPaidInCapitalMember2022-03-310001469443rkda:ArcadiaWellnessLimitedLiabilityCompanyMember2021-05-182021-05-310001469443us-gaap:LeaseholdImprovementsMember2021-12-310001469443us-gaap:ResearchAndDevelopmentExpenseMember2022-04-012022-06-300001469443us-gaap:CommonStockMember2022-03-310001469443us-gaap:EmployeeStockOptionMember2021-01-012021-06-300001469443us-gaap:FairValueInputsLevel1Member2022-06-300001469443us-gaap:EmployeeStockMember2015-05-132015-05-140001469443us-gaap:WarrantMemberrkda:JuneTwoThousandEighteenPurchaseAgreementMemberrkda:JuneTwoThousandEighteenPlacementAgentWarrantsMember2018-06-300001469443us-gaap:AdditionalPaidInCapitalMemberus-gaap:AccountingStandardsUpdate202006RetrospectiveMember2021-12-310001469443us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001469443rkda:AnawahIncMember2005-06-300001469443rkda:IndustrialSeedInnovationsMemberus-gaap:CommonStockMember2020-08-012020-08-310001469443rkda:BioceresCropSolutionsMember2022-01-012022-06-300001469443rkda:ArcadiaWellnessLimitedLiabilityCompanyMember2021-04-012021-06-300001469443us-gaap:VehiclesMember2022-06-3000014694432021-01-012021-12-310001469443rkda:InducementStockOptionMemberrkda:PresidentAndChiefExecutiveOfficerMember2022-02-022022-02-020001469443rkda:May2020WarrantsMember2021-12-310001469443us-gaap:WarrantMemberrkda:JuneTwoThousandNineteenSecuritiesPurchaseAgreementMember2019-06-012019-06-300001469443us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300001469443us-gaap:AdditionalPaidInCapitalMemberrkda:ArcadiaWellnessLimitedLiabilityCompanyMember2021-04-012021-06-300001469443srt:MinimumMember2022-01-012022-06-300001469443rkda:IndustrialSeedInnovationsMembersrt:MaximumMemberrkda:AchievementOfRevenueMilestoneIn2022Memberus-gaap:CommonStockMember2020-08-310001469443us-gaap:TrademarksAndTradeNamesMemberrkda:ArcadiaWellnessLimitedLiabilityCompanyMember2021-05-1700014694432021-01-012021-06-300001469443rkda:JanuaryTwoThousandAndTwentyOnePIPEMemberus-gaap:CommonStockMember2021-01-012021-03-310001469443rkda:May2020PlacementAgentWarrantsMember2021-12-310001469443us-gaap:IntellectualPropertyMember2021-12-310001469443rkda:March2018PlacementAgentWarrantsMember2022-01-012022-06-300001469443rkda:MarchTwoThousandEighteenWarrantsMember2022-01-012022-06-300001469443rkda:MarchTwoThousandEighteenPrivatePlacementMemberrkda:MarchTwoThousandEighteenSecuritiesPurchaseAgreementMemberrkda:MarchTwoThousandEighteenPlacementAgentMember2018-03-012018-03-310001469443rkda:JuneTwoThousandEighteenPlacementAgentWarrantsMember2022-01-012022-06-300001469443us-gaap:FairValueInputsLevel3Memberrkda:ContingentLiabilitiesMember2022-01-012022-06-300001469443us-gaap:SellingGeneralAndAdministrativeExpensesMemberrkda:ArcadiaWellnessLimitedLiabilityCompanyMember2021-01-012021-06-3000014694432022-08-080001469443us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2021-12-310001469443rkda:SeptemberTwoThousandNineteenPurchaseAgreementMember2019-09-012019-09-300001469443rkda:JuneTwoThousandNineteenWarrantsMember2022-06-300001469443rkda:IndustrialSeedInnovationsMember2020-08-012020-08-310001469443rkda:ArcadiaWellnessLimitedLiabilityCompanyMember2022-06-300001469443us-gaap:NoncontrollingInterestMember2022-03-310001469443rkda:June2019PlacementAgentWarrantsMember2022-01-012022-06-300001469443rkda:JanuaryTwoThousandTwentyOnePlacementAgentWarrantsMember2022-01-012022-06-300001469443rkda:MarchTwoThousandEighteenPrivatePlacementMemberrkda:MarchTwoThousandEighteenSecuritiesPurchaseAgreementMemberrkda:MarchTwoThousandEighteenPlacementAgentMember2018-03-310001469443us-gaap:WarrantMember2021-04-012021-06-300001469443rkda:June2019PlacementAgentWarrantsMember2021-12-310001469443rkda:AnawahIncMember2010-01-012010-12-310001469443us-gaap:WarrantMemberrkda:JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMemberrkda:JanuaryTwoThousandTwentyOnePrivatePlacementMemberus-gaap:MeasurementInputPriceVolatilityMember2021-01-280001469443rkda:TwoThousandSixStockIncentivePlanMember2015-05-200001469443rkda:JanuaryTwoThousandTwentyOneWarrantsMember2021-12-310001469443rkda:DecemberTwoThousandTwentyWarrantsMember2022-06-300001469443rkda:May2020WarrantsMember2022-01-012022-06-300001469443us-gaap:AccountingStandardsUpdate202006Member2022-06-300001469443us-gaap:RetainedEarningsMemberus-gaap:AccountingStandardsUpdate202006RetrospectiveMember2021-12-310001469443us-gaap:CustomerListsMember2022-06-30utr:acrerkda:Individualrkda:Leaserkda:Installmentxbrli:pureiso4217:USDxbrli:sharesxbrli:sharesrkda:IncentivePlaniso4217:USDrkda:Program

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2022

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from to

 

Commission File Number: 001-37383

 

Arcadia Biosciences, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

81-0571538

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer
Identification No.)

202 Cousteau Place, Suite 105

Davis, CA

95618

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s telephone number, including area code: (530) 756-7077

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common

RKDA

NASDAQ CAPITAL MARKET

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

 

Accelerated filer

 ☐

 

 

 

 

 

Non-accelerated filer

 

 

Smaller reporting company

 

 

 

 

 

 

 

 

Emerging growth company

 

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

As of August 8, 2022, the registrant had 22,192,960 shares of common stock outstanding, $0.001 par value per share.

 


 

Arcadia Biosciences, Inc.

FORM 10-Q FOR THE QUARTER ENDED June 30, 2022

INDEX

 

 

 

 

 

 

 

Page

Part I —

 

Financial Information (Unaudited)

 

 

 

 

 

 

 

 

 

Item 1.

 

Condensed Consolidated Financial Statements:

 

1

 

 

 

 

 

 

 

 

 

Condensed Consolidated Balance Sheets

 

1

 

 

 

 

 

 

 

 

 

Condensed Consolidated Statements of Operations and Comprehensive Loss

 

2

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Statements of Stockholders’ Equity

 

3

 

 

 

 

 

 

 

 

 

Condensed Consolidated Statements of Cash Flows

 

4

 

 

 

 

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements

 

5

 

 

 

 

 

 

 

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

20

 

 

 

 

 

 

 

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

 

29

 

 

 

 

 

 

 

Item 4.

 

Controls and Procedures

 

29

 

 

 

 

Part II —

 

Other Information

 

30

 

 

 

 

 

 

 

Item 1.

 

Legal Proceedings

 

30

 

 

 

 

 

 

 

Item 1A.

 

Risk Factors

 

30

 

 

 

 

 

 

 

Item 2.

 

Unregistered Sales of Equity Securities and Use of Proceeds

 

30

 

 

 

 

 

 

 

Item 3.

 

Defaults Upon Senior Securities

 

30

 

 

 

 

 

 

 

Item 4.

 

Mine Safety Disclosures

 

30

 

 

 

 

 

 

 

Item 5.

 

Other Information

 

30

 

 

 

 

 

 

 

Item 6.

 

Exhibits

 

31

 

 

 

 

 

 

 

SIGNATURES

 

32

 

 


 

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Arcadia Biosciences, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

(In thousands, except share data)

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

21,234

 

 

$

28,685

 

Accounts receivable, net of allowance for doubtful accounts of $89 and $76 
   as of June 30, 2022 and December 31, 2021, respectively

 

 

3,854

 

 

 

1,370

 

Inventories, net — current

 

 

3,275

 

 

 

4,433

 

Assets held for sale

 

 

254

 

 

 

 

Prepaid expenses and other current assets

 

 

1,441

 

 

 

900

 

Total current assets

 

 

30,058

 

 

 

35,388

 

Property and equipment, net

 

 

954

 

 

 

2,291

 

Right of use asset

 

 

2,308

 

 

 

3,081

 

Inventories, net — noncurrent

 

 

1,136

 

 

 

2,494

 

Intangible assets, net

 

 

386

 

 

 

484

 

Other noncurrent assets

 

 

166

 

 

 

180

 

Total assets

 

$

35,008

 

 

$

43,918

 

Liabilities and stockholders’ equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$

3,391

 

 

$

3,638

 

Amounts due to related parties

 

 

83

 

 

 

64

 

Operating lease liability — current

 

 

994

 

 

 

1,074

 

Other current liabilities

 

 

272

 

 

 

264

 

Total current liabilities

 

 

4,740

 

 

 

5,040

 

Operating lease liability — noncurrent

 

 

1,500

 

 

 

2,220

 

Common stock warrant liabilities

 

 

 

 

 

3,392

 

Other noncurrent liabilities

 

 

2,000

 

 

 

2,070

 

Total liabilities

 

 

8,240

 

 

 

12,722

 

Commitments and contingencies (Note 15)

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

Common stock, $0.001 par value—150,000,000 shares authorized as
   of June 30, 2022 and December 31, 2021;
22,188,918
   and
22,184,235 shares issued and outstanding as of June 30,
   2022 and December 31, 2021, respectively

 

 

63

 

 

 

63

 

Additional paid-in capital

 

 

277,492

 

 

 

257,515

 

Accumulated deficit

 

 

(250,748

)

 

 

(226,485

)

Total stockholders’ equity

 

 

26,807

 

 

 

31,093

 

Non-controlling interest

 

 

(39

)

 

 

103

 

Total stockholders' equity

 

 

26,768

 

 

 

31,196

 

Total liabilities and stockholders’ equity

 

$

35,008

 

 

$

43,918

 

 

See accompanying notes to the unaudited condensed consolidated financial statements.

1


 

Arcadia Biosciences, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)

(In thousands, except share and per share data)

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

Product

 

$

2,946

 

 

$

1,379

 

 

$

6,116

 

 

$

2,183

 

Royalty

 

 

50

 

 

 

26

 

 

 

100

 

 

 

51

 

License

 

 

862

 

 

 

 

 

 

862

 

 

 

 

Total revenues

 

 

3,858

 

 

 

1,405

 

 

 

7,078

 

 

 

2,234

 

Operating expenses (income):

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

3,447

 

 

 

1,587

 

 

 

6,906

 

 

 

2,443

 

Research and development

 

 

359

 

 

 

1,131

 

 

 

754

 

 

 

2,290

 

Gain on sale of Verdeca

 

 

(1,138

)

 

 

 

 

 

(1,138

)

 

 

 

Impairment of intangible assets

 

 

72

 

 

 

 

 

 

72

 

 

 

 

Change in fair value of contingent consideration

 

 

(39

)

 

 

 

 

 

(70

)

 

 

(140

)

Impairment of property and equipment

 

 

346

 

 

 

 

 

 

346

 

 

 

210

 

Gain on sale of property and equipment

 

 

(58

)

 

 

 

 

 

(386

)

 

 

 

Selling, general and administrative

 

 

4,652

 

 

 

6,370

 

 

 

9,000

 

 

 

10,439

 

Total operating expenses

 

 

7,641

 

 

 

9,088

 

 

 

15,484

 

 

 

15,243

 

Loss from operations

 

 

(3,783

)

 

 

(7,682

)

 

 

(8,406

)

 

 

(13,009

)

Interest income (expense)

 

 

30

 

 

 

(1

)

 

 

29

 

 

 

(8

)

Other (expense) income, net

 

 

(44

)

 

 

2,759

 

 

 

(3

)

 

 

10,222

 

Change in fair value of common stock warrant liabilities

 

 

 

 

 

(498

)

 

 

 

 

 

(176

)

Issuance and offering costs

 

 

 

 

 

 

 

 

(27

)

 

 

(769

)

Net loss before income taxes

 

 

(3,797

)

 

 

(5,422

)

 

 

(8,407

)

 

 

(3,740

)

Income tax provision

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

 

(3,797

)

 

 

(5,422

)

 

 

(8,407

)

 

 

(3,740

)

Net loss attributable to non-controlling interest

 

 

(20

)

 

 

(161

)

 

 

(142

)

 

 

(538

)

Net loss attributable to common stockholders

 

$

(3,777

)

 

$

(5,261

)

 

$

(8,265

)

 

$

(3,202

)

Net loss per share attributable to common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.17

)

 

$

(0.24

)

 

$

(0.37

)

 

$

(0.15

)

Weighted-average number of shares used in per share
   calculations:

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

 

22,188,918

 

 

 

21,745,403

 

 

 

22,187,961

 

 

 

21,271,960

 

Other comprehensive loss, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustment

 

 

 

 

 

(12

)

 

 

 

 

 

(12

)

Other comprehensive loss

 

 

 

 

 

(12

)

 

 

 

 

 

(12

)

Comprehensive loss attributable to common stockholders

 

$

(3,777

)

 

$

(5,273

)

 

$

(8,265

)

 

$

(3,214

)

 

See accompanying notes to the unaudited condensed consolidated financial statements.

2


 

Arcadia Biosciences, Inc.

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)

(In thousands, except share data)

 

 

 

Common Stock

 

 

Additional
Paid-In

 

 

Accumulated

 

 

Non-
Controlling

 

 

Total
Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Interest

 

 

Equity

 

Balance at December 31, 2021

 

 

22,184,235

 

 

$

63

 

 

$

257,515

 

 

$

(226,485

)

 

$

103

 

 

$

31,196

 

Reclassification upon adoption of ASU 2020-06

 

 

 

 

 

 

 

$

19,390

 

 

$

(15,998

)

 

 

 

 

 

3,392

 

Issuance of shares related to employee stock
   purchase plan

 

 

4,683

 

 

 

 

 

 

4

 

 

 

 

 

 

 

 

 

4

 

Stock-based compensation

 

 

 

 

 

 

 

 

260

 

 

 

 

 

 

 

 

 

260

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(4,488

)

 

 

(122

)

 

 

(4,610

)

Balance at March 31, 2022

 

 

22,188,918

 

 

$

63

 

 

$

277,169

 

 

$

(246,971

)

 

$

(19

)

 

$

30,242

 

Stock-based compensation

 

 

 

 

 

 

 

 

323

 

 

 

 

 

 

 

 

 

323

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(3,777

)

 

 

(20

)

 

 

(3,797

)

Balance at June 30, 2022

 

 

22,188,918

 

 

$

63

 

 

$

277,492

 

 

$

(250,748

)

 

$

(39

)

 

$

26,768

 

 

 

 

 

 

 

Common Stock

 

 

Additional
Paid-In

 

 

Accumulated

 

 

Accumulated Other Comprehensive

 

 

Non-
Controlling

 

 

Total
Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Loss

 

 

Interest

 

 

Equity

 

Balance at December 31, 2020

 

 

13,450,861

 

 

$

54

 

 

$

239,496

 

 

$

(211,825

)

 

$

 

 

$

827

 

 

$

28,552

 

Issuance of shares related to the
   January 2021 PIPE

 

 

7,876,784

 

 

 

8

 

 

 

15,508

 

 

 

 

 

 

 

 

 

 

 

 

15,516

 

Offering costs related to the January 2021 PIPE

 

 

 

 

 

 

 

 

(2,084

)

 

 

 

 

 

 

 

 

 

 

 

(2,084

)

Issuance of placement agent warrants related to
   issuance of January 2021 PIPE

 

 

 

 

 

 

 

 

942

 

 

 

 

 

 

 

 

 

 

 

 

942

 

Issuance of shares related to employee stock
   purchase plan

 

 

8,604

 

 

 

 

 

 

21

 

 

 

 

 

 

 

 

 

 

 

 

21

 

Non-controlling interest capital contribution

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

750

 

 

 

750

 

Stock-based compensation

 

 

 

 

 

 

 

 

325

 

 

 

 

 

 

 

 

 

 

 

 

325

 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

2,058

 

 

 

 

 

 

(377

)

 

 

1,681

 

Balance at March 31, 2021

 

 

21,336,249

 

 

$

62

 

 

$

254,208

 

 

$

(209,767

)

 

 

 

 

$

1,200

 

 

$

45,703

 

Issuance of shares at closing of Arcadia Wellness acquisition

 

 

827,401

 

 

 

1

 

 

 

2,052

 

 

 

 

 

 

 

 

 

 

 

 

2,053

 

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(12

)

 

 

 

 

 

(12

)

Stock-based compensation

 

 

 

 

 

 

 

 

356

 

 

 

 

 

 

 

 

 

 

 

 

356

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(5,261

)

 

 

 

 

 

(161

)

 

 

(5,422

)

Balance at June 30, 2021

 

 

22,163,650

 

 

$

63

 

 

$

256,616

 

 

$

(215,028

)

 

$

(12

)

 

$

1,039

 

 

$

42,678

 

 

See accompanying notes to the unaudited condensed consolidated financial statements.

3


 

Arcadia Biosciences, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(In thousands)

 

 

 

Six Months Ended June 30,

 

 

 

 

2022

 

 

 

2021

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

Net loss

 

$

(8,407

)

 

$

(3,740

)

Adjustments to reconcile net loss to cash used in operating activities:

 

 

 

 

 

 

Change in fair value of common stock warrant liabilities

 

 

 

 

 

176

 

Change in fair value of contingent consideration

 

 

(70

)

 

 

(140

)

Issuance and offering costs

 

 

 

 

 

769

 

Depreciation

 

 

277

 

 

 

484

 

Amortization of intangible assets

 

 

26

 

 

 

48

 

Lease amortization

 

 

420

 

 

 

639

 

Impairment of intangible assets

 

 

72

 

 

 

 

(Gain) loss on disposal of property and equipment

 

 

(386

)

 

 

135

 

Stock-based compensation

 

 

583

 

 

 

681

 

Bad debt expense

 

 

37

 

 

 

 

Realized gain on corporate securities

 

 

 

 

 

(10,222

)

Impairment of property and equipment

 

 

346

 

 

 

210

 

Write-down of inventories

 

 

1,515

 

 

 

983

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

(2,471

)

 

 

259

 

Inventories

 

 

1,001

 

 

 

(633

)

Prepaid expenses and other current assets

 

 

(541

)

 

 

(938

)

Other noncurrent assets

 

 

15

 

 

 

(153

)

Accounts payable and accrued expenses

 

 

(247

)

 

 

1,083

 

Amounts due to related parties

 

 

19

 

 

 

(47

)

Unearned revenue

 

 

 

 

 

56

 

Other current liabilities

 

 

8

 

 

 

1

 

Other noncurrent liabilities

 

 

(1

)

 

 

(1

)

Operating lease payments

 

 

(446

)

 

 

(590

)

Net cash used in operating activities

 

 

(8,250

)

 

 

(10,940

)

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

Proceeds from sale of property and equipment

 

 

841

 

 

 

 

Purchases of property and equipment

 

 

(46

)

 

 

(713

)

Acquisitions, net of cash acquired

 

 

 

 

 

(4,250

)

Proceeds from sales and maturities of investments

 

 

 

 

 

21,845

 

Net cash provided by (used in) investing activities

 

 

795

 

 

 

16,882

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

Proceeds from issuance of common stock and warrants from
   January 2021 PIPE securities purchase agreement

 

 

 

 

 

25,147

 

Payments of offering costs relating to January 2021 PIPE
   securities purchase agreement

 

 

 

 

 

(1,912

)

Principal payments on debt

 

 

 

 

 

(2,019

)

Proceeds from ESPP purchases

 

 

4

 

 

 

27

 

Capital contributions received from non-controlling interest

 

 

 

 

 

750

 

Net cash provided by financing activities

 

 

4

 

 

 

21,993

 

Effects of foreign currency translation on cash and cash equivalents

 

 

 

 

 

(1

)

Net (decrease) increase in cash and cash equivalents

 

 

(7,451

)

 

 

27,934

 

Cash and cash equivalents — beginning of period

 

 

28,685

 

 

 

16,043

 

Cash and cash equivalents — end of period

 

$

21,234

 

 

$

43,977

 

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:

 

 

 

 

 

 

Cash paid for income taxes

 

$

 

 

$

1

 

Cash paid for interest

 

$

1

 

 

$

21

 

NONCASH INVESTING AND FINANCING ACTIVITIES:

 

 

 

 

 

 

Shares of common stock issued at closing of Arcadia Wellness transaction

 

$

 

 

$

2,053

 

Common stock warrant liabilities reclassified to equity upon adoption of ASU 2020-06

 

$

3,392

 

 

$

 

Common stock warrants issued to placement agent and included in offering
   costs related to January 2021 PIPE securities purchase agreement

 

$

 

 

$

942

 

Right of use assets obtained in exchange for new operating lease liabilities

 

$

 

 

$

913

 

Proceeds from sale of property and equipment in accounts receivable

 

$

51

 

 

$

 

Purchases of property and equipment included in accounts payable and accrued expenses

 

$

 

 

$

58

 

 

See accompanying notes to the unaudited condensed consolidated financial statements.

4


 

Arcadia Biosciences, Inc.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

1. Description of Business and Basis of Presentation

Organization

Arcadia Biosciences, Inc. (the "Company," "Arcadia" or "management"), was incorporated in Arizona in 2002 and maintains its headquarters in Davis, California, with additional facilities in American Falls, Idaho and Chatsworth, California. The Company was reincorporated in Delaware in March 2015.

The Company is a producer and marketer of innovative, plant-based health and wellness products. Its history as a leader in science-based approaches to developing high-value crop improvements, as well as nutritionally enhanced food ingredients and health and wellness products, has laid the foundation for its path forward. The Company used advanced breeding techniques to develop these proprietary innovations which are now being commercialized through the sales of seed and grain, as well as food ingredients and products. The acquisition of the businesses of Lief Holdings, LLC (“Lief”), EKO Holdings, LLC (“Eko”) and Live Zola, LLC (“Zola”) added bath and body care products, as well as coconut water, to the Company’s portfolio.

In May 2021, the Company’s wholly owned subsidiary Arcadia Wellness, LLC (“Arcadia Wellness” or “AW”, see Note 6), acquired the businesses of Eko, Lief, and Zola. The acquisition included consumer CBD brands like Soul Spring™, a CBD-infused botanical therapy brand in the natural category, Saavy Naturals™, a line of natural body care products and ProVault™, a CBD-infused sports performance formula made with natural ingredients, providing effective support and recovery for athletes. Also included in the purchase is Zola, a coconut water sourced exclusively with sustainably grown coconuts from Thailand. On July 8, 2022, the Company entered into an agreement to license Saavy Naturals™ to Radiance Beauty and Wellness, Inc. ("Radiance Beauty"). See Note 6 for a discussion of the licensing agreement.

In August 2019, the Company entered into a joint venture agreement with Legacy Ventures Hawaii, LLC (“Legacy,” see Note 8) to grow, extract, and sell hemp products. The partnership Archipelago Ventures Hawaii, LLC (“Archipelago”), combines the Company’s extensive genetic expertise and resources with Legacy’s experience in hemp extraction and sales. In October 2021, Arcadia and Legacy mutually agreed to wind down the cultivation activities of Archipelago, due to regulatory challenges and a saturated hemp market.

In February 2012, the Company formed Verdeca, which was equally owned with Bioceres. Verdeca was formed to develop and deregulate soybean varieties using both partners’ agricultural technologies. In November 2020, Arcadia sold its membership interest in Verdeca to Bioceres in a transaction in which Arcadia received cash, shares of Bioceres stock and a royalty stream of up to $10.0 million on sales of Haab 4 soybeans (“HB4”) soybean. An additional $2.0 million in cash is to be paid upon achievement by Verdeca of reaching commercial plantings of at least 200,000 hectares of HB4 or China approving the HB4 soybean trait for “food and feed”. During the quarter ended June 30, 2022, Bioceres received China's approval of the HB4 soybean trait and as a result, Arcadia recorded license revenue of $862,000 and a gain on sale of Verdeca of $1.1 million on the condensed consolidated statements of operations and comprehensive loss.

Basis of Presentation and Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial statements and are in the form prescribed by the Securities and Exchange Commission (the “SEC”) in instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial position, results of operations and cash flows for the periods indicated. All material intercompany accounts and transactions have been eliminated in consolidation. The accompanying unaudited condensed consolidated financial statements include the accounts of the Company, Arcadia Wellness, and Archipelago.

The Company uses a qualitative approach in assessing the consolidation requirement for variable interest entities ("VIEs"). This approach focuses on determining whether the Company has the power to direct the activities of the VIE that most significantly affect the VIE’s economic performance and whether the Company has the obligation to absorb losses, or the right to receive benefits, that could potentially be significant to the VIE.

5


 

For all periods presented, the Company has determined that it is the primary beneficiary of Archipelago, a joint venture, as it has a controlling interest in Archipelago. Accordingly, the Company consolidates Archipelago in the condensed consolidated financial statements after eliminating intercompany transactions. For consolidated joint ventures, the non-controlling partner’s share of the assets, liabilities and operations of the joint venture is included in non-controlling interests as equity of the Company. The non-controlling partner’s interest is generally computed as the joint venture partner’s ownership percentage of Archipelago. Net loss attributable to non-controlling interest of $20,000 and $142,000 is recorded as an adjustment to net loss to arrive at net loss attributable to common stockholders for the three and six months ended June 30, 2022, respectively. Net loss attributable to non-controlling interest for three and six months ended June 30, 2021 was $161,000 and $538,000, respectively. The non-controlling partner’s equity interests are presented as non-controlling interests on the condensed consolidated balance sheets.

The information included in these condensed consolidated financial statements and notes thereto should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations included herein and Management’s Discussion and Analysis of Financial Condition and Results of Operations and the condensed consolidated financial statements and notes thereto for the fiscal year ended December 31, 2021 included in the Company’s Annual Report on Form 10-K, filed with the SEC on March 31, 2022.

Liquidity, Capital Resources, and Going Concern

The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities during the normal course of business. Since inception, the Company has financed its operations primarily through equity and debt financings. As of June 30, 2022, the Company had an accumulated deficit of $250.7 million, and cash and cash equivalents of $21.2 million. For the six months ended June 30, 2022, the Company had a net loss of $8.4 million and net cash used in operations of $8.3 million. For the twelve months ended December 31, 2021, the Company had net losses of $16.1 million and net cash used in operations of $25.9 million.

With cash and cash equivalents of $21.2 million as of June 30, 2022, the Company believes that its existing cash and cash equivalents will not be sufficient to meet its anticipated cash requirements for at least the next 12 months from the issuance date of these financial statements, and thus raises substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

The Company may seek to raise additional funds through debt or equity financings. The Company may also consider entering into additional partner arrangements. The sale of additional equity would result in dilution to the Company’s stockholders. The incurrence of debt would result in debt service obligations, and the instruments governing such debt could provide for additional operating and financing covenants that would restrict operations. If the Company does require additional funds and is unable to secure adequate additional funding at terms agreeable to the Company, the Company may be forced to reduce spending, extend payment terms with suppliers, liquidate assets, or suspend or curtail planned development programs. Any of these actions could materially harm the business, results of operations and financial condition.

2. Recent Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. Additionally, the FASB issued ASU No. 2019-04, Codification Improvements to Topic 326 in April 2019 and ASU 2019-05, Financial Instruments — Credit Losses (Topic 326) — Targeted Transition Relief in May 2019. The amendments affect loans, debt securities, trade receivables, net investments in leases, off-balance-sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. In November 2019, the FASB issued ASU No. 2019-10, which defers the effective date of ASU No. 2016-13 for smaller reporting companies to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is currently evaluating the impact of the adoption of ASU No. 2016-13 on the condensed consolidated financial statements.

In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40). The FASB Board is issuing this Update to address issues identified as a result of the complexity associated with applying GAAP for certain financial instruments with characteristics of liabilities and equity. In addressing the complexity, the FASB Board focused on amending the guidance on convertible instruments and the guidance on the derivatives scope exception for contracts in an entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The amendments in this Update are effective for public business entities that meet the definition of a smaller reporting company, as defined by the SEC, for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company early adopted ASU No. 2020-06 on January 1, 2022, using the modified retrospective method. Prior to the adoption of ASU No. 2020-06, the Company had liability classified awards due to the existence of certain contingent cash payment feature. Upon adoption, these clauses no longer preclude equity classification. Under the modified retrospective method, the historical mark-to-market adjustments related to outstanding awards were reversed through retained earnings and the original carrying value of the awards were reclassified to additional paid-in capital. Adoption of the new standard resulted in an increase to accumulated deficit of $16.0 million, an increase to additional paid-in capital of $19.4 million, and a decrease to common stock warrant liabilities of $3.4 million, on the condensed consolidated balance sheets.

6


 

In May 2021, the FASB issued ASU No. 2021-04, Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity's Own Equity (Subtopic 815-40): Issuer's Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. The amendments in this Update clarify and reduce diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The amendments in this Update affect all entities that issue freestanding written call options that are classified in equity. The amendments in this Update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The Company adopted ASU No. 2021-04 on January 1, 2022 with an immaterial impact on the Company’s disclosures.

3. Inventory

Inventory costs are tracked on a lot-identified basis and are included as cost of revenues when sold. Inventories are stated at the lower of cost or net realizable value. The Company makes adjustments to inventory when conditions indicate that the net realizable value may be less than cost due to physical deterioration, obsolescence, changes in price levels, or other factors. Additional adjustments to inventory are made for excess and slow-moving inventory on hand that is not expected to be sold within a reasonable timeframe to reduce the carrying amount to its estimated net realizable value. The write-downs to inventory are included in cost of revenues and are based upon estimates about future demand from the Company’s customers and distributors and market conditions. The Company recorded write-downs of wheat, hemp seed, CBD oil and body care inventories of $1.1 million and $1.5 million during the three and six months ended June 30, 2022, respectively. Of inventories write-downs during the three months ended June 30, 2022, $394,000 is related to the Radiance Beauty licensing agreement discussed in Note 6. The Company recorded write-downs of wheat inventory, and hemp seed inventories of $823,000 and $983,000 during the three and six months ended June 30, 2021, respectively. If there are significant changes in demand and market conditions, substantial future write-downs of inventory may be required, which would materially increase the Company’s expenses in the period the write down is taken and materially affect the Company’s operating results.

Inventories, net consist of the following (in thousands):

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Raw materials

 

$

1,133

 

 

$

1,851

 

Goods in process

 

 

108

 

 

 

842

 

Finished goods

 

 

3,170

 

 

 

4,234

 

Inventories

 

$

4,411

 

 

$

6,927

 

 

4. Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Laboratory equipment

 

$

1,790

 

 

$

2,659

 

Software and computer equipment

 

 

576

 

 

 

548

 

Machinery and equipment

 

 

653

 

 

 

1,809

 

Furniture and fixtures

 

 

198

 

 

 

211

 

Vehicles

 

 

333

 

 

 

417

 

Leasehold improvements

 

 

2,223

 

 

 

2,306

 

Property and equipment, gross

 

 

5,773

 

 

 

7,950

 

Less: accumulated depreciation and amortization

 

 

(4,819

)

 

 

(5,659

)

Property and equipment, net

 

$

954

 

 

$

2,291

 

 

Depreciation expense was $277,000 and $484,000 for the six months ended June 30, 2022 and 2021, respectively.

As of June 30, 2022, and December 31, 2021, respectively, there was $10,000 and $267,000 of construction in progress included in property and equipment that had not been placed into service and was not subject to depreciation.

Property and equipment are considered assets held for sale when management approves and commits to a plan to dispose of a property or group of properties. The property and equipment held for sale prior to the sale date is separately presented, within current assets, on the condensed consolidated balance sheet as assets held for sale.

During the three and six months ended June 30, 2022, management initiated the sale of property and equipment related to the Davis laboratory and Archipelago, respectively. The Company completed the sale of a portion of such property and equipment with a gain on sale of property and equipment in the amount of $58,000 and $386,000 recorded on the condensed consolidated statements of operations and comprehensive loss during the three and six months ended June 30, 2022, respectively. The proceeds related to the sale

7


 

of property and equipment during the three and six months ended June 30, 2022 are $54,000 and $841,000, respectively. The Company had no sales of assets held for sale during the three and six months ended June 30, 2021. Property and equipment related to Archipelago, in the amount of $254,000, have been classified as assets held for sale, and are recorded at fair value as of June 30, 2022. The fair value has been estimated using publicly available prices for some of the assets, and business partners' estimates for assets with prices not readily available, due to the relatively small size of the industry in which they can be used.

During the three and six months ended June 30, 2022, the Company recorded write-downs of property and equipment of $320,000 related to the Radiance Beauty licensing agreement. See Note 6 for further discussion of the licensing agreement. During the three and six months ended June 30, 2021, the Company recorded a write-down of property and equipment related to Archipelago in the amount of $210,000, calculated through an asset recoverability test.

5. Investments and Fair Value Instruments

Investments

The investments are carried at fair value, based on quoted market prices or other readily available market information. Unrealized and realized gains and losses are recognized as other income in the condensed consolidated statements of operations and comprehensive loss.

The following tables summarize the amortized cost and fair value of the investment securities portfolio at June 30, 2022 and December 31, 2021.

 

(Dollars in thousands)

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Estimated
Fair Value

 

June 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

19,283

 

 

$

 

 

$

 

 

$

19,283

 

Total Assets at Fair Value

 

$

19,283

 

 

$

 

 

$

 

 

$

19,283

 

 

(Dollars in thousands)

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Estimated
Fair Value

 

December 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

26,842

 

 

$

 

 

$

 

 

$

26,842

 

Total Assets at Fair Value

 

$

26,842

 

 

$

 

 

$

 

 

$

26,842

 

 

The Company did not have any investment categories that were in a continuous unrealized loss position for more than twelve months as of June 30, 2022.

 

Fair Value Measurement

 

The fair value of the investment securities at June 30, 2022 were as follows:

 

 

 

Fair Value Measurements at June 30, 2022

 

(Dollars in thousands)

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets at Fair Value

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

19,283

 

 

$

 

 

$

 

 

$

19,283

 

Total Assets at Fair Value

 

$

19,283

 

 

$

 

 

$

 

 

$

19,283

 

 

The fair value of the investment securities at December 31, 2021 were as follows:

 

 

 

Fair Value Measurements at December 31, 2021

 

(Dollars in thousands)

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets at Fair Value

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

26,842

 

 

$

 

 

$

 

 

$

26,842

 

Total Assets at Fair Value

 

$

26,842

 

 

$

 

 

$

 

 

$

26,842

 

 

The Company uses the market approach technique to value its financial instruments and there were no changes in valuation techniques during 2022 or 2021. The Company’s financial instruments consist primarily of cash and cash equivalents, accounts receivable,

8


 

accounts payable, accrued liabilities, and notes payable. For accounts receivable, accounts payable, accrued liabilities, and notes payable the carrying amounts of these financial instruments as of June 30, 2022 and December 31, 2021 were considered representative of their fair values due to their short term to maturity or repayment. Cash equivalents are carried at cost, which approximates their fair value.

The Company’s Level 3 liabilities consist of a contingent liability resulting from the Anawah, Inc. ("Anawah") acquisition and a contingent liability resulting from the Industrial Seed Innovations ("ISI") acquisition, as described in Note 15. As of December 31, 2021 the Company also had common stock warrant liabilities related to the March 2018, the June 2019, the September 2019, and the January 2021 Offerings, described in Note 11, which were reclassified to additional paid-in capital upon adoption of ASU 2020-06, as of January 1, 2022. See Note 2 for details of the adoption of ASU 2020-06.

The contingent liability related to the Anawah acquisition was measured and recorded on a recurring basis as of June 30, 2022 and December 31, 2021, using unobservable inputs, namely the Company’s ability and intent to pursue certain specific products developed using technology acquired in the purchase. A significant deviation in the Company’s ability and/or intent to pursue the technology acquired in the purchase could result in a significantly lower (higher) fair value measurement. The contingent liability related to the ISI acquisition was measured and recorded on a recurring basis as of June 30, 2022 and December 31, 2021, using unobservable inputs, namely ISI’s forecasted revenue. A significant deviation in ISI’s forecasted revenue could result in a lower (higher) fair value measurement.

The following table sets forth the establishment of the Company’s Level 3 liabilities, as well as a summary of the changes in the fair value and other adjustments (in thousands):

 

 

 

 

 

(Dollars in thousands)

 

Common Stock
Warrant
Liability -
March
2018
Purchase
Agreement

 

 

Common
Stock
Warrant
Liability -
June
2019
Offering

 

 

Common
Stock
Warrant
Liability -
September
2019
Offering

 

 

Common
Stock
Warrant
Liability -
January 2021
Offering

 

 

Contingent
Liabilities

 

 

Total

 

Balance as of December 31, 2021

 

$

7

 

 

$

170

 

 

$

223

 

 

$

2,993

 

 

$

2,070

 

 

$

5,463

 

Reclassification upon adoption
    of ASU 2020-06

 

 

(7

)

 

 

(170

)

 

 

(223

)

 

 

(2,993

)

 

 

 

 

 

(3,392

)

Change in fair value of contingent
   consideration

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(70

)

 

 

(70

)

Balance as of June 30, 2022

 

$

 

 

$

 

 

$

 

 

$

 

 

$

2,000

 

 

$

2,000

 

 

During the three and six months ended June 30, 2022, the Company recorded aggregate impairment charges of $418,000, and during the three and six months ended June 30, 2021, the Company recorded aggregate impairment charges of $0 and $210,000, respectively, related to intangible assets and other long-lived assets. The Company has classified the fair value measurements as a Level 3 measurement in the fair value hierarchy because they involve significant unobservable inputs such as cash flow projections, discount rates and management assumptions.



Assets classified as held for sale are recorded at fair value as of June 30, 2022. The Company has classified the fair value measurements as a Level 3 measurement in the fair value hierarchy as the fair value has been estimated using publicly available prices for some of the assets, and business partners' estimates for assets with prices not readily available, due to the relatively small size of the industry in which they can be used.




 

 

9


 

6. Arcadia Wellness Acquisition

On May 17, 2021, the Company’s wholly owned subsidiary Arcadia Wellness, acquired the assets of Eko, Lief, and Zola. The acquisition included consumer brands of bath and body care products such as Soul Spring, the CBD-infused botanical therapy brand, Saavy Naturals, a line of natural body care products and ProVault, a CBD-infused sports performance formula. Also included in the purchase was Zola, a coconut water sourced from Thailand.

The acquisition was recorded as a business combination, in accordance with ASC 805. The purchase price consideration for the acquisition totaled an estimated $6.1 million, of which $4.0 million in cash and $2.1 million in the form of 827,401 shares of the Company’s common stock, was paid during the month of May 2021. The cash consideration paid for the acquisition was funded by cash on hand.

Acquisition costs are not included as components of consideration transferred and instead are accounted for as expenses in the period in which the costs are incurred. The Company incurred costs related to the Arcadia Wellness acquisition of approximately $850,000 included in selling, general and administrative expenses in the Company's consolidated statements of operations and comprehensive loss for the six months ended June 30, 2021.

The Company performed an allocation of purchase price as of the acquisition date based on management's estimates of fair value. The Company believes its estimates and assumptions are reasonable.

The following table presents the allocation of the purchase price of the assets acquired at fair value at the acquisition date:

 

 

 

Purchase Price
Allocation

 

Inventory

 

$

840

 

Prepaid and other current assets

 

 

62

 

Fixed assets

 

 

308

 

Deposits

 

 

82

 

Customer list

 

 

360

 

Trade names and trademarks

 

 

2,900

 

Formulations

 

 

260

 

Goodwill

 

 

1,240

 

Total consideration allocated

 

$

6,052

 

 

The former shareholders of Eko, Lief, and Zola remain responsible for their pre-acquisition liabilities. In connection with the acquisition, the Company entered into a lease agreement for the use of offices, production equipment acquired, and storage warehouses. The lease was effective on May 17, 2021 and has a term of 3 years.

For the period from January 1, 2022 to June 30, 2022, the Company recognized approximately $3.9 million of revenue and $1.5 million of net loss relating to Arcadia Wellness, which included charges related to the Radiance Beauty licensing agreement discussed below, as well as the amortization of acquired intangible assets.

For the period from May 17, 2021 to December 31, 2021, the Company recognized approximately $4.3 million of revenue and $7.5 million of net loss relating to Arcadia Wellness, which included charges for the amortization of acquired intangible assets.

Acquired intangible assets of $3.5 million include trade names and trademarks of $2.9 million (indefinite useful life), customer list of $360,000 (fifteen-year useful life) and formulations of $260,000 (ten-year useful life). For impairments related to the acquired intangible assets see Note 7.

The total weighted average amortization period for the acquired intangibles is 12.9 years.

The acquisition produced $1.2 million of goodwill, which was fully impaired during the year ended December 31, 2021, due to weakness in some of the newly acquired consumer product margins, combined with a volatile economic climate and higher than normal inflation. Goodwill arising from the Arcadia Wellness acquisition was not deductible for tax purposes.

On July 8, 2022, the Company entered into a licensing agreement with Radiance Beauty. Under the terms of the licensing agreement, Radiance Beauty was granted an exclusive, transferable, sublicensable, perpetual, worldwide license to use the Saavy Naturals™ mark and to modify, manufacture, distribute, market and sell related products. In addition, as part of the licensing agreement, Radiance Beauty will receive the remaining accounts receivables and inventory balances after July 31, 2022, certain equipment, as well as three months of salaries in the amount of $355,000 and rent, maintenance and utilities in the amount of $19,000. Radiance Beauty will sublease space from the Company and pay the Company a 4% royalty of gross sales of products beginning January 1, 2023. As of

10


 

June 30, 2022, accounts receivables and inventories of $21,000 and $394,000, respectively, were written down. In addition, property and equipment and intangible assets were written down by $320,000 and $72,000, respectively, as of June 30, 2022.

Supplemental Pro-Forma Results of Operations (Unaudited)

The following unaudited pro-forma condensed consolidated results of operations for the three and six months ended June 30, 2022 and 2021, have been prepared as if the acquisition of Arcadia Wellness had occurred on January 1, 2021 and includes adjustments for amortization of intangibles, and the addition to basic and diluted weighted average number of shares outstanding.

 

 

 

For the three months
ended June 30,

 

 

For the six months
ended June 30,

 

 

 

2022
(Pro forma)

 

 

2021
(Pro forma)

 

 

2022
(Pro forma)

 

 

2021
(Pro forma)

 

Total revenues

 

$

3,858

 

 

$

2,203

 

 

$

7,078

 

 

$

4,516

 

Net loss

 

 

(3,797

)

 

 

(5,409

)

 

 

(8,407

)

 

 

(5,193

)

Net loss attributable to common stockholders

 

$

(3,777

)

 

$

(5,248

)

 

$

(8,265

)

 

$

(4,655

)

Weighted average shares - Basic and diluted

 

 

22,188,918

 

 

 

22,159,103

 

 

 

22,187,961

 

 

 

21,478,810

 

Net loss per share attributable to common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.17

)

 

$

(0.24

)

 

$

(0.37

)

 

$

(0.22

)

 

7. Intangible assets, net

 

The Company’s intangible assets, net as of June 30, 2022, consist of the following:

 

 

 

June 30, 2022

 

 

December 31, 2021

 

 

 

Gross
Carrying
Amount (2)

 

 

Accumulated Amortization

 

 

Net Carrying
Amount

 

 

Gross
Carrying
Amount (1)

 

 

Accumulated Amortization

 

 

Net Carrying
Amount

 

Amortized intangible assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Intellectual property

 

$

254

 

 

$

130

 

 

$

124

 

 

$

258

 

 

$

107

 

 

$

151

 

Customer lists

 

 

64

 

 

 

30

 

 

 

34

 

 

 

71

 

 

 

26

 

 

 

45

 

Total amortizable intangible assets

 

$

318

 

 

$

160

 

 

$

158

 

 

$

329

 

 

$

133

 

 

$

196

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Indefinite-lived intangible assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Brands and trademarks

 

$

228

 

 

$

 

 

$

228

 

 

$

288

 

 

$

 

 

$

288

 

Total intangible asset, net

 

$

546

 

 

$

160

 

 

$

386

 

 

$

617

 

 

$

133

 

 

$

484

 

 

(1) The gross carrying amounts included in this table reflect the effects of the impairments of intangible assets recorded during the year ended December 31, 2021, when the Company estimated an overall decrease in the sales forecast for AW products, due to an inventory item rationalization, in addition to a decrease in the sales forecast of ISI seeds, related to the saturated hemp seed market. As a result, Arcadia performed a quantitative intangible assets impairment test. The Company used a discounted cash flow approach to develop the fair value of the acquired intellectual property, customer lists, brands and trademarks. As a result of this assessment, Arcadia recorded an impairment of intangible assets in the amount of $3.3 million in the condensed consolidated statements of operations and comprehensive loss for the year ended December 31, 2021.

(2) The Company recorded an impairment of intangible assets in the amount of $72,000 during the three and six months ended June 30, 2022 related to the Radiance Beauty licensing agreement.

Intellectual property and customer lists will be amortized based on their useful lives ranging between 4 and 15 years. As of June 30, 2022, future amortization of intellectual property and customer lists is as follows:

 

Year Ending December 31,

 

 

 

2022 (excluding the six months ended June 30, 2022)

 

$

26

 

2023

 

 

53

 

2024

 

 

53

 

2025

 

 

4

 

2026

 

 

4

 

Thereafter

 

 

18

 

Total

 

$

158

 

 

11


 

8. Consolidated Joint Venture

In 2019, the Company and Legacy Ventures Hawaii, LLC, a Nevada limited liability company (“Legacy”), formed Archipelago Ventures Hawaii, LLC, a Delaware limited liability company and entered into a Limited Liability Company Operating Agreement (the “Operating Agreement”). The Company and Legacy formed Archipelago to develop, extract and commercialize hemp-derived products from industrial hemp grown in Hawaii.

Pursuant to the Operating Agreement, a joint operating committee consisting of two individuals appointed by the Company and two individuals appointed by Legacy will manage Archipelago. As of June 30, 2022, the Company and Legacy hold 50.75% and 49.25% interests in Archipelago, respectively, and have made capital contributions to Archipelago of $3,108,000 and $3,016,000, respectively, as determined by the joint operating committee. The Operating Agreement includes indemnification rights, non-competition obligations, and certain rights and obligations in connection with the transfer of membership interests, including rights of first refusal.

The Company consolidates Archipelago in the condensed consolidated financial statements after eliminating intercompany transactions. Net loss attributable to non-controlling interest of $20,000 and $142,000 is recorded as an adjustment to net loss to arrive at net loss attributable to common stockholders for the three and six months ended June 30, 2022, respectively. Net loss attributable to non-controlling interest of $161,000 and $538,000 is recorded as an adjustment to net loss to arrive at net loss attributable to common stockholders for the three and six months ended June 30, 2021, respectively. Legacy’s equity interests are presented as non-controlling interests on the condensed consolidated balance sheets. Refer to Note 1 for basis of presentation.

In October 2021, Arcadia and Legacy mutually agreed to wind down the cultivation activities of Archipelago, due to regulatory challenges and a saturated hemp market.

9. Collaborative Arrangements

In August 2017, the Company entered into a collaborative arrangement for the research, development and commercialization of an improved wheat quality trait in North America. This collaborative arrangement is a contractual agreement with Corteva AgriScience (“Corteva”) and involves a joint operating activity where both Arcadia and Corteva are active participants in the activities of the collaboration. Arcadia and Corteva participate in the research and development, and Arcadia has the primary responsibility for the intellectual property strategy while Corteva will generally lead the marketing and commercialization efforts. Both parties are exposed to significant risks and rewards of the collaboration and the agreement includes both cost sharing and profit sharing. The activities are performed with no guarantee of either technological or commercial success.

The Company accounts for research and development (“R&D”) costs in accordance ASC 730, Research and Development, which states R&D costs must be charged to expense as incurred. Accordingly, internal R&D costs are expensed as incurred. Third-party R&D costs are expensed when the contracted work has been performed or as milestone results are achieved.

10. Leases

Operating Leases

As of June 30, 2022, the Company leases office space in Davis, CA, and Chatsworth, CA, as well as additional buildings, land and equipment. Leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these short-term leases on a straight-line basis. The Company subleases a portion of the Davis office lease to a third party. In May 2022, the Company terminated its lease for office space in Chesterfield, MO effective August 1, 2022. The original lease term was scheduled to expire in May 2024. As a result, the Company paid $47,000 in early termination fees during the three months ended June 30, 2022. During the six months ended June 30, 2022, the Company did not enter new leases. On July 1, 2022, the Company entered into an agreement to lease office space in Dallas, TX. As of June 30, 2022, this lease had not yet commenced.

Some leases (the Davis office, a warehouse, and a copy machine) include one or more options to renew, with renewal terms that can extend the lease term from one to six years. The exercise of lease renewal options is at the Company’s sole discretion.

The Company’s lease agreements do not contain any material variable lease payments, material residual value guarantees or material restrictive covenants. Leases consisted of the following (in thousands):

 

Leases

 

Classification

 

June 30, 2022

 

 

December 31, 2021

 

Assets

 

 

 

 

 

 

 

 

Operating lease assets

 

 Right of use asset

 

$

2,308

 

 

$

3,081

 

Total leased assets

 

 

 

$

2,308

 

 

$

3,081

 

Liabilities

 

 

 

 

 

 

 

 

Current - Operating

 

 Operating lease liability- current

 

$

994

 

 

$

1,074

 

Noncurrent - Operating

 

 Operating lease liability- noncurrent

 

 

1,500

 

 

 

2,220

 

Total leased liabilities

 

 

 

$

2,494

 

 

$

3,294

 

 

12


 

 

Lease Cost

 

Classification

 

For the Three
Months Ended
June 30, 2022

 

 

For the Three
Months Ended
June 30, 2021

 

 

For the Six
Months Ended
June 30, 2022

 

 

For the Six
Months Ended
June 30, 2021

 

Operating lease cost

 

 SG&A and R&D Expenses

 

$

268

 

 

$

347

 

 

$

544

 

 

$

636

 

Short term lease cost (1)

 

 R&D Expenses

 

 

8

 

 

 

(17

)

 

 

11

 

 

 

30

 

Short term lease cost

 

 SG&A Expenses

 

 

 

 

 

4

 

 

 

 

 

 

15

 

Sublease income (2)

 

 SG&A and R&D Expenses

 

 

(90

)

 

 

(19

)

 

 

(177

)

 

 

(33

)

Net lease cost

 

 

 

$

186

 

 

$

315

 

 

$

378

 

 

$

648

 

 

(1)
Short term lease cost consists of field trial lease agreements with a lease term of 12 months or less.
(2)
Sublease income is recorded as a reduction to lease expense.

 

Lease Term
and Discount Rate

 

June 30, 2022

 

 

December 31, 2021

 

Weighted-average remaining
   lease term (years)

 

 

2.3

 

 

 

2.7

 

Weighted-average discount rate

 

 

6.4

%

 

 

6.0

%

 

11. Equity Financing

Private Placements

In January 2021, the Company issued in a private placement offering (the “January 2021 Private Placement”) pursuant to a securities purchase agreement (“January 2021 Purchase Agreement”) (i) 7,876,784 shares of its common stock, and (ii) warrants to purchase up to 3,938,392 shares of common stock at an exercise price of $3.13 per share (the “January 2021 Warrants”) and raised total gross proceeds of $25.1 million. The January 2021 Warrants are exercisable at any time at the option of the holder and expire 5.5 years from the date of issuance. In connection with the January 2021 Private Placement, the Company granted to a placement agent warrants to purchase a total of 393,839 shares of Common Stock (the “January 2021 Placement Agent Warrants”) that have an exercise price per share equal to $3.99 and a term of 5.5 years from the date of issuance.

The common stock warrants are classified as a liability within Level 3 due to a contingent cash payment feature. The Company utilized a Black Scholes Merton model on January 28, 2021 with the following assumptions: volatility of 123.8 percent, stock price of $2.88 and risk-free rate of 0.5%. The estimated fair value of the common stock warrant liability was subsequently remeasured at December 31, 2021 with the changes recorded on the Company’s consolidated statements of operations and comprehensive loss.

The January 2021 Placement Agent Warrants were issued for services performed by the placement agent as part of the January 2021 Private Placement and were treated as offering costs. The value of the January 2021 Placement Agent Warrants was determined to be $942,000, calculated using a Black-Scholes Model. The Company incurred additional offering costs totaling $1.9 million that consist of direct incremental legal, advisory, accounting and filing fees relating to the January 2021 Private Placement. The offering costs, inclusive of the January 2021 Placement Agent Warrants, totaled $2.8 million and allocated to the common stock warrant liability and the common stock using their relative fair values. A total of $769,000 was allocated to the common stock warrant liability and expensed and the remaining $2.0 million was allocated to the common stock and offset to additional paid in capital.

In March 2018, the Company issued in a private placement offering (the “March 2018 Private Placement”) pursuant to a securities purchase agreement (“March 2018 Purchase Agreement”) (i) 300,752 shares of its common stock and (ii) warrants to purchase up to 300,752 shares of common stock at an initial exercise price equal to $45.75 (the “March 2018 Warrants”) and raised total gross proceeds of $10.0 million. The March 2018 Warrants are exercisable at any time at the option of the holder and expire five years from the date of issuance. In connection with the March 2018 Private Placement, the Company granted to a placement agent warrants to purchase a total of 15,038 shares of Common Stock (the “March 2018 Placement Agent Warrants”) that have an exercise price per share equal to $41.5625 and a term of five years from the date of issuance.

The number of shares of common stock and the number and exercise price of the March 2018 Warrants issued in the March 2018 Private Placement were subject to adjustments as provided in the March 2018 Purchase Agreement. Following the adjustments as provided in the March 2018 Purchase Agreement, the number of shares issued to the purchasers was 1,201,634, the total number of shares issuable upon exercise of the March 2018 Warrants was 1,282,832 and the per share exercise price of the March 2018 Warrants was $10.7258.

Registered Direct Offerings

On May 11, 2018, the Company filed a shelf Registration Statement on Form S-3 with the SEC which was declared effective on June 8, 2018 (“Shelf Registration Statement”). This shelf registration process allows the Company to sell any combination of common

13


 

stock, preferred stock, warrants and units consisting of such securities in one or more offerings from time to time having aggregate offering prices of up to $50 million. This registration statement may no longer be used after June 8, 2021, the three-year anniversary of its effective date.

In December 2020, the Company entered into a securities purchase agreement (the “December 2020 Purchase Agreement”) pursuant to which it sold (i) 2,618,658 registered shares of its common stock pursuant to the Shelf Registration Statement and (ii) unregistered warrants to purchase 2,618,658 shares of its common stock (the “December 2020 Warrants”) in a private placement, for total gross proceeds of $8.0 million (the “December 2020 Registered Direct Offering”). The December 2020 Registered Direct Offering closed on December 22, 2020. The December 2020 Warrants have an exercise price of $3.00 per share, became exercisable upon issuance and expire 5.5 years after the date of issuance. In connection with the December 2020 Registered Direct Offering, the Company granted to a placement agent warrants to purchase a total of 130,933 shares of common stock (“December 2020 Placement Agent Warrants”) that have an exercise price per share equal to $3.8188 and a term of five years.

In September 2019, the Company entered into a securities purchase agreement (the “September 2019 Purchase Agreement”) pursuant to which it sold (i) 1,318,828 registered shares of its common stock pursuant to the Shelf Registration Statement and (ii) unregistered warrants to purchase 659,414 shares of its common stock (the “September 2019 Warrants”) in a private placement, for total gross proceeds of $10.0 million (the “September 2019 Registered Direct Offering”). The September 2019 Registered Direct Offering closed on September 5, 2019. The September 2019 Warrants have an exercise price of $7.52 per share, became exercisable upon issuance and expire 5.5 years after the date of issuance. In connection with the September 2019 Registered Direct Offering, the Company granted to a placement agent warrants to purchase a total of 65,942 shares of common stock (“September 2019 Placement Agent Warrants”) that have an exercise price per share equal to $9.4781 and a term of five years.

In June 2019, the Company entered into a securities purchase agreement (the “June 2019 Purchase Agreement”) pursuant to which it sold (i) 1,489,575 registered shares of its common stock pursuant to the Shelf Registration Statement and (ii) unregistered warrants to purchase 1,489,575 shares of its common stock (the “June 2019 Warrants”) in a private placement, for total gross proceeds of $7.5 million (the “June 2019 Registered Direct Offering”). The June 2019 Registered Direct Offering closed on June 14, 2019. The June 2019 Warrants have an exercise price of $5.00 per share, became exercisable upon issuance and expire 5.5 years after the date of issuance. In connection with the June 2019 Registered Direct Offering, the Company granted to a placement agent warrants to purchase a total of 74,479 shares of common stock (“June 2019 Placement Agent Warrants”) that have an exercise price per share equal to $6.2938 and a term of five years.

14


 

In June 2018, the Company entered into a securities purchase agreement (the “June 2018 Purchase Agreement”) pursuant to which it sold (i) 1,392,345 registered shares of its common stock pursuant to the Shelf Registration Statement and (ii) unregistered warrants to purchase 1,392,345 shares of its common stock (the “June 2018 Warrants”) in a private placement, for total gross proceeds of $14.0 million (the “June 2018 Registered Direct Offering”). The June 2018 Registered Direct Offering closed on June 14, 2018. The June 2018 Warrants have an exercise price of $9.94 per share, became exercisable upon issuance and expire 5.5 years after the date of issuance. In connection with the June 2018 Registered Direct Offering, the Company granted to a placement agent warrants to purchase a total of 69,617 shares of common stock (“June 2018 Placement Agent Warrants”) that have an exercise price per share equal to $12.568 and a term of five years.

12. Warrants

The Company issued the following warrants to purchase shares of its common stock, which are outstanding as of June 30, 2022 or December 31, 2021, respectively. These warrants are exercisable any time at the option of the holder until their expiration date.

 

 

 

Issuance Date

 

Term

 

Exercise
Price Per
Share

 

 

Warrants
Exercised
during the
Year Ended
December 31,
2021

 

 

Warrants
Outstanding at
December 31,
2021

 

 

Warrants
Exercised
during the
Six
Months Ended
June 30,
2022

 

 

Warrants
Outstanding at
June 30,
2022

 

January 2021 Placement Agent Warrants

 

January 2021

 

5.5 years

 

$

3.99

 

 

 

 

 

 

393,839

 

 

 

 

 

 

393,839

 

January 2021 Service and Performance Warrants (1)

 

January 2021

 

2 years

 

$

3.08

 

 

 

 

 

 

7,500

 

 

 

 

 

 

7,500

 

December 2020 Warrants

 

December 2020

 

5.5 years

 

$

3.00

 

 

 

 

 

 

2,618,658

 

 

 

 

 

 

2,618,658

 

December 2020 Placement Agent Warrants

 

December 2020

 

5 years

 

$

3.82

 

 

 

 

 

 

130,933

 

 

 

 

 

 

130,933

 

July 2020 Warrants

 

July 2020

 

5.5 years

 

$

3.85

 

 

 

 

 

 

641,416

 

 

 

 

 

 

641,416

 

July 2020 Placement Agent Warrants

 

July 2020

 

5.5 years

 

$

4.97

 

 

 

 

 

 

32,071

 

 

 

 

 

 

32,071

 

May 2020 Warrants

 

May 2020

 

5 years

 

$

4.78

 

 

 

 

 

 

1,392,345

 

 

 

 

 

 

1,392,345

 

May 2020 Placement Agent Warrants

 

May 2020

 

5 years

 

$

6.13

 

 

 

 

 

 

69,617

 

 

 

 

 

 

69,617

 

March 2020 Service and Performance Warrants (1)

 

March 2020

 

3 years

 

$

2.50

 

 

 

 

 

 

18,350

 

 

 

 

 

 

18,350

 

February 12, 2020 Service and Performance Warrants (1)(3)

 

February 2020

 

2 years

 

$

4.71

 

 

 

 

 

 

150,000

 

 

 

 

 

 

 

February 3, 2020 Service and Performance Warrants (1)(3)

 

February 2020

 

2 years

 

$

4.91

 

 

 

 

 

 

10,000

 

 

 

 

 

 

 

September 2019 Placement Agent Warrants

 

September 2019

 

5 years

 

$

9.48

 

 

 

 

 

 

65,942

 

 

 

 

 

 

65,942

 

June 2019 Placement Agent Warrants

 

June 2019

 

5 years

 

$

6.29

 

 

 

 

 

 

74,479

 

 

 

 

 

 

74,479

 

April 2019 Service and Performance Warrants (1)

 

April 2019

 

5 years

 

$

6.18

 

 

 

 

 

 

145,154

 

 

 

 

 

 

145,154

 

June 2018 Placement Agent Warrants

 

June 2018

 

5 years

 

$

12.57

 

 

 

 

 

 

69,617

 

 

 

 

 

 

69,617

 

March 2018 Placement Agent Warrants

 

March 2018

 

5 years

 

$

41.56

 

 

 

 

 

 

15,038

 

 

 

 

 

 

15,038

 

January 2021 Warrants (2)

 

January 2021

 

5.5 years

 

$

3.13

 

 

 

 

 

 

3,938,392

 

 

 

 

 

 

3,938,392

 

September 2019 Warrants (2)

 

September 2019

 

5.5 years

 

$

7.52

 

 

 

 

 

 

659,414

 

 

 

 

 

 

659,414

 

June 2019 Warrants (2)

 

June 2019

 

5.5 years

 

$

5.00

 

 

 

 

 

 

435,830

 

 

 

 

 

 

435,830

 

June 2018 Warrants (2)

 

June 2018

 

5.5 years

 

$

9.94

 

 

 

 

 

 

 

 

 

 

 

 

 

March 2018 Warrants (2)

 

March 2018

 

5 years

 

$

10.73

 

 

 

 

 

 

641,416

 

 

 

 

 

 

641,416

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

11,510,011

 

 

 

 

 

 

11,350,011

 

 

(1) The Company issued service and performance warrants (“Service and Performance Warrants”) in connection with professional services agreements with non-affiliated third party entities.

(2) Certain warrants contain a contingent cash payment feature and therefore were accounted for as a liability at the date of issuance and were adjusted to fair value at each balance sheet date. Upon adoption of ASU No. 2020-06 on January 1, 2022, all of the common stock warrant liabilities have been reclassified to equity classified common stock warrants, due to the elimination of the contingent cash payments as criteria for liability classification.

(3) These warrants expired in February 2022.

15


 

13. Stock-Based Compensation and Employee Stock Purchase Program

Stock Incentive Plans

The Company has two equity incentive plans: the 2006 Stock Plan (“2006 Plan”) and the 2015 Omnibus Equity Incentive Plan (“2015 Plan”).

In 2006, the Company adopted the 2006 Plan, which provided for the granting of stock options to executives, employees, and other service providers under terms and provisions established by the Board of Directors. The Company granted non-statutory stock options (“NSOs”) under the 2006 Plan until May 2015, when it was terminated as to future awards, although it continues to govern the terms of options that remain outstanding and were issued under the 2006 Plan. The 2015 Plan became effective upon the Company’s IPO in May 2015 and all shares that were reserved, but not issued, under the 2006 Plan were assumed by the 2015 Plan. Upon effectiveness, the 2015 Plan had 154,387 shares of common stock reserved for future issuance, which included 10,637 that were transferred to and assumed by the 2015 Plan. The 2015 Plan provides for automatic annual increases in shares available for grant. In addition, shares subject to awards under the 2006 Plan that are forfeited or canceled will be added to the 2015 Plan. The 2015 Plan provides for the grant of incentive stock options (“ISOs”), NSOs, restricted stock awards, stock units, stock appreciation rights, and other forms of equity compensation, all of which may be granted to employees, officers, non-employee directors, and consultants. The exercise price for ISOs and NSOs will be granted at a price per share not less than the fair value of our common stock at the date of grant. Options granted generally vest over a four-year period; however, there might be alternative vesting schedules, as approved by the Board. Options granted, once vested, are generally exercisable for up to 10 years, after grant to the extent vested.

In June 2019, the shareholders approved an amendment to the Company’s 2015 Plan for a one-time increase to the number of shares of common stock that may be issued under the 2015 Plan by 120,000 shares. On May 17, 2021, upon completion of the Arcadia Wellness transaction, the Company granted 248,000 inducement stock option pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. On May 28, 2021, the Company filed a registration statement on Form S-8 to register the issuance of shares upon exercise of these inducement stock options. On February 2, 2022, Stanley Jacot, Jr. was hired as the new president and chief executive officer of the Company. The Company granted Mr. Jacot an inducement stock option to purchase 316,108 shares of the Company’s common stock pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. The Company has not filed a registration statement on Form S-8 to register the issuance of shares upon exercise of this inducement stock option. The inducement options grants have been issued outside of the 2015 Plan, but are subject to the terms and conditions of the 2015 Plan. As of June 30, 2022, a total of 2,484,005 shares of common stock were reserved for issuance under the 2015 Plan, of which 584,777 shares of common stock are available for future grant. As of June 30, 2022, a total of 7,813 and 1,899,228 options are outstanding under the 2006 and 2015 Plans, respectively. As of December 31, 2021, a total of 8,240 and 1,345,955 options are outstanding under the 2006 and 2015 Plans, respectively. As of June 30, 2022 a total of 376,608 inducement options are outstanding.

The following is a summary of stock option information and weighted average exercise prices under the Company’s stock incentive plans (in thousands, except share data and price per share):

 

 

 

Shares
Subject to
Outstanding
Options

 

 

Weighted-
Average
Exercise
Price Per
Share

 

 

Aggregate
Intrinsic
Value

 

Outstanding — Balance at December 31, 2021

 

 

1,422,195

 

 

$

5.28

 

 

$

 

Options granted

 

 

1,030,822

 

 

 

1.16

 

 

 

 

Options exercised

 

 

 

 

 

 

 

 

 

Options forfeited

 

 

(130,263

)

 

 

2.86

 

 

 

 

Options expired

 

 

(39,105

)

 

 

6.21

 

 

 

 

Outstanding — Balance at June 30, 2022

 

 

2,283,649

 

 

$

3.54

 

 

$

31,230

 

Vested and expected to vest — June 30, 2022

 

 

2,011,343

 

 

$

3.82

 

 

$

24,452

 

Exercisable — June 30, 2022

 

 

862,726

 

 

$

6.76

 

 

$

 

 

Aggregate intrinsic value represents the difference between the exercise price of the options and the estimated fair value of the Company’s common stock determined by our Board of Directors for each of the respective periods. The intrinsic value of options exercised was $0 for both quarters ended June 30, 2022 and 2021.

As of June 30, 2022, there was $1.4 million of unrecognized compensation cost related to unvested stock-based compensation grants that will be recognized over the weighted-average remaining recognition period of 2.8 years.

On December 14, 2021, Matt Plavan provided notice to the Company of his resignation as Arcadia’s president, chief executive officer and director, effective as of December 31, 2021. On December 19, 2021, Arcadia and Mr. Plavan entered into a Separation and Release Agreement (the “Separation Agreement”) which provided that the vesting of all unvested options previously issued to Mr. Plavan accelerated pursuant to the terms of the Separation Agreement. In addition, the Separation Agreement extended the post-termination exercise period of the accelerated options from 90 days to up to two and one-half years. The stock compensation expense

16


 

related to the modification of Mr. Plavan’s stock options was $154,000 and it was recognized in selling, general and administrative expenses during the year ended December 31, 2021.

In determining the fair value of the stock-based awards, the Company uses the Black-Scholes option-pricing model and assumptions discussed below. Each of these inputs is subjective and generally requires significant judgment to determine.

Expected Term—The expected term is the estimated period of time outstanding for stock options granted and was estimated based on a simplified method allowed by the SEC, and defines the term as the average of the contractual term of the options and the weighted-average vesting period for all open employee awards.

Expected Volatility—The historical volatility data was computed using the daily closing prices for the Company’s shares during the equivalent period of the calculated expected term of the stock-based awards.

Risk-Free Interest Rate—The risk-free interest rate is based on the interest rate of U.S. Treasuries of comparable maturities on the date the options were granted.

Expected Dividend—The expected dividend yield is based on the Company’s expectation of future dividend payouts to common stockholders.

The fair value of stock option awards was estimated at the date of grant using a Black-Scholes option-pricing model with the following weighted-average assumption:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Expected term (years)

 

 

6.85

 

 

 

6.84

 

 

 

6.61

 

 

 

6.37

 

Expected volatility

 

 

123

%

 

 

122

%

 

 

122

%

 

 

122

%

Risk-free interest rate

 

 

2.85

%

 

 

1.06

%

 

 

2.48

%

 

 

0.81

%

Dividend yield

 

 

 

 

 

 

 

 

 

 

 

 

 

The Company recognized $323,000 and $583,000 of compensation expense for stock options awards for the three and six months ended June 30, 2022, respectively. The Company recognized $356,000 and $681,000 of compensation expense for stock options awards for the three and six months ended June 30, 2021, respectively.

Employee Stock Purchase Plan

The Company’s 2015 Employee Stock Purchase Plan (“ESPP”) became effective on May 14, 2015. The ESPP allows eligible employees to purchase shares of the Company’s common stock at a discount of up to 15% of their eligible compensation through payroll deductions, subject to any plan limitations. After the first offering period, which began on May 14, 2015 and ended on February 1, 2016, the ESPP provides for six-month offering periods, and at the end of each offering period, employees are able to purchase shares at 85% of the lower of the fair market value of the Company’s common stock on the first trading day of the offering period or on the last day of the offering period. As of June 30, 2022, the number of shares of common stock reserved for future issuance under the ESPP is 128,914. The ESPP provides for automatic annual increases in the shares available for purchase beginning on January 1, 2016. As of June 30, 2022, 54,928 shares had been issued under the ESPP. The Company recorded $1,000 and $2,000 of ESPP related compensation expense for the three and six months ended June 30, 2022, respectively. The Company recorded $8,000 and $13,000 of ESPP related compensation expense for the three and six months ended June 30, 2021, respectively.

14. Income Taxes

Income tax expense during interim periods is based on applying an estimated annual effective income tax rate to year-to-date income, plus any significant unusual or infrequently occurring items that are recorded in the interim period. The computation of the annual estimated effective tax rate at each interim period requires certain estimates and significant judgment including, but not limited to, the expected operating income for the year, projections of the proportion of income earned and taxed in various jurisdictions, permanent and temporary differences, and the likelihood of recovering deferred tax assets generated in the current year. The accounting estimates used to compute the provision for income taxes may change as new events occur, more experience is obtained, additional information becomes known, or as the tax environment changes.

The interim financial statement provision for income taxes is different from the amounts computed by applying the United States federal statutory income tax rate of 21%. The Company’s effective tax rate was 0.00% for each of the three and six months ended June 30, 2022, and was -0.01% for each of the three and six months ended June 30, 2021. The difference between the effective tax rate and the federal statutory rate of 21% was primarily due to the full valuation allowance recorded on the Company’s net deferred tax assets.

17


 

The Company experienced an ownership change under IRC Section 382 as a result of the common shares issued in connection with the January 2021 Offering. This ownership change limited the Company’s ability to utilize its net operating loss carryforwards prior to expiration and certain net operating loss carryforwards were written off as a result. The Company is currently conducting additional analysis regarding the valuation of the Company at the time of the ownership change to assess what, if any, portion of the limitation may be reversed. Any adjustment to the amount of limitation will not impact the deferred tax asset balance due to the full valuation allowance.

During the six months ended June 30, 2022, there were no material changes to the Company’s uncertain tax positions.

15. Commitments and Contingencies

Leases

The Company leases office and laboratory space, grain storage bins, warehouse space, farmland, and equipment under operating lease agreements having initial lease terms ranging from one to five years, including certain renewal options available to the Company at market rates. The Company also leases land for field trials on a short-term basis. See Note 10.

Legal Matters

From time to time, in the ordinary course of business, the Company may become involved in certain legal proceedings. The Company currently is not a party to any material litigation or other material legal proceedings.

Contingent Liability Related to the Anawah Acquisition

In June 2005, the Company completed its agreement and plan of merger and reorganization with Anawah, to purchase the Anawah’s food and agricultural research company through a non-cash stock purchase. Pursuant to the merger with Anawah, and in accordance with the ASC 805 - Business Combinations, the Company incurred a contingent liability not to exceed $5.0 million. This liability represents amounts to be paid to Anawah’s previous stockholders for cash collected on revenue recognized by the Company upon commercial sale of certain specific products developed using technology acquired in the purchase. As of December 31, 2010, the Company ceased activities relating to three of the six Anawah product programs thus, the contingent liability was reduced to $3.0 million. During the third quarter of 2016, one of the programs previously accrued for was abandoned and another program previously abandoned was reactivated. During the fourth quarter of 2019, the Company determined that one of the technologies was no longer active and decided to abandon the previously accrued program. As of June 30, 2022, the Company continues to pursue a total of two development programs using this technology and believes that the contingent liability is probable. As a result, $2.0 million remains on the condensed consolidated balance sheet as an other noncurrent liability.

Contingent Liability Related to the ISI Acquisition

In August 2020, the Company acquired by merger ISI. A portion of the purchase price consideration for the acquisition in the amount of $280,000 will be recognized in two annual installments, each of up to 132,626 shares of the Company’s common stock, subject to the achievement of revenue milestones in 2021 and 2022. The contingent consideration was measured and recorded at fair value. As a result of a remeasurement of the contingent consideration, we recorded a decrease to the related liability of $31,000 and $140,000 during the quarters ended March 31, 2022 and 2021, respectively. During the quarter ended June 30, 2022, the remaining contingent liability of $39,000 was written-down to $0 as the probability of achievement of the 2022 revenue milestone is remote.

Contracts

The Company has entered into contract research agreements with unrelated parties that require the Company to pay certain funding commitments. The initial terms of these agreements range from one to three years in duration and in certain cases are cancelable.

The Company licenses certain technologies via executed agreements (“In-Licensing Agreements”) that are used to develop and advance the Company’s own technologies. The Company has entered into various In-Licensing Agreements with related and unrelated parties that require the Company to pay certain license fees, royalties, and/or milestone fees. In addition, certain royalty payments ranging from 2% to 15% of net revenue amounts as defined in the In-Licensing Agreements are or will be due.

The Company could be adversely affected by certain actions by the government as it relates to government contract revenue received in prior years. Government agencies, such as the Defense Contract Audit Agency routinely audit and investigate government contractors. These agencies review a contractor’s performance under its agreements; cost structure; and compliance with applicable laws, regulations and standards. The agencies also review the adequacy of, and a contractor’s compliance with, its internal control systems and policies, including the contractor’s purchasing, property, estimating, compensation and management information systems. While the Company’s management anticipates no adverse result from an audit, should any costs be found to be improperly allocated to a government agreement, such costs will not be reimbursed, or if already reimbursed, may need to be refunded. If an audit uncovers improper or illegal activities, civil and criminal penalties and administrative sanctions, including termination of contracts, forfeiture of profits, suspension of payments or fines, and suspension or prohibition from doing business with the government could occur. In

18


 

addition, serious reputational harm or significant adverse financial effects could occur if allegations of impropriety were made against the Company. There currently are routine audits in process relating to government grant revenues.

16. Net Loss per Share

Basic net loss per share is calculated by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period and excludes any dilutive effects of stock-based awards and warrants. Diluted net loss per share attributable to common stockholders is computed giving effect to all potentially dilutive common shares, including common stock issuable upon exercise of stock options and warrants. As the Company had net losses for the three and six months ended June 30, 2022 and 2021, all potentially dilutive common shares were determined to be anti-dilutive.


Securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in shares):

 

 

 

For the Three Months Ended June 30,

 

 

For the Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Options to purchase common stock

 

 

2,283,649

 

 

 

1,711,145

 

 

 

2,283,649

 

 

 

1,711,145

 

Warrants to purchase common stock

 

 

11,350,011

 

 

 

11,540,011

 

 

 

11,350,011

 

 

 

11,540,011

 

Total

 

 

13,633,660

 

 

 

13,251,156

 

 

 

13,633,660

 

 

 

13,251,156

 

 

17. Related-Party Transactions

The Company’s related parties include Moral Compass Corporation (“MCC”) and the John Sperling Foundation (“JSF”). The rights to the intellectual property owned by Blue Horse Labs, Inc. (“BHL”) were assigned to its sole shareholder, the John Sperling Revocable Trust (“JSRT”) due to BHL’s dissolution and then subsequently to the JSF. The JSF is deemed a related party of the Company because MCC, the Company’s largest stockholder, and the JSF share common officers and directors.

JSF receives a single digit royalty from the Company when revenue has been collected on product sales or for license payments from third parties that involve certain intellectual property developed under research funding originally from BHL. Royalty fees due to JSF were $83,000 and $64,000 as of June 30, 2022 and December 31, 2021, respectively, and are included in the condensed consolidated balance sheets as amounts due to related parties.

During the six months ended June 30, 2021, the Company leased land on the island of Molokai, Hawaii from an entity owned by Kevin Comcowich, the Chair of the Company’s Board of Directors, and his wife. The Company used to grow hemp on this land to support the operations of its joint venture Archipelago Ventures Hawaii, until the expiration of the lease in February 2022. The original lease was executed in February 2019, covered 10 acres of land, had a term of two years and provided for rent payments of $1,200 per acre per year. In March and April 2020, the Company entered into two lease amendments for two additional 10-acre parcels and two additional 15-acre parcels, at the same lease rate of $1,200 per acre per year, and with a term of two years. The Company made lease payments in the amount of $0 for each of the three and six months ended June 30, 2022, and made lease payments in the amount of $6,000 and $42,000 during the three and six months ended June 30, 2021, respectively.

18. Subsequent Events

Saavy Naturals™

On July 8, 2022, the Company entered an agreement to license Saavy Naturals™ to Radiance Beauty & Wellness, Inc. Please refer to a discussion of the agreement in Note 6.

19


 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Special Note Regarding Forward-Looking Statements

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes to those statements included herein. In addition to historical financial information, this report contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those discussed in the forward-looking statements. The statements contained in this report that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. Forward-looking statements are often identified by the use of words such as, but not limited to, “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “project,” “seek,” “should,” “strategy,” “target,” “will,” “would” and similar expressions or variations intended to identify forward-looking statements. These statements are based on the beliefs and assumptions of our management based on information currently available to management. Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed in the section titled “Risk Factors” included in the most recent Annual Report on Form 10-K filed by the Company. Furthermore, such forward-looking statements speak only as of the date of this report. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.

Solely for convenience, the trademarks, service marks and trade names referred to in this report may appear without the ®, TM, or SM symbols, but such references do not constitute a waiver of any rights that might be associated with the respective trademarks, service marks, or trade names.

Overview

We are a producer and marketer of innovative, plant-based health and wellness products. Our history as a leader in science-based approaches to developing high value crop improvements, primarily in wheat, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications, has laid the foundation for our path forward. We have used non-genetically modified (“non-GMO”) advanced breeding techniques to develop these proprietary innovations which we are now commercializing through the sales of seed and grain, food ingredients and products, hemp extracts, trait licensing and royalty agreements. The acquisition of the assets of Lief Holdings, LLC (“Lief”), EKO Holdings, LLC (“EKO”) and Live Zola, LLC (“Zola”) added bath and body care products, CBD consumer products, as well as coconut water, to our portfolio of products.

Our commercial strategy is to satisfy consumer nutrition, health and wellness demands with the superior functional benefits our crops deliver directly from the farm, enabling us to share premium economics throughout the ag-food supply chain and to build a world-class estate of high value traits and varieties. The acquisition of the Lief, EKO and Zola brands allows us to broaden our reach within the health and wellness sector.

It is also estimated by the U.S. Department of Agriculture (“USDA”), that approximately one-fifth of the FDA recommended calories consumed by people in the US are from wheat. Therefore, the market opportunity for nutritional improvements in wheat are significant not only because the wheat market itself is vast, but also because of the “share of stomach” wheat represents. Considering that most people today are not getting enough fiber or protein in their daily diets, the superior nutrient density of our non-GMO GoodWheat™ (“GoodWheat”) technology can improve the dietary intake of average consumers, by increasing their fiber and protein consumption without changing the way they eat. We believe this proprietary advantage gives GoodWheat the potential to become a global standard in wheat.

Our Growth Strategy

We believe there are significant opportunities to grow our business by executing the following elements of our strategy:

Accelerate the monetization of our GoodWheat™ wheat trait portfolio. Our proprietary IP with multiple non-GMO wheat traits have clear functional benefits, and we will continue to build partnerships across the wheat value chain. We will continue to invest in acquisition, development and retention of the requisite management and industry experience and production and logistics capacity to fully participate in, and control, the route to market for our high value food ingredients.
Commercialize and Scale our Arcadia Wellness consumer brands through retail and e-commerce expansion. We plan to expand distribution of our core consumer brands through mass market retailers, grocery store chains, and other specialty nutrition stores, as well as through e-commerce. These brands can penetrate large and growing categories through high-value, differentiated benefits, with the ability to scale and generate attractive margins. We will continue to build our commercialization and scaling expertise, refine go-to-market strategies and invest in effective brand-building.

20


 

Evaluate acquisitive growth opportunities. We intend to evaluate potential acquisitions representing vertical integration opportunities with multiple benefits to Arcadia’s growth plans. These could include integrating further into our supply chains to enhance margin capture, as well as speed to market new product innovations and food formulations.

Arcadia Wellness, LLC

In May 2021, our wholly-owned subsidiary Arcadia Wellness, LLC, acquired the assets of Eko, Lief, and Zola. We intend for Arcadia Wellness, LLC, to house all of Arcadia Biosciences consumer goods businesses, including core brands GoodWheat, Zola Coconut Water and ProVault Topical Pain Relief, as well as non-core brand SoulSpring Body Care. The core brands will be the focus for investment and expansion.

Our Product Portfolio

GoodWheat™ Consumer Products

The GoodWheat brand is a portfolio of non-GMO wheat-based consumer products that simplifies food ingredient formulations for consumers that are demanding “clean labeling” in their foods, and that are willing to pay a higher retail price for products made with ingredients they recognize. Because GoodWheat increases the nutrient density directly in the primary grains and oils, it provides the mechanism for food formulation simplification naturally and cost effectively to meet evolving consumer demands.

The brand launch is a key element of the company’s go-to-market strategy to achieve greater value for its innovations by participating in downstream consumer revenue opportunities. We designed the brand to make an immediate connection with consumers that products made with GoodWheat meet their demands for healthier wheat options that also taste great.

In June 2022, we launched our GoodWheat pasta available in five varieties including penne, spaghetti, fettuccine, elbows and rotini, in select retailers nationwide. Our pasta products utilizes our GoodWheat grain as the sole ingredient, providing 4X the fiber of traditional pasta and 9g protein per serving without sacrificing taste. In fact, our research shows taste parity to leading pasta brands, which is unique in the growing better-for-you pasta segment. In addition, GoodWheat is the only better-for-you pasta brand made from one simple ingredient, matching consumers’ preference for cleaner labels. Additional categories of products are slated for launch in 2023.

Zola Coconut Water

We believe that natural hydration and the power of plant-based ingredients are the keys to unlock your inspiration from within, and we are proud to make delicious plant-powered beverages that provide the energy and focus you need to crush your day. From the coconut groves of Thailand, we bring you great tasting coconut water and are proud of our long-lasting relationships with partners around the world who are essential to the quality of our products.

ProVault Topical Pain Relief

ProVault’s proprietary THC-Free, CBD-infused blend of natural ingredients and fast-acting cooling agents are designed to safely and effectively relieve muscle and joint pain and soothe your skin. Our products are third-party tested for potency and purity from pesticides, fungicides, microbials and heavy metals. Our topical pain relievers are formulated to address performance concerns from everyday pain to skin protection. So whether you’re a true competitor, a weekend warrior or simply maintaining an active lifestyle, you can count on ProVault to help keep you in the game. We believe what you put on your body is just as important as what you put in your body.

SoulSpring Body Care

Inspired by nature’s ancient remedies and crafted with care, our SoulSpring products strive to help rejuvenate and renew your mind, body, and soul. Our CBD-infused blends of natural ingredients provide a more thoughtful, holistic approach to internal balance and overall well-being. SoulSpring premium, broad spectrum CBD is extracted from naturally-grown hemp and blended with nourishing botanicals and minerals. Our CBD is purity-tested, non-pshychoactive and non-intoxicating. Our passion for wellness means thoughtfully choosing honest, natural ingredients - inspired by ancient remedies and carefully selected for their healing properties. We then mindfully blend these ingredients to retain their inner essence and natural properties.

21


 

Components of Our Statements of Operations Data

Revenues

We derive our revenues primarily from product sales and royalties.

Product revenues

Our product revenues consist primarily of sales of Arcadia Wellness products, GoodWheat grain and pasta, and GLA products. We recognize revenue from product sales when control of the product is transferred to third-party distributors and manufacturers, collectively “our customers,” which generally occurs upon delivery. Our revenues fluctuate depending on the timing of shipments of product to our customers and are reported net of estimated chargebacks, returns and losses.

Royalty revenues

Our royalty revenues consist of amounts earned from the sale of commercial products that incorporate our traits by third parties. Our royalty revenues consist of a minimum annual royalty, offset by amounts earned from the sale of products. We recognize the minimum annual royalty on a straight-line basis over the year, and we recognize royalty revenue resulting from the sale of products when the third parties transfer control of the product to their customers, which generally occurs upon shipment. Our royalty revenues can fluctuate depending on the timing of shipments of product by the third parties to their customers.

License revenues

Our license revenues consist of up-front, nonrefundable license fees, annual license fees, and subsequent milestone payments that we receive under our license agreements. Revenue generated from up-front license fees are recognized upon execution of the agreement. We recognize annual license fees when it is probable that a material reversal will not occur.

Milestone fees are variable consideration that is initially constrained and recognized only when it is probable that such amounts would not be reversed. The Company assesses when achievement of milestones are probable in order to determine the timing of revenue recognition for milestone fees. Milestones typically represent significant stages of development for our traits in a potential commercial product, such as achievement of specific technological targets, completion of field trials, filing with regulatory agencies, completion of the regulatory process, and commercial launch of a product containing our traits. Given the seasonality of agriculture and time required to progress from one milestone to the next, achievement of milestones is inherently uneven, and our license revenues are likely to fluctuate significantly from period to period.
 

Operating Expenses

Cost of revenues

Cost of revenues relates to the sale of Arcadia Wellness, GoodWheat, and GLA products and consists of the cost of raw materials, including internal and third-party services costs related to procuring, processing, formulating, packaging and shipping our products, as well as in-licensing and royalty fees, any adjustments or write-downs to inventory or prepaid production costs.

Research and development expenses ("R&D")

Research and development expenses consist of costs incurred in the development and testing of our products and other products in development incorporating our traits. These expenses currently consist primarily of fees paid to product formulation consultants and are expensed as incurred. Additionally, we are required from time to time to make certain milestone payments in connection with the development of technologies in-licensed from third parties. Our research and development expenses may fluctuate from period to period.

22


 

Gain on sale of Verdeca
 

The gain on sale of Verdeca is the gain recognized for the sale our membership interests in the Verdeca joint venture to our partner Bioceres in November 2020.

Impairment of intangible assets
 

Impairments of intangible assets are recorded when the fair value of intangible assets drops below its carrying amount. See Note 7 to the Condensed Consolidated Financial Statements.
 

Change in fair value of contingent consideration

Change in the fair value of contingent consideration is comprised of the fair value remeasurement of the liabilities associated with our contingent consideration. See Note 15 to the Condensed Consolidated Financial Statements.

Gain on sale of property and equipment, net

Gain on sale of fixed assets includes gains from the sale of tangible assets sold above their net book value.

Impairment of property and equipment, net

Impairment of property and equipment, net includes losses from tangible assets due to impairment or recoverability test charges to write down fixed assets to their fair value or recoverability value.

Selling, general and administrative expenses

Selling, general and administrative expenses consist primarily of employee costs, professional service fees, broker and sales commission fees, and overhead costs. Our selling, general, and administrative expenses may fluctuate from period to period. In connection with our commercialization activities for our consumer products, we expect to increase our investments in sales and marketing, including additional consulting fees.

Other income, net

Other income, net, consists of unrealized gains on corporate securities, and interest income on our cash and cash equivalents and investments.

Issuance and offering costs

Issuance and offering costs generally include placement agent, legal, advisory, accounting and filing fees related to financing transactions.

Change in the estimated fair value of common stock warrant liabilities

Change in the estimated fair value of common stock warrant liabilities is comprised of the fair value remeasurement of the liabilities associated with our financing transactions.

23


 

Income Tax Provision

Our income tax provision has not been historically significant, as we have incurred losses since our inception. The provision for income taxes consists of state and foreign income taxes. Due to cumulative losses, we maintain a valuation allowance against our U.S. deferred tax assets as of June 30, 2022 and December 31, 2021. We consider all available evidence, both positive and negative, including but not limited to: earnings history, projected future outcomes, industry and market trends, and the nature of each of the deferred tax assets in assessing the extent to which a valuation allowance should be applied against our U.S. deferred tax assets.

Results of Operations

Comparison of the Three Months Ended June 30, 2022 and 2021

 

 

 

Three Months Ended June 30,

 

 

$ Change

 

 

% Change

 

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

 

(In thousands except percentage)

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

Product

 

$

2,946

 

 

$

1,379

 

 

$

1,567

 

 

 

114

%

Royalty

 

 

50

 

 

 

26

 

 

 

24

 

 

 

92

%

License

 

 

862

 

 

 

 

 

 

862

 

 

 

100

%

Total revenues

 

 

3,858

 

 

 

1,405

 

 

 

2,453

 

 

 

175

%

Operating expenses (income):

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

3,447

 

 

 

1,587

 

 

 

1,860

 

 

 

117

%

Research and development

 

 

359

 

 

 

1,131

 

 

 

(772

)

 

 

(68

)%

Gain on sale of Verdeca

 

 

(1,138

)

 

 

 

 

 

(1,138

)

 

 

(100

)%

Impairment of intangible assets

 

 

72

 

 

 

 

 

 

72

 

 

 

100

%

Change in fair value of contingent consideration

 

 

(39

)

 

 

 

 

 

(39

)

 

 

(100

)%

Impairment of property and equipment

 

 

346

 

 

 

 

 

 

346

 

 

 

100

%

Gain on sale of property and equipment

 

 

(58

)

 

 

 

 

 

(58

)

 

 

(100

)%

Selling, general and administrative

 

 

4,652

 

 

 

6,370

 

 

 

(1,718

)

 

 

(27

)%

Total operating expenses

 

 

7,641

 

 

 

9,088

 

 

 

(1,447

)

 

 

(16

)%

Loss from operations

 

 

(3,783

)

 

 

(7,683

)

 

 

3,900

 

 

 

51

%

Interest income (expense)

 

 

30

 

 

 

(1

)

 

 

31

 

 

 

(3100

)%

Other (expense) income, net

 

 

(44

)

 

 

2,759

 

 

 

(2,803

)

 

 

(102

)%

Change in fair value of common stock warrant liabilities

 

 

 

 

 

(498

)

 

 

498

 

 

 

(100

)%

Net loss before income taxes

 

 

(3,797

)

 

 

(5,422

)

 

 

1,625

 

 

 

(30

)%

Income tax provision

 

 

 

 

 

 

 

 

 

 

 

0

%

Net loss

 

 

(3,797

)

 

 

(5,422

)

 

 

1,625

 

 

 

(30

)%

Net loss attributable to non-controlling interest

 

 

(20

)

 

 

(161

)

 

 

141

 

 

 

(88

)%

Net loss attributable to common stockholders

 

$

(3,777

)

 

$

(5,261

)

 

$

1,484

 

 

 

(28

)%

 

Revenues

Product revenues accounted for 76% and 98% of our total revenues during the three months ended June 30, 2022 and 2021, respectively. The $1.6 million, or 114%, increase in product revenues for the three months ended June 30, 2022 compared to the same period in 2021 was primarily driven by sales of Zola coconut water and body care products.

Royalty revenues accounted for 1% and 2% of our total revenues during the three months ended June 30, 2022 and 2021, respectively. The $50,000 of royalty revenues for the three months ended June 30, 2022 represents the proportionate share of contracted minimum annual royalty fees.

License revenue accounted for 23% of our total revenue during the three months ended June 30, 2022 related to the Verdeca-Bioceres licensing agreement discussed below.

Cost of revenues

Cost of revenues increased by $1.9 million, or 117%, during the three months ended June 30, 2022 compared to the same period in 2021. The increase is mainly due to the cost of revenues related to the Arcadia Wellness products, in addition to higher inventory write-downs, which amounted to $1.0 million during the three months ended June 30, 2022 as compared to inventory write-downs of

24


 

$720,000 during the three months ended June 30, 2021. Gross profit, calculated as total revenues less cost of revenues, was $411,000 during the three months ended June 30, 2022 compared to gross loss of $182,000 during the three months ended June 30, 2021. The increase in the gross profit was attributable to the higher revenues offset by cost of revenues including inventory write-downs during the three months ended June 30, 2022.

Research and development

Research and development expenses decreased by $772,000, or 68%, during the three months ended June 30, 2022 compared to the same period in 2021. The decrease was primarily driven by the Company's recent focus on commercialization, which has led to lower employee-related expenses, and related activity costs as we right-sized our research teams, partially offset by $145,000 of inventory written-off to R&D during the three months ended June 30, 2022.

Gain on sale of Verdeca

In February 2012, we partnered with Bioceres to form Verdeca, which we equally owned. Verdeca was formed to develop and deregulate soybean varieties using both partners’ agricultural technologies. In November 2020, Arcadia sold its membership interest in Verdeca to Bioceres in a transaction in which Arcadia received cash, shares of Bioceres stock and a royalty stream of up to $10.0 million on sales of Haab 4 ("HB4") soybean. An additional $2.0 million in cash is to be paid upon achievement by Verdeca reaching commercial plantings of at least 200,000 hectares of HB4 or China approving the HB4 soybean trait for “food and feed”. During the three months ended June 30, 2022, we recognized a gain on sale of Verdeca of $1.1 million related to the regulatory approval of the HB4 soybeans.

Impairment of intangible assets

During the three months ended June 30, 2022, we recognized $72,000 of impairments of intangible assets related to the Radiance Beauty licensing agreement. No impairment of intangible assets was recognized during the three months ended June 30, 2021.

Change in fair value of contingent consideration

The change in fair value of contingent consideration during the three months ended June 30, 2022 was related to the Industrial Seed Innovations ("ISI") contingent consideration remeasurement that resulted in a decrease of the liability in the amount of $39,000. See Note 15 to the Condensed Consolidated Financial Statements. No change in fair value of contingent consideration was recognized during the three months ended June 30, 2021.

Impairment of property and equipment

During the three months ended June 30, 2022, we recognized $320,000 of impairments of property and equipment related to the Radiance Beauty licensing agreement and recorded additional impairments of $26,000 related to other property and equipment. No impairment of property and equipment was recognized during the three months ended June 30, 2021.

Gain on sale of property and equipment

During the three months ended June 30, 2022, we sold some of our property and equipment related to our Davis laboratory for net proceeds exceeding book value by $58,000. No gain on sale of property and equipment was recognized during the three months ended June 30, 2021.

Selling, general, and administrative

Selling, general, and administrative expenses decreased by $1.7 million, or 27%, during the three months ended June 30, 2022, compared to the same period in 2021. The decrease was primarily driven by lower salaries, lease expense and consulting fees. Selling, general, and administrative expenses during the three months ended June 30, 2021 included $850,000 of investment banker success fees, legal diligence and transaction fees associated with the Arcadia Wellness acquisition.

Change in the estimated fair value of common stock warrant liabilities

As a result of the adoption of ASU 2020-06, no change in the estimated fair value of common stock warrant liabilities was recorded during the three months ended June 30, 2022. See Note 2 to the Condensed Consolidated Financial Statements. Change in the estimated fair value of common stock warrant liabilities resulted in a loss of $498,000 during the three months ended June 30, 2021.

25


 

Comparison of the Six Months Ended June 30, 2022 and 2021

 

 

 

Six Months Ended June 30,

 

 

$ Change

 

 

% Change

 

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

 

(In thousands except percentage)

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

Product

 

$

6,116

 

 

$

2,183

 

 

$

3,933

 

 

 

180

%

Royalty

 

 

100

 

 

 

51

 

 

 

49

 

 

 

96

%

License

 

 

862

 

 

 

 

 

 

862

 

 

 

100

%

Total revenues

 

 

7,078

 

 

 

2,234

 

 

 

4,844

 

 

 

217

%

Operating expenses (income):

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

6,906

 

 

 

2,443

 

 

 

4,463

 

 

 

183

%

Research and development

 

 

754

 

 

 

2,290

 

 

 

(1,536

)

 

 

(67

)%

Gain on sale of Verdeca

 

 

(1,138

)

 

 

 

 

 

(1,138

)

 

 

(100

)%

Impairment of intangible assets

 

 

72

 

 

 

 

 

 

72

 

 

 

100

%

Change in fair value of contingent consideration

 

 

(70

)

 

 

(140

)

 

 

70

 

 

 

(50

)%

Impairment of property and equipment

 

 

346

 

 

 

210

 

 

 

136

 

 

 

65

%

Gain on sale of property and equipment

 

 

(386

)

 

 

 

 

 

(386

)

 

 

(100

)%

Selling, general and administrative

 

 

9,000

 

 

 

10,439

 

 

 

(1,439

)

 

 

(14

)%

Total operating expenses

 

 

15,484

 

 

 

15,243

 

 

 

241

 

 

 

2

%

Loss from operations

 

 

(8,406

)

 

 

(13,009

)

 

 

4,603

 

 

 

(35

)%

Interest income (expense)

 

 

29

 

 

 

(8

)

 

 

37

 

 

 

(463

)%

Other (expense) income, net

 

 

(3

)

 

 

10,222

 

 

 

(10,225

)

 

 

(100

)%

Change in fair value of common stock warrant liabilities

 

 

 

 

 

(176

)

 

 

176

 

 

 

(100

)%

Issuance and offering costs

 

 

(27

)

 

 

(769

)

 

 

742

 

 

 

(96

)%

Net loss before income taxes

 

 

(8,407

)

 

 

(3,740

)

 

 

(4,667

)

 

 

125

%

Income tax provision

 

 

 

 

 

 

 

 

 

 

 

0

%

Net loss

 

 

(8,407

)

 

 

(3,740

)

 

 

(4,667

)

 

 

125

%

Net loss attributable to non-controlling interest

 

 

(142

)

 

 

(538

)

 

 

396

 

 

 

(74

)%

Net loss attributable to common stockholders

 

$

(8,265

)

 

$

(3,202

)

 

$

(5,063

)

 

 

158

%

Revenues

Product revenues accounted for 86% and 98% of our total revenues during the six months ended June 30, 2022 and 2021, respectively. The $3.9 million, or 180%, increase in product revenues during the six months ended June 30, 2022 compared to the same period in 2021 was primarily driven by sales of the Zola coconut water and body care products, along with $1.7 million of GoodWheat grain and pasta inventory sales.

Royalty revenues accounted for 1% and 2% of our total revenues during the six months ended June 30, 2022 and 2021, respectively. The $100,000 of royalty revenues for the six months ended June 30, 2022 represents the proportionate share of contracted minimum annual royalty fees.

License revenue accounted for 13% of our total revenue during the six months ended June 30, 2022 related to the Verdeca-Bioceres licensing agreement discussed below.

Cost of revenues

Cost of revenues increased by $4.5 million, or 183%, during the six months ended June 30, 2022 compared to the same period in 2021. The increase is mainly due to the cost of revenues related to the Arcadia Wellness products and the GoodWheat grain and pasta inventory sales, in addition to higher inventory write-downs, which amounted to $1.4 million during the six months ended June 30, 2022 as compared to inventory write-downs of $880,000 during the six months ended June 30, 2021. Gross profit, calculated as total revenues less cost of revenues, was $172,000 during the six months ended June 30, 2022 compared to gross loss of $209,000 during the six months ended June 30, 2021. The increase in the gross profit was attributable to higher revenues offset by cost of revenues including inventory write-downs during the six months ended June 30, 2022.

26


 

Research and development

Research and development expenses decreased by $1.5 million or 67%, during the six months ended June 30, 2022 compared to the same period in 2021. The decrease was primarily driven by the Company's recent focus on commercialization, which has led to lower employee-related expenses, and related activity costs as we right-sized our research teams, partially offset by $145,000 of inventory written-off to R&D during the six months ended June 30, 2022.

Gain on sale of Verdeca

In February 2012, we partnered with Bioceres to form Verdeca, which we equally owned. Verdeca was formed to develop and deregulate soybean varieties using both partners’ agricultural technologies. In November 2020, Arcadia sold its membership interest in Verdeca to Bioceres in a transaction in which Arcadia received cash, shares of Bioceres stock and a royalty stream of up to $10.0 million on sales of Haab 4 ("HB4") soybean. An additional $2.0 million in cash is to be paid upon achievement by Verdeca reaching commercial plantings of at least 200,000 hectares of HB4 or China approving the HB4 soybean trait for “food and feed”. During the six months ended June 30, 2022, we recognized a gain on sale of Verdeca of $1.1 million related to the regulatory approval of the HB4 soybeans.

Impairment of intangible assets

During the six months ended June 30, 2022, we recognized $72,000 of impairments of intangible assets related to the Radiance Beauty licensing agreement. No impairment of intangible assets was recognized during the six months ended June 30, 2021.

Change in fair value of contingent consideration

The Industrial Seed Innovations contingent consideration remeasurement resulted in a decrease of the liability in the amount of $70,000 and $140,000 during the six months ended June 30, 2022 and 2021, respectively. See Note 15 to the Condensed Consolidated Financial Statements.

Impairment of property and equipment

During the six months ended June 30, 2022, we recognized $320,000 of impairments of property and equipment related to the Radiance Beauty licensing agreement and recorded additional impairments of $26,000 related to other property and equipment. During the six months ended June 30, 2021, we recognized $210,000 of impairments of Archipelago property and equipment related to CBD processing.

Gain on sale of property and equipment

During the six months ended June 30, 2022, we sold some property and equipment related to the Davis laboratory and Archipelago for net proceeds exceeding book value by $386,000. No gain on sale of property and equipment was recognized during the six months ended June 30, 2021.

Selling, general, and administrative

Selling, general, and administrative expenses decreased by $1.4 million, or 14%, during the six months ended June 30, 2022 compared to the same period in 2021. The decrease was primarily driven by lower salaries, lease expense and consulting fees. Selling, general, and administrative expenses during the six months ended June 30, 2021 included $850,000 of investment banker success fees, legal diligence and transaction fees associated with the Arcadia Wellness acquisition.

Change in the Estimated Fair Value of Common Stock Warrant Liabilities

As a result of the adoption of ASU 2020-06, no change in the estimated fair value of common stock warrant liabilities was recorded during the six months ended June 30, 2022. See Note 2 to the Condensed Consolidated Financial Statements. Change in the estimated fair value of common stock warrant liabilities resulted in a loss of $176,000 for the six months ended June 30, 2021.

Seasonality

We and our commercial partners operate in different geographies around the world and conduct field trials used for data generation, which must be conducted during the appropriate growing seasons for particular crops and markets. Demand for our consumer body care products tends to vary with major holidays and demand for coconut water products is generally higher in the summer months.

27


 

The level of seasonality in our business overall is difficult to evaluate at this time due to our relatively limited number of commercialized products, our expansion into new geographical markets and our introduction of new products and traits.

Liquidity, Capital Resources, and Going Concern

We have funded our operations primarily with the net proceeds from our private and public offerings of our equity securities and debt, as well as proceeds from the sale of our products and payments under license agreements, contract research agreements and government grants. Our principal use of cash is to fund our operations, which are primarily focused on commercializing our products. As of June 30, 2022, we had cash and cash equivalents of $21.2 million. For the six months ended June 30, 2022, the Company had a net loss of $8.4 million and net cash used in operations of $8.3 million. For the twelve months ended December 31, 2021, the Company had net losses of $16.1 million and net cash used in operations of $25.9 million.

We believe that our existing cash and cash equivalents will not be sufficient to meet our anticipated cash requirements for at least the next 12 months from the issuance date of our condensed consolidated financial statements, and thus raises substantial doubt about the Company’s ability to continue as a going concern. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

We may seek to raise additional funds through debt or equity financings, if necessary. We may also consider entering into additional partner arrangements. Any sale of additional equity would result in dilution to our stockholders. Our incurrence of debt would result in debt service obligations, and the instruments governing our debt could provide for additional operating and financing covenants that would restrict our operations. If we do require additional funds and are not able to secure adequate additional funding, we may be forced to reduce our spending, extend payment terms with our suppliers, liquidate assets, or suspend or curtail planned development programs. Any of these actions could materially harm our business, results of operations and financial condition.

Cash Flows

The following table summarizes our cash flows for the periods indicated (in thousands):

 

 

 

Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

Net cash (used in) provided by:

 

 

 

 

 

 

Operating activities

 

$

(8,250

)

 

$

(10,940

)

Investing activities

 

 

795

 

 

 

16,882

 

Financing activities

 

 

4

 

 

 

21,993

 

Net (decrease) increase in cash

 

$

(7,451

)

 

$

27,934

 

 

Cash flows from operating activities

Cash used in operating activities for the six months ended June 30, 2022, was $8.3 million. With respect to our net loss of $8.4 million, non-cash charges including $583,000 of stock-based compensation, $420,000 of lease amortization, $1.5 million of write-downs of inventories, $346,000 of write-downs of property and equipment, $72,000 of write-downs of intangible assets, and $277,000 of depreciation were offset by adjustments in our working capital accounts of $2.2 million, $386,000 of gain on disposal of property and equipment, other non-cash income from the change in fair value of contingent consideration of $70,000, and operating lease payments of $446,000.

Cash used in operating activities for the six months ended June 30, 2021, was $10.9 million. Our net loss of $3.7 million, non-cash charges including $676,000 of stock-based compensation, $639,000 of lease amortization, the change in fair value of common stock warrant liabilities of $176,000, $210,000 of write-down of fixed assets, and $484,000 of depreciation were offset by adjustments in our working capital accounts of $373,000, $10.2 million of realized gain on corporate securities, other non-cash income from the change in fair value of contingent consideration of $140,000, and operating lease payments of $590,000.
 

Cash flows from investing activities

Cash provided by investing activities for the six months ended June 30, 2022 consisted of $841,000 of proceeds from sales of property and equipment, partially offset by $46,000 of purchases of property and equipment.

Cash provided by investing activities for the six months ended June 30, 2021 consisted of $21.8 million of proceeds from sales of investments, partially offset by $4.3 million of acquisitions, and $713,000 in purchases of property and equipment.

Cash flows from financing activities

28


 

Cash provided by financing activities for the six months ended June 30, 2022 consisted of proceeds from the purchase of ESPP shares of $4,000.

Cash provided by financing activities for the six months ended June 30, 2021 consisted of proceeds from the issuance of common stock relating to the January 2021 PIPE financing transaction of $25.1 million gross proceeds, capital contributions from the non-controlling interest in our joint venture of $750,000, and proceeds from the purchase of ESPP shares of $27,000, which were offset by payments of transaction costs related to the January 2021 PIPE of $1.9 million and principal payments on debt of $2.0 million.
 

Off-Balance Sheet Arrangements

Since our inception, we have not engaged in any off-balance sheet arrangements, including the use of structured finance, special purpose entities, or variable interest entities other than Verdeca, which was disposed of in November 2020.

Critical Accounting Policies and Estimates

Our management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported revenue generated, and expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

We consider our critical accounting policies and estimates to be revenue recognition, determination of the provision for income taxes, and net realizable value of inventory.

ITEM 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not Required.

ITEM 4: CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain “disclosure controls and procedures,” as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, or Exchange Act, that are designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our President and Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Our disclosure controls and procedures have been designed to meet reasonable assurance standards. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Based on their evaluation as of the end of the period covered by this Quarterly Report on Form 10-Q, our President and Chief Executive Officer and our Chief Financial Officer have concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) identified in connection with the evaluation identified above that occurred during the quarter ended June 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

29


 

PART II. OTHER INFORMATION

 

We currently are not a party to any material litigation or other material legal proceedings. From time to time, we may be subject to legal proceedings and claims in the ordinary course of business.

ITEM 1A. RISK FACTORS

In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021, which could materially affect our business, financial condition, liquidity or future results. The risks described in our Annual Report on Form 10-K are not the only risks facing our company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, liquidity or future results.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

30


 

ITEM 6. EXHIBITS

The following exhibits are attached hereto or are incorporated herein by reference.

 

Exhibit

Number

 

Exhibit Description

 

 

 

  31.1

 

Principal Executive Officer’s Certifications Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

  31.2

 

Principal Financial Officer’s Certifications Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

  32.1(1)

 

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

  32.2(1)

 

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

101.INS

 

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

 

 

 

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document

 

 

 

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

101.LAB

 

Inline XBRL Taxonomy Extension Label Linkbase Document

 

 

 

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

104.1

 

Cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, formatted in inline XBRL (and contained in Exhibit 101)

 

(1)
This certification is deemed not filed for purpose of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.

31


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Arcadia Biosciences, Inc.

 

 

 

August 11, 2022

 

By:

 

/s/ STANLEY E. JACOT, JR.

 

 

 

 

Stanley E. Jacot, Jr.

 

 

 

 

President and Chief Executive Officer

 

August 11, 2022

 

By:

 

/s/ PAMELA HALEY

 

 

 

 

Pamela Haley

 

 

 

 

Chief Financial Officer

 

 

32


EX-31.1 2 rkda-ex31_1.htm EX-31.1 EX-31.1

 

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)

AS ADOPTED PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Stanley E. Jacot, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Arcadia Biosciences, Inc. for the period ended June 30, 2022;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: August 11, 2022

 

/s/ STANLEY E. JACOT, JR.

 

 

Stanley E. Jacot, Jr.

 

 

President and Chief Executive Officer

 

 

(Principal Executive Officer)

 

 


EX-31.2 3 rkda-ex31_2.htm EX-31.2 EX-31.2

 

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)

AS ADOPTED PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Pamela Haley, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Arcadia Biosciences, Inc. for the period ended June 30, 2022;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: August 11, 2022

 

/s/ PAMELA HALEY

 

 

Pamela Haley

 

 

Chief Financial Officer

 

 

(Principal Financial Officer)

 

 


EX-32.1 4 rkda-ex32_1.htm EX-32.1 EX-32.1

 

Exhibit 32.1

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the accompanying Quarterly Report of Arcadia Biosciences, Inc. (the “Company”), on Form 10-Q for the quarter ended June 30, 2022 (the “Report”), I, Stanley E. Jacot, Jr., President and Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002 that:

(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: August 11, 2022

 

/s/ STANLEY E. JACOT, JR.

 

 

Stanley E. Jacot, Jr.

 

 

President and Chief Executive Officer

 

 

(Principal Executive Officer)

 

 


EX-32.2 5 rkda-ex32_2.htm EX-32.2 EX-32.2

 

Exhibit 32.2

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the accompanying Quarterly Report of Arcadia Biosciences, Inc. (the “Company”), on Form 10-Q for the quarter ended June 30, 2022 (the “Report”), I, Pamela Haley, Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002 that:

(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: August 11, 2022

 

/s/ PAMELA HALEY

 

 

Pamela Haley

 

 

Chief Financial Officer

 

 

(Principal Financial Officer)

 

 


EX-101.CAL 6 rkda-20220630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.SCH 7 rkda-20220630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 100020 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets, Net (Detail) 2 link:presentationLink link:calculationLink link:definitionLink 100030 - Disclosure - Leases - Schedule of Leases (Detail) 2 link:presentationLink link:calculationLink link:definitionLink 100040 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 100050 - Disclosure - Leases - Schedule of Leases (Detail) 3 link:presentationLink link:calculationLink link:definitionLink 100060 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 100070 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 100080 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 100090 - Disclosure - Description of Business and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 100100 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 100110 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 100120 - Disclosure - Property and Equipment, Net link:presentationLink link:calculationLink link:definitionLink 100130 - Disclosure - Investments and Fair Value Instruments link:presentationLink link:calculationLink link:definitionLink 100140 - Disclosure - Arcadia Wellness Acquisition link:presentationLink link:calculationLink link:definitionLink 100150 - Disclosure - Intangible Assets, Net link:presentationLink link:calculationLink link:definitionLink 100160 - Disclosure - Consolidated Joint Venture link:presentationLink link:calculationLink link:definitionLink 100170 - Disclosure - Collaborative Arrangements link:presentationLink link:calculationLink link:definitionLink 100180 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 100190 - Disclosure - Equity Financing link:presentationLink link:calculationLink link:definitionLink 100200 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 100210 - Disclosure - Stock-Based Compensation and Employee Stock Purchase Program link:presentationLink link:calculationLink link:definitionLink 100220 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 100230 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 100240 - Disclosure - Commitment and Contingencies link:presentationLink link:calculationLink link:definitionLink 100250 - Disclosure - Net Loss per Share link:presentationLink link:calculationLink link:definitionLink 100260 - Disclosure - Related-Party Transactions link:presentationLink link:calculationLink link:definitionLink 100270 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 100280 - Disclosure - Description of Business and Basis of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 100290 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 100300 - Disclosure - Property and Equipment, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 100310 - Disclosure - Investments and Fair Value Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 100320 - Disclosure - Arcadia Wellness Acquisition (Tables) link:presentationLink link:calculationLink link:definitionLink 100330 - Disclosure - Intangible Assets, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 100340 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 100350 - Disclosure - Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 100360 - Disclosure - Stock-Based Compensation and Employee Stock Purchase Program (Tables) link:presentationLink link:calculationLink link:definitionLink 100370 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 100380 - Disclosure - Net Loss per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 100390 - Disclosure - Description of Business and Basis of Presentation - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100400 - Disclosure - Recent Accounting Pronouncements - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100410 - Disclosure - Inventory - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100420 - Disclosure - Inventory - Summary of Inventories (Detail) link:presentationLink link:calculationLink link:definitionLink 100430 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment, Net (Detail) link:presentationLink link:calculationLink link:definitionLink 100440 - Disclosure - Property and Equipment, Net - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100450 - Disclosure - Investments and Fair Value Instruments - Summary of Amortized Cost and Fair Value of Investment Securities Portfolio (Detail) link:presentationLink link:calculationLink link:definitionLink 100460 - Disclosure - Investments and Fair Value Instruments - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100470 - Disclosure - Investments and Fair Value Instruments - Summary of Fair Value of Investments Securities (Detail) link:presentationLink link:calculationLink link:definitionLink 100480 - Disclosure - Investments and Fair Value Instruments - Summary of Warrant Liabilities Measured and Recorded on Recurring Basis using Black-Scholes Model (Detail) link:presentationLink link:calculationLink link:definitionLink 100490 - Disclosure - Investments and Fair Value Instruments - Summary of Changes in Fair Value and Other Adjustments of Liabilities (Detail) link:presentationLink link:calculationLink link:definitionLink 100500 - Disclosure - Industrial Seed Innovations Acquisition - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100510 - Disclosure - Industrial Seed Innovations Acquisition - Schedule of Preliminary Allocation of the Purchase Price of ISI Assets Acquired Based on Fair Values (Detail) link:presentationLink link:calculationLink link:definitionLink 100520 - Disclosure - Arcadia Wellness Acquisition - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100530 - Disclosure - Arcadia Wellness Acquisition - Schedule of Allocation Purchase Price of Assets Acquired at Fair Value at Acquisition Date (Detail) link:presentationLink link:calculationLink link:definitionLink 100540 - Disclosure - Arcadia Wellness Acquisition - Schedule of Unaudited Pro-forma Condensed Consolidated Results of Operations (Detail) link:presentationLink link:calculationLink link:definitionLink 100550 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets, Net (Detail) link:presentationLink link:calculationLink link:definitionLink 100560 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets, Net (Parenthetical) (Detail) link:presentationLink link:calculationLink link:definitionLink 100570 - Disclosure - Intangible Assets, Net - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100580 - Disclosure - Intangible Assets, Net - Schedule of Future Amortization of Intellectual Property and Customer Lists (Detail) link:presentationLink link:calculationLink link:definitionLink 100590 - Disclosure - Consolidated Joint Venture - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100600 - Disclosure - Collaborative Arrangements - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100610 - Disclosure - Leases - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100620 - Disclosure - Leases - Schedule of Leases (Detail) link:presentationLink link:calculationLink link:definitionLink 100630 - Disclosure - Equity Financing - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100640 - Disclosure - Warrants - Summary of Warrants Issued to Purchase Common Stock (Detail) link:presentationLink link:calculationLink link:definitionLink 100650 - Disclosure - Warrants - Summary of Warrants Issued to Purchase Common Stock (Parenthetical) (Detail) link:presentationLink link:calculationLink link:definitionLink 100660 - Disclosure - Stock-Based Compensation and Employee Stock Purchase Program - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100670 - Disclosure - Stock-Based Compensation and Employee Stock Purchase Program - Summary of Activity Under Stock Incentive Plans (Detail) link:presentationLink link:calculationLink link:definitionLink 100680 - Disclosure - Stock-Based Compensation and Employee Stock Purchase Program - Weighted-Average Fair Value Assumption of Stock Option Awards (Detail) link:presentationLink link:calculationLink link:definitionLink 100690 - Disclosure - Debt - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100700 - Disclosure - Debt - Schedule of Maturities of Current and Noncurrent Debt (Detail) link:presentationLink link:calculationLink link:definitionLink 100710 - Disclosure - Income Taxes - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100720 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 100730 - Disclosure - Net Loss per Share - Summary of Securities Not Included in Diluted Per Share Calculations (Detail) link:presentationLink link:calculationLink link:definitionLink 100740 - Disclosure - Related-Party Transactions - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink EX-101.PRE 8 rkda-20220630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.DEF 9 rkda-20220630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 rkda-20220630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Address, City or Town Entity Address, City or Town Inventory raw materials current and non-current. Inventory Raw Materials Current And Non Current Raw materials Increase (Decrease) in Other Current Liabilities Other current liabilities Fair Value Disclosures [Abstract] First offering period end date. First Offering Period End Date First offering period, end date Accounting Standards Update and Change in Accounting Principle [Table] Net loss per share attributable to common stockholders: Earnings Per Share [Abstract] Earnings Per Share [Abstract] Fair Value, Inputs, Level 1 [Member] Level 1 [Member] Entity reincorporation date of reincorporation. Entity Reincorporation Date Of Reincorporation Date of reincorporation Stock Issued During Period, Value, New Issues Issuance of shares Fair Value Measurement Initial Recognition. Fair Value Measurement Initial Recognition Initial recognition Net Cash Provided by (Used in) Financing Activities [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES: Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Dividend yield Total intangible asset, Gross Carrying Amount Intangible Assets, Gross (Excluding Goodwill) Intangible Assets, Gross (Excluding Goodwill), Total May 2020 placement agent warrants. May2020 Placement Agent Warrants [Member] May 2020 Placement Agent Warrants [Member] Long-Term Line of Credit Debt instrument outstanding amount Long-term Line of Credit, Total Amendment Flag Amendment Flag March two thousand eighteen offering. March Two Thousand Eighteen Offering [Member] March 2018 Offering [Member] Inventory [Line Items] Long-Term Debt, Maturity, Year Four 2025 Payments for Rent Rent payments Purchases of property and equipment included in accounts payable and accrued expenses Capital Expenditures Incurred but Not yet Paid Arcadia Wellness Acquisition. Arcadia Wellness Acquisition [Member] Total intangible asset, Accumulated Amortization Amortized intangible assets, Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Debt instrument maturity year. Debt Instrument Maturity Year Debt instrument maturity year Goodwill Goodwill Goodwill, Total Goodwill, Beginning Balance Goodwill, Ending Balance Operating Lease, Right-of-Use Asset Operating lease assets Right of use asset Laboratory equipment. Laboratory Equipment [Member] Laboratory equipment [Member] Document Quarterly Report Document Quarterly Report Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Table] Equity Method Investments Capital contributions Inventory, Current [Table] Statement [Table] Statement [Table] Operating Lease, Liability, Noncurrent Noncurrent - Operating Operating lease liability — noncurrent Chief Executive Officer [Member] Chief Executive Officer [Member] Lessee Disclosure [Abstract] Proceeds from Contributed Capital Capital contributions received from non-controlling interest Warrant liabilities. Warrant Liabilities Warrant liabilities Operating lease term and discount rate. Operating Lease Term And Discount Rate [Abstract] Lease Term and Discount Rate Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false] Change in accounting principle, accounting standards update, immaterial effect [true false] Operating Lease, Payments Lease payments Stock Issued During Period, Shares, Employee Stock Purchase Plans Issuance of common stock pursuant to employee stock purchase plan Issuance of shares related to employee stock purchase plan, Shares Business Acquisition, Effective Date of Acquisition Date of merger and reorganization Business Acquisition [Axis] Business Acquisition Machinery and Equipment [Member] Machinery and equipment [Member] Common Stock, Capital Shares Reserved for Future Issuance Total number of shares reserved for issuance under plan Proceeds from sale of property and equipment in accounts receivable Proceeds from Sale of Property and Equipment in Accounts Receivable Proceeds from sale of property and equipment in accounts receivable. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Inventory Business Combination Disclosure [Text Block] Industrial Seed Innovations Acquisition Arcadia Wellness Acquisition July 2020 placement agent warrants. July2020 Placement Agent Warrants [Member] July 2020 Placement Agent Warrants [Member] Product and Service [Axis] Product and Service Employee Stock [Member] 2015 Employee Stock Purchase Plan [Member] Measurement Input, Share Price [Member] Stock Price [Member] December 2020 placement agent warrants. December Two Thousand Twenty Placement Agent Warrants [Member] December 2020 Placement Agent Warrants [Member] Business Combination, Contingent Consideration, Liability Contingent liability Business Combination, Contingent Consideration, Liability, Total Inventory goods ion process current and non current. Inventory Goods In Process Current And Non Current Goods in process Finite-Lived Intangible Asset, Useful Life Useful life Useful life of intangible assets amortized Lessee, Operating Leases [Text Block] Leases Intellectual Property [Member] Intellectual Property [Member] Share-Based Payment Arrangement, Option [Member] Employee Stock Option [Member] Option to Purchase Common Stock [Member] Operating Lease, Weighted Average Remaining Lease Term Weighted-average remaining lease term (years) Liabilities and Equity Total liabilities and stockholders’ equity Short term lease cost and cost (reclassifications). Short Term Lease Cost And Cost Reclassifications Short term lease cost Short term lease cost Plan Name [Domain] Plan Name Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets Fixed assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets, Total Other Liabilities, Current Other current liabilities Other Liabilities, Current, Total Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender Office Building [Member] Office Space [Member] Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Deferred tax liability Deferred tax liability Weighted Average Number of Shares Outstanding, Diluted [Abstract] Denominator: Fair Value Adjustment of Warrants Change in fair value of common stock warrant liabilities Change in fair value of common stock warrant liabilities Change in Accounting Principle, Accounting Standards Update, Adopted [true false] Change in accounting principle, accounting standards update, adopted [true false] December two thousand and twenty purchase agreement. December Two Thousand And Twenty Purchase Agreement [Member] December 2020 Purchase Agreement [Member] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Income Statement [Abstract] Board of Directors Chairman [Member] Mr. Kevin Comcowich [Member] June two thousand nineteen securities purchase agreement. June Two Thousand Nineteen Securities Purchase Agreement [Member] June 2019 Purchase Agreement [Member] September 2019 purchase agreement. September Two Thousand Nineteen Purchase Agreement [Member] September 2019 Purchase Agreement [Member] Proceeds from Stock Plans Proceeds from ESPP purchases Number of lease renewal term. Number Of Lease Renewal Term Number of lease renewal term Sale of Stock [Domain] Sale of Stock Liabilities, Current Total current liabilities Stock Issued During Period, Value, Employee Stock Purchase Plan Issuance of shares related to employee stock purchase plan Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree First offering period start date. First Offering Period Start Date First offering period, start date Short-Term Lease, Cost Short term lease cost Short term lease cost Business combination recognized identifiable assets acquired and liabilities assumed trade names and trademarks. Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Trade Names And Trademarks Trade names and trademarks Software and computer equipment. Software And Computer Equipment [Member] Software and computer equipment [Member] Additional properties under lease agreement. Additional Properties Under Lease Agreement Number of additional properties under lease agreement Increase (Decrease) in Contract with Customer, Liability Unearned revenue Business combination remaining contingent liability written-down Business Combination Remaining Contingent Liability Written-down Business combination remaining contingent liability written-down. Class of warrants or rights issuance month and year. Class Of Warrants Or Rights Issuance Month And Year Issuance Date Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate Percentage in payroll deductions to acquire shares of common stock Automobile Loan [Member] Vehicle Loans [Member] Debt and equity securities accumulated gross unrealized loss before tax. Debt And Equity Securities Accumulated Gross Unrealized Loss Before Tax Unrealized Losses January two thousand and twenty one PIPE securities purchase agreement. January Two Thousand And Twenty One P I P E Securities Purchase Agreement [Member] January 2021 PIPE Purchase Agreement [Member] Operating Lease, Weighted Average Discount Rate, Percent Weighted-average discount rate May two thousand twenty warrants. May Two Thousand Twenty Warrants [Member] May 2020 Warrants [Member] Entity Small Business Entity Small Business Amendment. Amendment [Member] Amendment [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table] Increase (Decrease) in Due to Related Parties Amounts due to related parties Increase (Decrease) in Due to Related Parties, Total Payments of offering costs. Payments Of Offering Costs Payments of offering costs Intangible Assets Disclosure [Text Block] Intangible Assets, Net Investments [Domain] Investments Accounting Standards Update 2020-06 [Member] ASU 2020-06 [Member] Inventory current and non current net. Inventory Current And Non Current Net Inventories Accrued rent, maintenance and utilities Rent Maintenance and Utilities Current and Noncurrent Rent maintenance and utilities current and noncurrent. Entity place of incorporation. Entity Place Of Incorporation Place of incorporation Area of Land Acres of land Assets, Current Total current assets Property, Plant and Equipment [Line Items] Property Plant And Equipment [Line Items] Formulations. Formulations [Member] Formulations [Member] Indefinite-Lived Intangible Assets [Axis] Indefinite-lived Intangible Assets Trademarks and Trade Names [Member] Trademarks and Trade Names Brands and Trademarks [Member] Indefinite-Lived Intangible Assets (Excluding Goodwill) Indefinite-lived intangible assets, Net Carrying Amount Indefinite-lived Intangible Assets (Excluding Goodwill), Beginning Balance Indefinite-lived Intangible Assets (Excluding Goodwill), Ending Balance Weighted average shares - Basic Weighted Average Number of Shares Outstanding, Basic, Total Weighted average number of common shares outstanding Weighted average number of common shares outstanding Operating Income (Loss) [Abstract] Operating expenses (income): City Area Code City Area Code Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate Intrinsic Value, Outstanding Balance Business Description and Basis of Presentation [Text Block] Description of Business and Basis of Presentation Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Shares Subject to Outstanding, Options Forfeited Share-Based Payment Arrangement [Abstract] January two thousand and twenty one offering. January Two Thousand And Twenty One Offering [Member] January 2021 Offering [Member] Liabilities Total liabilities Private Placement [Member] Purchase Agreement [Member] Document Period End Date Document Period End Date Investments and fair value of instruments disclosure. Investments And Fair Value Of Instruments Disclosure [Text Block] Investments and Fair Value Instruments Equity Method Investments and Joint Ventures Disclosure [Text Block] Consolidated Joint Venture Remaining contingent Remaining Contingent Liability Remaining contingent liability Schedule of Finite-Lived Intangible Assets [Table] Schedule Of Finite Lived Intangible Assets [Table] Construction in Progress [Member] Construction in Progress [Member] Finite lived intangible assets amortization expense after year four. Finite Lived Intangible Assets Amortization Expense After Year Four Thereafter New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements Or Change In Accounting Principle [Line Items] Lessee, Operating Lease, Renewal Term Option to extend lease, term Real Estate [Domain] Real Estate Finite-Lived Intangible Asset, Expected Amortization, Year One 2023 Statistical Measurement [Axis] Statistical Measurement Common stock warrants issued to placement agent and included in offering costs related to purchase agreement Warrant Issued Included In Offering Costs Warrant issued included in offering costs. Selling, general and administrative and research and development expenses. Selling General And Administrative And Research And Development Expenses [Member] SG&A and R&D Expenses [Member] Stockholders' Equity Attributable to Noncontrolling Interest Non-controlling interest Stockholders' Equity Attributable to Noncontrolling Interest, Total Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance Vehicles [Member] Vehicles [Member] Related Party [Axis] Related Party Assets Total assets Accounting Standards Update 2016-02 [Member] ASU 2016-02 June two thousand and nineteen offering. June Two Thousand And Nineteen Offering [Member] June 2019 Offering [Member] Diluted net loss per share attributable to common stockholders: Earnings Per Share, Diluted, Total Earnings Per Share, Diluted Assets Held-for-sale, Not Part of Disposal Group, Current, Total Assets Held-for-sale, Not Part of Disposal Group, Current Assets held for sale Schedule of Securities Not Included in Diluted per Share Calculations Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Anawah Inc. Anawah Inc [Member] Anawah, Inc [Member] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Ending Balance Beginning Balance Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] Common stock warrant liabilities reclassified to equity. Common stock warrant liabilities reclassified to equity Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity incorporation year of incorporation. Entity Incorporation Year Of Incorporation Year of incorporation March 2018 placement agent warrants. March2018 Placement Agent Warrants [Member] March 2018 Placement Agent Warrants [Member] Revision of Prior Period [Axis] Document Fiscal Period Focus Document Fiscal Period Focus Cost of revenues Cost of Goods and Services Sold Cost of Goods and Services Sold, Total Class of Warrant or Right [Table] Class Of Warrant Or Right [Table] Real Estate, Type of Property [Axis] Real Estate, Type of Property Increase (Decrease) in Accounts Receivable Accounts receivable Deferred Offering Costs Offering costs APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total Interest income (expense) Interest Income (Expense), Net Interest Income (Expense), Net, Total Counterparty Name [Domain] Counterparty Name Operating Lease, Liability Total leased liabilities Decrease in operating lease liability Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Schedule of finite and indefinite lived intangible assets. Schedule Of Finite And Indefinite Lived Intangible Assets Table [Text Block] Schedule of Intangible Assets, Net Impairment of Long-Lived Assets to be Disposed of Impairment of property and equipment Revision of Prior Period, Accounting Standards Update, Adjustment [Member] Reclassification upon Adoption [Member] Statement of Financial Position [Abstract] Number of development programs Number Of Technology Development Programs Number of technology development programs. Entity File Number Entity File Number John sperling foundation. John Sperling Foundation [Member] John Sperling Foundation [Member] Statement of Cash Flows [Abstract] Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process. Includes current and non-current inventory balances. Schedule Of Inventory Current And Non Current Table [Text Block] Summary of Inventories Sublease income Sublease Income Proceeds from sales and maturities of investments Proceeds from Sale, Maturity and Collection of Investments Proceeds from Sale, Maturity and Collection of Investments, Total Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrant issued, shares of common stock called by warrant Loans Insured or Guaranteed by Government Authorities [Axis] Loans Insured or Guaranteed by Government Authorities Class of Warrant or Right [Line Items] Class Of Warrant Or Right [Line Items] Loans Payable Loans Loans Payable, Total Geographical [Domain] Geographical Statistical Measurement [Domain] Statistical Measurement Statement of Stockholders' Equity [Abstract] Sale of Stock [Axis] Sale of Stock Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Employees are able to purchase company's common stock on first trading day of offering period, percentage March two thousand eighteen placement agent. March Two Thousand Eighteen Placement Agent [Member] March 2018 Placement Agent Warrants [Member] Equity Method Investment, Ownership Percentage Joint venture interest percentage Subsequent Events [Abstract] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Weighted-Average Exercise Price Per Share, Options expired July 2020 warrants. July2020 Warrants [Member] July 2020 Warrants [Member] Long-Term Debt, Type [Axis] Long-term Debt, Type Industrial seed innovations. Industrial Seed Innovations [Member] Industrial Seed Innovations [Member] Realized gain on corporate securities Realized gain on corporate securities Debt and Equity Securities, Realized Gain (Loss) Debt and Equity Securities, Realized Gain (Loss), Total Accounting Standards Update [Extensible Enumeration] Antidilutive Securities [Axis] June two thousand eighteen purchase agreement. June Two Thousand Eighteen Purchase Agreement [Member] June 2018 Purchase Agreement [Member] Line of Credit Facility, Maximum Borrowing Capacity Line of credit facility maximum borrowing capacity Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] Noncontrolling Interest, Increase from Sale of Parent Equity Interest Non-controlling interest capital contribution Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Summary of Warrants Issued to Purchase Common Stock 2022 (excluding the six months ended June 30, 2022) Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year January two thousand twenty one private placement. January Two Thousand Twenty One Private Placement [Member] January 2021 Private Placement [Member] Deposits Assets Deposit account Lessee, Lease, Description [Line Items] Lessee Lease Description [Line Items] Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Total consideration allocated Number of equity incentive plans. Number Of Equity Incentive Plans Number of equity incentive plans Subsequent Events [Text Block] Subsequent Events Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] Weighted average shares - Diluted Weighted average number of common shares outstanding - diluted Weighted average number of common shares outstanding - diluted Cash Equivalents [Member] Cash Equivalents [Member] Operating lease liabilities. Operating Lease Liabilities [Abstract] Liabilities Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name Corporate Debt Securities [Member] Corporate Securities [Member] Net loss Business Acquisition, Pro Forma Net Income (Loss) Net (loss) income June two thousand nineteen placement agent warrants. June Two Thousand Nineteen Placement Agent Warrants [Member] June 2019 Placement Agent Warrants [Member] Inducement stock option. Inducement Stock Option [Member] Inducement Stock Option [Member] January two thousand twenty one securities purchase purchase agreement. January Two Thousand Twenty One Securities Purchase Purchase Agreement [Member] January 2021 Purchase Agreement [Member] State or Country Name where an entity is re-incorporated. Entity Reincorporation State Country Name Place of reincorporation Current Fiscal Year End Date Current Fiscal Year End Date Registration Payment Arrangement, Term Registration statement expiration term Investment Type [Axis] Investment Type Bioceres Crop Solutions. Bioceres Crop Solutions [Member] Bioceres Crop Solutions [Member] August 2019 service and performance warrants. August2019 Service And Performance Warrants [Member] August 2019 Service and Performance Warrants [Member] Liability Class [Axis] Liability Class Depreciation Depreciation Depreciation, Total Depreciation expense Financial Instruments [Domain] Financial Instruments Basis of presentation and principles of consolidation. Basis Of Presentation And Principles Of Consolidation Policy Policy [Text Block] Basis of Presentation and Principles of Consolidation Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total Cash and cash equivalents - beginning of period Cash and cash equivalents - end of period Other Assets, Noncurrent Other noncurrent assets Other Assets, Noncurrent, Total Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Stockholders Equity, Ending Balance Stockholders Equity, Beginning Balance Total stockholders' equity Entity Address, Address Line One Entity Address, Address Line One Customer Lists [Member] Customer Lists [Member] Noncontrolling Interest [Member] Non-Controlling Interest [Member] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class Supplemental Cash Flow Information [Abstract] SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: January two thousand twenty one warrants. January Two Thousand Twenty One Warrants [Member] January 2021 Warrants [Member] Accounting Standards Update and Change in Accounting Principle [Text Block] Recent Accounting Pronouncements Royalty [Member] Royalty Income Tax Expense (Benefit) Income Tax Expense (Benefit), Total Income tax provision Business acquisition pro forma earnings per share basic and diluted. Business Acquisition Pro Forma Earnings Per Share Basic And Diluted Basic and diluted Income Tax Disclosure [Text Block] Income Taxes Balance Sheet Location [Domain] Balance Sheet Location Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment, Total Indefinite lived intangible assets excluding goodwill gross. Indefinite Lived Intangible Assets Excluding Goodwill Gross Indefinite-lived intangible assets, Gross Carrying Amount Income Tax Disclosure [Abstract] Change in Accounting Principle, Accounting Standards Update, Adoption Date Change in accounting principle, accounting standards update, adoption date Measurement Input, Expected Dividend Rate [Member] Expected Dividend Yield [Member] Stock Issued During Period, Shares, New Issues Issuance of shares, Shares Shares of common stock issued Proceeds from issuance of common stock and warrants gross. Proceeds From Issuance Of Common Stock And Warrants Gross Proceeds from issuance of common stock and warrants gross MidFirst Bank. Mid First Bank [Member] MidFirst Bank [Member] Assets, Fair Value Disclosure [Abstract] Assets at Fair Value Costs and Expenses Total operating expenses Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV January two thousand twenty one placement agent warrants. January Two Thousand Twenty One Placement Agent Warrants [Member] January 2021 Placement Agent Warrants [Member] Goodwill and Intangible Assets Disclosure [Abstract] Equity [Abstract] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted-Average Exercise Price Per Share, Options forfeited Other noncurrent liabilities Increase (Decrease) in Other Noncurrent Liabilities Operating Income (Loss) Loss from operations Debt Instrument, Interest Rate, Stated Percentage Interest rate Archipelago Ventures Hawaii, LLC. Archipelago Ventures Hawaii L L C [Member] Archipelago Ventures Hawaii, LLC [Member] Lessee, Operating Lease, Option to Extend Lease option to extend, description Related Party [Domain] Related Party Additional Paid in Capital, Common Stock Additional paid-in capital Additional Paid in Capital, Common Stock, Beginning Balance Additional Paid in Capital, Common Stock, Ending Balance March two thousand eighteen securities purchase agreement. March Two Thousand Eighteen Securities Purchase Agreement [Member] March 2018 Purchase Agreement [Member] Acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Payments to Acquire Businesses, Net of Cash Acquired, Total Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award Terms under the plan Collaborative Arrangement and Arrangement Other than Collaborative [Table] Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table] Legacy Ventures Hawaii, LLC. Legacy Ventures Hawaii L L C [Member] Legacy Ventures Hawaii, LLC [Member] Class of Warrant or Right [Domain] Class of Warrant or Right Entity Filer Category Entity Filer Category Schedule of Equity Method Investments [Line Items] Schedule Of Equity Method Investments [Line Items] Proceeds from issuance of common stock and warrants from Offering. Proceeds From Issuance Of Common Stock And Warrants From Offering Proceeds from issuance of common stock and warrants from offering Number of annual installment of common stock, shares payable. Number Of Annual Installment Of Common Stock Shares Payable Number of annual installment of common stock shares payable Number of annual installment of common stock shares payable Increase Decrease in Operating Lease Payments. Increase Decrease In Operating Lease Payments Operating lease payments Fair Value by Liability Class [Domain] Fair Value by Liability Class Entity Current Reporting Status Entity Current Reporting Status Asset Class [Domain] Asset Class Inventory, Net Inventories, net — current Inventory, Net, Total Inventory, Noncurrent Inventories, net — noncurrent Inventory, Noncurrent, Total Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Aggregate Intrinsic Value, Exercisable Common Stock Warrant Liability [Member] Common stock warrant liability. Common Stock Warrant Liability [Member] Impairment charges Asset Impairment Charges Asset Impairment Charges, Total Inventory Disclosure [Text Block] Inventory Operating lease assets. Operating Lease Assets Total leased assets Stockholders' Equity Note Disclosure [Text Block] Equity Financing Organization policy. Organization Policy Policy [Text Block] Organization Business Combinations [Abstract] Finite-Lived Intangible Assets, Net Finite-Lived Intangible Assets, Net, Beginning Balance Finite-Lived Intangible Assets, Net, Ending Balance Finite-Lived Intangible Assets, Net, Total Total stockholders' equity Stockholders' Equity Attributable to Parent Stockholders' Equity Attributable to Parent, Beginning Balance Stockholders' Equity Attributable to Parent, Ending Balance Accumulated Other Comprehensive Loss [Member] AOCI Attributable to Parent [Member] Short-Term Investments [Member] Short-term Investments [Member] Effects of foreign currency translation on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total Asset Class [Axis] Asset Class Long-Term Debt, Maturity, Year Two 2023 Entity Tax Identification Number Entity Tax Identification Number Income Statement Location [Axis] Income Statement Location Common stock, $0.001 par value - 150,000,000 shares authorized as of June 30, 2022 and December 31, 2021; 22,188,918 and 22,184,235 shares issued and outstanding as of March 31,2022 and December 31, 2021, respectively Common Stock, Value, Issued Common Stock, Value, Issued, Total Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Ending Balance Retained Earnings (Accumulated Deficit) Accumulated deficit Retained Earnings (Accumulated Deficit), Total Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Ending Balance Line of credit facility agreement date. Line Of Credit Facility Agreement Date Line of credit facility agreement date Equity Components [Axis] Additional Paid-In Capital [Member] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease), Total Change in fair value of contingent consideration Business Combination, Acquisition Related Costs Acquisition related costs Accrued salaries Accrued Salaries Accounting Standards Update [Domain] Collaborative arrangements, copromotion. Collaborative Arrangements Copromotion [Member] Collaborative Arrangements [Member] Customer Relationships [Member] Customer List [Member] Employee stock purchase plan offering period. Employee Stock Purchase Plan Offering Period Purchase plan offering period Equity Method Investments and Joint Ventures [Abstract] September 2019 placement agent warrants. September2019 Placement Agent Warrants [Member] September 2019 Placement Agent Warrants [Member] Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total Entity Emerging Growth Company Entity Emerging Growth Company Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss Investment in continuous unrealized loss position for more than twelve months Schedule of Business Acquisitions, by Acquisition [Table] Schedule Of Business Acquisitions By Acquisition [Table] Achievement of Revenue Milestone in 2022. Achievement Of Revenue Milestone In2022 [Member] Revenue Milestone in 2022 [Member] Measurement Input, Price Volatility [Member] Expected Volatility [Member] Expected Volatility [Member] Finite and indefinite lived intangible assets. Finite And Indefinite Lived Intangible Assets [Line Items] Finite And Indefinite Lived Intangible Assets [Line Items] Arcadia Wellness limited liability company. Arcadia Wellness Limited Liability Company [Member] Arcadia Wellness [Member] Commitments and contingencies table. Commitments And Contingencies [Table] Commitments And Contingencies [Table] Arcadia Wellness Transaction [Member] Arcadia wellness transaction. Adjustments to Additional Paid in Capital, Warrant Issued Issuance of placement agent warrants Noninterest Expense Offering Cost Issuance and offering costs Offering costs allocated to common stock warrant liability and expensed Issuance and offering costs Contractual agreement month and year. Contractual Agreement Month And Year Contractual agreement month and year Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected term (years) Two thousand fifteen omnibus equity incentive plan. Two Thousand Fifteen Omnibus Equity Incentive Plan [Member] 2015 Omnibus Equity Incentive Plan [Member] Business combination recognized identifiable assets acquired and liabilities assumed customer list. Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Customer List Customer list Net loss per share attributable to common stockholders: Net Income (Loss) Available to Common Stockholders, Basic, Operations [Abstract] Document Transition Report Document Transition Report Business combination consideration transferred remaining amount. Business Combination Consideration Transferred Remaining Amount Remaining amount paid in multiple installments Number of installment become due within twelve months as full amount contingent consideration included in other noncurrent liabilities. Number Of Installment Become Due Within Twelve Months As Full Amount Contingent Consideration Included In Other Noncurrent Liabilities Number of installment become due within 12 months as full amount contingent consideration included in other noncurrent liabilities Assets, Fair Value Disclosure Total Assets at Fair Value Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Prepaid and other current assets Long-Term Debt, Maturity, Year Three 2024 Accounting Standards Update 2020-06 Retrospective [Member] Accounting Standards Update 2020-06 [Member] Collaborative Arrangement Disclosure [Text Block] Collaborative Arrangements Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted-Average Exercise Price Per Share, Options exercised Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accounts receivable, net of allowance for doubtful accounts of $89 and $76 as of June 30, 2022 and December 31, 2021, respectively Accounts Receivable, after Allowance for Credit Loss, Current Accounts Receivable, after Allowance for Credit Loss, Current, Total Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Other Comprehensive loss Other comprehensive loss Other Comprehensive Income (Loss), Net of Tax Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table] Net loss per share attributable to common stockholders: Earnings Per Share Reconciliation [Abstract] Revision of Prior Period [Domain] Debt and equity securities accumulated gross unrealized gain before tax. Debt And Equity Securities Accumulated Gross Unrealized Gain Before Tax Unrealized Gains Net loss attributable to common stockholders Net Income (Loss) Attributable to Parent Net income attributable to common stockholders Net loss attributable to common stockholders Inventory finished goods current and non-current. Inventory Finished Goods Current And Non Current Finished goods Operating Lease, Liability, Current Current - Operating Operating lease liability — current Achievement of Revenue Milestone in 2021. Achievement Of Revenue Milestone In2021 [Member] Revenue Milestone in 2021 [Member] Business combination recognized identifiable assets acquired and liabilities assumed formulations. Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Formulations Formulations Operating lease term, expiration Operating Lease Term Expiration Month and Year Operating lease term expiration month and year. Additional Paid-in Capital [Member] Additional Paid-In Capital [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative Noncontrolling Interest, Increase from Subsidiary Equity Issuance Non-controlling interest contributions Shares of common stock issued at closing of Arcadia Wellness transaction Stock Issued Schedule of Maturities of Long-Term Debt [Table Text Block] Schedule of Maturities of Current and Noncurrent Debt Accounting Standards Update 2021-04 [Member] Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Summary of Warrant Liabilities Measured and Recorded on Recurring Basis using Black-Scholes Model Entity Registrant Name Entity Registrant Name Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total Number of development programs ceased Number Of Technology Development Programs Ceased Number of technology development programs ceased. Accounts Receivable, Allowance for Credit Loss, Current Allowance for doubtful accounts Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Ending Balance Net Loss per Share Earnings Per Share [Text Block] Net (Loss) Income per Share Disclosure of compensation related costs share based payments and warrants. Disclosure Of Compensation Related Costs Share Based Payments And Warrants [Abstract] Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Weighted-Average Fair Value Assumption of Stock Option Awards Debt Instrument, Maturity Date Debt instrument maturity date Lessee, Lease, Description [Table] Lessee Lease Description [Table] Chesterfield and Chatsworth. Chesterfield And Chatsworth [Member] Chesterfield, MO And Chatsworth, CA [Member] Share-Based Payment Arrangement, Noncash Expense Stock-based compensation Share-based Payment Arrangement, Noncash Expense, Total Property, Plant and Equipment, Net Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net, Beginning Balance Property, Plant and Equipment, Net, Ending Balance Award Type [Domain] Award Type Statement [Line Items] Statement [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Weighted Average Exercise Price Per Share, Vested and expected to vest December 2020 warrants. December Two Thousand Twenty Warrants [Member] December 2020 Warrants [Member] Title of 12(b) Security Title of 12(b) Security Finite-Lived Intangible Assets, Gross Amortized intangible assets, Gross Carrying Amount Finite-Lived Intangible Assets, Gross, Total Ownership [Domain] Ownership Common Stock [Member] Common Stock [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Options exercisable period Net Cash Provided by (Used in) Operating Activities [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: July two thousand and twenty warrants transaction. July Two Thousand And Twenty Warrants Transaction Member July 2020 Warrants Transaction [Member] Equity Component [Domain] Equity Component License revenue Revenue from Contract with Customer, Excluding Assessed Tax Total revenues Revenue from Contract with Customer, Excluding Assessed Tax, Total Entity Address, State or Province Entity Address, State or Province Geographical [Axis] Geographical Warrant expiration month and year. Warrant Expiration Month and Year Warrant expiration month and year Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net (decrease) increase in cash and cash equivalents Document Type Document Type Interest Paid, Excluding Capitalized Interest, Operating Activities Cash paid for interest Business Acquisition, Pro Forma Information [Table Text Block] Schedule of Unaudited Pro-forma Condensed Consolidated Results of Operations Entity Shell Company Entity Shell Company Class of Warrant or Right, Outstanding Warrants Outstanding Remaining contingent liability Business Combination, remaining Contingent Liability Business Combination, remaining contingent liability. Increase (Decrease) in Inventories Inventories Increase (Decrease) in Inventories, Total June 2019 placement agent warrants. June2019 Placement Agent Warrants [Member] June 2019 Placement Agent Warrants [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value, Recurring and Nonrecurring [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Security Exchange Name Security Exchange Name Arcadia Biosciences incorporation. Arcadia Biosciences Incorporation [Member] Arcadia Biosciences, Inc [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Net Cash Provided by (Used in) Operating Activities Net cash used in operations Net cash used in operating activities Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted-average remaining recognition period Number of lease amendments. Number Of Lease Amendments Number of lease amendments Other Comprehensive Income (Loss), Net of Tax [Abstract] Payments to Acquire Businesses, Gross Cash paid for Acquisition Commitments and Contingencies Disclosure [Abstract] June two thousand eighteen warrants. June Two Thousand Eighteen Warrants [Member] June 2018 Warrants [Member] Measurement Input, Expected Term [Member] Remaining Term [Member] Operating Lease, Cost Operating lease cost Operating lease cost May two thousand and twenty warrant transaction. May Two Thousand And Twenty Warrant Transaction [Member] May 2020 Warrant Transaction [Member] Separation Agreement [Member] Separation Agreement [Member] Separation agreement. Business Acquisition, Pro Forma Revenue Total revenues Warrant [Member] Warrants [Member] Warrants to Purchase Common Stock [Member] Share-Based Payment Arrangement, Option, Activity [Table Text Block] Summary of Activity Under Stock Incentive Plans Common Stock, Shares, Outstanding Common stock, outstanding Common Stock, Shares, Outstanding, Beginning Balance Common Stock, Shares, Outstanding, Ending Balance Business Acquisition [Line Items] Business Acquisition [Line Items] Debt Disclosure [Text Block] Debt Fair Value, Inputs, Level 2 [Member] Level 2 [Member] Net Cash Provided by (Used in) Investing Activities [Abstract] CASH FLOWS FROM INVESTING ACTIVITIES: Promissory note. Promissory Note [Member] Promissory Notes [Member[ Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Schedule of Future Amortization of Intellectual Property and Customer Lists Commitments and Contingencies Commitments and contingencies (Note 17) Common Stock, Shares, Issued Common stock, issued Common Stock, Shares, Issued, Total Due to Related Parties, Current Amounts due to related parties Royalty fees due Due to Related Parties, Current, Total September 2019 warrants. September Two Thousand Nineteen Warrants [Member] September 2019 Warrants [Member] Minimum [Member] Minimum [Member] Warrants expiration period. Warrants Expiration Period Warrants expiration period Long term debt maturities repayments of principal after year four. Long Term Debt Maturities Repayments Of Principal After Year Four Thereafter Schedule of operating lease. Schedule Of Operating Lease Table [Text Block] Schedule of Leases Debt and equity securities. Debt And Equity Securities Estimated Fair Value Number of individuals appointed. Number Of Individuals Appointed Number of individuals appointed Restricted cash. Restricted Cash [Member] Restricted Cash [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted Average Exercise Price Per Share, Exercisable Repayments of Lines of Credit Repayments of line of credit Accounting Standards Update [Axis] Summary of amortized cost and fair value of investment securities. Summary Of Amortized Cost And Fair Value Of Investment Securities Table [Text Block] Summary of Amortized Cost and Fair Value of Investment Securities Portfolio Debt Instrument [Axis] Debt Instrument Stockholders' Equity Attributable to Parent [Abstract] Stockholders’ equity: Schedule of Available-for-Sale Securities [Table] Schedule Of Available For Sale Securities [Table] March 2020 service and performance warrants. March2020 Service And Performance Warrants [Member] March 2020 Service and Performance Warrants [Member] Counterparty Name [Axis] Counterparty Name Entity Address, Address Line Two Entity Address, Address Line Two Debt and equity securities current. Debt And Equity Securities Current Short-term investments Revenues [Abstract] Revenues: Product [Member] Product Amortization of Intangible Assets Amortization of intangible assets Amortization of Intangible Assets, Total Award Type [Axis] Award Type Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Unrecognized compensation cost related to unvested stock-based compensation grants Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Business Combination, Consideration Transferred Purchase price consideration Business Combination, Consideration Transferred, Total Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Intrinsic value of options exercised Other (expense) income, net Other Nonoperating Income (Expense) Other Nonoperating Income (Expense), Total Research and Development Expense Research and development Research and Development Expense, Total Lessee, Operating Lease, Term of Contract Operating leases, term of contract Offering closing period. Offering Closing Period Offering closing period Entity Central Index Key Entity Central Index Key Finite-Lived Intangible Assets [Line Items] Finite Lived Intangible Assets [Line Items] Accounting Policies [Abstract] Investments, Debt and Equity Securities [Abstract] Debt Securities, Available-for-Sale [Line Items] Schedule Of Available For Sale Securities [Line Items] February 3, 2020 service and performance warrants. February32020 Service And Performance Warrants [Member] February 3, 2020 Service and Performance Warrants [Member] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Property, Plant and Equipment [Table] Schedule Of Property Plant And Equipment [Table] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Two thousand six stock incentive plan. Two Thousand Six Stock Incentive Plan [Member] 2006 Stock Incentive Plan [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Common stock available for future grant Share-Based Payment Arrangement [Text Block] Stock-Based Compensation and Employee Stock Purchase Program Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Aggregate Intrinsic Value, Vested and expected to vest Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Change in fair value of contingent consideration Measurement Input Type [Domain] Measurement Input Type Organization, Consolidation and Presentation of Financial Statements [Abstract] Accounts receivable written-down Accounts Receivable Written-down Accounts receivable written-down. Schedule of Equity Method Investments [Table] Schedule Of Equity Method Investments [Table] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted Average Exercise Price Per Share, Outstanding Ending Balance Weighted-Average Exercise Price Per Share, Outstanding Beginning Balance Research and Development Expense [Member] R&D Expenses [Member] Warrants and Rights Outstanding, Measurement Input Warrants and rights outstanding, measurement input Cash shares and royalty receivable cash shares and royalty receivable from sale of interest in joint venture cash shares and royalty receivable from sale of interest in joint venture Lease, Cost Net lease cost Net lease cost Indefinite lived intangible assets accumulated amortization and impairment. Indefinite Lived Intangible Assets Accumulated Amortization And Impairment Indefinite-lived intangible assets, Accumulated Amortization and Impairment Right of use assets obtained in exchange for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to cash used in operating activities: Operating lease assets. Operating Lease Assets [Abstract] Assets Warrants and rights note disclosure. Warrants And Rights Note Disclosure [Text Block] Warrants Retained Earnings [Member] Accumulated Deficit [Member] Common stock warrant liabilities. Common Stock Warrant Liabilities Common stock warrant liabilities Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Business combination, equity interest issuable, shares Contingent liabilities. Contingent Liabilities [Member] Contingent Liabilities [Member] Money Market Funds [Member] Money Market Funds [Member] Measurement Input Type [Axis] Measurement Input Type Effective Income Tax Rate Reconciliation, Percent Effective tax rate Effective Income Tax Rate Reconciliation, Percent, Total Gain (Loss) on Disposition of Property Plant Equipment, Total Gain (Loss) on Disposition of Property Plant Equipment Gain on sale of property and equipment Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Business combination, equity interest issuable, value Property, Plant and Equipment, Gross Property and equipment, gross Property, Plant and Equipment, Gross, Total Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Ending Balance Investments and fair value instruments. Investments And Fair Value Instruments [Abstract] Business combination recognized identifiable assets acquired and liabilities assumed deposits. Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deposits Deposits Debt and equity securities amortized cost basis. Debt And Equity Securities Amortized Cost Basis Amortized Cost Entity Interactive Data Current Entity Interactive Data Current Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Shares Subject to Outstanding, Vested and expected to vest March two thousand eighteen P I P E. March Two Thousand Eighteen P I P E Member March 2018 PIPE [Member] Related Party Transactions Disclosure [Text Block] Related-Party Transactions May 2020 warrants. May2020 Warrants [Member] May 2020 Warrants [Member] Class of warrant or right exercisable term. Class Of Warrant Or Right Exercisable Term Warrant, exercisable term Assets Held-for-sale, Not Part of Disposal Group, Total Assets Held-for-sale, Not Part of Disposal Group Assets held for sale Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Intangible assets, net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total Early termination fees Payments for Termination Fees Payments for termination fees. Related Party Transactions [Abstract] Bad debt expense Accounts Receivable, Credit Loss Expense (Reversal) Leasehold Improvements [Member] Leasehold improvements [Member] Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Remaining offering costs allocated to common stock and offset to additional paid in capital Offering costs Decrease in common stock warrant liabilities. Decrease in Common Stock Warrant Liabilities Decrease in common stock warrant liabilities License [Member] License Proceeds from Issuance Initial Public Offering Proceeds from issuance, aggregate offering prices Local Phone Number Local Phone Number Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Federal statutory tax rate Property and equipment classified as assets held for sale, fair value Unrecognized Tax Benefits Uncertain tax positions Unrecognized Tax Benefits, Beginning Balance Unrecognized Tax Benefits, Ending Balance Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Schedule of Allocation Purchase Price of Assets Acquired at Fair Value at Acquisition Date July two thousand twenty warrants. July Two Thousand Twenty Warrants [Member] July 2020 Warrants [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Options vesting period Debt Disclosure [Abstract] Net Income (Loss) Attributable to Noncontrolling Interest Net Income (Loss) Attributable to Noncontrolling Interest, Total Net loss attributable to non-controlling interest Net loss attributable to noncontrolling interest Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Shares Subject to Outstanding, Exercisable Warrants and Rights Note Disclosure [Abstract] Lender Name [Axis] Lender Name Lessee, Operating Lease, Existence of Option to Extend [true false] Existence of option to extend Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Shares Subject to Outstanding, Options granted Options granted Other Liabilities, Noncurrent Other noncurrent liabilities Other noncurrent liability Other Liabilities, Noncurrent, Total Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Summary of Changes in Fair Value and Other Adjustments of Liabilities Gain on sale of Verdeca Gain on sale of Verdeca Equity Method Investment, Realized Gain (Loss) on Disposal Income Statement Location [Domain] Income Statement Location Measurement Input, Risk Free Interest Rate [Member] Risk-Free Interest Rate [Member] Risk-Free Interest Rate [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Shares Subject to Outstanding, Options Expired Long-Term Debt, Maturity, Year One 2022 Selling, General and Administrative Expenses [Member] Selling, General and Administrative Expenses [Member] SG&A Expenses [Member] Property, Plant and Equipment [Abstract] March 2018 warrants. March Two Thousand Eighteen Warrants [Member] March 2018 Warrants [Member] Long-Term Debt Total Shares, Outstanding Stockholders Equity, Ending Balance, Shares Stockholders Equity, Beginning Balance, Shares Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets, Total Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Inventory Disclosure [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Shares Subject to Outstanding, Ending Balance Shares Subject to Outstanding, Beginning Balance Total number of options outstanding Debt Instrument, Name [Domain] Debt Instrument, Name Document Fiscal Year Focus Document Fiscal Year Focus Total intangible asset, Net Carrying Amount Intangible Assets, Net (Excluding Goodwill) Intangible assets, net Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Summary of Fair Value of Investment Securities Class of Warrant or Right [Axis] Class of Warrant or Right Basic net loss per share attributable to common stockholders: Earnings Per Share, Basic, Total Earnings Per Share, Basic Cash paid for income taxes Income Taxes Paid September two thousand and nineteen offering. September Two Thousand And Nineteen Offering [Member] September 2019 Offering [Member] Assets [Abstract] Assets Additional cash receivable from sale of interest in joint venture. Additional Cash Receivable From Sale Of Interest In Joint Venture Additional cash receivable from sale of interest in joint venture September Two Thousand Nineteen Placement Agent Warrant. September Two Thousand Nineteen Placement Agent Warrant [Member] September 2019 Placement Agent Warrants [Member] Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Liquidity capital resources and going concern. Liquidity Capital Resources And Going Concern Policy Policy [Text Block] Liquidity, Capital Resources, and Going Concern Debt Instrument, Face Amount Debt instrument, face amount Stock issued during period shares related to exercise of warrants. Investors exercised warrants and purchase shares of common stock Stock Issued During Period Shares Related To Exercise Of Warrants Warrants Exercised during the Year Financial Instrument [Axis] Financial Instrument Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset Liabilities and Equity [Abstract] Liabilities and stockholders’ equity Paycheck protection program. Paycheck Protection Program [Member] Paycheck Protection Program [Member] Impairment of intangible assets Impairment of Intangible Assets, Finite-Lived Impairment of intangible asset July 2019 service and performance warrants. July2019 Service And Performance Warrants [Member] July 2019 Service and Performance Warrants [Member] Antidilutive Securities, Name [Domain] February 12, 2020 service and performance warrants. February122020 Service And Performance Warrants [Member] February 12, 2020 Service and Performance Warrants [Member] Net income (loss) Net loss Net loss Net (loss) income Intellectual property and customer lists. Intellectual Property And Customer Lists [Member] Intellectual Property and Customer Lists [Member] Assets, Current [Abstract] Current assets: Finite-Lived Intangible Asset, Expected Amortization, Year Four 2026 March two thousand eighteen private placement. March Two Thousand Eighteen Private Placement [Member] March 2018 Private Placement [Member] Finite-Lived Intangible Asset, Expected Amortization, Year Two 2024 Loans Insured or Guaranteed by Government Authorities [Domain] Loans Insured or Guaranteed by Government Authorities Class of Warrant or Right, Exercise Price of Warrants or Rights Warrants issued, exercise price Exercise Price Per Share Radiance Beauty Licensing Agreement [Member] Radiance Beauty Licensing Agreement [Member] Radiance beauty licensing agreement. Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV Inventories written down Inventory Write-down Write-down of inventory Restructuring and Related Activities, Description Restructuring activities, description June two thousand eighteen placement agent warrants. June Two Thousand Eighteen Placement Agent Warrants [Member] June 2018 Placement Agent Warrants [Member] Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Repayments of Notes Payable Principal payments on debt Related Party Transaction [Line Items] Related Party Transaction [Line Items] Lease, Cost [Abstract] Lease Cost Business combination, equity interest issuable upon achievement of revenue milestone share. Business Combination Equity Interest Issuable Upon Achievement Of Revenue Milestone Share Business combination, equity interest issuable upon achievement of revenue milestone Cover [Abstract] Product and Service [Domain] Product and Service Accounting Changes and Error Corrections [Abstract] Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Weighted average useful life Verdeca LLC. Verdeca L L C [Member] Verdeca LLC [Member] Net loss before income taxes Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net January two thousand and twenty one PIPE. January Two Thousand And Twenty One P I P E [Member] January 2021 PIPE [Member] Liabilities, Current [Abstract] Current liabilities: April 2019 service and performance warrants. April2019 Service And Performance Warrants [Member] April 2019 Service and Performance Warrants [Member] Maximum [Member] Maximum [Member] Maximum [Member] Warrants and Rights Outstanding, Term Remaining term (in years) Term Finite and indefinite lived intangible assets. Finite And Indefinite Lived Intangible Assets [Table] Finite And Indefinite Lived Intangible Assets [Table] June 2019 warrants. June Two Thousand Nineteen Warrants [Member] June 2019 Warrants [Member] Net Cash Provided by (Used in) Investing Activities Net cash provided by (used in) investing activities Furniture and Fixtures [Member] Furniture and fixtures [Member] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Issuance of shares related to employee stock option exercises, Shares Shares Subject to Outstanding, Options exercised Schedule of property plant and equipment. Schedule Of Property Plant And Equipment Table [Text Block] Summary of Property and Equipment, Net Fair Value, Inputs, Level 3 [Member] Level 3 [Member] Accounts Payable and Accrued Liabilities, Current Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities, Current, Total Commitments and contingencies line items. Commitments And Contingencies [Line Items] Commitments And Contingencies [Line Items] Long-Term Debt, Maturity, Remainder of Fiscal Year Remainder of 2021 Net loss attributable to common stockholders Business acquisition net income loss attributable to common stockholders. Business Acquisition Net Income Loss Attributable To Common Stockholders Net (loss) income attributable to common stockholders January two thousand twenty one service and performance warrants. January Two Thousand Twenty One Service And Performance Warrants [Member] January 2021 Service and Performance Warrants [Member] Finite-Lived Intangible Asset, Expected Amortization, Year Three 2025 Common Stock, Shares Authorized Common stock, authorized Trading Symbol Trading Symbol Ownership [Axis] Ownership Selling, General and Administrative Expense Selling, general and administrative Selling, General and Administrative Expense, Total President and Chief Executive Officer [Member] President and Chief Executive Officer [Member] Stanley Jacot, Jr. [Member] Title of Individual [Domain] Title of Individual Operating Lease, Right-of-Use Asset, Amortization Expense Lease amortization Debt Instrument, Interest Rate Terms Debt instrument interest rate terms Balance Sheet Location [Axis] Balance Sheet Location Comprehensive loss attributable to common stockholders Comprehensive loss attributable to common stockholders Comprehensive Income (Loss), Net of Tax, Attributable to Parent Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Proceeds from Sale of Property, Plant, and Equipment Proceeds from Sale of Property, Plant, and Equipment, Total Proceeds from sale of property and equipment Plan Name [Axis] Plan Name Schedule of Related Party Transactions, by Related Party [Table] Schedule Of Related Party Transactions By Related Party [Table] Title of Individual [Axis] Title of Individual Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset Common Stock, Par or Stated Value Per Share Common stock, par value (Gain) loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Stock Issued During Period, Shares, Acquisitions Issuance of common stock at closing of acquisition transaction, Shares Unrealized Gain (Loss) on Securities Unrealized gains on corporate securities Stock Issued During Period, Value, Acquisitions Issuance of common stock at closing of acquisition transaction Line of Credit Facility, Initiation Date Line of credit facility initiation date Property, Plant and Equipment Disclosure [Text Block] Property and Equipment, Net Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted-Average Exercise Price Per Share, Options granted Effective rate of royalty of gross sales Effective rate of royalty of gross sales Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Additional shares authorized for issuance under the plan Debt Instrument [Line Items] Debt Instrument [Line Items] Long-Term Debt, Type [Domain] Long-term Debt, Type Antidilutive securities not included in the diluted per share calculations, amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Indefinite-Lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents Royalty Payments Due, Percentage Of Net Revenue As Defined In Agreements Royalty Payments Due Percentage Of Net Revenue As Defined In Agreements Royalty payments due, percentage of net revenue as defined in the In-Licensing agreements Increase (Decrease) in Other Noncurrent Assets Other noncurrent assets Noncash Investing and Financing Items [Abstract] NONCASH INVESTING AND FINANCING ACTIVITIES: XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2022
Aug. 08, 2022
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q2  
Entity Registrant Name Arcadia Biosciences, Inc.  
Entity Central Index Key 0001469443  
Entity Current Reporting Status Yes  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Common Stock, Shares Outstanding   22,192,960
Entity Shell Company false  
Entity Emerging Growth Company false  
Entity Small Business true  
Entity File Number 001-37383  
Entity Tax Identification Number 81-0571538  
Entity Address, Address Line One 202 Cousteau Place  
Entity Address, Address Line Two Suite 105  
Entity Address, City or Town Davis  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 95618  
City Area Code 530  
Local Phone Number 756-7077  
Entity Incorporation, State or Country Code DE  
Trading Symbol RKDA  
Title of 12(b) Security Common  
Security Exchange Name NASDAQ  
Entity Interactive Data Current Yes  
Document Quarterly Report true  
Document Transition Report false  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 21,234 $ 28,685
Accounts receivable, net of allowance for doubtful accounts of $89 and $76 as of June 30, 2022 and December 31, 2021, respectively 3,854 1,370
Inventories, net — current 3,275 4,433
Assets held for sale 254  
Prepaid expenses and other current assets 1,441 900
Total current assets 30,058 35,388
Property and equipment, net 954 2,291
Right of use asset 2,308 3,081
Inventories, net — noncurrent 1,136 2,494
Intangible assets, net 386 484
Other noncurrent assets 166 180
Total assets 35,008 43,918
Current liabilities:    
Accounts payable and accrued expenses 3,391 3,638
Amounts due to related parties 83 64
Operating lease liability — current 994 1,074
Other current liabilities 272 264
Total current liabilities 4,740 5,040
Operating lease liability — noncurrent 1,500 2,220
Common stock warrant liabilities   3,392
Other noncurrent liabilities 2,000 2,070
Total liabilities 8,240 12,722
Commitments and contingencies (Note 17)
Stockholders’ equity:    
Common stock, $0.001 par value - 150,000,000 shares authorized as of June 30, 2022 and December 31, 2021; 22,188,918 and 22,184,235 shares issued and outstanding as of March 31,2022 and December 31, 2021, respectively 63 63
Additional paid-in capital 277,492 257,515
Accumulated deficit (250,748) (226,485)
Total stockholders' equity 26,807 31,093
Non-controlling interest (39) 103
Total stockholders' equity 26,768 31,196
Total liabilities and stockholders’ equity $ 35,008 $ 43,918
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 89 $ 76
Common stock, par value $ 0.001 $ 0.001
Common stock, authorized 150,000,000 150,000,000
Common stock, issued 22,188,918 22,184,235
Common stock, outstanding 22,188,918 22,184,235
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenues:        
Total revenues $ 3,858,000 $ 1,405,000 $ 7,078,000 $ 2,234,000
Operating expenses (income):        
Cost of revenues 3,447,000 1,587,000 6,906,000 2,443,000
Research and development 359,000 1,131,000 754,000 2,290,000
Gain on sale of Verdeca (1,138,000)   (1,138,000)  
Impairment of intangible asset 72,000   72,000  
Change in fair value of contingent consideration (39,000)   (70,000) (140,000)
Impairment of property and equipment 346,000   346,000 210,000
(Gain) loss on disposal of property and equipment (58,000)   (386,000) 135,000
Selling, general and administrative 4,652,000 6,370,000 9,000,000 10,439,000
Total operating expenses 7,641,000 9,088,000 15,484,000 15,243,000
Loss from operations (3,783,000) (7,682,000) (8,406,000) (13,009,000)
Interest income (expense) 30,000 (1,000) 29,000 (8,000)
Other (expense) income, net (44,000) 2,759,000 (3,000) 10,222,000
Change in fair value of common stock warrant liabilities   (498,000)   (176,000)
Issuance and offering costs     (27,000) (769,000)
Net loss before income taxes (3,797,000) (5,422,000) (8,407,000) (3,740,000)
Income tax provision 0 0 0 0
Net loss (3,797,000) (5,422,000) (8,407,000) (3,740,000)
Net loss attributable to non-controlling interest (20,000) (161,000) (142,000) (538,000)
Net loss attributable to common stockholders $ (3,777,000) $ (5,261,000) $ (8,265,000) $ (3,202,000)
Net loss per share attributable to common stockholders:        
Basic net loss per share attributable to common stockholders: $ (0.17) $ (0.24) $ (0.37) $ (0.15)
Diluted net loss per share attributable to common stockholders: $ (0.17) $ (0.24) $ (0.37) $ (0.15)
Denominator:        
Weighted average number of common shares outstanding 22,188,918 21,745,403 22,187,961 21,271,960
Weighted average number of common shares outstanding - diluted 22,188,918 21,745,403 22,187,961 21,271,960
Other Comprehensive Income (Loss), Net of Tax [Abstract]        
Foreign currency translation adjustment   $ (12,000)   $ (12,000)
Other Comprehensive loss   (12,000)   (12,000)
Comprehensive loss attributable to common stockholders $ (3,777,000) (5,273,000) $ (8,265,000) (3,214,000)
Product        
Revenues:        
Total revenues 2,946,000 1,379,000 6,116,000 2,183,000
License        
Revenues:        
Total revenues 862,000   862,000  
Royalty        
Revenues:        
Total revenues $ 50,000 $ 26,000 $ 100,000 $ 51,000
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Arcadia Wellness [Member]
January 2021 PIPE [Member]
Common Stock [Member]
Common Stock [Member]
Arcadia Wellness [Member]
Common Stock [Member]
January 2021 PIPE [Member]
Additional Paid-In Capital [Member]
Additional Paid-In Capital [Member]
Arcadia Wellness [Member]
Additional Paid-In Capital [Member]
January 2021 PIPE [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Non-Controlling Interest [Member]
Stockholders Equity, Beginning Balance at Dec. 31, 2020 $ 28,552     $ 54     $ 239,496     $ (211,825)   $ 827
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2020       13,450,861                
Issuance of shares     $ 15,516     $ 8     $ 15,508      
Issuance of shares, Shares           7,876,784            
Offering costs     (2,084)           (2,084)      
Issuance of placement agent warrants     $ 942           $ 942      
Issuance of shares related to employee stock purchase plan 21           21          
Issuance of shares related to employee stock purchase plan, Shares       8,604                
Stock-based compensation 325           325          
Non-controlling interest contributions 750                     750
Net income (loss) 1,681                 2,058   (377)
Stockholders Equity, Ending Balance at Mar. 31, 2021 45,703     $ 62     254,208     (209,767)   1,200
Stockholders Equity, Ending Balance, Shares at Mar. 31, 2021       21,336,249                
Stockholders Equity, Beginning Balance at Dec. 31, 2020 28,552     $ 54     239,496     (211,825)   827
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2020       13,450,861                
Foreign currency translation adjustment (12)                      
Net income (loss) (3,740)                      
Stockholders Equity, Ending Balance at Jun. 30, 2021 42,678     $ 63     256,616     (215,028) $ (12) 1,039
Stockholders Equity, Ending Balance, Shares at Jun. 30, 2021       22,163,650                
Stockholders Equity, Beginning Balance at Dec. 31, 2020 $ 28,552     $ 54     239,496     (211,825)   827
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2020       13,450,861                
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]                      
Net income (loss) $ (16,100)                      
Stockholders Equity, Ending Balance at Dec. 31, 2021 31,196     $ 63     257,515     (226,485)   103
Stockholders Equity, Ending Balance (Accounting Standards Update 2020-06 [Member]) at Dec. 31, 2021 3,392           19,390     (15,998)    
Stockholders Equity, Ending Balance, Shares at Dec. 31, 2021       22,184,235                
Stockholders Equity, Beginning Balance at Mar. 31, 2021 45,703     $ 62     254,208     (209,767)   1,200
Stockholders Equity, Beginning Balance, Shares at Mar. 31, 2021       21,336,249                
Issuance of common stock at closing of acquisition transaction   $ 2,053     $ 1     $ 2,052        
Issuance of common stock at closing of acquisition transaction, Shares         827,401              
Foreign currency translation adjustment (12)                   (12)  
Stock-based compensation 356           356          
Net income (loss) (5,422)                 (5,261)   (161)
Stockholders Equity, Ending Balance at Jun. 30, 2021 42,678     $ 63     256,616     (215,028) $ (12) 1,039
Stockholders Equity, Ending Balance, Shares at Jun. 30, 2021       22,163,650                
Stockholders Equity, Beginning Balance at Dec. 31, 2021 31,196     $ 63     257,515     (226,485)   103
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2021       22,184,235                
Issuance of shares related to employee stock purchase plan 4           4          
Issuance of shares related to employee stock purchase plan, Shares       4,683                
Stock-based compensation 260           260          
Net income (loss) (4,610)                 (4,488)   (122)
Stockholders Equity, Ending Balance at Mar. 31, 2022 30,242     $ 63     277,169     (246,971)   (19)
Stockholders Equity, Ending Balance, Shares at Mar. 31, 2022       22,188,918                
Stockholders Equity, Beginning Balance at Dec. 31, 2021 31,196     $ 63     257,515     (226,485)   103
Stockholders Equity, Beginning Balance (Accounting Standards Update 2020-06 [Member]) at Dec. 31, 2021 3,392           19,390     (15,998)    
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2021       22,184,235                
Net income (loss) (8,407)                      
Stockholders Equity, Ending Balance at Jun. 30, 2022 26,768     $ 63     277,492     (250,748)   (39)
Stockholders Equity, Ending Balance, Shares at Jun. 30, 2022       22,188,918                
Stockholders Equity, Beginning Balance at Mar. 31, 2022 30,242     $ 63     277,169     (246,971)   (19)
Stockholders Equity, Beginning Balance, Shares at Mar. 31, 2022       22,188,918                
Stock-based compensation 323           323          
Net income (loss) (3,797)                 (3,777)   (20)
Stockholders Equity, Ending Balance at Jun. 30, 2022 $ 26,768     $ 63     $ 277,492     $ (250,748)   $ (39)
Stockholders Equity, Ending Balance, Shares at Jun. 30, 2022       22,188,918                
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:              
Net loss $ (3,797,000) $ (4,610,000) $ (5,422,000) $ 1,681,000 $ (8,407,000) $ (3,740,000) $ (16,100,000)
Adjustments to reconcile net loss to cash used in operating activities:              
Change in fair value of common stock warrant liabilities     498,000     176,000  
Change in fair value of contingent consideration (39,000)       (70,000) (140,000)  
Issuance and offering costs         27,000 769,000  
Depreciation         277,000 484,000  
Amortization of intangible assets         26,000 48,000  
Lease amortization         420,000 639,000  
Impairment of intangible assets 72,000       72,000   3,300,000
(Gain) loss on disposal of property and equipment (58,000)       (386,000) 135,000  
Stock-based compensation 323,000   356,000   583,000 681,000  
Bad debt expense         37,000    
Realized gain on corporate securities           (10,222,000)  
Impairment of property and equipment 346,000       346,000 210,000  
Write-down of inventory 1,100,000   823,000   1,515,000 983,000  
Changes in operating assets and liabilities:              
Accounts receivable         (2,471,000) 259,000  
Inventories         1,001,000 (633,000)  
Prepaid expenses and other current assets         (541,000) (938,000)  
Other noncurrent assets         15,000 (153,000)  
Accounts payable and accrued expenses         (247,000) 1,083,000  
Amounts due to related parties         19,000 (47,000)  
Unearned revenue           56,000  
Other current liabilities         8,000 1,000  
Other noncurrent liabilities         (1,000) (1,000)  
Operating lease payments         (446,000) (590,000)  
Net cash used in operating activities         (8,250,000) (10,940,000) (25,900,000)
CASH FLOWS FROM INVESTING ACTIVITIES:              
Proceeds from sale of property and equipment 54,000       841,000    
Purchases of property and equipment         (46,000) (713,000)  
Acquisitions, net of cash acquired           (4,250,000)  
Proceeds from sales and maturities of investments           21,845,000  
Net cash provided by (used in) investing activities         795,000 16,882,000  
CASH FLOWS FROM FINANCING ACTIVITIES:              
Principal payments on debt           (2,019,000)  
Proceeds from ESPP purchases         4,000 27,000  
Capital contributions received from non-controlling interest           750,000  
Net cash provided by financing activities         4,000 21,993,000  
Effects of foreign currency translation on cash and cash equivalents           (1,000)  
Net (decrease) increase in cash and cash equivalents         (7,451,000) 27,934,000  
Cash and cash equivalents - beginning of period   $ 28,685,000   $ 16,043,000 28,685,000 16,043,000 16,043,000
Cash and cash equivalents - end of period $ 21,234,000   $ 43,977,000   21,234,000 43,977,000 $ 28,685,000
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:              
Cash paid for income taxes           1,000  
Cash paid for interest         1,000 21,000  
NONCASH INVESTING AND FINANCING ACTIVITIES:              
Shares of common stock issued at closing of Arcadia Wellness transaction           2,053,000  
Right of use assets obtained in exchange for new operating lease liabilities           913,000  
Proceeds from sale of property and equipment in accounts receivable         51,000    
Purchases of property and equipment included in accounts payable and accrued expenses           58,000  
January 2021 PIPE Purchase Agreement [Member]              
CASH FLOWS FROM FINANCING ACTIVITIES:              
Proceeds from issuance of common stock and warrants from offering           25,147,000  
Payments of offering costs           (1,912,000)  
NONCASH INVESTING AND FINANCING ACTIVITIES:              
Common stock warrants issued to placement agent and included in offering costs related to purchase agreement           $ 942,000  
Accounting Standards Update 2020-06 [Member]              
NONCASH INVESTING AND FINANCING ACTIVITIES:              
Common stock warrant liabilities reclassified to equity         $ 3,392,000    
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Description of Business and Basis of Presentation
6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
Description of Business and Basis of Presentation

1. Description of Business and Basis of Presentation

Organization

Arcadia Biosciences, Inc. (the "Company," "Arcadia" or "management"), was incorporated in Arizona in 2002 and maintains its headquarters in Davis, California, with additional facilities in American Falls, Idaho and Chatsworth, California. The Company was reincorporated in Delaware in March 2015.

The Company is a producer and marketer of innovative, plant-based health and wellness products. Its history as a leader in science-based approaches to developing high-value crop improvements, as well as nutritionally enhanced food ingredients and health and wellness products, has laid the foundation for its path forward. The Company used advanced breeding techniques to develop these proprietary innovations which are now being commercialized through the sales of seed and grain, as well as food ingredients and products. The acquisition of the businesses of Lief Holdings, LLC (“Lief”), EKO Holdings, LLC (“Eko”) and Live Zola, LLC (“Zola”) added bath and body care products, as well as coconut water, to the Company’s portfolio.

In May 2021, the Company’s wholly owned subsidiary Arcadia Wellness, LLC (“Arcadia Wellness” or “AW”, see Note 6), acquired the businesses of Eko, Lief, and Zola. The acquisition included consumer CBD brands like Soul Spring™, a CBD-infused botanical therapy brand in the natural category, Saavy Naturals™, a line of natural body care products and ProVault™, a CBD-infused sports performance formula made with natural ingredients, providing effective support and recovery for athletes. Also included in the purchase is Zola, a coconut water sourced exclusively with sustainably grown coconuts from Thailand. On July 8, 2022, the Company entered into an agreement to license Saavy Naturals™ to Radiance Beauty and Wellness, Inc. ("Radiance Beauty"). See Note 6 for a discussion of the licensing agreement.

In August 2019, the Company entered into a joint venture agreement with Legacy Ventures Hawaii, LLC (“Legacy,” see Note 8) to grow, extract, and sell hemp products. The partnership Archipelago Ventures Hawaii, LLC (“Archipelago”), combines the Company’s extensive genetic expertise and resources with Legacy’s experience in hemp extraction and sales. In October 2021, Arcadia and Legacy mutually agreed to wind down the cultivation activities of Archipelago, due to regulatory challenges and a saturated hemp market.

In February 2012, the Company formed Verdeca, which was equally owned with Bioceres. Verdeca was formed to develop and deregulate soybean varieties using both partners’ agricultural technologies. In November 2020, Arcadia sold its membership interest in Verdeca to Bioceres in a transaction in which Arcadia received cash, shares of Bioceres stock and a royalty stream of up to $10.0 million on sales of Haab 4 soybeans (“HB4”) soybean. An additional $2.0 million in cash is to be paid upon achievement by Verdeca of reaching commercial plantings of at least 200,000 hectares of HB4 or China approving the HB4 soybean trait for “food and feed”. During the quarter ended June 30, 2022, Bioceres received China's approval of the HB4 soybean trait and as a result, Arcadia recorded license revenue of $862,000 and a gain on sale of Verdeca of $1.1 million on the condensed consolidated statements of operations and comprehensive loss.

Basis of Presentation and Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial statements and are in the form prescribed by the Securities and Exchange Commission (the “SEC”) in instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial position, results of operations and cash flows for the periods indicated. All material intercompany accounts and transactions have been eliminated in consolidation. The accompanying unaudited condensed consolidated financial statements include the accounts of the Company, Arcadia Wellness, and Archipelago.

The Company uses a qualitative approach in assessing the consolidation requirement for variable interest entities ("VIEs"). This approach focuses on determining whether the Company has the power to direct the activities of the VIE that most significantly affect the VIE’s economic performance and whether the Company has the obligation to absorb losses, or the right to receive benefits, that could potentially be significant to the VIE.

For all periods presented, the Company has determined that it is the primary beneficiary of Archipelago, a joint venture, as it has a controlling interest in Archipelago. Accordingly, the Company consolidates Archipelago in the condensed consolidated financial statements after eliminating intercompany transactions. For consolidated joint ventures, the non-controlling partner’s share of the assets, liabilities and operations of the joint venture is included in non-controlling interests as equity of the Company. The non-controlling partner’s interest is generally computed as the joint venture partner’s ownership percentage of Archipelago. Net loss attributable to non-controlling interest of $20,000 and $142,000 is recorded as an adjustment to net loss to arrive at net loss attributable to common stockholders for the three and six months ended June 30, 2022, respectively. Net loss attributable to non-controlling interest for three and six months ended June 30, 2021 was $161,000 and $538,000, respectively. The non-controlling partner’s equity interests are presented as non-controlling interests on the condensed consolidated balance sheets.

The information included in these condensed consolidated financial statements and notes thereto should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations included herein and Management’s Discussion and Analysis of Financial Condition and Results of Operations and the condensed consolidated financial statements and notes thereto for the fiscal year ended December 31, 2021 included in the Company’s Annual Report on Form 10-K, filed with the SEC on March 31, 2022.

Liquidity, Capital Resources, and Going Concern

The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities during the normal course of business. Since inception, the Company has financed its operations primarily through equity and debt financings. As of June 30, 2022, the Company had an accumulated deficit of $250.7 million, and cash and cash equivalents of $21.2 million. For the six months ended June 30, 2022, the Company had a net loss of $8.4 million and net cash used in operations of $8.3 million. For the twelve months ended December 31, 2021, the Company had net losses of $16.1 million and net cash used in operations of $25.9 million.

With cash and cash equivalents of $21.2 million as of June 30, 2022, the Company believes that its existing cash and cash equivalents will not be sufficient to meet its anticipated cash requirements for at least the next 12 months from the issuance date of these financial statements, and thus raises substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

The Company may seek to raise additional funds through debt or equity financings. The Company may also consider entering into additional partner arrangements. The sale of additional equity would result in dilution to the Company’s stockholders. The incurrence of debt would result in debt service obligations, and the instruments governing such debt could provide for additional operating and financing covenants that would restrict operations. If the Company does require additional funds and is unable to secure adequate additional funding at terms agreeable to the Company, the Company may be forced to reduce spending, extend payment terms with suppliers, liquidate assets, or suspend or curtail planned development programs. Any of these actions could materially harm the business, results of operations and financial condition.

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2
Recent Accounting Pronouncements
6 Months Ended
Jun. 30, 2022
Accounting Changes and Error Corrections [Abstract]  
Recent Accounting Pronouncements

2. Recent Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. Additionally, the FASB issued ASU No. 2019-04, Codification Improvements to Topic 326 in April 2019 and ASU 2019-05, Financial Instruments — Credit Losses (Topic 326) — Targeted Transition Relief in May 2019. The amendments affect loans, debt securities, trade receivables, net investments in leases, off-balance-sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. In November 2019, the FASB issued ASU No. 2019-10, which defers the effective date of ASU No. 2016-13 for smaller reporting companies to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is currently evaluating the impact of the adoption of ASU No. 2016-13 on the condensed consolidated financial statements.

In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40). The FASB Board is issuing this Update to address issues identified as a result of the complexity associated with applying GAAP for certain financial instruments with characteristics of liabilities and equity. In addressing the complexity, the FASB Board focused on amending the guidance on convertible instruments and the guidance on the derivatives scope exception for contracts in an entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The amendments in this Update are effective for public business entities that meet the definition of a smaller reporting company, as defined by the SEC, for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company early adopted ASU No. 2020-06 on January 1, 2022, using the modified retrospective method. Prior to the adoption of ASU No. 2020-06, the Company had liability classified awards due to the existence of certain contingent cash payment feature. Upon adoption, these clauses no longer preclude equity classification. Under the modified retrospective method, the historical mark-to-market adjustments related to outstanding awards were reversed through retained earnings and the original carrying value of the awards were reclassified to additional paid-in capital. Adoption of the new standard resulted in an increase to accumulated deficit of $16.0 million, an increase to additional paid-in capital of $19.4 million, and a decrease to common stock warrant liabilities of $3.4 million, on the condensed consolidated balance sheets.

In May 2021, the FASB issued ASU No. 2021-04, Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity's Own Equity (Subtopic 815-40): Issuer's Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. The amendments in this Update clarify and reduce diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The amendments in this Update affect all entities that issue freestanding written call options that are classified in equity. The amendments in this Update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The Company adopted ASU No. 2021-04 on January 1, 2022 with an immaterial impact on the Company’s disclosures.

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.2
Inventory
6 Months Ended
Jun. 30, 2022
Inventory Disclosure [Abstract]  
Inventory

3. Inventory

Inventory costs are tracked on a lot-identified basis and are included as cost of revenues when sold. Inventories are stated at the lower of cost or net realizable value. The Company makes adjustments to inventory when conditions indicate that the net realizable value may be less than cost due to physical deterioration, obsolescence, changes in price levels, or other factors. Additional adjustments to inventory are made for excess and slow-moving inventory on hand that is not expected to be sold within a reasonable timeframe to reduce the carrying amount to its estimated net realizable value. The write-downs to inventory are included in cost of revenues and are based upon estimates about future demand from the Company’s customers and distributors and market conditions. The Company recorded write-downs of wheat, hemp seed, CBD oil and body care inventories of $1.1 million and $1.5 million during the three and six months ended June 30, 2022, respectively. Of inventories write-downs during the three months ended June 30, 2022, $394,000 is related to the Radiance Beauty licensing agreement discussed in Note 6. The Company recorded write-downs of wheat inventory, and hemp seed inventories of $823,000 and $983,000 during the three and six months ended June 30, 2021, respectively. If there are significant changes in demand and market conditions, substantial future write-downs of inventory may be required, which would materially increase the Company’s expenses in the period the write down is taken and materially affect the Company’s operating results.

Inventories, net consist of the following (in thousands):

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Raw materials

 

$

1,133

 

 

$

1,851

 

Goods in process

 

 

108

 

 

 

842

 

Finished goods

 

 

3,170

 

 

 

4,234

 

Inventories

 

$

4,411

 

 

$

6,927

 

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.2
Property and Equipment, Net
6 Months Ended
Jun. 30, 2022
Property, Plant and Equipment [Abstract]  
Property and Equipment, Net

4. Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Laboratory equipment

 

$

1,790

 

 

$

2,659

 

Software and computer equipment

 

 

576

 

 

 

548

 

Machinery and equipment

 

 

653

 

 

 

1,809

 

Furniture and fixtures

 

 

198

 

 

 

211

 

Vehicles

 

 

333

 

 

 

417

 

Leasehold improvements

 

 

2,223

 

 

 

2,306

 

Property and equipment, gross

 

 

5,773

 

 

 

7,950

 

Less: accumulated depreciation and amortization

 

 

(4,819

)

 

 

(5,659

)

Property and equipment, net

 

$

954

 

 

$

2,291

 

 

Depreciation expense was $277,000 and $484,000 for the six months ended June 30, 2022 and 2021, respectively.

As of June 30, 2022, and December 31, 2021, respectively, there was $10,000 and $267,000 of construction in progress included in property and equipment that had not been placed into service and was not subject to depreciation.

Property and equipment are considered assets held for sale when management approves and commits to a plan to dispose of a property or group of properties. The property and equipment held for sale prior to the sale date is separately presented, within current assets, on the condensed consolidated balance sheet as assets held for sale.

During the three and six months ended June 30, 2022, management initiated the sale of property and equipment related to the Davis laboratory and Archipelago, respectively. The Company completed the sale of a portion of such property and equipment with a gain on sale of property and equipment in the amount of $58,000 and $386,000 recorded on the condensed consolidated statements of operations and comprehensive loss during the three and six months ended June 30, 2022, respectively. The proceeds related to the sale

of property and equipment during the three and six months ended June 30, 2022 are $54,000 and $841,000, respectively. The Company had no sales of assets held for sale during the three and six months ended June 30, 2021. Property and equipment related to Archipelago, in the amount of $254,000, have been classified as assets held for sale, and are recorded at fair value as of June 30, 2022. The fair value has been estimated using publicly available prices for some of the assets, and business partners' estimates for assets with prices not readily available, due to the relatively small size of the industry in which they can be used.

During the three and six months ended June 30, 2022, the Company recorded write-downs of property and equipment of $320,000 related to the Radiance Beauty licensing agreement. See Note 6 for further discussion of the licensing agreement. During the three and six months ended June 30, 2021, the Company recorded a write-down of property and equipment related to Archipelago in the amount of $210,000, calculated through an asset recoverability test.

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.2
Investments and Fair Value Instruments
6 Months Ended
Jun. 30, 2022
Investments And Fair Value Instruments [Abstract]  
Investments and Fair Value Instruments

5. Investments and Fair Value Instruments

Investments

The investments are carried at fair value, based on quoted market prices or other readily available market information. Unrealized and realized gains and losses are recognized as other income in the condensed consolidated statements of operations and comprehensive loss.

The following tables summarize the amortized cost and fair value of the investment securities portfolio at June 30, 2022 and December 31, 2021.

 

(Dollars in thousands)

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Estimated
Fair Value

 

June 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

19,283

 

 

$

 

 

$

 

 

$

19,283

 

Total Assets at Fair Value

 

$

19,283

 

 

$

 

 

$

 

 

$

19,283

 

 

(Dollars in thousands)

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Estimated
Fair Value

 

December 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

26,842

 

 

$

 

 

$

 

 

$

26,842

 

Total Assets at Fair Value

 

$

26,842

 

 

$

 

 

$

 

 

$

26,842

 

 

The Company did not have any investment categories that were in a continuous unrealized loss position for more than twelve months as of June 30, 2022.

 

Fair Value Measurement

 

The fair value of the investment securities at June 30, 2022 were as follows:

 

 

 

Fair Value Measurements at June 30, 2022

 

(Dollars in thousands)

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets at Fair Value

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

19,283

 

 

$

 

 

$

 

 

$

19,283

 

Total Assets at Fair Value

 

$

19,283

 

 

$

 

 

$

 

 

$

19,283

 

 

The fair value of the investment securities at December 31, 2021 were as follows:

 

 

 

Fair Value Measurements at December 31, 2021

 

(Dollars in thousands)

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets at Fair Value

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

26,842

 

 

$

 

 

$

 

 

$

26,842

 

Total Assets at Fair Value

 

$

26,842

 

 

$

 

 

$

 

 

$

26,842

 

 

The Company uses the market approach technique to value its financial instruments and there were no changes in valuation techniques during 2022 or 2021. The Company’s financial instruments consist primarily of cash and cash equivalents, accounts receivable,

accounts payable, accrued liabilities, and notes payable. For accounts receivable, accounts payable, accrued liabilities, and notes payable the carrying amounts of these financial instruments as of June 30, 2022 and December 31, 2021 were considered representative of their fair values due to their short term to maturity or repayment. Cash equivalents are carried at cost, which approximates their fair value.

The Company’s Level 3 liabilities consist of a contingent liability resulting from the Anawah, Inc. ("Anawah") acquisition and a contingent liability resulting from the Industrial Seed Innovations ("ISI") acquisition, as described in Note 15. As of December 31, 2021 the Company also had common stock warrant liabilities related to the March 2018, the June 2019, the September 2019, and the January 2021 Offerings, described in Note 11, which were reclassified to additional paid-in capital upon adoption of ASU 2020-06, as of January 1, 2022. See Note 2 for details of the adoption of ASU 2020-06.

The contingent liability related to the Anawah acquisition was measured and recorded on a recurring basis as of June 30, 2022 and December 31, 2021, using unobservable inputs, namely the Company’s ability and intent to pursue certain specific products developed using technology acquired in the purchase. A significant deviation in the Company’s ability and/or intent to pursue the technology acquired in the purchase could result in a significantly lower (higher) fair value measurement. The contingent liability related to the ISI acquisition was measured and recorded on a recurring basis as of June 30, 2022 and December 31, 2021, using unobservable inputs, namely ISI’s forecasted revenue. A significant deviation in ISI’s forecasted revenue could result in a lower (higher) fair value measurement.

The following table sets forth the establishment of the Company’s Level 3 liabilities, as well as a summary of the changes in the fair value and other adjustments (in thousands):

 

 

 

 

 

(Dollars in thousands)

 

Common Stock
Warrant
Liability -
March
2018
Purchase
Agreement

 

 

Common
Stock
Warrant
Liability -
June
2019
Offering

 

 

Common
Stock
Warrant
Liability -
September
2019
Offering

 

 

Common
Stock
Warrant
Liability -
January 2021
Offering

 

 

Contingent
Liabilities

 

 

Total

 

Balance as of December 31, 2021

 

$

7

 

 

$

170

 

 

$

223

 

 

$

2,993

 

 

$

2,070

 

 

$

5,463

 

Reclassification upon adoption
    of ASU 2020-06

 

 

(7

)

 

 

(170

)

 

 

(223

)

 

 

(2,993

)

 

 

 

 

 

(3,392

)

Change in fair value of contingent
   consideration

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(70

)

 

 

(70

)

Balance as of June 30, 2022

 

$

 

 

$

 

 

$

 

 

$

 

 

$

2,000

 

 

$

2,000

 

 

During the three and six months ended June 30, 2022, the Company recorded aggregate impairment charges of $418,000, and during the three and six months ended June 30, 2021, the Company recorded aggregate impairment charges of $0 and $210,000, respectively, related to intangible assets and other long-lived assets. The Company has classified the fair value measurements as a Level 3 measurement in the fair value hierarchy because they involve significant unobservable inputs such as cash flow projections, discount rates and management assumptions.



Assets classified as held for sale are recorded at fair value as of June 30, 2022. The Company has classified the fair value measurements as a Level 3 measurement in the fair value hierarchy as the fair value has been estimated using publicly available prices for some of the assets, and business partners' estimates for assets with prices not readily available, due to the relatively small size of the industry in which they can be used.




 

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.2
Arcadia Wellness Acquisition
6 Months Ended
Jun. 30, 2022
Arcadia Wellness Acquisition [Member]  
Business Acquisition [Line Items]  
Arcadia Wellness Acquisition

6. Arcadia Wellness Acquisition

On May 17, 2021, the Company’s wholly owned subsidiary Arcadia Wellness, acquired the assets of Eko, Lief, and Zola. The acquisition included consumer brands of bath and body care products such as Soul Spring, the CBD-infused botanical therapy brand, Saavy Naturals, a line of natural body care products and ProVault, a CBD-infused sports performance formula. Also included in the purchase was Zola, a coconut water sourced from Thailand.

The acquisition was recorded as a business combination, in accordance with ASC 805. The purchase price consideration for the acquisition totaled an estimated $6.1 million, of which $4.0 million in cash and $2.1 million in the form of 827,401 shares of the Company’s common stock, was paid during the month of May 2021. The cash consideration paid for the acquisition was funded by cash on hand.

Acquisition costs are not included as components of consideration transferred and instead are accounted for as expenses in the period in which the costs are incurred. The Company incurred costs related to the Arcadia Wellness acquisition of approximately $850,000 included in selling, general and administrative expenses in the Company's consolidated statements of operations and comprehensive loss for the six months ended June 30, 2021.

The Company performed an allocation of purchase price as of the acquisition date based on management's estimates of fair value. The Company believes its estimates and assumptions are reasonable.

The following table presents the allocation of the purchase price of the assets acquired at fair value at the acquisition date:

 

 

 

Purchase Price
Allocation

 

Inventory

 

$

840

 

Prepaid and other current assets

 

 

62

 

Fixed assets

 

 

308

 

Deposits

 

 

82

 

Customer list

 

 

360

 

Trade names and trademarks

 

 

2,900

 

Formulations

 

 

260

 

Goodwill

 

 

1,240

 

Total consideration allocated

 

$

6,052

 

 

The former shareholders of Eko, Lief, and Zola remain responsible for their pre-acquisition liabilities. In connection with the acquisition, the Company entered into a lease agreement for the use of offices, production equipment acquired, and storage warehouses. The lease was effective on May 17, 2021 and has a term of 3 years.

For the period from January 1, 2022 to June 30, 2022, the Company recognized approximately $3.9 million of revenue and $1.5 million of net loss relating to Arcadia Wellness, which included charges related to the Radiance Beauty licensing agreement discussed below, as well as the amortization of acquired intangible assets.

For the period from May 17, 2021 to December 31, 2021, the Company recognized approximately $4.3 million of revenue and $7.5 million of net loss relating to Arcadia Wellness, which included charges for the amortization of acquired intangible assets.

Acquired intangible assets of $3.5 million include trade names and trademarks of $2.9 million (indefinite useful life), customer list of $360,000 (fifteen-year useful life) and formulations of $260,000 (ten-year useful life). For impairments related to the acquired intangible assets see Note 7.

The total weighted average amortization period for the acquired intangibles is 12.9 years.

The acquisition produced $1.2 million of goodwill, which was fully impaired during the year ended December 31, 2021, due to weakness in some of the newly acquired consumer product margins, combined with a volatile economic climate and higher than normal inflation. Goodwill arising from the Arcadia Wellness acquisition was not deductible for tax purposes.

On July 8, 2022, the Company entered into a licensing agreement with Radiance Beauty. Under the terms of the licensing agreement, Radiance Beauty was granted an exclusive, transferable, sublicensable, perpetual, worldwide license to use the Saavy Naturals™ mark and to modify, manufacture, distribute, market and sell related products. In addition, as part of the licensing agreement, Radiance Beauty will receive the remaining accounts receivables and inventory balances after July 31, 2022, certain equipment, as well as three months of salaries in the amount of $355,000 and rent, maintenance and utilities in the amount of $19,000. Radiance Beauty will sublease space from the Company and pay the Company a 4% royalty of gross sales of products beginning January 1, 2023. As of

June 30, 2022, accounts receivables and inventories of $21,000 and $394,000, respectively, were written down. In addition, property and equipment and intangible assets were written down by $320,000 and $72,000, respectively, as of June 30, 2022.

Supplemental Pro-Forma Results of Operations (Unaudited)

The following unaudited pro-forma condensed consolidated results of operations for the three and six months ended June 30, 2022 and 2021, have been prepared as if the acquisition of Arcadia Wellness had occurred on January 1, 2021 and includes adjustments for amortization of intangibles, and the addition to basic and diluted weighted average number of shares outstanding.

 

 

 

For the three months
ended June 30,

 

 

For the six months
ended June 30,

 

 

 

2022
(Pro forma)

 

 

2021
(Pro forma)

 

 

2022
(Pro forma)

 

 

2021
(Pro forma)

 

Total revenues

 

$

3,858

 

 

$

2,203

 

 

$

7,078

 

 

$

4,516

 

Net loss

 

 

(3,797

)

 

 

(5,409

)

 

 

(8,407

)

 

 

(5,193

)

Net loss attributable to common stockholders

 

$

(3,777

)

 

$

(5,248

)

 

$

(8,265

)

 

$

(4,655

)

Weighted average shares - Basic and diluted

 

 

22,188,918

 

 

 

22,159,103

 

 

 

22,187,961

 

 

 

21,478,810

 

Net loss per share attributable to common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.17

)

 

$

(0.24

)

 

$

(0.37

)

 

$

(0.22

)

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.2
Intangible Assets, Net
6 Months Ended
Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets, Net

7. Intangible assets, net

 

The Company’s intangible assets, net as of June 30, 2022, consist of the following:

 

 

 

June 30, 2022

 

 

December 31, 2021

 

 

 

Gross
Carrying
Amount (2)

 

 

Accumulated Amortization

 

 

Net Carrying
Amount

 

 

Gross
Carrying
Amount (1)

 

 

Accumulated Amortization

 

 

Net Carrying
Amount

 

Amortized intangible assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Intellectual property

 

$

254

 

 

$

130

 

 

$

124

 

 

$

258

 

 

$

107

 

 

$

151

 

Customer lists

 

 

64

 

 

 

30

 

 

 

34

 

 

 

71

 

 

 

26

 

 

 

45

 

Total amortizable intangible assets

 

$

318

 

 

$

160

 

 

$

158

 

 

$

329

 

 

$

133

 

 

$

196

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Indefinite-lived intangible assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Brands and trademarks

 

$

228

 

 

$

 

 

$

228

 

 

$

288

 

 

$

 

 

$

288

 

Total intangible asset, net

 

$

546

 

 

$

160

 

 

$

386

 

 

$

617

 

 

$

133

 

 

$

484

 

 

(1) The gross carrying amounts included in this table reflect the effects of the impairments of intangible assets recorded during the year ended December 31, 2021, when the Company estimated an overall decrease in the sales forecast for AW products, due to an inventory item rationalization, in addition to a decrease in the sales forecast of ISI seeds, related to the saturated hemp seed market. As a result, Arcadia performed a quantitative intangible assets impairment test. The Company used a discounted cash flow approach to develop the fair value of the acquired intellectual property, customer lists, brands and trademarks. As a result of this assessment, Arcadia recorded an impairment of intangible assets in the amount of $3.3 million in the condensed consolidated statements of operations and comprehensive loss for the year ended December 31, 2021.

(2) The Company recorded an impairment of intangible assets in the amount of $72,000 during the three and six months ended June 30, 2022 related to the Radiance Beauty licensing agreement.

Intellectual property and customer lists will be amortized based on their useful lives ranging between 4 and 15 years. As of June 30, 2022, future amortization of intellectual property and customer lists is as follows:

 

Year Ending December 31,

 

 

 

2022 (excluding the six months ended June 30, 2022)

 

$

26

 

2023

 

 

53

 

2024

 

 

53

 

2025

 

 

4

 

2026

 

 

4

 

Thereafter

 

 

18

 

Total

 

$

158

 

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Joint Venture
6 Months Ended
Jun. 30, 2022
Equity Method Investments and Joint Ventures [Abstract]  
Consolidated Joint Venture . Consolidated Joint Venture

In 2019, the Company and Legacy Ventures Hawaii, LLC, a Nevada limited liability company (“Legacy”), formed Archipelago Ventures Hawaii, LLC, a Delaware limited liability company and entered into a Limited Liability Company Operating Agreement (the “Operating Agreement”). The Company and Legacy formed Archipelago to develop, extract and commercialize hemp-derived products from industrial hemp grown in Hawaii.

Pursuant to the Operating Agreement, a joint operating committee consisting of two individuals appointed by the Company and two individuals appointed by Legacy will manage Archipelago. As of June 30, 2022, the Company and Legacy hold 50.75% and 49.25% interests in Archipelago, respectively, and have made capital contributions to Archipelago of $3,108,000 and $3,016,000, respectively, as determined by the joint operating committee. The Operating Agreement includes indemnification rights, non-competition obligations, and certain rights and obligations in connection with the transfer of membership interests, including rights of first refusal.

The Company consolidates Archipelago in the condensed consolidated financial statements after eliminating intercompany transactions. Net loss attributable to non-controlling interest of $20,000 and $142,000 is recorded as an adjustment to net loss to arrive at net loss attributable to common stockholders for the three and six months ended June 30, 2022, respectively. Net loss attributable to non-controlling interest of $161,000 and $538,000 is recorded as an adjustment to net loss to arrive at net loss attributable to common stockholders for the three and six months ended June 30, 2021, respectively. Legacy’s equity interests are presented as non-controlling interests on the condensed consolidated balance sheets. Refer to Note 1 for basis of presentation.

In October 2021, Arcadia and Legacy mutually agreed to wind down the cultivation activities of Archipelago, due to regulatory challenges and a saturated hemp market.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.2
Collaborative Arrangements
6 Months Ended
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Collaborative Arrangements

9. Collaborative Arrangements

In August 2017, the Company entered into a collaborative arrangement for the research, development and commercialization of an improved wheat quality trait in North America. This collaborative arrangement is a contractual agreement with Corteva AgriScience (“Corteva”) and involves a joint operating activity where both Arcadia and Corteva are active participants in the activities of the collaboration. Arcadia and Corteva participate in the research and development, and Arcadia has the primary responsibility for the intellectual property strategy while Corteva will generally lead the marketing and commercialization efforts. Both parties are exposed to significant risks and rewards of the collaboration and the agreement includes both cost sharing and profit sharing. The activities are performed with no guarantee of either technological or commercial success.

The Company accounts for research and development (“R&D”) costs in accordance ASC 730, Research and Development, which states R&D costs must be charged to expense as incurred. Accordingly, internal R&D costs are expensed as incurred. Third-party R&D costs are expensed when the contracted work has been performed or as milestone results are achieved.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.2
Leases
6 Months Ended
Jun. 30, 2022
Lessee Disclosure [Abstract]  
Leases

10. Leases

Operating Leases

As of June 30, 2022, the Company leases office space in Davis, CA, and Chatsworth, CA, as well as additional buildings, land and equipment. Leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these short-term leases on a straight-line basis. The Company subleases a portion of the Davis office lease to a third party. In May 2022, the Company terminated its lease for office space in Chesterfield, MO effective August 1, 2022. The original lease term was scheduled to expire in May 2024. As a result, the Company paid $47,000 in early termination fees during the three months ended June 30, 2022. During the six months ended June 30, 2022, the Company did not enter new leases. On July 1, 2022, the Company entered into an agreement to lease office space in Dallas, TX. As of June 30, 2022, this lease had not yet commenced.

Some leases (the Davis office, a warehouse, and a copy machine) include one or more options to renew, with renewal terms that can extend the lease term from one to six years. The exercise of lease renewal options is at the Company’s sole discretion.

The Company’s lease agreements do not contain any material variable lease payments, material residual value guarantees or material restrictive covenants. Leases consisted of the following (in thousands):

 

Leases

 

Classification

 

June 30, 2022

 

 

December 31, 2021

 

Assets

 

 

 

 

 

 

 

 

Operating lease assets

 

 Right of use asset

 

$

2,308

 

 

$

3,081

 

Total leased assets

 

 

 

$

2,308

 

 

$

3,081

 

Liabilities

 

 

 

 

 

 

 

 

Current - Operating

 

 Operating lease liability- current

 

$

994

 

 

$

1,074

 

Noncurrent - Operating

 

 Operating lease liability- noncurrent

 

 

1,500

 

 

 

2,220

 

Total leased liabilities

 

 

 

$

2,494

 

 

$

3,294

 

 

 

Lease Cost

 

Classification

 

For the Three
Months Ended
June 30, 2022

 

 

For the Three
Months Ended
June 30, 2021

 

 

For the Six
Months Ended
June 30, 2022

 

 

For the Six
Months Ended
June 30, 2021

 

Operating lease cost

 

 SG&A and R&D Expenses

 

$

268

 

 

$

347

 

 

$

544

 

 

$

636

 

Short term lease cost (1)

 

 R&D Expenses

 

 

8

 

 

 

(17

)

 

 

11

 

 

 

30

 

Short term lease cost

 

 SG&A Expenses

 

 

 

 

 

4

 

 

 

 

 

 

15

 

Sublease income (2)

 

 SG&A and R&D Expenses

 

 

(90

)

 

 

(19

)

 

 

(177

)

 

 

(33

)

Net lease cost

 

 

 

$

186

 

 

$

315

 

 

$

378

 

 

$

648

 

 

(1)
Short term lease cost consists of field trial lease agreements with a lease term of 12 months or less.
(2)
Sublease income is recorded as a reduction to lease expense.

 

Lease Term
and Discount Rate

 

June 30, 2022

 

 

December 31, 2021

 

Weighted-average remaining
   lease term (years)

 

 

2.3

 

 

 

2.7

 

Weighted-average discount rate

 

 

6.4

%

 

 

6.0

%

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.2
Equity Financing
6 Months Ended
Jun. 30, 2022
Equity [Abstract]  
Equity Financing

11. Equity Financing

Private Placements

In January 2021, the Company issued in a private placement offering (the “January 2021 Private Placement”) pursuant to a securities purchase agreement (“January 2021 Purchase Agreement”) (i) 7,876,784 shares of its common stock, and (ii) warrants to purchase up to 3,938,392 shares of common stock at an exercise price of $3.13 per share (the “January 2021 Warrants”) and raised total gross proceeds of $25.1 million. The January 2021 Warrants are exercisable at any time at the option of the holder and expire 5.5 years from the date of issuance. In connection with the January 2021 Private Placement, the Company granted to a placement agent warrants to purchase a total of 393,839 shares of Common Stock (the “January 2021 Placement Agent Warrants”) that have an exercise price per share equal to $3.99 and a term of 5.5 years from the date of issuance.

The common stock warrants are classified as a liability within Level 3 due to a contingent cash payment feature. The Company utilized a Black Scholes Merton model on January 28, 2021 with the following assumptions: volatility of 123.8 percent, stock price of $2.88 and risk-free rate of 0.5%. The estimated fair value of the common stock warrant liability was subsequently remeasured at December 31, 2021 with the changes recorded on the Company’s consolidated statements of operations and comprehensive loss.

The January 2021 Placement Agent Warrants were issued for services performed by the placement agent as part of the January 2021 Private Placement and were treated as offering costs. The value of the January 2021 Placement Agent Warrants was determined to be $942,000, calculated using a Black-Scholes Model. The Company incurred additional offering costs totaling $1.9 million that consist of direct incremental legal, advisory, accounting and filing fees relating to the January 2021 Private Placement. The offering costs, inclusive of the January 2021 Placement Agent Warrants, totaled $2.8 million and allocated to the common stock warrant liability and the common stock using their relative fair values. A total of $769,000 was allocated to the common stock warrant liability and expensed and the remaining $2.0 million was allocated to the common stock and offset to additional paid in capital.

In March 2018, the Company issued in a private placement offering (the “March 2018 Private Placement”) pursuant to a securities purchase agreement (“March 2018 Purchase Agreement”) (i) 300,752 shares of its common stock and (ii) warrants to purchase up to 300,752 shares of common stock at an initial exercise price equal to $45.75 (the “March 2018 Warrants”) and raised total gross proceeds of $10.0 million. The March 2018 Warrants are exercisable at any time at the option of the holder and expire five years from the date of issuance. In connection with the March 2018 Private Placement, the Company granted to a placement agent warrants to purchase a total of 15,038 shares of Common Stock (the “March 2018 Placement Agent Warrants”) that have an exercise price per share equal to $41.5625 and a term of five years from the date of issuance.

The number of shares of common stock and the number and exercise price of the March 2018 Warrants issued in the March 2018 Private Placement were subject to adjustments as provided in the March 2018 Purchase Agreement. Following the adjustments as provided in the March 2018 Purchase Agreement, the number of shares issued to the purchasers was 1,201,634, the total number of shares issuable upon exercise of the March 2018 Warrants was 1,282,832 and the per share exercise price of the March 2018 Warrants was $10.7258.

Registered Direct Offerings

On May 11, 2018, the Company filed a shelf Registration Statement on Form S-3 with the SEC which was declared effective on June 8, 2018 (“Shelf Registration Statement”). This shelf registration process allows the Company to sell any combination of common

stock, preferred stock, warrants and units consisting of such securities in one or more offerings from time to time having aggregate offering prices of up to $50 million. This registration statement may no longer be used after June 8, 2021, the three-year anniversary of its effective date.

In December 2020, the Company entered into a securities purchase agreement (the “December 2020 Purchase Agreement”) pursuant to which it sold (i) 2,618,658 registered shares of its common stock pursuant to the Shelf Registration Statement and (ii) unregistered warrants to purchase 2,618,658 shares of its common stock (the “December 2020 Warrants”) in a private placement, for total gross proceeds of $8.0 million (the “December 2020 Registered Direct Offering”). The December 2020 Registered Direct Offering closed on December 22, 2020. The December 2020 Warrants have an exercise price of $3.00 per share, became exercisable upon issuance and expire 5.5 years after the date of issuance. In connection with the December 2020 Registered Direct Offering, the Company granted to a placement agent warrants to purchase a total of 130,933 shares of common stock (“December 2020 Placement Agent Warrants”) that have an exercise price per share equal to $3.8188 and a term of five years.

In September 2019, the Company entered into a securities purchase agreement (the “September 2019 Purchase Agreement”) pursuant to which it sold (i) 1,318,828 registered shares of its common stock pursuant to the Shelf Registration Statement and (ii) unregistered warrants to purchase 659,414 shares of its common stock (the “September 2019 Warrants”) in a private placement, for total gross proceeds of $10.0 million (the “September 2019 Registered Direct Offering”). The September 2019 Registered Direct Offering closed on September 5, 2019. The September 2019 Warrants have an exercise price of $7.52 per share, became exercisable upon issuance and expire 5.5 years after the date of issuance. In connection with the September 2019 Registered Direct Offering, the Company granted to a placement agent warrants to purchase a total of 65,942 shares of common stock (“September 2019 Placement Agent Warrants”) that have an exercise price per share equal to $9.4781 and a term of five years.

In June 2019, the Company entered into a securities purchase agreement (the “June 2019 Purchase Agreement”) pursuant to which it sold (i) 1,489,575 registered shares of its common stock pursuant to the Shelf Registration Statement and (ii) unregistered warrants to purchase 1,489,575 shares of its common stock (the “June 2019 Warrants”) in a private placement, for total gross proceeds of $7.5 million (the “June 2019 Registered Direct Offering”). The June 2019 Registered Direct Offering closed on June 14, 2019. The June 2019 Warrants have an exercise price of $5.00 per share, became exercisable upon issuance and expire 5.5 years after the date of issuance. In connection with the June 2019 Registered Direct Offering, the Company granted to a placement agent warrants to purchase a total of 74,479 shares of common stock (“June 2019 Placement Agent Warrants”) that have an exercise price per share equal to $6.2938 and a term of five years.

In June 2018, the Company entered into a securities purchase agreement (the “June 2018 Purchase Agreement”) pursuant to which it sold (i) 1,392,345 registered shares of its common stock pursuant to the Shelf Registration Statement and (ii) unregistered warrants to purchase 1,392,345 shares of its common stock (the “June 2018 Warrants”) in a private placement, for total gross proceeds of $14.0 million (the “June 2018 Registered Direct Offering”). The June 2018 Registered Direct Offering closed on June 14, 2018. The June 2018 Warrants have an exercise price of $9.94 per share, became exercisable upon issuance and expire 5.5 years after the date of issuance. In connection with the June 2018 Registered Direct Offering, the Company granted to a placement agent warrants to purchase a total of 69,617 shares of common stock (“June 2018 Placement Agent Warrants”) that have an exercise price per share equal to $12.568 and a term of five years.

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.2
Warrants
6 Months Ended
Jun. 30, 2022
Warrants and Rights Note Disclosure [Abstract]  
Warrants

12. Warrants

The Company issued the following warrants to purchase shares of its common stock, which are outstanding as of June 30, 2022 or December 31, 2021, respectively. These warrants are exercisable any time at the option of the holder until their expiration date.

 

 

 

Issuance Date

 

Term

 

Exercise
Price Per
Share

 

 

Warrants
Exercised
during the
Year Ended
December 31,
2021

 

 

Warrants
Outstanding at
December 31,
2021

 

 

Warrants
Exercised
during the
Six
Months Ended
June 30,
2022

 

 

Warrants
Outstanding at
June 30,
2022

 

January 2021 Placement Agent Warrants

 

January 2021

 

5.5 years

 

$

3.99

 

 

 

 

 

 

393,839

 

 

 

 

 

 

393,839

 

January 2021 Service and Performance Warrants (1)

 

January 2021

 

2 years

 

$

3.08

 

 

 

 

 

 

7,500

 

 

 

 

 

 

7,500

 

December 2020 Warrants

 

December 2020

 

5.5 years

 

$

3.00

 

 

 

 

 

 

2,618,658

 

 

 

 

 

 

2,618,658

 

December 2020 Placement Agent Warrants

 

December 2020

 

5 years

 

$

3.82

 

 

 

 

 

 

130,933

 

 

 

 

 

 

130,933

 

July 2020 Warrants

 

July 2020

 

5.5 years

 

$

3.85

 

 

 

 

 

 

641,416

 

 

 

 

 

 

641,416

 

July 2020 Placement Agent Warrants

 

July 2020

 

5.5 years

 

$

4.97

 

 

 

 

 

 

32,071

 

 

 

 

 

 

32,071

 

May 2020 Warrants

 

May 2020

 

5 years

 

$

4.78

 

 

 

 

 

 

1,392,345

 

 

 

 

 

 

1,392,345

 

May 2020 Placement Agent Warrants

 

May 2020

 

5 years

 

$

6.13

 

 

 

 

 

 

69,617

 

 

 

 

 

 

69,617

 

March 2020 Service and Performance Warrants (1)

 

March 2020

 

3 years

 

$

2.50

 

 

 

 

 

 

18,350

 

 

 

 

 

 

18,350

 

February 12, 2020 Service and Performance Warrants (1)(3)

 

February 2020

 

2 years

 

$

4.71

 

 

 

 

 

 

150,000

 

 

 

 

 

 

 

February 3, 2020 Service and Performance Warrants (1)(3)

 

February 2020

 

2 years

 

$

4.91

 

 

 

 

 

 

10,000

 

 

 

 

 

 

 

September 2019 Placement Agent Warrants

 

September 2019

 

5 years

 

$

9.48

 

 

 

 

 

 

65,942

 

 

 

 

 

 

65,942

 

June 2019 Placement Agent Warrants

 

June 2019

 

5 years

 

$

6.29

 

 

 

 

 

 

74,479

 

 

 

 

 

 

74,479

 

April 2019 Service and Performance Warrants (1)

 

April 2019

 

5 years

 

$

6.18

 

 

 

 

 

 

145,154

 

 

 

 

 

 

145,154

 

June 2018 Placement Agent Warrants

 

June 2018

 

5 years

 

$

12.57

 

 

 

 

 

 

69,617

 

 

 

 

 

 

69,617

 

March 2018 Placement Agent Warrants

 

March 2018

 

5 years

 

$

41.56

 

 

 

 

 

 

15,038

 

 

 

 

 

 

15,038

 

January 2021 Warrants (2)

 

January 2021

 

5.5 years

 

$

3.13

 

 

 

 

 

 

3,938,392

 

 

 

 

 

 

3,938,392

 

September 2019 Warrants (2)

 

September 2019

 

5.5 years

 

$

7.52

 

 

 

 

 

 

659,414

 

 

 

 

 

 

659,414

 

June 2019 Warrants (2)

 

June 2019

 

5.5 years

 

$

5.00

 

 

 

 

 

 

435,830

 

 

 

 

 

 

435,830

 

June 2018 Warrants (2)

 

June 2018

 

5.5 years

 

$

9.94

 

 

 

 

 

 

 

 

 

 

 

 

 

March 2018 Warrants (2)

 

March 2018

 

5 years

 

$

10.73

 

 

 

 

 

 

641,416

 

 

 

 

 

 

641,416

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

11,510,011

 

 

 

 

 

 

11,350,011

 

 

(1) The Company issued service and performance warrants (“Service and Performance Warrants”) in connection with professional services agreements with non-affiliated third party entities.

(2) Certain warrants contain a contingent cash payment feature and therefore were accounted for as a liability at the date of issuance and were adjusted to fair value at each balance sheet date. Upon adoption of ASU No. 2020-06 on January 1, 2022, all of the common stock warrant liabilities have been reclassified to equity classified common stock warrants, due to the elimination of the contingent cash payments as criteria for liability classification.

(3) These warrants expired in February 2022.

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Compensation and Employee Stock Purchase Program
6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation and Employee Stock Purchase Program

13. Stock-Based Compensation and Employee Stock Purchase Program

Stock Incentive Plans

The Company has two equity incentive plans: the 2006 Stock Plan (“2006 Plan”) and the 2015 Omnibus Equity Incentive Plan (“2015 Plan”).

In 2006, the Company adopted the 2006 Plan, which provided for the granting of stock options to executives, employees, and other service providers under terms and provisions established by the Board of Directors. The Company granted non-statutory stock options (“NSOs”) under the 2006 Plan until May 2015, when it was terminated as to future awards, although it continues to govern the terms of options that remain outstanding and were issued under the 2006 Plan. The 2015 Plan became effective upon the Company’s IPO in May 2015 and all shares that were reserved, but not issued, under the 2006 Plan were assumed by the 2015 Plan. Upon effectiveness, the 2015 Plan had 154,387 shares of common stock reserved for future issuance, which included 10,637 that were transferred to and assumed by the 2015 Plan. The 2015 Plan provides for automatic annual increases in shares available for grant. In addition, shares subject to awards under the 2006 Plan that are forfeited or canceled will be added to the 2015 Plan. The 2015 Plan provides for the grant of incentive stock options (“ISOs”), NSOs, restricted stock awards, stock units, stock appreciation rights, and other forms of equity compensation, all of which may be granted to employees, officers, non-employee directors, and consultants. The exercise price for ISOs and NSOs will be granted at a price per share not less than the fair value of our common stock at the date of grant. Options granted generally vest over a four-year period; however, there might be alternative vesting schedules, as approved by the Board. Options granted, once vested, are generally exercisable for up to 10 years, after grant to the extent vested.

In June 2019, the shareholders approved an amendment to the Company’s 2015 Plan for a one-time increase to the number of shares of common stock that may be issued under the 2015 Plan by 120,000 shares. On May 17, 2021, upon completion of the Arcadia Wellness transaction, the Company granted 248,000 inducement stock option pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. On May 28, 2021, the Company filed a registration statement on Form S-8 to register the issuance of shares upon exercise of these inducement stock options. On February 2, 2022, Stanley Jacot, Jr. was hired as the new president and chief executive officer of the Company. The Company granted Mr. Jacot an inducement stock option to purchase 316,108 shares of the Company’s common stock pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. The Company has not filed a registration statement on Form S-8 to register the issuance of shares upon exercise of this inducement stock option. The inducement options grants have been issued outside of the 2015 Plan, but are subject to the terms and conditions of the 2015 Plan. As of June 30, 2022, a total of 2,484,005 shares of common stock were reserved for issuance under the 2015 Plan, of which 584,777 shares of common stock are available for future grant. As of June 30, 2022, a total of 7,813 and 1,899,228 options are outstanding under the 2006 and 2015 Plans, respectively. As of December 31, 2021, a total of 8,240 and 1,345,955 options are outstanding under the 2006 and 2015 Plans, respectively. As of June 30, 2022 a total of 376,608 inducement options are outstanding.

The following is a summary of stock option information and weighted average exercise prices under the Company’s stock incentive plans (in thousands, except share data and price per share):

 

 

 

Shares
Subject to
Outstanding
Options

 

 

Weighted-
Average
Exercise
Price Per
Share

 

 

Aggregate
Intrinsic
Value

 

Outstanding — Balance at December 31, 2021

 

 

1,422,195

 

 

$

5.28

 

 

$

 

Options granted

 

 

1,030,822

 

 

 

1.16

 

 

 

 

Options exercised

 

 

 

 

 

 

 

 

 

Options forfeited

 

 

(130,263

)

 

 

2.86

 

 

 

 

Options expired

 

 

(39,105

)

 

 

6.21

 

 

 

 

Outstanding — Balance at June 30, 2022

 

 

2,283,649

 

 

$

3.54

 

 

$

31,230

 

Vested and expected to vest — June 30, 2022

 

 

2,011,343

 

 

$

3.82

 

 

$

24,452

 

Exercisable — June 30, 2022

 

 

862,726

 

 

$

6.76

 

 

$

 

 

Aggregate intrinsic value represents the difference between the exercise price of the options and the estimated fair value of the Company’s common stock determined by our Board of Directors for each of the respective periods. The intrinsic value of options exercised was $0 for both quarters ended June 30, 2022 and 2021.

As of June 30, 2022, there was $1.4 million of unrecognized compensation cost related to unvested stock-based compensation grants that will be recognized over the weighted-average remaining recognition period of 2.8 years.

On December 14, 2021, Matt Plavan provided notice to the Company of his resignation as Arcadia’s president, chief executive officer and director, effective as of December 31, 2021. On December 19, 2021, Arcadia and Mr. Plavan entered into a Separation and Release Agreement (the “Separation Agreement”) which provided that the vesting of all unvested options previously issued to Mr. Plavan accelerated pursuant to the terms of the Separation Agreement. In addition, the Separation Agreement extended the post-termination exercise period of the accelerated options from 90 days to up to two and one-half years. The stock compensation expense

related to the modification of Mr. Plavan’s stock options was $154,000 and it was recognized in selling, general and administrative expenses during the year ended December 31, 2021.

In determining the fair value of the stock-based awards, the Company uses the Black-Scholes option-pricing model and assumptions discussed below. Each of these inputs is subjective and generally requires significant judgment to determine.

Expected Term—The expected term is the estimated period of time outstanding for stock options granted and was estimated based on a simplified method allowed by the SEC, and defines the term as the average of the contractual term of the options and the weighted-average vesting period for all open employee awards.

Expected Volatility—The historical volatility data was computed using the daily closing prices for the Company’s shares during the equivalent period of the calculated expected term of the stock-based awards.

Risk-Free Interest Rate—The risk-free interest rate is based on the interest rate of U.S. Treasuries of comparable maturities on the date the options were granted.

Expected Dividend—The expected dividend yield is based on the Company’s expectation of future dividend payouts to common stockholders.

The fair value of stock option awards was estimated at the date of grant using a Black-Scholes option-pricing model with the following weighted-average assumption:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Expected term (years)

 

 

6.85

 

 

 

6.84

 

 

 

6.61

 

 

 

6.37

 

Expected volatility

 

 

123

%

 

 

122

%

 

 

122

%

 

 

122

%

Risk-free interest rate

 

 

2.85

%

 

 

1.06

%

 

 

2.48

%

 

 

0.81

%

Dividend yield

 

 

 

 

 

 

 

 

 

 

 

 

 

The Company recognized $323,000 and $583,000 of compensation expense for stock options awards for the three and six months ended June 30, 2022, respectively. The Company recognized $356,000 and $681,000 of compensation expense for stock options awards for the three and six months ended June 30, 2021, respectively.

Employee Stock Purchase Plan

The Company’s 2015 Employee Stock Purchase Plan (“ESPP”) became effective on May 14, 2015. The ESPP allows eligible employees to purchase shares of the Company’s common stock at a discount of up to 15% of their eligible compensation through payroll deductions, subject to any plan limitations. After the first offering period, which began on May 14, 2015 and ended on February 1, 2016, the ESPP provides for six-month offering periods, and at the end of each offering period, employees are able to purchase shares at 85% of the lower of the fair market value of the Company’s common stock on the first trading day of the offering period or on the last day of the offering period. As of June 30, 2022, the number of shares of common stock reserved for future issuance under the ESPP is 128,914. The ESPP provides for automatic annual increases in the shares available for purchase beginning on January 1, 2016. As of June 30, 2022, 54,928 shares had been issued under the ESPP. The Company recorded $1,000 and $2,000 of ESPP related compensation expense for the three and six months ended June 30, 2022, respectively. The Company recorded $8,000 and $13,000 of ESPP related compensation expense for the three and six months ended June 30, 2021, respectively.

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.2
Income Taxes
6 Months Ended
Jun. 30, 2022
Income Tax Disclosure [Abstract]  
Income Taxes

14. Income Taxes

Income tax expense during interim periods is based on applying an estimated annual effective income tax rate to year-to-date income, plus any significant unusual or infrequently occurring items that are recorded in the interim period. The computation of the annual estimated effective tax rate at each interim period requires certain estimates and significant judgment including, but not limited to, the expected operating income for the year, projections of the proportion of income earned and taxed in various jurisdictions, permanent and temporary differences, and the likelihood of recovering deferred tax assets generated in the current year. The accounting estimates used to compute the provision for income taxes may change as new events occur, more experience is obtained, additional information becomes known, or as the tax environment changes.

The interim financial statement provision for income taxes is different from the amounts computed by applying the United States federal statutory income tax rate of 21%. The Company’s effective tax rate was 0.00% for each of the three and six months ended June 30, 2022, and was -0.01% for each of the three and six months ended June 30, 2021. The difference between the effective tax rate and the federal statutory rate of 21% was primarily due to the full valuation allowance recorded on the Company’s net deferred tax assets.

The Company experienced an ownership change under IRC Section 382 as a result of the common shares issued in connection with the January 2021 Offering. This ownership change limited the Company’s ability to utilize its net operating loss carryforwards prior to expiration and certain net operating loss carryforwards were written off as a result. The Company is currently conducting additional analysis regarding the valuation of the Company at the time of the ownership change to assess what, if any, portion of the limitation may be reversed. Any adjustment to the amount of limitation will not impact the deferred tax asset balance due to the full valuation allowance.

During the six months ended June 30, 2022, there were no material changes to the Company’s uncertain tax positions.

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.22.2
Commitment and Contingencies
6 Months Ended
Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

15. Commitments and Contingencies

Leases

The Company leases office and laboratory space, grain storage bins, warehouse space, farmland, and equipment under operating lease agreements having initial lease terms ranging from one to five years, including certain renewal options available to the Company at market rates. The Company also leases land for field trials on a short-term basis. See Note 10.

Legal Matters

From time to time, in the ordinary course of business, the Company may become involved in certain legal proceedings. The Company currently is not a party to any material litigation or other material legal proceedings.

Contingent Liability Related to the Anawah Acquisition

In June 2005, the Company completed its agreement and plan of merger and reorganization with Anawah, to purchase the Anawah’s food and agricultural research company through a non-cash stock purchase. Pursuant to the merger with Anawah, and in accordance with the ASC 805 - Business Combinations, the Company incurred a contingent liability not to exceed $5.0 million. This liability represents amounts to be paid to Anawah’s previous stockholders for cash collected on revenue recognized by the Company upon commercial sale of certain specific products developed using technology acquired in the purchase. As of December 31, 2010, the Company ceased activities relating to three of the six Anawah product programs thus, the contingent liability was reduced to $3.0 million. During the third quarter of 2016, one of the programs previously accrued for was abandoned and another program previously abandoned was reactivated. During the fourth quarter of 2019, the Company determined that one of the technologies was no longer active and decided to abandon the previously accrued program. As of June 30, 2022, the Company continues to pursue a total of two development programs using this technology and believes that the contingent liability is probable. As a result, $2.0 million remains on the condensed consolidated balance sheet as an other noncurrent liability.

Contingent Liability Related to the ISI Acquisition

In August 2020, the Company acquired by merger ISI. A portion of the purchase price consideration for the acquisition in the amount of $280,000 will be recognized in two annual installments, each of up to 132,626 shares of the Company’s common stock, subject to the achievement of revenue milestones in 2021 and 2022. The contingent consideration was measured and recorded at fair value. As a result of a remeasurement of the contingent consideration, we recorded a decrease to the related liability of $31,000 and $140,000 during the quarters ended March 31, 2022 and 2021, respectively. During the quarter ended June 30, 2022, the remaining contingent liability of $39,000 was written-down to $0 as the probability of achievement of the 2022 revenue milestone is remote.

Contracts

The Company has entered into contract research agreements with unrelated parties that require the Company to pay certain funding commitments. The initial terms of these agreements range from one to three years in duration and in certain cases are cancelable.

The Company licenses certain technologies via executed agreements (“In-Licensing Agreements”) that are used to develop and advance the Company’s own technologies. The Company has entered into various In-Licensing Agreements with related and unrelated parties that require the Company to pay certain license fees, royalties, and/or milestone fees. In addition, certain royalty payments ranging from 2% to 15% of net revenue amounts as defined in the In-Licensing Agreements are or will be due.

The Company could be adversely affected by certain actions by the government as it relates to government contract revenue received in prior years. Government agencies, such as the Defense Contract Audit Agency routinely audit and investigate government contractors. These agencies review a contractor’s performance under its agreements; cost structure; and compliance with applicable laws, regulations and standards. The agencies also review the adequacy of, and a contractor’s compliance with, its internal control systems and policies, including the contractor’s purchasing, property, estimating, compensation and management information systems. While the Company’s management anticipates no adverse result from an audit, should any costs be found to be improperly allocated to a government agreement, such costs will not be reimbursed, or if already reimbursed, may need to be refunded. If an audit uncovers improper or illegal activities, civil and criminal penalties and administrative sanctions, including termination of contracts, forfeiture of profits, suspension of payments or fines, and suspension or prohibition from doing business with the government could occur. In

addition, serious reputational harm or significant adverse financial effects could occur if allegations of impropriety were made against the Company. There currently are routine audits in process relating to government grant revenues.

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2
Net Loss per Share
6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Net Loss per Share

16. Net Loss per Share

Basic net loss per share is calculated by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period and excludes any dilutive effects of stock-based awards and warrants. Diluted net loss per share attributable to common stockholders is computed giving effect to all potentially dilutive common shares, including common stock issuable upon exercise of stock options and warrants. As the Company had net losses for the three and six months ended June 30, 2022 and 2021, all potentially dilutive common shares were determined to be anti-dilutive.


Securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in shares):

 

 

 

For the Three Months Ended June 30,

 

 

For the Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Options to purchase common stock

 

 

2,283,649

 

 

 

1,711,145

 

 

 

2,283,649

 

 

 

1,711,145

 

Warrants to purchase common stock

 

 

11,350,011

 

 

 

11,540,011

 

 

 

11,350,011

 

 

 

11,540,011

 

Total

 

 

13,633,660

 

 

 

13,251,156

 

 

 

13,633,660

 

 

 

13,251,156

 

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.2
Related-Party Transactions
6 Months Ended
Jun. 30, 2022
Related Party Transactions [Abstract]  
Related-Party Transactions

17. Related-Party Transactions

The Company’s related parties include Moral Compass Corporation (“MCC”) and the John Sperling Foundation (“JSF”). The rights to the intellectual property owned by Blue Horse Labs, Inc. (“BHL”) were assigned to its sole shareholder, the John Sperling Revocable Trust (“JSRT”) due to BHL’s dissolution and then subsequently to the JSF. The JSF is deemed a related party of the Company because MCC, the Company’s largest stockholder, and the JSF share common officers and directors.

JSF receives a single digit royalty from the Company when revenue has been collected on product sales or for license payments from third parties that involve certain intellectual property developed under research funding originally from BHL. Royalty fees due to JSF were $83,000 and $64,000 as of June 30, 2022 and December 31, 2021, respectively, and are included in the condensed consolidated balance sheets as amounts due to related parties.

During the six months ended June 30, 2021, the Company leased land on the island of Molokai, Hawaii from an entity owned by Kevin Comcowich, the Chair of the Company’s Board of Directors, and his wife. The Company used to grow hemp on this land to support the operations of its joint venture Archipelago Ventures Hawaii, until the expiration of the lease in February 2022. The original lease was executed in February 2019, covered 10 acres of land, had a term of two years and provided for rent payments of $1,200 per acre per year. In March and April 2020, the Company entered into two lease amendments for two additional 10-acre parcels and two additional 15-acre parcels, at the same lease rate of $1,200 per acre per year, and with a term of two years. The Company made lease payments in the amount of $0 for each of the three and six months ended June 30, 2022, and made lease payments in the amount of $6,000 and $42,000 during the three and six months ended June 30, 2021, respectively.

XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.2
Subsequent Events
6 Months Ended
Jun. 30, 2022
Subsequent Events [Abstract]  
Subsequent Events

18. Subsequent Events

Saavy Naturals™

On July 8, 2022, the Company entered an agreement to license Saavy Naturals™ to Radiance Beauty & Wellness, Inc. Please refer to a discussion of the agreement in Note 6.

XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.2
Description of Business and Basis of Presentation (Policies)
6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
Organization

Organization

Arcadia Biosciences, Inc. (the "Company," "Arcadia" or "management"), was incorporated in Arizona in 2002 and maintains its headquarters in Davis, California, with additional facilities in American Falls, Idaho and Chatsworth, California. The Company was reincorporated in Delaware in March 2015.

The Company is a producer and marketer of innovative, plant-based health and wellness products. Its history as a leader in science-based approaches to developing high-value crop improvements, as well as nutritionally enhanced food ingredients and health and wellness products, has laid the foundation for its path forward. The Company used advanced breeding techniques to develop these proprietary innovations which are now being commercialized through the sales of seed and grain, as well as food ingredients and products. The acquisition of the businesses of Lief Holdings, LLC (“Lief”), EKO Holdings, LLC (“Eko”) and Live Zola, LLC (“Zola”) added bath and body care products, as well as coconut water, to the Company’s portfolio.

In May 2021, the Company’s wholly owned subsidiary Arcadia Wellness, LLC (“Arcadia Wellness” or “AW”, see Note 6), acquired the businesses of Eko, Lief, and Zola. The acquisition included consumer CBD brands like Soul Spring™, a CBD-infused botanical therapy brand in the natural category, Saavy Naturals™, a line of natural body care products and ProVault™, a CBD-infused sports performance formula made with natural ingredients, providing effective support and recovery for athletes. Also included in the purchase is Zola, a coconut water sourced exclusively with sustainably grown coconuts from Thailand. On July 8, 2022, the Company entered into an agreement to license Saavy Naturals™ to Radiance Beauty and Wellness, Inc. ("Radiance Beauty"). See Note 6 for a discussion of the licensing agreement.

In August 2019, the Company entered into a joint venture agreement with Legacy Ventures Hawaii, LLC (“Legacy,” see Note 8) to grow, extract, and sell hemp products. The partnership Archipelago Ventures Hawaii, LLC (“Archipelago”), combines the Company’s extensive genetic expertise and resources with Legacy’s experience in hemp extraction and sales. In October 2021, Arcadia and Legacy mutually agreed to wind down the cultivation activities of Archipelago, due to regulatory challenges and a saturated hemp market.

In February 2012, the Company formed Verdeca, which was equally owned with Bioceres. Verdeca was formed to develop and deregulate soybean varieties using both partners’ agricultural technologies. In November 2020, Arcadia sold its membership interest in Verdeca to Bioceres in a transaction in which Arcadia received cash, shares of Bioceres stock and a royalty stream of up to $10.0 million on sales of Haab 4 soybeans (“HB4”) soybean. An additional $2.0 million in cash is to be paid upon achievement by Verdeca of reaching commercial plantings of at least 200,000 hectares of HB4 or China approving the HB4 soybean trait for “food and feed”. During the quarter ended June 30, 2022, Bioceres received China's approval of the HB4 soybean trait and as a result, Arcadia recorded license revenue of $862,000 and a gain on sale of Verdeca of $1.1 million on the condensed consolidated statements of operations and comprehensive loss.

Basis of Presentation and Principles of Consolidation

Basis of Presentation and Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial statements and are in the form prescribed by the Securities and Exchange Commission (the “SEC”) in instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial position, results of operations and cash flows for the periods indicated. All material intercompany accounts and transactions have been eliminated in consolidation. The accompanying unaudited condensed consolidated financial statements include the accounts of the Company, Arcadia Wellness, and Archipelago.

The Company uses a qualitative approach in assessing the consolidation requirement for variable interest entities ("VIEs"). This approach focuses on determining whether the Company has the power to direct the activities of the VIE that most significantly affect the VIE’s economic performance and whether the Company has the obligation to absorb losses, or the right to receive benefits, that could potentially be significant to the VIE.

For all periods presented, the Company has determined that it is the primary beneficiary of Archipelago, a joint venture, as it has a controlling interest in Archipelago. Accordingly, the Company consolidates Archipelago in the condensed consolidated financial statements after eliminating intercompany transactions. For consolidated joint ventures, the non-controlling partner’s share of the assets, liabilities and operations of the joint venture is included in non-controlling interests as equity of the Company. The non-controlling partner’s interest is generally computed as the joint venture partner’s ownership percentage of Archipelago. Net loss attributable to non-controlling interest of $20,000 and $142,000 is recorded as an adjustment to net loss to arrive at net loss attributable to common stockholders for the three and six months ended June 30, 2022, respectively. Net loss attributable to non-controlling interest for three and six months ended June 30, 2021 was $161,000 and $538,000, respectively. The non-controlling partner’s equity interests are presented as non-controlling interests on the condensed consolidated balance sheets.

The information included in these condensed consolidated financial statements and notes thereto should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations included herein and Management’s Discussion and Analysis of Financial Condition and Results of Operations and the condensed consolidated financial statements and notes thereto for the fiscal year ended December 31, 2021 included in the Company’s Annual Report on Form 10-K, filed with the SEC on March 31, 2022.

Liquidity, Capital Resources, and Going Concern

Liquidity, Capital Resources, and Going Concern

The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities during the normal course of business. Since inception, the Company has financed its operations primarily through equity and debt financings. As of June 30, 2022, the Company had an accumulated deficit of $250.7 million, and cash and cash equivalents of $21.2 million. For the six months ended June 30, 2022, the Company had a net loss of $8.4 million and net cash used in operations of $8.3 million. For the twelve months ended December 31, 2021, the Company had net losses of $16.1 million and net cash used in operations of $25.9 million.

With cash and cash equivalents of $21.2 million as of June 30, 2022, the Company believes that its existing cash and cash equivalents will not be sufficient to meet its anticipated cash requirements for at least the next 12 months from the issuance date of these financial statements, and thus raises substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

The Company may seek to raise additional funds through debt or equity financings. The Company may also consider entering into additional partner arrangements. The sale of additional equity would result in dilution to the Company’s stockholders. The incurrence of debt would result in debt service obligations, and the instruments governing such debt could provide for additional operating and financing covenants that would restrict operations. If the Company does require additional funds and is unable to secure adequate additional funding at terms agreeable to the Company, the Company may be forced to reduce spending, extend payment terms with suppliers, liquidate assets, or suspend or curtail planned development programs. Any of these actions could materially harm the business, results of operations and financial condition.

XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.2
Inventory (Tables)
6 Months Ended
Jun. 30, 2022
Inventory Disclosure [Abstract]  
Summary of Inventories

Inventories, net consist of the following (in thousands):

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Raw materials

 

$

1,133

 

 

$

1,851

 

Goods in process

 

 

108

 

 

 

842

 

Finished goods

 

 

3,170

 

 

 

4,234

 

Inventories

 

$

4,411

 

 

$

6,927

 

XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2
Property and Equipment, Net (Tables)
6 Months Ended
Jun. 30, 2022
Property, Plant and Equipment [Abstract]  
Summary of Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

 

 

 

June 30, 2022

 

 

December 31, 2021

 

Laboratory equipment

 

$

1,790

 

 

$

2,659

 

Software and computer equipment

 

 

576

 

 

 

548

 

Machinery and equipment

 

 

653

 

 

 

1,809

 

Furniture and fixtures

 

 

198

 

 

 

211

 

Vehicles

 

 

333

 

 

 

417

 

Leasehold improvements

 

 

2,223

 

 

 

2,306

 

Property and equipment, gross

 

 

5,773

 

 

 

7,950

 

Less: accumulated depreciation and amortization

 

 

(4,819

)

 

 

(5,659

)

Property and equipment, net

 

$

954

 

 

$

2,291

 

XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.2
Investments and Fair Value Instruments (Tables)
6 Months Ended
Jun. 30, 2022
Investments And Fair Value Instruments [Abstract]  
Summary of Amortized Cost and Fair Value of Investment Securities Portfolio

The following tables summarize the amortized cost and fair value of the investment securities portfolio at June 30, 2022 and December 31, 2021.

 

(Dollars in thousands)

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Estimated
Fair Value

 

June 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

19,283

 

 

$

 

 

$

 

 

$

19,283

 

Total Assets at Fair Value

 

$

19,283

 

 

$

 

 

$

 

 

$

19,283

 

 

(Dollars in thousands)

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Estimated
Fair Value

 

December 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

26,842

 

 

$

 

 

$

 

 

$

26,842

 

Total Assets at Fair Value

 

$

26,842

 

 

$

 

 

$

 

 

$

26,842

 

Summary of Fair Value of Investment Securities

The fair value of the investment securities at June 30, 2022 were as follows:

 

 

 

Fair Value Measurements at June 30, 2022

 

(Dollars in thousands)

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets at Fair Value

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

19,283

 

 

$

 

 

$

 

 

$

19,283

 

Total Assets at Fair Value

 

$

19,283

 

 

$

 

 

$

 

 

$

19,283

 

 

The fair value of the investment securities at December 31, 2021 were as follows:

 

 

 

Fair Value Measurements at December 31, 2021

 

(Dollars in thousands)

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets at Fair Value

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

26,842

 

 

$

 

 

$

 

 

$

26,842

 

Total Assets at Fair Value

 

$

26,842

 

 

$

 

 

$

 

 

$

26,842

 

Summary of Changes in Fair Value and Other Adjustments of Liabilities

The following table sets forth the establishment of the Company’s Level 3 liabilities, as well as a summary of the changes in the fair value and other adjustments (in thousands):

 

 

 

 

 

(Dollars in thousands)

 

Common Stock
Warrant
Liability -
March
2018
Purchase
Agreement

 

 

Common
Stock
Warrant
Liability -
June
2019
Offering

 

 

Common
Stock
Warrant
Liability -
September
2019
Offering

 

 

Common
Stock
Warrant
Liability -
January 2021
Offering

 

 

Contingent
Liabilities

 

 

Total

 

Balance as of December 31, 2021

 

$

7

 

 

$

170

 

 

$

223

 

 

$

2,993

 

 

$

2,070

 

 

$

5,463

 

Reclassification upon adoption
    of ASU 2020-06

 

 

(7

)

 

 

(170

)

 

 

(223

)

 

 

(2,993

)

 

 

 

 

 

(3,392

)

Change in fair value of contingent
   consideration

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(70

)

 

 

(70

)

Balance as of June 30, 2022

 

$

 

 

$

 

 

$

 

 

$

 

 

$

2,000

 

 

$

2,000

 

XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.2
Arcadia Wellness Acquisition (Tables)
6 Months Ended
Jun. 30, 2022
Business Combinations [Abstract]  
Schedule of Allocation Purchase Price of Assets Acquired at Fair Value at Acquisition Date

The following table presents the allocation of the purchase price of the assets acquired at fair value at the acquisition date:

 

 

 

Purchase Price
Allocation

 

Inventory

 

$

840

 

Prepaid and other current assets

 

 

62

 

Fixed assets

 

 

308

 

Deposits

 

 

82

 

Customer list

 

 

360

 

Trade names and trademarks

 

 

2,900

 

Formulations

 

 

260

 

Goodwill

 

 

1,240

 

Total consideration allocated

 

$

6,052

 

Schedule of Unaudited Pro-forma Condensed Consolidated Results of Operations

The following unaudited pro-forma condensed consolidated results of operations for the three and six months ended June 30, 2022 and 2021, have been prepared as if the acquisition of Arcadia Wellness had occurred on January 1, 2021 and includes adjustments for amortization of intangibles, and the addition to basic and diluted weighted average number of shares outstanding.

 

 

 

For the three months
ended June 30,

 

 

For the six months
ended June 30,

 

 

 

2022
(Pro forma)

 

 

2021
(Pro forma)

 

 

2022
(Pro forma)

 

 

2021
(Pro forma)

 

Total revenues

 

$

3,858

 

 

$

2,203

 

 

$

7,078

 

 

$

4,516

 

Net loss

 

 

(3,797

)

 

 

(5,409

)

 

 

(8,407

)

 

 

(5,193

)

Net loss attributable to common stockholders

 

$

(3,777

)

 

$

(5,248

)

 

$

(8,265

)

 

$

(4,655

)

Weighted average shares - Basic and diluted

 

 

22,188,918

 

 

 

22,159,103

 

 

 

22,187,961

 

 

 

21,478,810

 

Net loss per share attributable to common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.17

)

 

$

(0.24

)

 

$

(0.37

)

 

$

(0.22

)

XML 40 R30.htm IDEA: XBRL DOCUMENT v3.22.2
Intangible Assets, Net (Tables)
6 Months Ended
Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets, Net

The Company’s intangible assets, net as of June 30, 2022, consist of the following:

 

 

 

June 30, 2022

 

 

December 31, 2021

 

 

 

Gross
Carrying
Amount (2)

 

 

Accumulated Amortization

 

 

Net Carrying
Amount

 

 

Gross
Carrying
Amount (1)

 

 

Accumulated Amortization

 

 

Net Carrying
Amount

 

Amortized intangible assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Intellectual property

 

$

254

 

 

$

130

 

 

$

124

 

 

$

258

 

 

$

107

 

 

$

151

 

Customer lists

 

 

64

 

 

 

30

 

 

 

34

 

 

 

71

 

 

 

26

 

 

 

45

 

Total amortizable intangible assets

 

$

318

 

 

$

160

 

 

$

158

 

 

$

329

 

 

$

133

 

 

$

196

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Indefinite-lived intangible assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Brands and trademarks

 

$

228

 

 

$

 

 

$

228

 

 

$

288

 

 

$

 

 

$

288

 

Total intangible asset, net

 

$

546

 

 

$

160

 

 

$

386

 

 

$

617

 

 

$

133

 

 

$

484

 

 

(1) The gross carrying amounts included in this table reflect the effects of the impairments of intangible assets recorded during the year ended December 31, 2021, when the Company estimated an overall decrease in the sales forecast for AW products, due to an inventory item rationalization, in addition to a decrease in the sales forecast of ISI seeds, related to the saturated hemp seed market. As a result, Arcadia performed a quantitative intangible assets impairment test. The Company used a discounted cash flow approach to develop the fair value of the acquired intellectual property, customer lists, brands and trademarks. As a result of this assessment, Arcadia recorded an impairment of intangible assets in the amount of $3.3 million in the condensed consolidated statements of operations and comprehensive loss for the year ended December 31, 2021.

(2) The Company recorded an impairment of intangible assets in the amount of $72,000 during the three and six months ended June 30, 2022 related to the Radiance Beauty licensing agreement.

Schedule of Future Amortization of Intellectual Property and Customer Lists As of June 30, 2022, future amortization of intellectual property and customer lists is as follows:

 

Year Ending December 31,

 

 

 

2022 (excluding the six months ended June 30, 2022)

 

$

26

 

2023

 

 

53

 

2024

 

 

53

 

2025

 

 

4

 

2026

 

 

4

 

Thereafter

 

 

18

 

Total

 

$

158

 

XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.2
Leases (Tables)
6 Months Ended
Jun. 30, 2022
Lessee Disclosure [Abstract]  
Schedule of Leases Leases consisted of the following (in thousands):

 

Leases

 

Classification

 

June 30, 2022

 

 

December 31, 2021

 

Assets

 

 

 

 

 

 

 

 

Operating lease assets

 

 Right of use asset

 

$

2,308

 

 

$

3,081

 

Total leased assets

 

 

 

$

2,308

 

 

$

3,081

 

Liabilities

 

 

 

 

 

 

 

 

Current - Operating

 

 Operating lease liability- current

 

$

994

 

 

$

1,074

 

Noncurrent - Operating

 

 Operating lease liability- noncurrent

 

 

1,500

 

 

 

2,220

 

Total leased liabilities

 

 

 

$

2,494

 

 

$

3,294

 

 

 

Lease Cost

 

Classification

 

For the Three
Months Ended
June 30, 2022

 

 

For the Three
Months Ended
June 30, 2021

 

 

For the Six
Months Ended
June 30, 2022

 

 

For the Six
Months Ended
June 30, 2021

 

Operating lease cost

 

 SG&A and R&D Expenses

 

$

268

 

 

$

347

 

 

$

544

 

 

$

636

 

Short term lease cost (1)

 

 R&D Expenses

 

 

8

 

 

 

(17

)

 

 

11

 

 

 

30

 

Short term lease cost

 

 SG&A Expenses

 

 

 

 

 

4

 

 

 

 

 

 

15

 

Sublease income (2)

 

 SG&A and R&D Expenses

 

 

(90

)

 

 

(19

)

 

 

(177

)

 

 

(33

)

Net lease cost

 

 

 

$

186

 

 

$

315

 

 

$

378

 

 

$

648

 

 

(1)
Short term lease cost consists of field trial lease agreements with a lease term of 12 months or less.
(2)
Sublease income is recorded as a reduction to lease expense.

 

Lease Term
and Discount Rate

 

June 30, 2022

 

 

December 31, 2021

 

Weighted-average remaining
   lease term (years)

 

 

2.3

 

 

 

2.7

 

Weighted-average discount rate

 

 

6.4

%

 

 

6.0

%

XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2
Warrants (Tables)
6 Months Ended
Jun. 30, 2022
Warrants and Rights Note Disclosure [Abstract]  
Summary of Warrants Issued to Purchase Common Stock

The Company issued the following warrants to purchase shares of its common stock, which are outstanding as of June 30, 2022 or December 31, 2021, respectively. These warrants are exercisable any time at the option of the holder until their expiration date.

 

 

 

Issuance Date

 

Term

 

Exercise
Price Per
Share

 

 

Warrants
Exercised
during the
Year Ended
December 31,
2021

 

 

Warrants
Outstanding at
December 31,
2021

 

 

Warrants
Exercised
during the
Six
Months Ended
June 30,
2022

 

 

Warrants
Outstanding at
June 30,
2022

 

January 2021 Placement Agent Warrants

 

January 2021

 

5.5 years

 

$

3.99

 

 

 

 

 

 

393,839

 

 

 

 

 

 

393,839

 

January 2021 Service and Performance Warrants (1)

 

January 2021

 

2 years

 

$

3.08

 

 

 

 

 

 

7,500

 

 

 

 

 

 

7,500

 

December 2020 Warrants

 

December 2020

 

5.5 years

 

$

3.00

 

 

 

 

 

 

2,618,658

 

 

 

 

 

 

2,618,658

 

December 2020 Placement Agent Warrants

 

December 2020

 

5 years

 

$

3.82

 

 

 

 

 

 

130,933

 

 

 

 

 

 

130,933

 

July 2020 Warrants

 

July 2020

 

5.5 years

 

$

3.85

 

 

 

 

 

 

641,416

 

 

 

 

 

 

641,416

 

July 2020 Placement Agent Warrants

 

July 2020

 

5.5 years

 

$

4.97

 

 

 

 

 

 

32,071

 

 

 

 

 

 

32,071

 

May 2020 Warrants

 

May 2020

 

5 years

 

$

4.78

 

 

 

 

 

 

1,392,345

 

 

 

 

 

 

1,392,345

 

May 2020 Placement Agent Warrants

 

May 2020

 

5 years

 

$

6.13

 

 

 

 

 

 

69,617

 

 

 

 

 

 

69,617

 

March 2020 Service and Performance Warrants (1)

 

March 2020

 

3 years

 

$

2.50

 

 

 

 

 

 

18,350

 

 

 

 

 

 

18,350

 

February 12, 2020 Service and Performance Warrants (1)(3)

 

February 2020

 

2 years

 

$

4.71

 

 

 

 

 

 

150,000

 

 

 

 

 

 

 

February 3, 2020 Service and Performance Warrants (1)(3)

 

February 2020

 

2 years

 

$

4.91

 

 

 

 

 

 

10,000

 

 

 

 

 

 

 

September 2019 Placement Agent Warrants

 

September 2019

 

5 years

 

$

9.48

 

 

 

 

 

 

65,942

 

 

 

 

 

 

65,942

 

June 2019 Placement Agent Warrants

 

June 2019

 

5 years

 

$

6.29

 

 

 

 

 

 

74,479

 

 

 

 

 

 

74,479

 

April 2019 Service and Performance Warrants (1)

 

April 2019

 

5 years

 

$

6.18

 

 

 

 

 

 

145,154

 

 

 

 

 

 

145,154

 

June 2018 Placement Agent Warrants

 

June 2018

 

5 years

 

$

12.57

 

 

 

 

 

 

69,617

 

 

 

 

 

 

69,617

 

March 2018 Placement Agent Warrants

 

March 2018

 

5 years

 

$

41.56

 

 

 

 

 

 

15,038

 

 

 

 

 

 

15,038

 

January 2021 Warrants (2)

 

January 2021

 

5.5 years

 

$

3.13

 

 

 

 

 

 

3,938,392

 

 

 

 

 

 

3,938,392

 

September 2019 Warrants (2)

 

September 2019

 

5.5 years

 

$

7.52

 

 

 

 

 

 

659,414

 

 

 

 

 

 

659,414

 

June 2019 Warrants (2)

 

June 2019

 

5.5 years

 

$

5.00

 

 

 

 

 

 

435,830

 

 

 

 

 

 

435,830

 

June 2018 Warrants (2)

 

June 2018

 

5.5 years

 

$

9.94

 

 

 

 

 

 

 

 

 

 

 

 

 

March 2018 Warrants (2)

 

March 2018

 

5 years

 

$

10.73

 

 

 

 

 

 

641,416

 

 

 

 

 

 

641,416

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

11,510,011

 

 

 

 

 

 

11,350,011

 

XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Compensation and Employee Stock Purchase Program (Tables)
6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of Activity Under Stock Incentive Plans

The following is a summary of stock option information and weighted average exercise prices under the Company’s stock incentive plans (in thousands, except share data and price per share):

 

 

 

Shares
Subject to
Outstanding
Options

 

 

Weighted-
Average
Exercise
Price Per
Share

 

 

Aggregate
Intrinsic
Value

 

Outstanding — Balance at December 31, 2021

 

 

1,422,195

 

 

$

5.28

 

 

$

 

Options granted

 

 

1,030,822

 

 

 

1.16

 

 

 

 

Options exercised

 

 

 

 

 

 

 

 

 

Options forfeited

 

 

(130,263

)

 

 

2.86

 

 

 

 

Options expired

 

 

(39,105

)

 

 

6.21

 

 

 

 

Outstanding — Balance at June 30, 2022

 

 

2,283,649

 

 

$

3.54

 

 

$

31,230

 

Vested and expected to vest — June 30, 2022

 

 

2,011,343

 

 

$

3.82

 

 

$

24,452

 

Exercisable — June 30, 2022

 

 

862,726

 

 

$

6.76

 

 

$

 

Weighted-Average Fair Value Assumption of Stock Option Awards

The fair value of stock option awards was estimated at the date of grant using a Black-Scholes option-pricing model with the following weighted-average assumption:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Expected term (years)

 

 

6.85

 

 

 

6.84

 

 

 

6.61

 

 

 

6.37

 

Expected volatility

 

 

123

%

 

 

122

%

 

 

122

%

 

 

122

%

Risk-free interest rate

 

 

2.85

%

 

 

1.06

%

 

 

2.48

%

 

 

0.81

%

Dividend yield

 

 

 

 

 

 

 

 

 

 

 

 

XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.2
Net Loss per Share (Tables)
6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Schedule of Securities Not Included in Diluted per Share Calculations Securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in shares):

 

 

 

For the Three Months Ended June 30,

 

 

For the Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Options to purchase common stock

 

 

2,283,649

 

 

 

1,711,145

 

 

 

2,283,649

 

 

 

1,711,145

 

Warrants to purchase common stock

 

 

11,350,011

 

 

 

11,540,011

 

 

 

11,350,011

 

 

 

11,540,011

 

Total

 

 

13,633,660

 

 

 

13,251,156

 

 

 

13,633,660

 

 

 

13,251,156

 

XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.2
Description of Business and Basis of Presentation - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Nov. 30, 2020
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Place of incorporation           Arizona    
Year of incorporation           2002    
Place of reincorporation           Delaware    
Date of reincorporation           2015-03    
Gain on sale of Verdeca   $ 1,138,000       $ 1,138,000    
License revenue   3,858,000   $ 1,405,000   7,078,000 $ 2,234,000  
Net loss attributable to non-controlling interest   (20,000)   (161,000)   (142,000) (538,000)  
Accumulated deficit   (250,748,000)       (250,748,000)   $ (226,485,000)
Cash and cash equivalents   21,234,000       21,234,000   28,685,000
Net loss   $ (3,797,000) $ (4,610,000) $ (5,422,000) $ 1,681,000 (8,407,000) (3,740,000) (16,100,000)
Net cash used in operations           (8,250,000) $ (10,940,000) $ (25,900,000)
Verdeca LLC [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Gain on sale of Verdeca           1,100,000    
Bioceres Crop Solutions [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
License revenue           $ 862,000    
Bioceres Crop Solutions [Member] | Verdeca LLC [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Additional cash receivable from sale of interest in joint venture $ 2,000,000.0              
Bioceres Crop Solutions [Member] | Verdeca LLC [Member] | Maximum [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Cash shares and royalty receivable $ 10,000,000.0              
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.2
Recent Accounting Pronouncements - Additional Information (Detail) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Dec. 31, 2021
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]    
Accumulated deficit $ (250,748) $ (226,485)
Additional paid-in capital 277,492 257,515
Common stock warrant liabilities   $ 3,392
Accounting Standards Update 2020-06 [Member]    
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]    
Accumulated deficit 16,000  
Additional paid-in capital 19,400  
Decrease in common stock warrant liabilities $ 3,400  
Change in accounting principle, accounting standards update, adopted [true false] true  
Change in accounting principle, accounting standards update, adoption date Jan. 01, 2022  
Accounting Standards Update 2021-04 [Member]    
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]    
Change in accounting principle, accounting standards update, adopted [true false] true  
Change in accounting principle, accounting standards update, adoption date Jan. 01, 2022  
Change in accounting principle, accounting standards update, immaterial effect [true false] true  
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.2
Inventory - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Inventory [Line Items]        
Write-down of inventory $ 1,100,000 $ 823,000 $ 1,515,000 $ 983,000
Radiance Beauty Licensing Agreement [Member]        
Inventory [Line Items]        
Write-down of inventory $ 394,000   $ 394,000  
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.22.2
Inventory - Summary of Inventories (Detail) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Inventory Disclosure [Abstract]    
Raw materials $ 1,133 $ 1,851
Goods in process 108 842
Finished goods 3,170 4,234
Inventories $ 4,411 $ 6,927
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.2
Property and Equipment, Net - Summary of Property and Equipment, Net (Detail) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Property Plant And Equipment [Line Items]    
Property and equipment, gross $ 5,773 $ 7,950
Less accumulated depreciation and amortization (4,819) (5,659)
Property and equipment, net 954 2,291
Laboratory equipment [Member]    
Property Plant And Equipment [Line Items]    
Property and equipment, gross 1,790 2,659
Software and computer equipment [Member]    
Property Plant And Equipment [Line Items]    
Property and equipment, gross 576 548
Machinery and equipment [Member]    
Property Plant And Equipment [Line Items]    
Property and equipment, gross 653 1,809
Furniture and fixtures [Member]    
Property Plant And Equipment [Line Items]    
Property and equipment, gross 198 211
Vehicles [Member]    
Property Plant And Equipment [Line Items]    
Property and equipment, gross 333 417
Leasehold improvements [Member]    
Property Plant And Equipment [Line Items]    
Property and equipment, gross $ 2,223 $ 2,306
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.22.2
Property and Equipment, Net - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Property Plant And Equipment [Line Items]          
Depreciation expense     $ 277,000 $ 484,000  
Property and equipment, gross $ 5,773,000   5,773,000   $ 7,950,000
Impairment of property and equipment 346,000   346,000 210,000  
Gain on sale of property and equipment 58,000   386,000    
Proceeds from sale of property and equipment 54,000   841,000    
Assets held for sale   $ 0   0  
Property and equipment classified as assets held for sale, fair value 254,000   254,000    
Radiance Beauty Licensing Agreement [Member]          
Property Plant And Equipment [Line Items]          
Impairment of property and equipment 320,000   320,000    
Archipelago Ventures Hawaii, LLC [Member]          
Property Plant And Equipment [Line Items]          
Impairment of property and equipment   $ 210,000   $ 210,000  
Construction in Progress [Member]          
Property Plant And Equipment [Line Items]          
Property and equipment, gross $ 10,000   $ 10,000   $ 267,000
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.22.2
Investments and Fair Value Instruments - Summary of Amortized Cost and Fair Value of Investment Securities Portfolio (Detail) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Schedule Of Available For Sale Securities [Line Items]    
Amortized Cost $ 19,283 $ 26,842
Estimated Fair Value 19,283 26,842
Cash Equivalents [Member] | Money Market Funds [Member]    
Schedule Of Available For Sale Securities [Line Items]    
Amortized Cost 19,283 26,842
Estimated Fair Value $ 19,283 $ 26,842
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.22.2
Investments and Fair Value Instruments - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Investments, Debt and Equity Securities [Abstract]        
Investment in continuous unrealized loss position for more than twelve months $ 0   $ 0  
Impairment charges $ 418,000 $ 0 $ 418,000 $ 210,000
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.22.2
Investments and Fair Value Instruments - Summary of Fair Value of Investments Securities (Detail) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Assets at Fair Value    
Total Assets at Fair Value $ 19,283 $ 26,842
Money Market Funds [Member]    
Assets at Fair Value    
Cash equivalents 19,283 26,842
Level 1 [Member]    
Assets at Fair Value    
Total Assets at Fair Value 19,283 26,842
Level 1 [Member] | Money Market Funds [Member]    
Assets at Fair Value    
Cash equivalents $ 19,283 $ 26,842
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.22.2
Investments and Fair Value Instruments - Summary of Changes in Fair Value and Other Adjustments of Liabilities (Detail) - Level 3 [Member]
$ in Thousands
6 Months Ended
Jun. 30, 2022
USD ($)
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]  
Beginning Balance $ 5,463
Ending Balance 2,000
Common Stock Warrant Liability [Member] | Purchase Agreement [Member]  
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]  
Beginning Balance 7
Common Stock Warrant Liability [Member] | June 2019 Offering [Member]  
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]  
Beginning Balance 170
Common Stock Warrant Liability [Member] | September 2019 Offering [Member]  
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]  
Beginning Balance 223
Common Stock Warrant Liability [Member] | January 2021 Offering [Member]  
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]  
Beginning Balance 2,993
Contingent Liabilities [Member]  
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]  
Beginning Balance 2,070
Change in fair value of contingent consideration (70)
Ending Balance 2,000
ASU 2020-06 [Member]  
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]  
Change in fair value of contingent consideration (70)
ASU 2020-06 [Member] | Reclassification upon Adoption [Member]  
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]  
Beginning Balance (3,392)
ASU 2020-06 [Member] | Reclassification upon Adoption [Member] | Common Stock Warrant Liability [Member] | Purchase Agreement [Member]  
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]  
Beginning Balance (7)
ASU 2020-06 [Member] | Reclassification upon Adoption [Member] | Common Stock Warrant Liability [Member] | June 2019 Offering [Member]  
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]  
Beginning Balance (170)
ASU 2020-06 [Member] | Reclassification upon Adoption [Member] | Common Stock Warrant Liability [Member] | September 2019 Offering [Member]  
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]  
Beginning Balance (223)
ASU 2020-06 [Member] | Reclassification upon Adoption [Member] | Common Stock Warrant Liability [Member] | January 2021 Offering [Member]  
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]  
Beginning Balance $ (2,993)
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.22.2
Industrial Seed Innovations Acquisition - Additional Information (Detail)
1 Months Ended 3 Months Ended 6 Months Ended
Aug. 31, 2020
USD ($)
Installment
shares
Jun. 30, 2022
USD ($)
Mar. 31, 2022
USD ($)
Mar. 31, 2021
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Business Acquisition [Line Items]            
Change in fair value of contingent consideration   $ (39,000)     $ (70,000) $ (140,000)
Existence of option to extend         true  
Lease option to extend, description         Some leases (the Davis office, a warehouse, and a copy machine) include one or more options to renew, with renewal terms that can extend the lease term from one to six years.  
Maximum [Member]            
Business Acquisition [Line Items]            
Operating leases, term of contract   5 years     5 years  
Option to extend lease, term   6 years     6 years  
Minimum [Member]            
Business Acquisition [Line Items]            
Operating leases, term of contract   1 year     1 year  
Option to extend lease, term   1 year     1 year  
Industrial Seed Innovations [Member]            
Business Acquisition [Line Items]            
Remaining amount paid in multiple installments $ 280,000          
Change in fair value of contingent consideration     $ (31,000) $ (140,000)    
Operating leases, term of contract   3 years     3 years  
Industrial Seed Innovations [Member] | Common Stock [Member]            
Business Acquisition [Line Items]            
Number of annual installment of common stock shares payable | Installment 2          
Industrial Seed Innovations [Member] | Common Stock [Member] | Revenue Milestone in 2022 [Member] | Maximum [Member]            
Business Acquisition [Line Items]            
Business combination, equity interest issuable upon achievement of revenue milestone | shares 132,626          
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.22.2
Arcadia Wellness Acquisition - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended 7 Months Ended 12 Months Ended
May 31, 2021
May 17, 2021
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Dec. 31, 2021
Business Acquisition [Line Items]                
Lease option to extend, description         Some leases (the Davis office, a warehouse, and a copy machine) include one or more options to renew, with renewal terms that can extend the lease term from one to six years.      
Total revenues     $ 3,858,000 $ 1,405,000 $ 7,078,000 $ 2,234,000    
Net loss attributable to common stockholders     3,777,000 5,261,000 8,265,000 3,202,000    
Inventories written down     1,100,000 $ 823,000 1,515,000 983,000    
Impairment of property and equipment     346,000   346,000 210,000    
Impairment of intangible asset     72,000   $ 72,000     $ 3,300,000
Radiance Beauty Licensing Agreement [Member]                
Business Acquisition [Line Items]                
Effective rate of royalty of gross sales         4.00%      
Accounts receivable written-down         $ 21,000      
Inventories written down     394,000   394,000      
Impairment of property and equipment     320,000   320,000      
Impairment of intangible asset     72,000   72,000      
Accrued salaries     355,000   355,000      
Accrued rent, maintenance and utilities     $ 19,000   $ 19,000      
Arcadia Wellness [Member]                
Business Acquisition [Line Items]                
Purchase price consideration $ 6,100,000              
Cash paid for Acquisition 4,000,000.0              
Business combination, equity interest issuable, value $ 2,100,000              
Operating leases, term of contract     3 years   3 years      
Lease option to extend, description         The lease was effective on May 17, 2021 and has a term of 3 years.      
Total revenues         $ 3,900,000   $ 4,300,000  
Net loss attributable to common stockholders         $ (1,500,000)   $ 7,500,000  
Intangible assets, net   $ 3,500,000            
Weighted average useful life   12 years 10 months 24 days            
Goodwill   $ 1,240,000            
Arcadia Wellness [Member] | Trademarks and Trade Names [Member]                
Business Acquisition [Line Items]                
Intangible assets, net   2,900,000            
Arcadia Wellness [Member] | Customer List [Member]                
Business Acquisition [Line Items]                
Intangible assets, net   $ 360,000            
Useful life   15 years            
Arcadia Wellness [Member] | Formulations [Member]                
Business Acquisition [Line Items]                
Intangible assets, net   $ 260,000            
Useful life   10 years            
Arcadia Wellness [Member] | Selling, General and Administrative Expenses [Member]                
Business Acquisition [Line Items]                
Acquisition related costs           $ 850,000    
Common Stock [Member] | Arcadia Wellness [Member]                
Business Acquisition [Line Items]                
Business combination, equity interest issuable, shares 827,401              
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.22.2
Arcadia Wellness Acquisition - Schedule of Allocation Purchase Price of Assets Acquired at Fair Value at Acquisition Date (Detail) - Arcadia Wellness [Member]
$ in Thousands
May 17, 2021
USD ($)
Business Acquisition [Line Items]  
Inventory $ 840
Prepaid and other current assets 62
Fixed assets 308
Deposits 82
Customer list 360
Trade names and trademarks 2,900
Formulations 260
Goodwill 1,240
Total consideration allocated $ 6,052
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.22.2
Arcadia Wellness Acquisition - Schedule of Unaudited Pro-forma Condensed Consolidated Results of Operations (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Business Acquisition [Line Items]        
Weighted average shares - Basic 22,188,918 21,745,403 22,187,961 21,271,960
Weighted average shares - Diluted 22,188,918 21,745,403 22,187,961 21,271,960
Arcadia Wellness [Member]        
Business Acquisition [Line Items]        
Total revenues $ 3,858 $ 2,203 $ 7,078 $ 4,516
Net loss (3,797) (5,409) (8,407) (5,193)
Net loss attributable to common stockholders $ (3,777) $ (5,248) $ (8,265) $ (4,655)
Weighted average shares - Basic 22,188,918 22,159,103 22,187,961 21,478,810
Weighted average shares - Diluted 22,188,918 22,159,103 22,187,961 21,478,810
Net loss per share attributable to common stockholders:        
Basic and diluted $ (0.17) $ 0.24 $ (0.37) $ (0.22)
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.22.2
Intangible Assets, Net - Schedule of Intangible Assets, Net (Detail) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Finite And Indefinite Lived Intangible Assets [Line Items]    
Amortized intangible assets, Gross Carrying Amount $ 318 [1] $ 329 [2]
Amortized intangible assets, Accumulated Amortization 160 133
Finite-Lived Intangible Assets, Net, Total 158 196
Total intangible asset, Gross Carrying Amount 546 [1] 617 [2]
Total intangible asset, Net Carrying Amount 386 484
Brands and Trademarks [Member]    
Finite And Indefinite Lived Intangible Assets [Line Items]    
Indefinite-lived intangible assets, Gross Carrying Amount 228 [1] 288 [2]
Indefinite-lived intangible assets, Net Carrying Amount 228 288
Intellectual Property [Member]    
Finite And Indefinite Lived Intangible Assets [Line Items]    
Amortized intangible assets, Gross Carrying Amount 254 [1] 258 [2]
Amortized intangible assets, Accumulated Amortization 130 107
Finite-Lived Intangible Assets, Net, Total 124 151
Customer Lists [Member]    
Finite And Indefinite Lived Intangible Assets [Line Items]    
Amortized intangible assets, Gross Carrying Amount 64 [1] 71 [2]
Amortized intangible assets, Accumulated Amortization 30 26
Finite-Lived Intangible Assets, Net, Total $ 34 $ 45
[1] The Company recorded an impairment of intangible assets in the amount of $72,000 during the three and six months ended June 30, 2022 related to the Radiance Beauty licensing agreement.
[2] The gross carrying amounts included in this table reflect the effects of the impairments of intangible assets recorded during the year ended December 31, 2021, when the Company estimated an overall decrease in the sales forecast for AW products, due to an inventory item rationalization, in addition to a decrease in the sales forecast of ISI seeds, related to the saturated hemp seed market. As a result, Arcadia performed a quantitative intangible assets impairment test. The Company used a discounted cash flow approach to develop the fair value of the acquired intellectual property, customer lists, brands and trademarks. As a result of this assessment, Arcadia recorded an impairment of intangible assets in the amount of $3.3 million in the condensed consolidated statements of operations and comprehensive loss for the year ended December 31, 2021.
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.22.2
Intangible Assets, Net - Schedule of Intangible Assets, Net (Parenthetical) (Detail) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]      
Impairment of intangible asset $ 72,000 $ 72,000 $ 3,300,000
Radiance Beauty Licensing Agreement [Member]      
Finite-Lived Intangible Assets [Line Items]      
Impairment of intangible asset $ 72,000 $ 72,000  
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.22.2
Intangible Assets, Net - Additional Information (Detail) - Intellectual Property and Customer Lists [Member]
6 Months Ended
Jun. 30, 2022
Minimum [Member]  
Finite Lived Intangible Assets [Line Items]  
Useful life of intangible assets amortized 4 years
Maximum [Member]  
Finite Lived Intangible Assets [Line Items]  
Useful life of intangible assets amortized 15 years
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.22.2
Intangible Assets, Net - Schedule of Future Amortization of Intellectual Property and Customer Lists (Detail) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Finite Lived Intangible Assets [Line Items]    
2022 (excluding the six months ended June 30, 2022) $ 26  
2023 53  
2024 53  
2025 4  
2026 4  
Thereafter 18  
Finite-Lived Intangible Assets, Net, Total $ 158 $ 196
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Joint Venture - Additional Information (Detail)
3 Months Ended 6 Months Ended
Aug. 09, 2019
Individual
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Schedule Of Equity Method Investments [Line Items]          
Net loss attributable to noncontrolling interest   $ 20,000 $ 161,000 $ 142,000 $ 538,000
Archipelago Ventures Hawaii, LLC [Member] | Arcadia Biosciences, Inc [Member]          
Schedule Of Equity Method Investments [Line Items]          
Number of individuals appointed | Individual 2        
Joint venture interest percentage   50.75%   50.75%  
Capital contributions   $ 3,108,000   $ 3,108,000  
Archipelago Ventures Hawaii, LLC [Member] | Legacy Ventures Hawaii, LLC [Member]          
Schedule Of Equity Method Investments [Line Items]          
Number of individuals appointed | Individual 2        
Joint venture interest percentage   49.25%   49.25%  
Capital contributions   $ 3,016,000   $ 3,016,000  
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.22.2
Collaborative Arrangements - Additional Information (Detail)
1 Months Ended
Aug. 31, 2017
Collaborative Arrangements [Member]  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]  
Contractual agreement month and year 2017-08
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.22.2
Leases - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
May 31, 2022
Jun. 30, 2022
Jun. 30, 2022
Lessee Lease Description [Line Items]      
Operating lease term, expiration 2024-05    
Early termination fees   $ 47,000  
Existence of option to extend     true
Lease option to extend, description     Some leases (the Davis office, a warehouse, and a copy machine) include one or more options to renew, with renewal terms that can extend the lease term from one to six years.
Minimum [Member]      
Lessee Lease Description [Line Items]      
Option to extend lease, term   1 year 1 year
Maximum [Member]      
Lessee Lease Description [Line Items]      
Option to extend lease, term   6 years 6 years
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.22.2
Leases - Schedule of Leases (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Assets          
Operating lease assets $ 2,308   $ 2,308   $ 3,081
Total leased assets 2,308   2,308   3,081
Liabilities          
Current - Operating 994   994   1,074
Noncurrent - Operating 1,500   1,500   2,220
Total leased liabilities 2,494   2,494   $ 3,294
Lease Cost          
Net lease cost $ 186 $ 315 $ 378 $ 648  
Lease Term and Discount Rate          
Weighted-average remaining lease term (years) 2 years 3 months 18 days   2 years 3 months 18 days   2 years 8 months 12 days
Weighted-average discount rate 6.40%   6.40%   6.00%
SG&A and R&D Expenses [Member]          
Lease Cost          
Operating lease cost $ 268 347 $ 544 636  
Sublease income (90) (19) (177) (33)  
R&D Expenses [Member]          
Lease Cost          
Short term lease cost $ 8 (17) $ 11 30  
SG&A Expenses [Member]          
Lease Cost          
Short term lease cost   $ 4   $ 15  
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.22.2
Equity Financing - Additional Information (Detail)
1 Months Ended 6 Months Ended
Jan. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Sep. 30, 2019
USD ($)
$ / shares
shares
Jun. 30, 2019
USD ($)
$ / shares
shares
Jun. 30, 2018
USD ($)
$ / shares
shares
Mar. 31, 2018
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Jan. 28, 2021
Class Of Warrant Or Right [Line Items]                  
Offering costs allocated to common stock warrant liability and expensed | $             $ 27,000 $ 769,000  
Registration statement expiration term             On May 11, 2018, the Company filed a shelf Registration Statement on Form S-3 with the SEC which was declared effective on June 8, 2018 (“Shelf Registration Statement”). This shelf registration process allows the Company to sell any combination of common stock, preferred stock, warrants and units consisting of such securities in one or more offerings from time to time having aggregate offering prices of up to $50 million. This registration statement may no longer be used after June 8, 2021, the three-year anniversary of its effective date.    
Maximum [Member]                  
Class Of Warrant Or Right [Line Items]                  
Proceeds from issuance, aggregate offering prices | $             $ 50,000,000    
March 2018 Purchase Agreement [Member]                  
Class Of Warrant Or Right [Line Items]                  
Shares of common stock issued           1,201,634      
Warrant issued, shares of common stock called by warrant           1,282,832      
Warrants issued, exercise price | $ / shares           $ 10.7258      
December 2020 Purchase Agreement [Member]                  
Class Of Warrant Or Right [Line Items]                  
Shares of common stock issued   2,618,658              
Proceeds from issuance of common stock and warrants gross | $   $ 8,000,000.0              
Offering closing period   Dec. 22, 2020              
December 2020 Purchase Agreement [Member] | Warrants [Member]                  
Class Of Warrant Or Right [Line Items]                  
Warrant issued, shares of common stock called by warrant   2,618,658              
Warrants issued, exercise price | $ / shares   $ 3.00              
Warrants expiration period   5 years 6 months              
September 2019 Purchase Agreement [Member]                  
Class Of Warrant Or Right [Line Items]                  
Shares of common stock issued     1,318,828            
Proceeds from issuance of common stock and warrants gross | $     $ 10,000,000.0            
Offering closing period     Sep. 05, 2019            
September 2019 Purchase Agreement [Member] | Warrants [Member]                  
Class Of Warrant Or Right [Line Items]                  
Warrant issued, shares of common stock called by warrant     659,414            
Warrants issued, exercise price | $ / shares     $ 7.52            
Warrants expiration period     5 years 6 months            
June 2019 Purchase Agreement [Member]                  
Class Of Warrant Or Right [Line Items]                  
Shares of common stock issued       1,489,575          
Proceeds from issuance of common stock and warrants gross | $       $ 7,500,000          
Offering closing period       Jun. 14, 2019          
June 2019 Purchase Agreement [Member] | Warrants [Member]                  
Class Of Warrant Or Right [Line Items]                  
Warrant issued, shares of common stock called by warrant       1,489,575          
Warrants issued, exercise price | $ / shares       $ 5.00          
Warrants expiration period       5 years 6 months          
June 2018 Purchase Agreement [Member]                  
Class Of Warrant Or Right [Line Items]                  
Shares of common stock issued         1,392,345        
Proceeds from issuance of common stock and warrants gross | $         $ 14,000,000.0        
Offering closing period         Jun. 14, 2018        
June 2018 Purchase Agreement [Member] | Warrants [Member]                  
Class Of Warrant Or Right [Line Items]                  
Warrant issued, shares of common stock called by warrant         1,392,345        
Warrants issued, exercise price | $ / shares         $ 9.94        
Warrants expiration period         5 years 6 months        
June 2018 Placement Agent Warrants [Member] | June 2018 Purchase Agreement [Member] | Warrants [Member]                  
Class Of Warrant Or Right [Line Items]                  
Warrant issued, shares of common stock called by warrant         69,617        
Warrants issued, exercise price | $ / shares         $ 12.568        
Warrant, exercisable term         5 years        
June 2019 Placement Agent Warrants [Member] | June 2019 Purchase Agreement [Member] | Warrants [Member]                  
Class Of Warrant Or Right [Line Items]                  
Warrant issued, shares of common stock called by warrant       74,479          
Warrants issued, exercise price | $ / shares       $ 6.2938          
Warrant, exercisable term       5 years          
September 2019 Placement Agent Warrants [Member] | September 2019 Purchase Agreement [Member] | Warrants [Member]                  
Class Of Warrant Or Right [Line Items]                  
Warrant issued, shares of common stock called by warrant     65,942            
Warrants issued, exercise price | $ / shares     $ 9.4781            
Warrant, exercisable term     5 years            
December 2020 Placement Agent Warrants [Member] | December 2020 Purchase Agreement [Member] | Warrants [Member]                  
Class Of Warrant Or Right [Line Items]                  
Warrant issued, shares of common stock called by warrant   130,933              
Warrants issued, exercise price | $ / shares   $ 3.8188              
Warrant, exercisable term   5 years              
March 2018 Private Placement [Member] | March 2018 Purchase Agreement [Member]                  
Class Of Warrant Or Right [Line Items]                  
Shares of common stock issued           300,752      
Warrant issued, shares of common stock called by warrant           300,752      
Warrants issued, exercise price | $ / shares           $ 45.75      
Proceeds from issuance of common stock and warrants gross | $           $ 10,000,000.0      
Warrants expiration period           5 years      
March 2018 Private Placement [Member] | March 2018 Placement Agent Warrants [Member] | March 2018 Purchase Agreement [Member]                  
Class Of Warrant Or Right [Line Items]                  
Warrant issued, shares of common stock called by warrant           15,038      
Warrants issued, exercise price | $ / shares           $ 41.5625      
Warrant, exercisable term           5 years      
January 2021 Private Placement [Member] | January 2021 Purchase Agreement [Member]                  
Class Of Warrant Or Right [Line Items]                  
Shares of common stock issued 7,876,784                
Warrant issued, shares of common stock called by warrant 3,938,392                
Warrants issued, exercise price | $ / shares $ 3.13                
Proceeds from issuance of common stock and warrants gross | $ $ 25,100,000                
Warrants expiration period 5 years 6 months                
Remaining offering costs allocated to common stock and offset to additional paid in capital | $ $ 2,000,000.0                
January 2021 Private Placement [Member] | January 2021 Purchase Agreement [Member] | Warrants [Member]                  
Class Of Warrant Or Right [Line Items]                  
Offering costs allocated to common stock warrant liability and expensed | $ $ 769,000                
January 2021 Private Placement [Member] | January 2021 Purchase Agreement [Member] | Warrants [Member] | Expected Volatility [Member]                  
Class Of Warrant Or Right [Line Items]                  
Warrants and rights outstanding, measurement input                 123.8
January 2021 Private Placement [Member] | January 2021 Purchase Agreement [Member] | Warrants [Member] | Stock Price [Member]                  
Class Of Warrant Or Right [Line Items]                  
Warrants and rights outstanding, measurement input                 2.88
January 2021 Private Placement [Member] | January 2021 Purchase Agreement [Member] | Warrants [Member] | Risk-Free Interest Rate [Member]                  
Class Of Warrant Or Right [Line Items]                  
Warrants and rights outstanding, measurement input                 0.5
January 2021 Private Placement [Member] | January 2021 Placement Agent Warrants [Member] | January 2021 Purchase Agreement [Member]                  
Class Of Warrant Or Right [Line Items]                  
Warrant issued, shares of common stock called by warrant 393,839                
Warrants issued, exercise price | $ / shares $ 3.99                
Warrant, exercisable term 5 years 6 months                
Issuance of placement agent warrants | $ $ 942,000                
Offering costs | $ 1,900,000                
January 2021 Private Placement [Member] | January 2021 Placement Agent Warrants [Member] | January 2021 Purchase Agreement [Member] | Warrants [Member]                  
Class Of Warrant Or Right [Line Items]                  
Offering costs | $ $ 2,800,000                
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.22.2
Warrants - Summary of Warrants Issued to Purchase Common Stock (Detail) - $ / shares
6 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Class Of Warrant Or Right [Line Items]    
Warrants Outstanding 11,350,011 11,510,011
January 2021 Placement Agent Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2021-01  
Term 5 years 6 months  
Exercise Price Per Share $ 3.99  
Warrants Outstanding 393,839 393,839
January 2021 Service and Performance Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2021-01  
Term 2 years  
Exercise Price Per Share $ 3.08  
Warrants Outstanding 7,500 7,500
December 2020 Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2020-12  
Term 5 years 6 months  
Exercise Price Per Share $ 3.00  
Warrants Outstanding 2,618,658 2,618,658
December 2020 Placement Agent Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2020-12  
Term 5 years  
Exercise Price Per Share $ 3.82  
Warrants Outstanding 130,933 130,933
July 2020 Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2020-07  
Term 5 years 6 months  
Exercise Price Per Share $ 3.85  
Warrants Outstanding 641,416 641,416
July 2020 Placement Agent Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2020-07  
Term 5 years 6 months  
Exercise Price Per Share $ 4.97  
Warrants Outstanding 32,071 32,071
May 2020 Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2020-05  
Term 5 years  
Exercise Price Per Share $ 4.78  
Warrants Outstanding 1,392,345 1,392,345
May 2020 Placement Agent Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2020-05  
Term 5 years  
Exercise Price Per Share $ 6.13  
Warrants Outstanding 69,617 69,617
March 2020 Service and Performance Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2020-03  
Term 3 years  
Exercise Price Per Share $ 2.50  
Warrants Outstanding 18,350 18,350
February 12, 2020 Service and Performance Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2020-02  
Term 2 years  
Exercise Price Per Share $ 4.71  
Warrants Outstanding   150,000
February 3, 2020 Service and Performance Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2020-02  
Term 2 years  
Exercise Price Per Share $ 4.91  
Warrants Outstanding   10,000
September 2019 Placement Agent Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2019-09  
Term 5 years  
Exercise Price Per Share $ 9.48  
Warrants Outstanding 65,942 65,942
June 2019 Placement Agent Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2019-06  
Term 5 years  
Exercise Price Per Share $ 6.29  
Warrants Outstanding 74,479 74,479
April 2019 Service and Performance Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2019-04  
Term 5 years  
Exercise Price Per Share $ 6.18  
Warrants Outstanding 145,154 145,154
June 2018 Placement Agent Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2018-06  
Term 5 years  
Exercise Price Per Share $ 12.57  
Warrants Outstanding 69,617 69,617
March 2018 Placement Agent Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2018-03  
Term 5 years  
Exercise Price Per Share $ 41.56  
Warrants Outstanding 15,038 15,038
January 2021 Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2021-01  
Term 5 years 6 months  
Exercise Price Per Share $ 3.13  
Warrants Outstanding 3,938,392 3,938,392
September 2019 Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2019-09  
Term 5 years 6 months  
Exercise Price Per Share $ 7.52  
Warrants Outstanding 659,414 659,414
June 2019 Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2019-06  
Term 5 years 6 months  
Exercise Price Per Share $ 5.00  
Warrants Outstanding 435,830 435,830
June 2018 Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2018-06  
Term 5 years 6 months  
Exercise Price Per Share $ 9.94  
March 2018 Warrants [Member]    
Class Of Warrant Or Right [Line Items]    
Issuance Date 2018-03  
Term 5 years  
Exercise Price Per Share $ 10.73  
Warrants Outstanding 641,416 641,416
XML 69 R59.htm IDEA: XBRL DOCUMENT v3.22.2
Warrants - Summary of Warrants Issued to Purchase Common Stock (Parenthetical) (Detail)
6 Months Ended
Jun. 30, 2022
February 12, 2020 Service and Performance Warrants [Member]  
Class of Warrant or Right [Line Items]  
Warrant expiration month and year 2022-02
February 3, 2020 Service and Performance Warrants [Member]  
Class of Warrant or Right [Line Items]  
Warrant expiration month and year 2022-02
XML 70 R60.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Compensation and Employee Stock Purchase Program - Additional Information (Detail)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Feb. 02, 2022
shares
Dec. 19, 2021
Dec. 14, 2021
May 17, 2021
shares
May 20, 2015
shares
May 14, 2015
Jun. 30, 2019
shares
Jun. 30, 2022
USD ($)
shares
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
IncentivePlan
shares
Jun. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of equity incentive plans | IncentivePlan                   2    
Shares Subject to Outstanding, Options granted                   1,030,822    
Total number of options outstanding               2,283,649   2,283,649   1,422,195
Intrinsic value of options exercised | $                   $ 0 $ 0  
Unrecognized compensation cost related to unvested stock-based compensation grants | $               $ 1,400,000   $ 1,400,000    
Weighted-average remaining recognition period                   2 years 9 months 18 days    
Stock-based compensation | $               $ 323,000 $ 356,000 $ 583,000 681,000  
2015 Employee Stock Purchase Plan [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Total number of shares reserved for issuance under plan               128,914   128,914    
Stock-based compensation | $               $ 1,000 $ 8,000 $ 2,000 $ 13,000  
Percentage in payroll deductions to acquire shares of common stock           15.00%            
Purchase plan offering period           6 months            
Employees are able to purchase company's common stock on first trading day of offering period, percentage           85.00%            
Issuance of common stock pursuant to employee stock purchase plan                   54,928    
First offering period, start date           May 14, 2015            
First offering period, end date           Feb. 01, 2016            
Inducement Stock Option [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Shares Subject to Outstanding, Options granted       248,000                
Total number of options outstanding               376,608   376,608    
Inducement Stock Option [Member] | Stanley Jacot, Jr. [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Shares Subject to Outstanding, Options granted 316,108                      
Separation Agreement [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Options exercisable period   2 years 6 months 90 days                  
Separation Agreement [Member] | Selling, General and Administrative Expenses [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Stock-based compensation | $                       $ 154,000
2015 Omnibus Equity Incentive Plan [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Terms under the plan                   The 2015 Plan became effective upon the Company’s IPO in May 2015 and all shares that were reserved, but not issued, under the 2006 Plan were assumed by the 2015 Plan. Upon effectiveness, the 2015 Plan had 154,387 shares of common stock reserved for future issuance, which included 10,637 that were transferred to and assumed by the 2015 Plan. The 2015 Plan provides for automatic annual increases in shares available for grant. In addition, shares subject to awards under the 2006 Plan that are forfeited or canceled will be added to the 2015 Plan.    
Total number of shares reserved for issuance under plan         154,387     2,484,005   2,484,005    
Options vesting period         4 years              
Additional shares authorized for issuance under the plan             120,000          
Common stock available for future grant               584,777   584,777    
Total number of options outstanding               1,899,228   1,899,228   1,345,955
2015 Omnibus Equity Incentive Plan [Member] | Maximum [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Options exercisable period         10 years              
2006 Stock Incentive Plan [Member]                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Total number of shares reserved for issuance under plan         10,637              
Total number of options outstanding               7,813   7,813   8,240
XML 71 R61.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Compensation and Employee Stock Purchase Program - Summary of Activity Under Stock Incentive Plans (Detail)
$ / shares in Units, $ in Thousands
6 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
shares
Share-Based Payment Arrangement [Abstract]  
Shares Subject to Outstanding, Beginning Balance | shares 1,422,195
Shares Subject to Outstanding, Options granted | shares 1,030,822
Shares Subject to Outstanding, Options Forfeited | shares (130,263)
Shares Subject to Outstanding, Options Expired | shares (39,105)
Shares Subject to Outstanding, Ending Balance | shares 2,283,649
Shares Subject to Outstanding, Vested and expected to vest | shares 2,011,343
Shares Subject to Outstanding, Exercisable | shares 862,726
Weighted-Average Exercise Price Per Share, Outstanding Beginning Balance | $ / shares $ 5.28
Weighted-Average Exercise Price Per Share, Options granted | $ / shares 1.16
Weighted-Average Exercise Price Per Share, Options forfeited | $ / shares 2.86
Weighted-Average Exercise Price Per Share, Options expired | $ / shares 6.21
Weighted Average Exercise Price Per Share, Outstanding Ending Balance | $ / shares 3.54
Weighted Average Exercise Price Per Share, Vested and expected to vest | $ / shares 3.82
Weighted Average Exercise Price Per Share, Exercisable | $ / shares $ 6.76
Aggregate Intrinsic Value, Vested and expected to vest | $ $ 31,230
Aggregate Intrinsic Value, Exercisable | $ $ 24,452
XML 72 R62.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Compensation and Employee Stock Purchase Program - Weighted-Average Fair Value Assumption of Stock Option Awards (Detail) - Employee Stock Option [Member]
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expected term (years) 6 years 10 months 6 days 6 years 10 months 2 days 6 years 7 months 9 days 6 years 4 months 13 days
Expected volatility 123.00% 122.00% 122.00% 122.00%
Risk-free interest rate 2.85% 1.06% 2.48% 0.81%
XML 73 R63.htm IDEA: XBRL DOCUMENT v3.22.2
Income Taxes - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Tax Disclosure [Abstract]        
Federal statutory tax rate     21.00%  
Effective tax rate 0.00% (0.01%) 0.00% (0.01%)
Uncertain tax positions $ 0   $ 0  
XML 74 R64.htm IDEA: XBRL DOCUMENT v3.22.2
Commitments and Contingencies - Additional Information (Detail)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Aug. 31, 2020
USD ($)
Installment
shares
Jun. 30, 2022
USD ($)
Mar. 31, 2022
USD ($)
Mar. 31, 2021
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Dec. 31, 2010
USD ($)
Program
Installment
Dec. 31, 2021
USD ($)
Jun. 30, 2005
USD ($)
Commitments And Contingencies [Line Items]                  
Other noncurrent liability   $ 2,000,000     $ 2,000,000     $ 2,070,000  
Change in fair value of contingent consideration   (39,000)     $ (70,000) $ (140,000)      
Anawah, Inc [Member]                  
Commitments And Contingencies [Line Items]                  
Contingent liability             $ 3,000,000.0   $ 5,000,000.0
Date of merger and reorganization         Jun. 30, 2005        
Restructuring activities, description         As of December 31, 2010, the Company ceased activities relating to three of the six Anawah product programs        
Number of development programs ceased | Installment             3    
Number of development programs | Program             6    
Other noncurrent liability   $ 2,000,000.0     $ 2,000,000.0        
Industrial Seed Innovations [Member]                  
Commitments And Contingencies [Line Items]                  
Operating leases, term of contract   3 years     3 years        
Remaining amount paid in multiple installments $ 280,000                
Change in fair value of contingent consideration     $ (31,000) $ (140,000)          
Remaining contingent liability   $ 39,000     $ 39,000        
Business combination remaining contingent liability written-down   $ 0              
Industrial Seed Innovations [Member] | Common Stock [Member]                  
Commitments And Contingencies [Line Items]                  
Number of annual installment of common stock shares payable | Installment 2                
Minimum [Member]                  
Commitments And Contingencies [Line Items]                  
Operating leases, term of contract   1 year     1 year        
Royalty payments due, percentage of net revenue as defined in the In-Licensing agreements         2.00%        
Maximum [Member]                  
Commitments And Contingencies [Line Items]                  
Operating leases, term of contract   5 years     5 years        
Royalty payments due, percentage of net revenue as defined in the In-Licensing agreements         15.00%        
Maximum [Member] | Industrial Seed Innovations [Member] | Common Stock [Member] | Revenue Milestone in 2022 [Member]                  
Commitments And Contingencies [Line Items]                  
Business combination, equity interest issuable upon achievement of revenue milestone | shares 132,626                
XML 75 R65.htm IDEA: XBRL DOCUMENT v3.22.2
Net Loss per Share - Summary of Securities Not Included in Diluted Per Share Calculations (Detail) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities not included in the diluted per share calculations, amount 13,633,660 13,251,156 13,633,660 13,251,156
Option to Purchase Common Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities not included in the diluted per share calculations, amount 2,283,649 1,711,145 2,283,649 1,711,145
Warrants to Purchase Common Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities not included in the diluted per share calculations, amount 11,350,011 11,540,011 11,350,011 11,540,011
XML 76 R66.htm IDEA: XBRL DOCUMENT v3.22.2
Related-Party Transactions - Additional Information (Detail)
1 Months Ended 3 Months Ended 6 Months Ended
Apr. 30, 2020
USD ($)
a
Lease
Mar. 31, 2020
USD ($)
a
Feb. 28, 2019
USD ($)
a
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
Related Party Transaction [Line Items]                
Royalty fees due       $ 83,000   $ 83,000   $ 64,000
Number of lease amendments | Lease 2              
Lease payments       0 $ 6,000 0 $ 42,000  
Mr. Kevin Comcowich [Member]                
Related Party Transaction [Line Items]                
Acres of land | a     10          
Operating leases, term of contract     2 years          
Rent payments     $ 1,200          
Mr. Kevin Comcowich [Member] | Amendment [Member]                
Related Party Transaction [Line Items]                
Acres of land | a 15 10            
Operating leases, term of contract 2 years 2 years            
Number of additional properties under lease agreement two additional 15-acre parcels two additional 10-acre parcels            
Rent payments $ 1,200 $ 1,200            
John Sperling Foundation [Member]                
Related Party Transaction [Line Items]                
Royalty fees due       $ 83,000   $ 83,000   $ 64,000
XML 77 rkda-20220630_htm.xml IDEA: XBRL DOCUMENT 0001469443 us-gaap:TrademarksAndTradeNamesMember 2022-06-30 0001469443 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001469443 us-gaap:EmployeeStockMember 2021-04-01 2021-06-30 0001469443 2022-03-31 0001469443 rkda:April2019ServiceAndPerformanceWarrantsMember 2021-12-31 0001469443 2022-06-30 0001469443 us-gaap:EmployeeStockMember 2022-06-30 0001469443 us-gaap:LeaseholdImprovementsMember 2022-06-30 0001469443 rkda:ArcadiaWellnessLimitedLiabilityCompanyMember 2021-05-17 2021-05-17 0001469443 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001469443 rkda:JuneTwoThousandEighteenPurchaseAgreementMember 2018-06-01 2018-06-30 0001469443 rkda:JuneTwoThousandNineteenPlacementAgentWarrantsMember us-gaap:WarrantMember rkda:JuneTwoThousandNineteenSecuritiesPurchaseAgreementMember 2019-06-01 2019-06-30 0001469443 us-gaap:ProductMember 2022-01-01 2022-06-30 0001469443 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001469443 rkda:DecemberTwoThousandTwentyPlacementAgentWarrantsMember us-gaap:WarrantMember rkda:DecemberTwoThousandAndTwentyPurchaseAgreementMember 2020-12-01 2020-12-31 0001469443 us-gaap:EmployeeStockOptionMember 2021-04-01 2021-06-30 0001469443 rkda:LaboratoryEquipmentMember 2021-12-31 0001469443 rkda:SeptemberTwoThousandNineteenPlacementAgentWarrantMember us-gaap:WarrantMember rkda:SeptemberTwoThousandNineteenPurchaseAgreementMember 2019-09-30 0001469443 us-gaap:WarrantMember rkda:DecemberTwoThousandAndTwentyPurchaseAgreementMember 2020-12-31 0001469443 srt:MinimumMember rkda:IntellectualPropertyAndCustomerListsMember 2022-01-01 2022-06-30 0001469443 rkda:April2019ServiceAndPerformanceWarrantsMember 2022-01-01 2022-06-30 0001469443 us-gaap:AdditionalPaidInCapitalMember rkda:JanuaryTwoThousandAndTwentyOnePIPEMember 2021-01-01 2021-03-31 0001469443 us-gaap:CustomerListsMember 2021-12-31 0001469443 2020-12-31 0001469443 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-06-30 0001469443 us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30 0001469443 rkda:JanuaryTwoThousandTwentyOnePlacementAgentWarrantsMember 2022-06-30 0001469443 rkda:September2019PlacementAgentWarrantsMember 2022-06-30 0001469443 2022-05-01 2022-05-31 0001469443 rkda:JanuaryTwoThousandTwentyOnePlacementAgentWarrantsMember 2021-12-31 0001469443 us-gaap:MoneyMarketFundsMember us-gaap:CashEquivalentsMember 2022-06-30 0001469443 rkda:February122020ServiceAndPerformanceWarrantsMember 2022-06-30 0001469443 us-gaap:CommonStockMember 2021-12-31 0001469443 srt:MaximumMember rkda:IntellectualPropertyAndCustomerListsMember 2022-01-01 2022-06-30 0001469443 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001469443 rkda:JuneTwoThousandEighteenPlacementAgentWarrantsMember 2022-06-30 0001469443 rkda:ArcadiaWellnessLimitedLiabilityCompanyMember rkda:FormulationsMember 2021-05-17 0001469443 rkda:July2020PlacementAgentWarrantsMember 2022-01-01 2022-06-30 0001469443 us-gaap:CommonStockMember 2021-06-30 0001469443 us-gaap:FurnitureAndFixturesMember 2022-06-30 0001469443 us-gaap:SellingGeneralAndAdministrativeExpensesMember rkda:SeparationAgreementMember 2021-01-01 2021-12-31 0001469443 us-gaap:MachineryAndEquipmentMember 2021-12-31 0001469443 us-gaap:WarrantMember 2021-01-01 2021-06-30 0001469443 us-gaap:RoyaltyMember 2021-04-01 2021-06-30 0001469443 rkda:SoftwareAndComputerEquipmentMember 2021-12-31 0001469443 rkda:ArcadiaWellnessLimitedLiabilityCompanyMember 2021-05-17 2021-12-31 0001469443 us-gaap:ResearchAndDevelopmentExpenseMember 2021-04-01 2021-06-30 0001469443 rkda:SeptemberTwoThousandNineteenWarrantsMember 2022-01-01 2022-06-30 0001469443 2021-03-31 0001469443 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001469443 us-gaap:AccountingStandardsUpdate202006Member us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-06-30 0001469443 rkda:RadianceBeautyLicensingAgreementMember 2022-01-01 2022-06-30 0001469443 us-gaap:NoncontrollingInterestMember 2022-06-30 0001469443 rkda:July2020PlacementAgentWarrantsMember 2022-06-30 0001469443 rkda:JanuaryTwoThousandTwentyOneWarrantsMember 2022-06-30 0001469443 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001469443 us-gaap:ProductMember 2021-01-01 2021-06-30 0001469443 rkda:DecemberTwoThousandTwentyPlacementAgentWarrantsMember 2021-12-31 0001469443 rkda:JanuaryTwoThousandTwentyOneWarrantsMember 2022-01-01 2022-06-30 0001469443 rkda:LegacyVenturesHawaiiLLCMember rkda:ArchipelagoVenturesHawaiiLLCMember 2019-08-09 2019-08-09 0001469443 rkda:JanuaryTwoThousandAndTwentyOnePIPEMember 2021-01-01 2021-03-31 0001469443 srt:BoardOfDirectorsChairmanMember rkda:AmendmentMember 2020-04-01 2020-04-30 0001469443 us-gaap:WarrantMember rkda:DecemberTwoThousandAndTwentyPurchaseAgreementMember 2020-12-01 2020-12-31 0001469443 us-gaap:EmployeeStockMember 2015-05-14 0001469443 rkda:InducementStockOptionMember 2022-06-30 0001469443 us-gaap:FairValueInputsLevel3Member rkda:ContingentLiabilitiesMember 2022-06-30 0001469443 rkda:ArcadiaWellnessLimitedLiabilityCompanyMember us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001469443 rkda:JanuaryTwoThousandTwentyOnePrivatePlacementMember rkda:JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMember 2021-01-01 2021-01-31 0001469443 us-gaap:AccountingStandardsUpdate202006Member 2022-01-01 2022-06-30 0001469443 rkda:ArcadiaWellnessLimitedLiabilityCompanyMember us-gaap:CommonStockMember 2021-05-18 2021-05-31 0001469443 rkda:IndustrialSeedInnovationsMember 2022-01-01 2022-03-31 0001469443 rkda:VerdecaLLCMember 2022-01-01 2022-06-30 0001469443 srt:BoardOfDirectorsChairmanMember 2019-02-28 0001469443 us-gaap:WarrantMember rkda:JuneTwoThousandNineteenSecuritiesPurchaseAgreementMember 2019-06-30 0001469443 us-gaap:CommonStockMember 2022-06-30 0001469443 rkda:February32020ServiceAndPerformanceWarrantsMember 2022-06-30 0001469443 us-gaap:WarrantMember rkda:JanuaryTwoThousandTwentyOnePrivatePlacementMember rkda:JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMember 2021-01-01 2021-01-31 0001469443 us-gaap:EmployeeStockMember 2022-04-01 2022-06-30 0001469443 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001469443 rkda:February32020ServiceAndPerformanceWarrantsMember 2021-12-31 0001469443 rkda:JohnSperlingFoundationMember 2022-06-30 0001469443 srt:BoardOfDirectorsChairmanMember 2019-02-01 2019-02-28 0001469443 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-06-30 0001469443 us-gaap:RoyaltyMember 2021-01-01 2021-06-30 0001469443 srt:MaximumMember 2022-01-01 2022-06-30 0001469443 rkda:ArcadiaBiosciencesIncorporationMember rkda:ArchipelagoVenturesHawaiiLLCMember 2019-08-09 2019-08-09 0001469443 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001469443 rkda:DecemberTwoThousandTwentyWarrantsMember 2021-12-31 0001469443 us-gaap:ConstructionInProgressMember 2021-12-31 0001469443 rkda:April2019ServiceAndPerformanceWarrantsMember 2022-06-30 0001469443 rkda:ArcadiaWellnessLimitedLiabilityCompanyMember 2021-01-01 2021-06-30 0001469443 us-gaap:RetainedEarningsMember 2021-12-31 0001469443 us-gaap:TrademarksAndTradeNamesMember 2021-12-31 0001469443 rkda:AnawahIncMember 2010-12-31 0001469443 2022-01-01 2022-03-31 0001469443 rkda:SoftwareAndComputerEquipmentMember 2022-06-30 0001469443 us-gaap:NoncontrollingInterestMember 2021-06-30 0001469443 us-gaap:RoyaltyMember 2022-04-01 2022-06-30 0001469443 2022-01-01 2022-06-30 0001469443 2022-04-01 2022-06-30 0001469443 rkda:March2020ServiceAndPerformanceWarrantsMember 2022-06-30 0001469443 rkda:DecemberTwoThousandTwentyPlacementAgentWarrantsMember 2022-01-01 2022-06-30 0001469443 rkda:IndustrialSeedInnovationsMember 2022-06-30 0001469443 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-06-30 0001469443 rkda:TwoThousandFifteenOmnibusEquityIncentivePlanMember 2021-12-31 0001469443 rkda:JuneTwoThousandEighteenPlacementAgentWarrantsMember us-gaap:WarrantMember rkda:JuneTwoThousandEighteenPurchaseAgreementMember 2018-06-01 2018-06-30 0001469443 rkda:DecemberTwoThousandAndTwentyPurchaseAgreementMember 2020-12-01 2020-12-31 0001469443 rkda:IndustrialSeedInnovationsMember 2022-04-01 2022-06-30 0001469443 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001469443 us-gaap:FairValueInputsLevel3Member 2022-06-30 0001469443 us-gaap:FairValueInputsLevel3Member rkda:CommonStockWarrantLiabilityMember rkda:JuneTwoThousandAndNineteenOfferingMember 2021-12-31 0001469443 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001469443 us-gaap:EmployeeStockOptionMember 2021-04-01 2021-06-30 0001469443 rkda:March2018PlacementAgentWarrantsMember 2022-06-30 0001469443 rkda:MarchTwoThousandEighteenWarrantsMember 2022-06-30 0001469443 rkda:ArcadiaWellnessLimitedLiabilityCompanyMember us-gaap:CustomerRelationshipsMember 2021-05-17 0001469443 rkda:February122020ServiceAndPerformanceWarrantsMember 2022-01-01 2022-06-30 0001469443 us-gaap:LicenseMember 2022-01-01 2022-06-30 0001469443 us-gaap:NoncontrollingInterestMember 2020-12-31 0001469443 2021-06-30 0001469443 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001469443 rkda:JuneTwoThousandNineteenSecuritiesPurchaseAgreementMember 2019-06-01 2019-06-30 0001469443 srt:BoardOfDirectorsChairmanMember rkda:AmendmentMember 2020-03-01 2020-03-31 0001469443 rkda:JanuaryTwoThousandTwentyOneServiceAndPerformanceWarrantsMember 2022-01-01 2022-06-30 0001469443 rkda:MarchTwoThousandEighteenPrivatePlacementMember rkda:MarchTwoThousandEighteenSecuritiesPurchaseAgreementMember 2018-03-31 0001469443 rkda:SellingGeneralAndAdministrativeAndResearchAndDevelopmentExpensesMember 2022-04-01 2022-06-30 0001469443 rkda:February32020ServiceAndPerformanceWarrantsMember 2022-01-01 2022-06-30 0001469443 rkda:ArcadiaWellnessLimitedLiabilityCompanyMember rkda:FormulationsMember 2021-05-17 2021-05-17 0001469443 srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember us-gaap:AccountingStandardsUpdate202006Member us-gaap:FairValueInputsLevel3Member rkda:CommonStockWarrantLiabilityMember rkda:JanuaryTwoThousandAndTwentyOneOfferingMember 2021-12-31 0001469443 us-gaap:VehiclesMember 2021-12-31 0001469443 2021-01-01 2021-03-31 0001469443 us-gaap:EmployeeStockMember 2022-01-01 2022-06-30 0001469443 us-gaap:ProductMember 2022-04-01 2022-06-30 0001469443 rkda:DecemberTwoThousandTwentyPlacementAgentWarrantsMember us-gaap:WarrantMember rkda:DecemberTwoThousandAndTwentyPurchaseAgreementMember 2020-12-31 0001469443 rkda:JuneTwoThousandEighteenWarrantsMember 2022-01-01 2022-06-30 0001469443 rkda:March2018PlacementAgentWarrantsMember 2021-12-31 0001469443 us-gaap:NoncontrollingInterestMember 2021-12-31 0001469443 rkda:June2019PlacementAgentWarrantsMember 2022-06-30 0001469443 rkda:July2020PlacementAgentWarrantsMember 2021-12-31 0001469443 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-06-30 0001469443 rkda:DecemberTwoThousandTwentyWarrantsMember 2022-01-01 2022-06-30 0001469443 us-gaap:RetainedEarningsMember 2021-03-31 0001469443 rkda:IndustrialSeedInnovationsMember 2021-01-01 2021-03-31 0001469443 us-gaap:WarrantMember 2022-04-01 2022-06-30 0001469443 rkda:JuneTwoThousandEighteenPlacementAgentWarrantsMember 2021-12-31 0001469443 rkda:JanuaryTwoThousandTwentyOnePrivatePlacementMember rkda:JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMember 2021-01-31 0001469443 rkda:AnawahIncMember 2022-06-30 0001469443 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001469443 srt:BoardOfDirectorsChairmanMember rkda:AmendmentMember 2020-04-30 0001469443 rkda:JuneTwoThousandNineteenWarrantsMember 2022-01-01 2022-06-30 0001469443 us-gaap:FairValueInputsLevel3Member rkda:CommonStockWarrantLiabilityMember us-gaap:PrivatePlacementMember 2021-12-31 0001469443 rkda:BioceresCropSolutionsMember rkda:VerdecaLLCMember 2020-11-01 2020-11-30 0001469443 rkda:SeparationAgreementMember 2021-12-19 2021-12-19 0001469443 srt:BoardOfDirectorsChairmanMember rkda:AmendmentMember 2020-03-31 0001469443 srt:MaximumMember 2022-06-30 0001469443 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001469443 us-gaap:CommonStockMember 2021-03-31 0001469443 rkda:MarchTwoThousandEighteenSecuritiesPurchaseAgreementMember 2018-03-01 2018-03-31 0001469443 rkda:May2020PlacementAgentWarrantsMember 2022-06-30 0001469443 us-gaap:MoneyMarketFundsMember 2021-12-31 0001469443 us-gaap:MoneyMarketFundsMember us-gaap:CashEquivalentsMember 2021-12-31 0001469443 rkda:TwoThousandFifteenOmnibusEquityIncentivePlanMember 2015-05-19 2015-05-20 0001469443 us-gaap:WarrantMember rkda:JuneTwoThousandEighteenPurchaseAgreementMember 2018-06-30 0001469443 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001469443 srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember us-gaap:AccountingStandardsUpdate202006Member us-gaap:FairValueInputsLevel3Member rkda:CommonStockWarrantLiabilityMember rkda:JuneTwoThousandAndNineteenOfferingMember 2021-12-31 0001469443 rkda:TwoThousandFifteenOmnibusEquityIncentivePlanMember 2022-06-30 0001469443 us-gaap:NoncontrollingInterestMember 2021-03-31 0001469443 rkda:LaboratoryEquipmentMember 2022-06-30 0001469443 rkda:JanuaryTwoThousandTwentyOneServiceAndPerformanceWarrantsMember 2022-06-30 0001469443 us-gaap:CommonStockMember 2020-12-31 0001469443 2021-12-31 0001469443 us-gaap:FairValueInputsLevel3Member rkda:CommonStockWarrantLiabilityMember rkda:SeptemberTwoThousandAndNineteenOfferingMember 2021-12-31 0001469443 us-gaap:ProductMember 2021-04-01 2021-06-30 0001469443 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001469443 rkda:September2019PlacementAgentWarrantsMember 2021-12-31 0001469443 us-gaap:MoneyMarketFundsMember 2022-06-30 0001469443 rkda:July2020WarrantsMember 2022-06-30 0001469443 rkda:TwoThousandSixStockIncentivePlanMember 2021-12-31 0001469443 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001469443 rkda:DecemberTwoThousandTwentyPlacementAgentWarrantsMember 2022-06-30 0001469443 rkda:May2020PlacementAgentWarrantsMember 2022-01-01 2022-06-30 0001469443 us-gaap:RetainedEarningsMember 2020-12-31 0001469443 rkda:ArcadiaWellnessLimitedLiabilityCompanyMember 2021-05-17 0001469443 rkda:MarchTwoThousandEighteenWarrantsMember 2021-12-31 0001469443 us-gaap:WarrantMember rkda:JuneTwoThousandEighteenPurchaseAgreementMember 2018-06-01 2018-06-30 0001469443 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-06-30 0001469443 rkda:InducementStockOptionMember 2021-05-17 2021-05-17 0001469443 rkda:SeparationAgreementMember 2021-12-14 2021-12-14 0001469443 rkda:TwoThousandFifteenOmnibusEquityIncentivePlanMember 2022-01-01 2022-06-30 0001469443 rkda:JohnSperlingFoundationMember 2021-12-31 0001469443 rkda:JanuaryTwoThousandAndTwentyOnePIPESecuritiesPurchaseAgreementMember 2021-01-01 2021-06-30 0001469443 us-gaap:RetainedEarningsMember 2021-06-30 0001469443 us-gaap:MachineryAndEquipmentMember 2022-06-30 0001469443 us-gaap:MeasurementInputSharePriceMember us-gaap:WarrantMember rkda:JanuaryTwoThousandTwentyOnePrivatePlacementMember rkda:JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMember 2021-01-28 0001469443 us-gaap:EmployeeStockOptionMember 2022-04-01 2022-06-30 0001469443 rkda:TwoThousandFifteenOmnibusEquityIncentivePlanMember 2019-06-01 2019-06-30 0001469443 rkda:JanuaryTwoThousandTwentyOnePlacementAgentWarrantsMember rkda:JanuaryTwoThousandTwentyOnePrivatePlacementMember rkda:JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMember 2021-01-31 0001469443 rkda:AnawahIncMember 2022-01-01 2022-06-30 0001469443 rkda:ArcadiaWellnessAcquisitionMember 2022-01-01 2022-06-30 0001469443 rkda:ArcadiaBiosciencesIncorporationMember rkda:ArchipelagoVenturesHawaiiLLCMember 2022-06-30 0001469443 rkda:SellingGeneralAndAdministrativeAndResearchAndDevelopmentExpensesMember 2021-01-01 2021-06-30 0001469443 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001469443 us-gaap:RoyaltyMember 2022-01-01 2022-06-30 0001469443 srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember us-gaap:AccountingStandardsUpdate202006Member us-gaap:FairValueInputsLevel3Member rkda:CommonStockWarrantLiabilityMember rkda:SeptemberTwoThousandAndNineteenOfferingMember 2021-12-31 0001469443 rkda:July2020WarrantsMember 2021-12-31 0001469443 rkda:MarchTwoThousandEighteenPrivatePlacementMember rkda:MarchTwoThousandEighteenSecuritiesPurchaseAgreementMember 2018-03-01 2018-03-31 0001469443 rkda:MarchTwoThousandEighteenSecuritiesPurchaseAgreementMember 2018-03-31 0001469443 us-gaap:AccountingStandardsUpdate202006RetrospectiveMember 2021-12-31 0001469443 rkda:ArchipelagoVenturesHawaiiLLCMember 2021-04-01 2021-06-30 0001469443 us-gaap:FairValueInputsLevel3Member rkda:ContingentLiabilitiesMember 2021-12-31 0001469443 rkda:February122020ServiceAndPerformanceWarrantsMember 2021-12-31 0001469443 rkda:RadianceBeautyLicensingAgreementMember 2022-04-01 2022-06-30 0001469443 rkda:ArcadiaWellnessLimitedLiabilityCompanyMember us-gaap:CustomerRelationshipsMember 2021-05-17 2021-05-17 0001469443 rkda:RadianceBeautyLicensingAgreementMember 2022-06-30 0001469443 srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember us-gaap:AccountingStandardsUpdate202006Member us-gaap:FairValueInputsLevel3Member 2021-12-31 0001469443 rkda:SeptemberTwoThousandNineteenWarrantsMember 2021-12-31 0001469443 us-gaap:EmployeeStockMember 2021-01-01 2021-06-30 0001469443 us-gaap:IntellectualPropertyMember 2022-06-30 0001469443 srt:MaximumMember rkda:TwoThousandFifteenOmnibusEquityIncentivePlanMember 2015-05-19 2015-05-20 0001469443 us-gaap:RetainedEarningsMember 2022-03-31 0001469443 rkda:ArcadiaWellnessLimitedLiabilityCompanyMember 2022-01-01 2022-06-30 0001469443 us-gaap:ConstructionInProgressMember 2022-06-30 0001469443 rkda:JuneTwoThousandNineteenPlacementAgentWarrantsMember us-gaap:WarrantMember rkda:JuneTwoThousandNineteenSecuritiesPurchaseAgreementMember 2019-06-30 0001469443 rkda:JanuaryTwoThousandTwentyOneServiceAndPerformanceWarrantsMember 2021-12-31 0001469443 rkda:SeptemberTwoThousandNineteenPlacementAgentWarrantMember us-gaap:WarrantMember rkda:SeptemberTwoThousandNineteenPurchaseAgreementMember 2019-09-01 2019-09-30 0001469443 rkda:JanuaryTwoThousandTwentyOnePlacementAgentWarrantsMember rkda:JanuaryTwoThousandTwentyOnePrivatePlacementMember rkda:JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMember 2021-01-01 2021-01-31 0001469443 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:WarrantMember rkda:JanuaryTwoThousandTwentyOnePrivatePlacementMember rkda:JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMember 2021-01-28 0001469443 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0001469443 rkda:ArcadiaWellnessLimitedLiabilityCompanyMember 2022-04-01 2022-06-30 0001469443 2020-04-30 0001469443 2021-04-01 2021-06-30 0001469443 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001469443 rkda:JanuaryTwoThousandTwentyOnePlacementAgentWarrantsMember us-gaap:WarrantMember rkda:JanuaryTwoThousandTwentyOnePrivatePlacementMember rkda:JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMember 2021-01-31 0001469443 rkda:BioceresCropSolutionsMember srt:MaximumMember rkda:VerdecaLLCMember 2020-11-01 2020-11-30 0001469443 us-gaap:AccountingStandardsUpdate202104Member 2022-06-30 0001469443 srt:MinimumMember 2022-06-30 0001469443 srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember us-gaap:AccountingStandardsUpdate202006Member us-gaap:FairValueInputsLevel3Member rkda:CommonStockWarrantLiabilityMember us-gaap:PrivatePlacementMember 2021-12-31 0001469443 rkda:September2019PlacementAgentWarrantsMember 2022-01-01 2022-06-30 0001469443 rkda:SeptemberTwoThousandNineteenWarrantsMember 2022-06-30 0001469443 us-gaap:FairValueInputsLevel3Member rkda:CommonStockWarrantLiabilityMember rkda:JanuaryTwoThousandAndTwentyOneOfferingMember 2021-12-31 0001469443 rkda:May2020WarrantsMember 2022-06-30 0001469443 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001469443 rkda:JuneTwoThousandNineteenWarrantsMember 2021-12-31 0001469443 rkda:CollaborativeArrangementsCopromotionMember 2017-08-01 2017-08-31 0001469443 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001469443 rkda:TwoThousandSixStockIncentivePlanMember 2022-06-30 0001469443 rkda:SellingGeneralAndAdministrativeAndResearchAndDevelopmentExpensesMember 2022-01-01 2022-06-30 0001469443 rkda:March2020ServiceAndPerformanceWarrantsMember 2021-12-31 0001469443 rkda:July2020WarrantsMember 2022-01-01 2022-06-30 0001469443 rkda:JuneTwoThousandEighteenWarrantsMember 2022-06-30 0001469443 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001469443 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001469443 us-gaap:WarrantMember rkda:SeptemberTwoThousandNineteenPurchaseAgreementMember 2019-09-30 0001469443 rkda:ArchipelagoVenturesHawaiiLLCMember 2021-01-01 2021-06-30 0001469443 us-gaap:RetainedEarningsMember 2022-06-30 0001469443 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-04-01 2021-06-30 0001469443 rkda:LegacyVenturesHawaiiLLCMember rkda:ArchipelagoVenturesHawaiiLLCMember 2022-06-30 0001469443 rkda:TwoThousandFifteenOmnibusEquityIncentivePlanMember 2015-05-20 0001469443 us-gaap:WarrantMember rkda:SeptemberTwoThousandNineteenPurchaseAgreementMember 2019-09-01 2019-09-30 0001469443 us-gaap:EmployeeStockOptionMember 2022-04-01 2022-06-30 0001469443 rkda:March2020ServiceAndPerformanceWarrantsMember 2022-01-01 2022-06-30 0001469443 us-gaap:LicenseMember 2022-04-01 2022-06-30 0001469443 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001469443 rkda:SellingGeneralAndAdministrativeAndResearchAndDevelopmentExpensesMember 2021-04-01 2021-06-30 0001469443 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001469443 rkda:ArcadiaWellnessLimitedLiabilityCompanyMember 2021-05-18 2021-05-31 0001469443 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001469443 us-gaap:ResearchAndDevelopmentExpenseMember 2022-04-01 2022-06-30 0001469443 us-gaap:CommonStockMember 2022-03-31 0001469443 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-06-30 0001469443 us-gaap:FairValueInputsLevel1Member 2022-06-30 0001469443 us-gaap:EmployeeStockMember 2015-05-13 2015-05-14 0001469443 rkda:JuneTwoThousandEighteenPlacementAgentWarrantsMember us-gaap:WarrantMember rkda:JuneTwoThousandEighteenPurchaseAgreementMember 2018-06-30 0001469443 us-gaap:AccountingStandardsUpdate202006RetrospectiveMember us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001469443 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001469443 rkda:AnawahIncMember 2005-06-30 0001469443 rkda:IndustrialSeedInnovationsMember us-gaap:CommonStockMember 2020-08-01 2020-08-31 0001469443 rkda:BioceresCropSolutionsMember 2022-01-01 2022-06-30 0001469443 rkda:ArcadiaWellnessLimitedLiabilityCompanyMember 2021-04-01 2021-06-30 0001469443 us-gaap:VehiclesMember 2022-06-30 0001469443 2021-01-01 2021-12-31 0001469443 rkda:PresidentAndChiefExecutiveOfficerMember rkda:InducementStockOptionMember 2022-02-02 2022-02-02 0001469443 rkda:May2020WarrantsMember 2021-12-31 0001469443 us-gaap:WarrantMember rkda:JuneTwoThousandNineteenSecuritiesPurchaseAgreementMember 2019-06-01 2019-06-30 0001469443 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001469443 rkda:ArcadiaWellnessLimitedLiabilityCompanyMember us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001469443 srt:MinimumMember 2022-01-01 2022-06-30 0001469443 srt:MaximumMember rkda:IndustrialSeedInnovationsMember us-gaap:CommonStockMember rkda:AchievementOfRevenueMilestoneIn2022Member 2020-08-31 0001469443 rkda:ArcadiaWellnessLimitedLiabilityCompanyMember us-gaap:TrademarksAndTradeNamesMember 2021-05-17 0001469443 2021-01-01 2021-06-30 0001469443 us-gaap:CommonStockMember rkda:JanuaryTwoThousandAndTwentyOnePIPEMember 2021-01-01 2021-03-31 0001469443 rkda:May2020PlacementAgentWarrantsMember 2021-12-31 0001469443 us-gaap:IntellectualPropertyMember 2021-12-31 0001469443 rkda:March2018PlacementAgentWarrantsMember 2022-01-01 2022-06-30 0001469443 rkda:MarchTwoThousandEighteenWarrantsMember 2022-01-01 2022-06-30 0001469443 rkda:MarchTwoThousandEighteenPlacementAgentMember rkda:MarchTwoThousandEighteenPrivatePlacementMember rkda:MarchTwoThousandEighteenSecuritiesPurchaseAgreementMember 2018-03-01 2018-03-31 0001469443 rkda:JuneTwoThousandEighteenPlacementAgentWarrantsMember 2022-01-01 2022-06-30 0001469443 us-gaap:FairValueInputsLevel3Member rkda:ContingentLiabilitiesMember 2022-01-01 2022-06-30 0001469443 rkda:ArcadiaWellnessLimitedLiabilityCompanyMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-06-30 0001469443 2022-08-08 0001469443 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001469443 rkda:SeptemberTwoThousandNineteenPurchaseAgreementMember 2019-09-01 2019-09-30 0001469443 rkda:JuneTwoThousandNineteenWarrantsMember 2022-06-30 0001469443 rkda:IndustrialSeedInnovationsMember 2020-08-01 2020-08-31 0001469443 rkda:ArcadiaWellnessLimitedLiabilityCompanyMember 2022-06-30 0001469443 us-gaap:NoncontrollingInterestMember 2022-03-31 0001469443 rkda:June2019PlacementAgentWarrantsMember 2022-01-01 2022-06-30 0001469443 rkda:JanuaryTwoThousandTwentyOnePlacementAgentWarrantsMember 2022-01-01 2022-06-30 0001469443 rkda:MarchTwoThousandEighteenPlacementAgentMember rkda:MarchTwoThousandEighteenPrivatePlacementMember rkda:MarchTwoThousandEighteenSecuritiesPurchaseAgreementMember 2018-03-31 0001469443 us-gaap:WarrantMember 2021-04-01 2021-06-30 0001469443 rkda:June2019PlacementAgentWarrantsMember 2021-12-31 0001469443 rkda:AnawahIncMember 2010-01-01 2010-12-31 0001469443 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:WarrantMember rkda:JanuaryTwoThousandTwentyOnePrivatePlacementMember rkda:JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMember 2021-01-28 0001469443 rkda:TwoThousandSixStockIncentivePlanMember 2015-05-20 0001469443 rkda:JanuaryTwoThousandTwentyOneWarrantsMember 2021-12-31 0001469443 rkda:DecemberTwoThousandTwentyWarrantsMember 2022-06-30 0001469443 rkda:May2020WarrantsMember 2022-01-01 2022-06-30 0001469443 us-gaap:AccountingStandardsUpdate202006Member 2022-06-30 0001469443 us-gaap:AccountingStandardsUpdate202006RetrospectiveMember us-gaap:RetainedEarningsMember 2021-12-31 0001469443 us-gaap:CustomerListsMember 2022-06-30 utr:acre rkda:Individual rkda:Lease rkda:Installment pure iso4217:USD shares shares rkda:IncentivePlan iso4217:USD rkda:Program 0001469443 --12-31 P1Y false Q2 P1Y P2Y6M 2005-06-30 http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member 10-Q true 2022-06-30 2022 false 001-37383 Arcadia Biosciences, Inc. DE 81-0571538 202 Cousteau Place Suite 105 Davis CA 95618 530 756-7077 Common RKDA NASDAQ Yes Yes Non-accelerated Filer true false false 22192960 21234000 28685000 89000 76000 3854000 1370000 3275000 4433000 254000 1441000 900000 30058000 35388000 954000 2291000 2308000 3081000 1136000 2494000 386000 484000 166000 180000 35008000 43918000 3391000 3638000 83000 64000 994000 1074000 272000 264000 4740000 5040000 1500000 2220000 3392000 2000000 2070000 8240000 12722000 0.001 0.001 150000000 150000000 22188918 22188918 22184235 22184235 63000 63000 277492000 257515000 -250748000 -226485000 26807000 31093000 -39000 103000 26768000 31196000 35008000 43918000 2946000 1379000 6116000 2183000 50000 26000 100000 51000 862000 862000 3858000 1405000 7078000 2234000 3447000 1587000 6906000 2443000 359000 1131000 754000 2290000 1138000 1138000 72000 72000 -39000 -70000 -140000 346000 346000 210000 58000 386000 4652000 6370000 9000000 10439000 7641000 9088000 15484000 15243000 -3783000 -7682000 -8406000 -13009000 30000 -1000 29000 -8000 -44000 2759000 -3000 10222000 498000 176000 27000 769000 -3797000 -5422000 -8407000 -3740000 0 0 0 0 -3797000 -5422000 -8407000 -3740000 -20000 -161000 -142000 -538000 -3777000 -5261000 -8265000 -3202000 -0.17 -0.17 -0.24 -0.24 -0.37 -0.37 -0.15 -0.15 22188918 22188918 21745403 21745403 22187961 22187961 21271960 21271960 -12000 -12000 -12000 -12000 -3777000 -5273000 -8265000 -3214000 22184235 63000 257515000 -226485000 103000 31196000 19390000 -15998000 3392000 4683 4000 4000 260000 260000 -4488000 -122000 -4610000 22188918 63000 277169000 -246971000 -19000 30242000 323000 323000 -3777000 -20000 -3797000 22188918 63000 277492000 -250748000 -39000 26768000 13450861 54000 239496000 -211825000 827000 28552000 7876784 8000 15508000 15516000 2084000 2084000 942000 942000 8604 21000 21000 750000 750000 325000 325000 2058000 -377000 1681000 21336249 62000 254208000 -209767000 1200000 45703000 827401 1000 2052000 2053000 -12000 -12000 356000 356000 -5261000 -161000 -5422000 22163650 63000 256616000 -215028000 -12000 1039000 42678000 -8407000 -3740000 176000 -70000 -140000 769000 277000 484000 26000 48000 420000 639000 72000 386000 -135000 583000 681000 37000 10222000 346000 210000 1515000 983000 2471000 -259000 -1001000 633000 541000 938000 -15000 153000 -247000 1083000 19000 -47000 56000 8000 1000 -1000 -1000 -446000 -590000 -8250000 -10940000 841000 46000 713000 4250000 21845000 795000 16882000 25147000 1912000 2019000 4000 27000 750000 4000 21993000 -1000 -7451000 27934000 28685000 16043000 21234000 43977000 1000 1000 21000 2053000 3392000 942000 913000 51000 58000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1. Description of Business and Basis of Presentation</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Organization</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Arcadia Biosciences, Inc. (the "Company," "Arcadia" or "management"), was incorporated in </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Arizona</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> in </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2002</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and maintains its headquarters in Davis, California, with additional facilities in American Falls, Idaho and Chatsworth, California. The Company was reincorporated in </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Delaware</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> in </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">March 2015</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company is a producer and marketer of innovative, plant-based health and wellness products. Its history as a leader in science-based approaches to developing high-value crop improvements, as well as nutritionally enhanced food ingredients and health and wellness products, has laid the foundation for its path forward. The Company used advanced breeding techniques to develop these proprietary innovations which are now being commercialized through the sales of seed and grain, as well as food ingredients and products. The acquisition of the businesses of Lief Holdings, LLC (“Lief”), EKO Holdings, LLC (“Eko”) and Live Zola, LLC (“Zola”) added bath and body care products, as well as coconut water, to the Company’s portfolio.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In May 2021, the Company’s wholly owned subsidiary Arcadia Wellness, LLC (“Arcadia Wellness” or “AW”, see Note 6), acquired the businesses of Eko, Lief, and Zola. The acquisition included consumer CBD brands like Soul Spring™, a CBD-infused botanical therapy brand in the natural category, Saavy Naturals™, a line of natural body care products and ProVault™, a CBD-infused sports performance formula made with natural ingredients, providing effective support and recovery for athletes. Also included in the purchase is Zola, a coconut water sourced exclusively with sustainably grown coconuts from Thailand. On July 8, 2022, the Company entered into an agreement to license Saavy Naturals™ to Radiance Beauty and Wellness, Inc. ("Radiance Beauty"). See Note 6 for a discussion of the licensing agreement.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In August 2019, the Company entered into a joint venture agreement with Legacy Ventures Hawaii, LLC (“Legacy,” see Note 8) to grow, extract, and sell hemp products. The partnership Archipelago Ventures Hawaii, LLC (“Archipelago”), combines the Company’s extensive genetic expertise and resources with Legacy’s experience in hemp extraction and sales. In October 2021, Arcadia and Legacy mutually agreed to wind down the cultivation activities of Archipelago, due to regulatory challenges and a saturated hemp market.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In February 2012, the Company formed Verdeca, which was equally owned with Bioceres. Verdeca was formed to develop and deregulate soybean varieties using both partners’ agricultural technologies. In November 2020, Arcadia sold its membership interest in Verdeca to Bioceres in a transaction in which Arcadia received cash, shares of Bioceres stock and a royalty stream of up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">10.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million on sales of Haab 4 soybeans (“HB4”) soybean. An additional $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million in cash is to be paid upon achievement by Verdeca of reaching commercial plantings of at least 200,000 hectares of HB4 or China approving the HB4 soybean trait for “food and feed”. During the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">quarter ended June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, Bioceres received China's approval of the HB4 soybean trait and as a result, Arcadia recorded license revenue of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">862,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and a gain on sale of Verdeca of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million on the condensed consolidated statements of operations and comprehensive loss.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial statements and are in the form prescribed by the Securities and Exchange Commission (the “SEC”) in instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial position, results of operations and cash flows for the periods indicated. All material intercompany accounts and transactions have been eliminated in consolidation. The accompanying unaudited condensed consolidated financial statements include the accounts of the Company, Arcadia Wellness, and Archipelago.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company uses a qualitative approach in assessing the consolidation requirement for variable interest entities ("VIEs"). This approach focuses on determining whether the Company has the power to direct the activities of the VIE that most significantly affect the VIE’s economic performance and whether the Company has the obligation to absorb losses, or the right to receive benefits, that could potentially be significant to the VIE.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">For all periods presented, the Company has determined that it is the primary beneficiary of Archipelago, a joint venture, as it has a controlling interest in Archipelago. Accordingly, the Company consolidates Archipelago in the condensed consolidated financial statements after eliminating intercompany transactions. For consolidated joint ventures, the non-controlling partner’s share of the assets, liabilities and operations of the joint venture is included in non-controlling interests as equity of the Company. The non-controlling partner’s interest is generally computed as the joint venture partner’s ownership percentage of Archipelago. Net loss attributable to non-controlling interest of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">20,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">142,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> is recorded as an adjustment to net loss to arrive at net loss attributable to common stockholders for the three and six months ended June 30, 2022, respectively. Net loss attributable to non-controlling interest for three and six months ended June 30, 2021 was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">161,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">538,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, respectively. The non-controlling partner’s equity interests are presented as non-controlling interests on the condensed consolidated balance sheets.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The information included in these condensed consolidated financial statements and notes thereto should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations included herein and Management’s Discussion and Analysis of Financial Condition and Results of Operations and the condensed consolidated financial statements and notes thereto for the fiscal year ended December 31, 2021 included in the Company’s Annual Report on Form 10-K, filed with the SEC on March 31, 2022.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Liquidity, Capital Resources, and Going Concern</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities during the normal course of business. Since inception, the Company has financed its operations primarily through equity and debt financings. As of June 30, 2022, the Company had an accumulated deficit of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">250.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million, and cash and cash equivalents of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">21.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. For the six months ended June 30, 2022, the Company had a net loss of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million and net cash used in operations of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million. For the twelve months ended December 31, 2021, the Company had net losses of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">16.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million and net cash used in operations of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">25.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">With cash and cash equivalents of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">21.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> as of June 30, 2022, the Company believes that its existing cash and cash equivalents will not be sufficient to meet its anticipated cash requirements for at least the next 12 months from the issuance date of these financial statements, and thus raises substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company may seek to raise additional funds through debt or equity financings. The Company may also consider entering into additional partner arrangements. The sale of additional equity would result in dilution to the Company’s stockholders. The incurrence of debt would result in debt service obligations, and the instruments governing such debt could provide for additional operating and financing covenants that would restrict operations. If the Company does require additional funds and is unable to secure adequate additional funding at terms agreeable to the Company, the Company may be forced to reduce spending, extend payment terms with suppliers, liquidate assets, or suspend or curtail planned development programs. Any of these actions could materially harm the business, results of operations and financial condition.</span></p></div> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Organization</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Arcadia Biosciences, Inc. (the "Company," "Arcadia" or "management"), was incorporated in </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Arizona</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> in </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2002</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and maintains its headquarters in Davis, California, with additional facilities in American Falls, Idaho and Chatsworth, California. The Company was reincorporated in </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Delaware</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> in </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">March 2015</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company is a producer and marketer of innovative, plant-based health and wellness products. Its history as a leader in science-based approaches to developing high-value crop improvements, as well as nutritionally enhanced food ingredients and health and wellness products, has laid the foundation for its path forward. The Company used advanced breeding techniques to develop these proprietary innovations which are now being commercialized through the sales of seed and grain, as well as food ingredients and products. The acquisition of the businesses of Lief Holdings, LLC (“Lief”), EKO Holdings, LLC (“Eko”) and Live Zola, LLC (“Zola”) added bath and body care products, as well as coconut water, to the Company’s portfolio.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In May 2021, the Company’s wholly owned subsidiary Arcadia Wellness, LLC (“Arcadia Wellness” or “AW”, see Note 6), acquired the businesses of Eko, Lief, and Zola. The acquisition included consumer CBD brands like Soul Spring™, a CBD-infused botanical therapy brand in the natural category, Saavy Naturals™, a line of natural body care products and ProVault™, a CBD-infused sports performance formula made with natural ingredients, providing effective support and recovery for athletes. Also included in the purchase is Zola, a coconut water sourced exclusively with sustainably grown coconuts from Thailand. On July 8, 2022, the Company entered into an agreement to license Saavy Naturals™ to Radiance Beauty and Wellness, Inc. ("Radiance Beauty"). See Note 6 for a discussion of the licensing agreement.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In August 2019, the Company entered into a joint venture agreement with Legacy Ventures Hawaii, LLC (“Legacy,” see Note 8) to grow, extract, and sell hemp products. The partnership Archipelago Ventures Hawaii, LLC (“Archipelago”), combines the Company’s extensive genetic expertise and resources with Legacy’s experience in hemp extraction and sales. In October 2021, Arcadia and Legacy mutually agreed to wind down the cultivation activities of Archipelago, due to regulatory challenges and a saturated hemp market.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In February 2012, the Company formed Verdeca, which was equally owned with Bioceres. Verdeca was formed to develop and deregulate soybean varieties using both partners’ agricultural technologies. In November 2020, Arcadia sold its membership interest in Verdeca to Bioceres in a transaction in which Arcadia received cash, shares of Bioceres stock and a royalty stream of up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">10.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million on sales of Haab 4 soybeans (“HB4”) soybean. An additional $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million in cash is to be paid upon achievement by Verdeca of reaching commercial plantings of at least 200,000 hectares of HB4 or China approving the HB4 soybean trait for “food and feed”. During the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">quarter ended June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, Bioceres received China's approval of the HB4 soybean trait and as a result, Arcadia recorded license revenue of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">862,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and a gain on sale of Verdeca of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million on the condensed consolidated statements of operations and comprehensive loss.</span></p> Arizona 2002 Delaware 2015-03 10000000.0 2000000.0 862000 1100000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Basis of Presentation and Principles of Consolidation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial statements and are in the form prescribed by the Securities and Exchange Commission (the “SEC”) in instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial position, results of operations and cash flows for the periods indicated. All material intercompany accounts and transactions have been eliminated in consolidation. The accompanying unaudited condensed consolidated financial statements include the accounts of the Company, Arcadia Wellness, and Archipelago.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company uses a qualitative approach in assessing the consolidation requirement for variable interest entities ("VIEs"). This approach focuses on determining whether the Company has the power to direct the activities of the VIE that most significantly affect the VIE’s economic performance and whether the Company has the obligation to absorb losses, or the right to receive benefits, that could potentially be significant to the VIE.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">For all periods presented, the Company has determined that it is the primary beneficiary of Archipelago, a joint venture, as it has a controlling interest in Archipelago. Accordingly, the Company consolidates Archipelago in the condensed consolidated financial statements after eliminating intercompany transactions. For consolidated joint ventures, the non-controlling partner’s share of the assets, liabilities and operations of the joint venture is included in non-controlling interests as equity of the Company. The non-controlling partner’s interest is generally computed as the joint venture partner’s ownership percentage of Archipelago. Net loss attributable to non-controlling interest of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">20,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">142,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> is recorded as an adjustment to net loss to arrive at net loss attributable to common stockholders for the three and six months ended June 30, 2022, respectively. Net loss attributable to non-controlling interest for three and six months ended June 30, 2021 was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">161,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">538,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, respectively. The non-controlling partner’s equity interests are presented as non-controlling interests on the condensed consolidated balance sheets.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The information included in these condensed consolidated financial statements and notes thereto should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations included herein and Management’s Discussion and Analysis of Financial Condition and Results of Operations and the condensed consolidated financial statements and notes thereto for the fiscal year ended December 31, 2021 included in the Company’s Annual Report on Form 10-K, filed with the SEC on March 31, 2022.</span></p> -20000 -142000 -161000 -538000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Liquidity, Capital Resources, and Going Concern</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities during the normal course of business. Since inception, the Company has financed its operations primarily through equity and debt financings. As of June 30, 2022, the Company had an accumulated deficit of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">250.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million, and cash and cash equivalents of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">21.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. For the six months ended June 30, 2022, the Company had a net loss of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million and net cash used in operations of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million. For the twelve months ended December 31, 2021, the Company had net losses of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">16.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million and net cash used in operations of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">25.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">With cash and cash equivalents of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">21.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> as of June 30, 2022, the Company believes that its existing cash and cash equivalents will not be sufficient to meet its anticipated cash requirements for at least the next 12 months from the issuance date of these financial statements, and thus raises substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company may seek to raise additional funds through debt or equity financings. The Company may also consider entering into additional partner arrangements. The sale of additional equity would result in dilution to the Company’s stockholders. The incurrence of debt would result in debt service obligations, and the instruments governing such debt could provide for additional operating and financing covenants that would restrict operations. If the Company does require additional funds and is unable to secure adequate additional funding at terms agreeable to the Company, the Company may be forced to reduce spending, extend payment terms with suppliers, liquidate assets, or suspend or curtail planned development programs. Any of these actions could materially harm the business, results of operations and financial condition.</span></p> -250700000 21200000 -8400000 -8300000 -16100000 -25900000 21200000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Recent Accounting Pronouncements</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. Additionally, the FASB issued ASU No. 2019-04, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Codification Improvements to Topic 326</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> in April 2019 and ASU 2019-05, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Financial Instruments — Credit Losses (Topic 326) — Targeted Transition Relief</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> in May 2019. The amendments affect loans, debt securities, trade receivables, net investments in leases, off-balance-sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. In November 2019, the FASB issued ASU No. 2019-10, which defers the effective date of ASU No. 2016-13 for smaller reporting companies to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is currently evaluating the impact of the adoption of ASU No. 2016-13 on the condensed consolidated financial statements.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In August 2020, the FASB issued ASU No. 2020-06, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The FASB Board is issuing this Update to address issues identified as a result of the complexity associated with applying GAAP for certain financial instruments with characteristics of liabilities and equity. In addressing the complexity, the FASB Board focused on amending the guidance on convertible instruments and the guidance on the derivatives scope exception for contracts in an entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The amendments in this Update are effective for public business entities that meet the definition of a smaller reporting company, as defined by the SEC, for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company early </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">adopted</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> ASU No. 2020-06 on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">January 1, 2022</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, using the modified retrospective method. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Prior to the adoption of ASU No. 2020-06, the Company had liability classified awards due to the existence of certain contingent cash payment feature. Upon adoption, these clauses no longer preclude equity classification. Under the modified retrospective method, the historical mark-to-market adjustments related to outstanding awards were reversed through retained earnings and the original carrying value of the awards were reclassified to additional paid-in capital. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Adoption of the new standard resulted in an increase to accumulated deficit of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">16.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million, an increase to additional paid-in capital of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million, and a decrease to common stock warrant liabilities of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million, on the condensed consolidated balance sheets.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In May 2021, the FASB issued ASU No. 2021-04, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity's Own Equity (Subtopic 815-40): Issuer's Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The amendments in this Update clarify and reduce diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The amendments in this Update affect all entities that issue freestanding written call options that are classified in equity. The amendments in this Update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The Company </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">adopted</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> ASU No. 2021-04 on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">January 1, 2022</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> with an </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">immaterial</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> impact on the Company’s disclosures.</span></p> true 2022-01-01 16000000.0 19400000 3400000 true 2022-01-01 true <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3. Inventory</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Inventory costs are tracked on a lot-identified basis and are included as cost of revenues when sold. Inventories are stated at the lower of cost or net realizable value. The Company makes adjustments to inventory when conditions indicate that the net realizable value may be less than cost due to physical deterioration, obsolescence, changes in price levels, or other factors. Additional adjustments to inventory are made for excess and slow-moving inventory on hand that is not expected to be sold within a reasonable timeframe to reduce the carrying amount to its estimated net realizable value. The write-downs to inventory are included in cost of revenues and are based upon estimates about future demand from the Company’s customers and distributors and market conditions. The Company recorded write-downs of wheat, hemp seed, CBD oil and body care inventories of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million during the three and six months ended June 30, 2022, respectively. Of inventories write-downs during the three months ended June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">394,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> is related to the Radiance Beauty licensing agreement discussed in Note 6. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company recorded write-downs of wheat inventory, and hemp seed inventories of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">823,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">983,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> during the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2021, respectively. If there are significant changes in demand and market conditions, substantial future write-downs of inventory may be required, which would materially increase the Company’s expenses in the period the write down is taken and materially affect the Company’s operating results.</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Inventories, net consist of the following (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.287%;"/> <td style="width:1.3%;"/> <td style="width:1.0%;"/> <td style="width:17.679000000000002%;"/> <td style="width:1.0%;"/> <td style="width:1.3%;"/> <td style="width:1.0%;"/> <td style="width:18.435000000000002%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Raw materials</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,133</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,851</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Goods in process</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">108</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">842</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Finished goods</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,170</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4,234</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Inventories</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4,411</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,927</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table></div> 1100000 1500000 394000 823000 983000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Inventories, net consist of the following (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.287%;"/> <td style="width:1.3%;"/> <td style="width:1.0%;"/> <td style="width:17.679000000000002%;"/> <td style="width:1.0%;"/> <td style="width:1.3%;"/> <td style="width:1.0%;"/> <td style="width:18.435000000000002%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Raw materials</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,133</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,851</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Goods in process</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">108</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">842</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Finished goods</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,170</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4,234</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Inventories</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4,411</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,927</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table> 1133000 1851000 108000 842000 3170000 4234000 4411000 6927000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Property and Equipment, Net</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment, net consisted of the following (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:59.026%;"/> <td style="width:1.671%;"/> <td style="width:1.0%;"/> <td style="width:16.557%;"/> <td style="width:1.0%;"/> <td style="width:1.671%;"/> <td style="width:1.0%;"/> <td style="width:17.075%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Laboratory equipment</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,790</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,659</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Software and computer equipment</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">576</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">548</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Machinery and equipment</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">653</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,809</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Furniture and fixtures</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">198</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">211</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Vehicles</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">333</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">417</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Leasehold improvements</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,223</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,306</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment, gross</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5,773</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7,950</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Less: accumulated depreciation and amortization</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4,819</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5,659</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment, net</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">954</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,291</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Depreciation expense was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">277,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">484,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> for the six months ended June 30, 2022 and 2021, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2022, and December 31, 2021, respectively, there was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">10,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">267,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> of construction in progress included in property and equipment that had not been placed into service and was not subject to depreciation.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment are considered assets held for sale when management approves and commits to a plan to dispose of a property or group of properties. The property and equipment held for sale prior to the sale date is separately presented, within current assets, on the condensed consolidated balance sheet as assets held for sale.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">During the three and six months ended June 30, 2022, management initiated the sale of property and equipment related to the Davis laboratory and Archipelago, respectively. The Company completed the sale of a portion of such property and equipment with a gain on sale of property and equipment in the amount of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">58,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">386,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> recorded on the condensed consolidated statements of operations and comprehensive loss during the three and six months ended June 30, 2022, respectively. The proceeds related to the sale</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">of property and equipment during the three and six months ended June 30, 2022 are </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">54,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">841,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, respectively. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> sales of assets held for sale during the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2021.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Property and equipment related to Archipelago, in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">254,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, have been classified as assets held for sale, and are recorded at fair value as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022. The fair value has been estimated using publicly available prices for some of the assets, and business partners' estimates for assets with prices not readily available, due to the relatively small size of the industry in which they can be used.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">During the three and six months ended June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, the Company recorded write-downs of property and equipment of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">320,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> related to the Radiance Beauty licensing agreement. See Note 6 for further discussion of the licensing agreement. During the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, the Company recorded a write-down of property and equipment related to Archipelago in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">210,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, calculated through an asset recoverability test.</span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment, net consisted of the following (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:59.026%;"/> <td style="width:1.671%;"/> <td style="width:1.0%;"/> <td style="width:16.557%;"/> <td style="width:1.0%;"/> <td style="width:1.671%;"/> <td style="width:1.0%;"/> <td style="width:17.075%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Laboratory equipment</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,790</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,659</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Software and computer equipment</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">576</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">548</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Machinery and equipment</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">653</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,809</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Furniture and fixtures</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">198</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">211</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Vehicles</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">333</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">417</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Leasehold improvements</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,223</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,306</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment, gross</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5,773</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7,950</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Less: accumulated depreciation and amortization</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4,819</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5,659</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Property and equipment, net</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">954</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,291</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table> 1790000 2659000 576000 548000 653000 1809000 198000 211000 333000 417000 2223000 2306000 5773000 7950000 4819000 5659000 954000 2291000 277000 484000 10000 267000 58000 386000 54000 841000 0 254000 320000 320000 210000 210000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Investments and Fair Value Instruments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Investments</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The investments are carried at fair value, based on quoted market prices or other readily available market information. Unrealized and realized gains and losses are recognized as other income in the condensed consolidated statements of operations and comprehensive loss.</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following tables summarize the amortized cost and fair value of the investment securities portfolio at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022 and December 31, 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:46.459%;"/> <td style="width:1.124%;"/> <td style="width:1.0%;"/> <td style="width:9.535%;"/> <td style="width:1.0%;"/> <td style="width:1.124%;"/> <td style="width:1.0%;"/> <td style="width:11.03%;"/> <td style="width:1.0%;"/> <td style="width:1.124%;"/> <td style="width:1.0%;"/> <td style="width:11.03%;"/> <td style="width:1.0%;"/> <td style="width:1.124%;"/> <td style="width:1.0%;"/> <td style="width:9.452%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(Dollars in thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Amortized<br/>Cost</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Unrealized<br/>Gains</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Unrealized<br/>Losses</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Estimated<br/>Fair Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Cash equivalents:</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Money market funds</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19,283</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19,283</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total Assets at Fair Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19,283</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19,283</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:46.459%;"/> <td style="width:1.124%;"/> <td style="width:1.0%;"/> <td style="width:9.535%;"/> <td style="width:1.0%;"/> <td style="width:1.124%;"/> <td style="width:1.0%;"/> <td style="width:11.03%;"/> <td style="width:1.0%;"/> <td style="width:1.124%;"/> <td style="width:1.0%;"/> <td style="width:11.03%;"/> <td style="width:1.0%;"/> <td style="width:1.124%;"/> <td style="width:1.0%;"/> <td style="width:9.452%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(Dollars in thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Amortized<br/>Cost</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Unrealized<br/>Gains</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Unrealized<br/>Losses</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Estimated<br/>Fair Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2021</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Cash equivalents:</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Money market funds</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26,842</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26,842</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total Assets at Fair Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26,842</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26,842</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company did </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">t have any investment categories that were in a continuous unrealized loss position for more than twelve months as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair Value Measurement</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The fair value of the investment securities at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022 were as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:49.448%;"/> <td style="width:1.196%;"/> <td style="width:1.0%;"/> <td style="width:9.115%;"/> <td style="width:1.0%;"/> <td style="width:1.196%;"/> <td style="width:1.0%;"/> <td style="width:9.6%;"/> <td style="width:1.0%;"/> <td style="width:1.196%;"/> <td style="width:1.0%;"/> <td style="width:9.6%;"/> <td style="width:1.0%;"/> <td style="width:1.196%;"/> <td style="width:1.0%;"/> <td style="width:9.455%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Fair Value Measurements at June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(Dollars in thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 1</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 2</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 3</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Assets at Fair Value</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Cash equivalents:</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Money market funds</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19,283</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19,283</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total Assets at Fair Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19,283</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19,283</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The fair value of the investment securities at December 31, 2021 were as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:49.448%;"/> <td style="width:1.196%;"/> <td style="width:1.0%;"/> <td style="width:9.115%;"/> <td style="width:1.0%;"/> <td style="width:1.196%;"/> <td style="width:1.0%;"/> <td style="width:9.6%;"/> <td style="width:1.0%;"/> <td style="width:1.196%;"/> <td style="width:1.0%;"/> <td style="width:9.6%;"/> <td style="width:1.0%;"/> <td style="width:1.196%;"/> <td style="width:1.0%;"/> <td style="width:9.455%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Fair Value Measurements at December 31, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(Dollars in thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 1</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 2</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 3</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Assets at Fair Value</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Cash equivalents:</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Money market funds</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26,842</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26,842</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total Assets at Fair Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26,842</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26,842</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company uses the market approach technique to value its financial instruments and there were no changes in valuation techniques during 2022 or 2021. The Company’s financial instruments consist primarily of cash and cash equivalents, accounts receivable,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">accounts payable, accrued liabilities, and notes payable. For accounts receivable, accounts payable, accrued liabilities, and notes payable the carrying amounts of these financial instruments as of June 30, 2022 and December 31, 2021 were considered representative of their fair values due to their short term to maturity or repayment. Cash equivalents are carried at cost, which approximates their fair value.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company’s Level 3 liabilities consist of a contingent liability resulting from the Anawah, Inc. ("Anawah") acquisition and a contingent liability resulting from the Industrial Seed Innovations ("ISI") acquisition, as described in Note 15. As of December 31, 2021 the Company also had common stock warrant liabilities related to the March 2018, the June 2019, the September 2019, and the January 2021 Offerings, described in Note 11, which were reclassified to additional paid-in capital upon adoption of ASU 2020-06, as of January 1, 2022. See Note 2 for details of the adoption of ASU 2020-06.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The contingent liability related to the Anawah acquisition was measured and recorded on a recurring basis as of June 30, 2022 and December 31, 2021, using unobservable inputs, namely the Company’s ability and intent to pursue certain specific products developed using technology acquired in the purchase. A significant deviation in the Company’s ability and/or intent to pursue the technology acquired in the purchase could result in a significantly lower (higher) fair value measurement. The contingent liability related to the ISI acquisition was measured and recorded on a recurring basis as of June 30, 2022 and December 31, 2021, using unobservable inputs, namely ISI’s forecasted revenue. A significant deviation in ISI’s forecasted revenue could result in a lower (higher) fair value measurement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following table sets forth the establishment of the Company’s Level 3 liabilities, as well as a summary of the changes in the fair value and other adjustments (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:21.972%;"/> <td style="width:1.298%;"/> <td style="width:1.0%;"/> <td style="width:10.761999999999999%;"/> <td style="width:1.0%;"/> <td style="width:1.298%;"/> <td style="width:1.0%;"/> <td style="width:9.575000000000001%;"/> <td style="width:1.0%;"/> <td style="width:1.298%;"/> <td style="width:1.0%;"/> <td style="width:9.797%;"/> <td style="width:1.0%;"/> <td style="width:0.955%;"/> <td style="width:1.0%;"/> <td style="width:9.259%;"/> <td style="width:1.0%;"/> <td style="width:1.298%;"/> <td style="width:1.0%;"/> <td style="width:9.621%;"/> <td style="width:1.0%;"/> <td style="width:1.419%;"/> <td style="width:1.0%;"/> <td style="width:9.445%;"/> <td style="width:1.0%;"/> </tr> <tr> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="22" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:7.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(Dollars in thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Common Stock<br/>Warrant<br/>Liability -<br/>March<br/>2018<br/>Purchase<br/>Agreement</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Common <br/>Stock<br/>Warrant<br/>Liability - <br/>June<br/>2019<br/>Offering</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Common <br/>Stock<br/>Warrant<br/>Liability -<br/>September<br/>2019<br/>Offering</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Common <br/>Stock<br/>Warrant<br/>Liability -<br/>January 2021<br/>Offering</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Contingent<br/>Liabilities</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:7.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Balance as of December 31, 2021</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">7</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">170</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">223</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">2,993</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">2,070</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">5,463</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:7.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:8.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Reclassification upon adoption<br/>    of ASU 2020-06</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">7</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">170</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">223</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">2,993</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">3,392</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:7.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:8.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Change in fair value of contingent <br/>   consideration</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">70</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">70</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:7.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Balance as of June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">2,000</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">2,000</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">During the three and six months ended June 30, 2022, the Company recorded aggregate impairment charges of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">418,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, and during the three and six months ended June 30, 2021, the Company recorded aggregate impairment charges of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">210,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, respectively, related to intangible assets and other long-lived assets. The Company has classified the fair value measurements as a Level 3 measurement in the fair value hierarchy because they involve significant unobservable inputs such as cash flow projections, discount rates and management assumptions.<br/><br/><br/><br/>Assets classified as held for sale are recorded at fair value as of June 30, 2022. The Company has classified the fair value measurements as a Level 3 measurement in the fair value hierarchy as the fair value has been estimated using publicly available prices for some of the assets, and business partners' estimates for assets with prices not readily available, due to the relatively small size of the industry in which they can be used.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;"><br/><br/><br/><br/></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following tables summarize the amortized cost and fair value of the investment securities portfolio at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022 and December 31, 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:46.459%;"/> <td style="width:1.124%;"/> <td style="width:1.0%;"/> <td style="width:9.535%;"/> <td style="width:1.0%;"/> <td style="width:1.124%;"/> <td style="width:1.0%;"/> <td style="width:11.03%;"/> <td style="width:1.0%;"/> <td style="width:1.124%;"/> <td style="width:1.0%;"/> <td style="width:11.03%;"/> <td style="width:1.0%;"/> <td style="width:1.124%;"/> <td style="width:1.0%;"/> <td style="width:9.452%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(Dollars in thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Amortized<br/>Cost</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Unrealized<br/>Gains</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Unrealized<br/>Losses</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Estimated<br/>Fair Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Cash equivalents:</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Money market funds</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19,283</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19,283</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total Assets at Fair Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19,283</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19,283</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:46.459%;"/> <td style="width:1.124%;"/> <td style="width:1.0%;"/> <td style="width:9.535%;"/> <td style="width:1.0%;"/> <td style="width:1.124%;"/> <td style="width:1.0%;"/> <td style="width:11.03%;"/> <td style="width:1.0%;"/> <td style="width:1.124%;"/> <td style="width:1.0%;"/> <td style="width:11.03%;"/> <td style="width:1.0%;"/> <td style="width:1.124%;"/> <td style="width:1.0%;"/> <td style="width:9.452%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(Dollars in thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Amortized<br/>Cost</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Unrealized<br/>Gains</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Unrealized<br/>Losses</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Estimated<br/>Fair Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2021</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Cash equivalents:</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Money market funds</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26,842</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26,842</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total Assets at Fair Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26,842</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26,842</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table> 19283000 19283000 19283000 19283000 26842000 26842000 26842000 26842000 0 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The fair value of the investment securities at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022 were as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:49.448%;"/> <td style="width:1.196%;"/> <td style="width:1.0%;"/> <td style="width:9.115%;"/> <td style="width:1.0%;"/> <td style="width:1.196%;"/> <td style="width:1.0%;"/> <td style="width:9.6%;"/> <td style="width:1.0%;"/> <td style="width:1.196%;"/> <td style="width:1.0%;"/> <td style="width:9.6%;"/> <td style="width:1.0%;"/> <td style="width:1.196%;"/> <td style="width:1.0%;"/> <td style="width:9.455%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Fair Value Measurements at June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(Dollars in thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 1</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 2</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 3</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Assets at Fair Value</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Cash equivalents:</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Money market funds</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19,283</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19,283</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total Assets at Fair Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19,283</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19,283</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The fair value of the investment securities at December 31, 2021 were as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:49.448%;"/> <td style="width:1.196%;"/> <td style="width:1.0%;"/> <td style="width:9.115%;"/> <td style="width:1.0%;"/> <td style="width:1.196%;"/> <td style="width:1.0%;"/> <td style="width:9.6%;"/> <td style="width:1.0%;"/> <td style="width:1.196%;"/> <td style="width:1.0%;"/> <td style="width:9.6%;"/> <td style="width:1.0%;"/> <td style="width:1.196%;"/> <td style="width:1.0%;"/> <td style="width:9.455%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Fair Value Measurements at December 31, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(Dollars in thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 1</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 2</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Level 3</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Assets at Fair Value</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Cash equivalents:</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Money market funds</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26,842</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26,842</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total Assets at Fair Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26,842</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26,842</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table> 19283000 19283000 19283000 19283000 26842000 26842000 26842000 26842000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following table sets forth the establishment of the Company’s Level 3 liabilities, as well as a summary of the changes in the fair value and other adjustments (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:21.972%;"/> <td style="width:1.298%;"/> <td style="width:1.0%;"/> <td style="width:10.761999999999999%;"/> <td style="width:1.0%;"/> <td style="width:1.298%;"/> <td style="width:1.0%;"/> <td style="width:9.575000000000001%;"/> <td style="width:1.0%;"/> <td style="width:1.298%;"/> <td style="width:1.0%;"/> <td style="width:9.797%;"/> <td style="width:1.0%;"/> <td style="width:0.955%;"/> <td style="width:1.0%;"/> <td style="width:9.259%;"/> <td style="width:1.0%;"/> <td style="width:1.298%;"/> <td style="width:1.0%;"/> <td style="width:9.621%;"/> <td style="width:1.0%;"/> <td style="width:1.419%;"/> <td style="width:1.0%;"/> <td style="width:9.445%;"/> <td style="width:1.0%;"/> </tr> <tr> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="22" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:7.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(Dollars in thousands)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Common Stock<br/>Warrant<br/>Liability -<br/>March<br/>2018<br/>Purchase<br/>Agreement</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Common <br/>Stock<br/>Warrant<br/>Liability - <br/>June<br/>2019<br/>Offering</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Common <br/>Stock<br/>Warrant<br/>Liability -<br/>September<br/>2019<br/>Offering</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Common <br/>Stock<br/>Warrant<br/>Liability -<br/>January 2021<br/>Offering</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Contingent<br/>Liabilities</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:7.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Balance as of December 31, 2021</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">7</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">170</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">223</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">2,993</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">2,070</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">5,463</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:7.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:8.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Reclassification upon adoption<br/>    of ASU 2020-06</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">7</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">170</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">223</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">2,993</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">3,392</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:7.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:8.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Change in fair value of contingent <br/>   consideration</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">70</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">70</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:7.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">Balance as of June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">2,000</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;">2,000</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table> 7000 170000 223000 2993000 2070000 5463000 -7000 -170000 -223000 -2993000 -3392000 -70000 -70000 2000000 2000000 418000 418000 0 210000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6. Arcadia Wellness Acquisition</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">On May 17, 2021, the Company’s wholly owned subsidiary Arcadia Wellness, acquired the assets of Eko, Lief, and Zola. The acquisition included consumer brands of bath and body care products such as Soul Spring, the CBD-infused botanical therapy brand, Saavy Naturals, a line of natural body care products and ProVault, a CBD-infused sports performance formula. Also included in the purchase was Zola, a coconut water sourced from Thailand.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The acquisition was recorded as a business combination, in accordance with ASC 805. The purchase price consideration for the acquisition totaled an estimated $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million, of which $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million in cash and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million in the form of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">827,401</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company’s common stock, was paid during the month of May 2021. The cash consideration paid for the acquisition was funded by cash on hand.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Acquisition costs are not included as components of consideration transferred and instead are accounted for as expenses in the period in which the costs are incurred. The Company incurred costs related to the Arcadia Wellness acquisition of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">850,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> included in selling, general and administrative expenses in the Company's consolidated statements of operations and comprehensive loss for the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">six months ended June 30, 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company performed an allocation of purchase price as of the acquisition date based on management's estimates of fair value. The Company believes its estimates and assumptions are reasonable.</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the allocation of the purchase price of the assets acquired at fair value at the acquisition date:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.39%;"/> <td style="width:1.134%;"/> <td style="width:1.0%;"/> <td style="width:16.477%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Purchase Price<br/>Allocation</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Inventory</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">840</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Prepaid and other current assets</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">62</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Fixed assets</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">308</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Deposits</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">82</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Customer list</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">360</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Trade names and trademarks</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,900</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Formulations</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">260</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Goodwill</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,240</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total consideration allocated</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,052</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The former shareholders of Eko, Lief, and Zola remain responsible for their pre-acquisition liabilities. In connection with the acquisition, the Company entered into a lease agreement for the use of offices, production equipment acquired, and storage warehouses.</span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> The lease was effective on May 17, 2021 and has a term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3 years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">.</span></span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">For the period from January 1, 2022 to June 30, 2022, the Company recognized approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million of revenue and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million of net loss relating to Arcadia Wellness, which included charges related to the Radiance Beauty licensing agreement discussed below, as well as the amortization of acquired intangible assets.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">For the period from May 17, 2021 to December 31, 2021, the Company recognized approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million of revenue and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million of net loss relating to Arcadia Wellness, which included charges for the amortization of acquired intangible assets.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Acquired intangible assets of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million include trade names and trademarks of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million (indefinite useful life), customer list of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">360,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">fifteen-year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> useful life) and formulations of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">260,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">ten-year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> useful life). For impairments related to the acquired intangible assets see Note 7.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The total weighted average amortization period for the acquired intangibles is </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12.9</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> years.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The acquisition produced $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million of goodwill, which was fully impaired during the year ended December 31, 2021, due to </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">weakness in some of the newly acquired consumer product margins, combined with a volatile economic climate and higher than normal inflation. Goodwill arising from the Arcadia Wellness acquisition was not deductible for tax purposes.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">On July 8, 2022, the Company entered into a licensing agreement with Radiance Beauty. Under the terms of the licensing agreement, Radiance Beauty was granted an exclusive, transferable, sublicensable, perpetual, worldwide license to use the Saavy Naturals™ mark and to modify, manufacture, distribute, market and sell related products. In addition, as part of the licensing agreement, Radiance Beauty will receive the remaining accounts receivables and inventory balances after July 31, 2022, certain equipment, as well as three months of salaries in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">355,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and rent, maintenance and utilities in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. Radiance Beauty will sublease space from the Company and pay the Company a </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% royalty </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">of gross sales of products beginning January 1, 2023. As of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">30, 2022, accounts receivables and inventories of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">21,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">394,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, respectively, were written down. In addition, property and equipment and intangible assets were written down by $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">320,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">72,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, respectively, as of June 30, 2022.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Supplemental Pro-Forma Results of Operations (Unaudited)</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following unaudited pro-forma condensed consolidated results of operations for the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2022 and 2021, have been prepared as if the acquisition of Arcadia Wellness had occurred on January 1, 2021 and includes adjustments for amortization of intangibles, and the addition to basic and diluted weighted average number of shares outstanding.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;"> <tr style="visibility:collapse;"> <td style="width:46.269%;"/> <td style="width:1.308%;"/> <td style="width:1.0%;"/> <td style="width:10.026%;"/> <td style="width:1.0%;"/> <td style="width:1.308%;"/> <td style="width:1.0%;"/> <td style="width:10.221%;"/> <td style="width:1.0%;"/> <td style="width:1.308%;"/> <td style="width:1.0%;"/> <td style="width:10.026%;"/> <td style="width:1.0%;"/> <td style="width:1.308%;"/> <td style="width:1.0%;"/> <td style="width:10.221%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">For the three months<br/>ended June 30,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">For the six months<br/>ended June 30,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022 <br/>(Pro forma)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021<br/>(Pro forma)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022 <br/>(Pro forma)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021<br/>(Pro forma)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total revenues</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,858</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,203</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7,078</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4,516</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,797</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5,409</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8,407</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5,193</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net loss attributable to common stockholders</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,777</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5,248</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8,265</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4,655</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Weighted average shares - Basic and diluted</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">22,188,918</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">22,159,103</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">22,187,961</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">21,478,810</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net loss per share attributable to common stockholders:</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Basic and diluted</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.17</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.24</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.37</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.22</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> </table></div> 6100000 4000000.0 2100000 827401 850000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following table presents the allocation of the purchase price of the assets acquired at fair value at the acquisition date:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.39%;"/> <td style="width:1.134%;"/> <td style="width:1.0%;"/> <td style="width:16.477%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Purchase Price<br/>Allocation</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Inventory</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">840</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Prepaid and other current assets</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">62</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Fixed assets</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">308</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Deposits</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">82</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Customer list</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">360</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Trade names and trademarks</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,900</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Formulations</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">260</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Goodwill</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,240</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total consideration allocated</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,052</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table> 840000 62000 308000 82000 360000 2900000 260000 1240000 6052000 The lease was effective on May 17, 2021 and has a term of 3 years. P3Y 3900000 1500000 4300000 -7500000 3500000 2900000 360000 P15Y 260000 P10Y P12Y10M24D 1200000 355000 19000 0.04 21000 394000 320000 72000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following unaudited pro-forma condensed consolidated results of operations for the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2022 and 2021, have been prepared as if the acquisition of Arcadia Wellness had occurred on January 1, 2021 and includes adjustments for amortization of intangibles, and the addition to basic and diluted weighted average number of shares outstanding.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;"> <tr style="visibility:collapse;"> <td style="width:46.269%;"/> <td style="width:1.308%;"/> <td style="width:1.0%;"/> <td style="width:10.026%;"/> <td style="width:1.0%;"/> <td style="width:1.308%;"/> <td style="width:1.0%;"/> <td style="width:10.221%;"/> <td style="width:1.0%;"/> <td style="width:1.308%;"/> <td style="width:1.0%;"/> <td style="width:10.026%;"/> <td style="width:1.0%;"/> <td style="width:1.308%;"/> <td style="width:1.0%;"/> <td style="width:10.221%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">For the three months<br/>ended June 30,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">For the six months<br/>ended June 30,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022 <br/>(Pro forma)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021<br/>(Pro forma)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022 <br/>(Pro forma)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021<br/>(Pro forma)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total revenues</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,858</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,203</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7,078</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4,516</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,797</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5,409</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8,407</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5,193</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net loss attributable to common stockholders</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,777</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5,248</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8,265</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4,655</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Weighted average shares - Basic and diluted</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">22,188,918</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">22,159,103</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">22,187,961</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">21,478,810</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net loss per share attributable to common stockholders:</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Basic and diluted</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.17</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.24</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.37</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.22</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> </table> 3858000 2203000 7078000 4516000 -3797000 -5409000 -8407000 -5193000 -3777000 -5248000 -8265000 -4655000 22188918 22188918 22159103 22159103 22187961 22187961 21478810 21478810 -0.17 0.24 -0.37 -0.22 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7. Intangible assets, net</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p><div style="font-size:10.5pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company’s intangible assets, net as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022, consist of the following:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;"> <tr style="visibility:collapse;"> <td style="width:36.293%;"/> <td style="width:0.956%;"/> <td style="width:1.0%;"/> <td style="width:6.747999999999999%;"/> <td style="width:1.0%;"/> <td style="width:0.956%;"/> <td style="width:1.0%;"/> <td style="width:8.604%;"/> <td style="width:1.0%;"/> <td style="width:0.956%;"/> <td style="width:1.0%;"/> <td style="width:7.5649999999999995%;"/> <td style="width:1.0%;"/> <td style="width:0.956%;"/> <td style="width:1.0%;"/> <td style="width:6.747999999999999%;"/> <td style="width:1.0%;"/> <td style="width:0.956%;"/> <td style="width:1.0%;"/> <td style="width:8.743%;"/> <td style="width:1.0%;"/> <td style="width:0.956%;"/> <td style="width:1.0%;"/> <td style="width:7.5649999999999995%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="10" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="10" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Gross<br/>Carrying<br/>Amount (2)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Accumulated Amortization</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Net Carrying<br/>Amount</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Gross<br/>Carrying<br/>Amount (1)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Accumulated Amortization</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Net Carrying<br/>Amount</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Amortized intangible assets</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Intellectual property</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">254</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">130</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">124</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">258</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">107</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">151</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Customer lists</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">64</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">30</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">34</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">71</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">45</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total amortizable intangible assets</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">318</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">160</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">158</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">329</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">133</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">196</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Indefinite-lived intangible assets</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Brands and trademarks</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">228</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">228</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">288</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">288</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total intangible asset, net</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">546</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">160</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">386</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">617</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">133</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">484</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">(1)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The gross carrying amounts included in this table reflect the effects of the impairments of intangible assets recorded during the year ended December 31, 2021, when the Company estimated an overall decrease in the sales forecast for AW products, due to an inventory item rationalization, in addition to a decrease in the sales forecast of ISI seeds, related to the saturated hemp seed market. As a result, Arcadia performed a quantitative intangible assets impairment test. The Company used a discounted cash flow approach to develop the fair value of the acquired intellectual property, customer lists, brands and trademarks. As a result of this assessment, Arcadia recorded an impairment of intangible assets in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million in the condensed consolidated statements of operations and comprehensive loss for the year ended December 31, 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">(2)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company recorded an impairment of intangible assets in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">72,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> during the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> related to the Radiance Beauty licensing agreement.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Intellectual property and customer lists will be amortized based on their useful lives ranging between </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4 </span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">and </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">15 years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022, future amortization of intellectual property and customer lists is as follows:</span></span></p><div style="font-size:11.0pt;font-family:Calibri;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.162%;"/> <td style="width:1.798%;"/> <td style="width:1.0%;"/> <td style="width:16.04%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Year Ending December 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2022 (excluding the six months ended June 30, 2022)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">53</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2024</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">53</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2025</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2026</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Thereafter</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">18</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">158</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table></div> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company’s intangible assets, net as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022, consist of the following:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;"> <tr style="visibility:collapse;"> <td style="width:36.293%;"/> <td style="width:0.956%;"/> <td style="width:1.0%;"/> <td style="width:6.747999999999999%;"/> <td style="width:1.0%;"/> <td style="width:0.956%;"/> <td style="width:1.0%;"/> <td style="width:8.604%;"/> <td style="width:1.0%;"/> <td style="width:0.956%;"/> <td style="width:1.0%;"/> <td style="width:7.5649999999999995%;"/> <td style="width:1.0%;"/> <td style="width:0.956%;"/> <td style="width:1.0%;"/> <td style="width:6.747999999999999%;"/> <td style="width:1.0%;"/> <td style="width:0.956%;"/> <td style="width:1.0%;"/> <td style="width:8.743%;"/> <td style="width:1.0%;"/> <td style="width:0.956%;"/> <td style="width:1.0%;"/> <td style="width:7.5649999999999995%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="10" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="10" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Gross<br/>Carrying<br/>Amount (2)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Accumulated Amortization</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Net Carrying<br/>Amount</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Gross<br/>Carrying<br/>Amount (1)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Accumulated Amortization</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Net Carrying<br/>Amount</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Amortized intangible assets</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Intellectual property</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">254</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">130</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">124</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">258</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">107</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">151</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Customer lists</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">64</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">30</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">34</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">71</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">45</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total amortizable intangible assets</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">318</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">160</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">158</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">329</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">133</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">196</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Indefinite-lived intangible assets</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Brands and trademarks</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">228</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">228</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">288</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">288</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total intangible asset, net</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">546</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">160</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">386</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">617</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">133</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">484</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">(1)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The gross carrying amounts included in this table reflect the effects of the impairments of intangible assets recorded during the year ended December 31, 2021, when the Company estimated an overall decrease in the sales forecast for AW products, due to an inventory item rationalization, in addition to a decrease in the sales forecast of ISI seeds, related to the saturated hemp seed market. As a result, Arcadia performed a quantitative intangible assets impairment test. The Company used a discounted cash flow approach to develop the fair value of the acquired intellectual property, customer lists, brands and trademarks. As a result of this assessment, Arcadia recorded an impairment of intangible assets in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million in the condensed consolidated statements of operations and comprehensive loss for the year ended December 31, 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">(2)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company recorded an impairment of intangible assets in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">72,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> during the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> related to the Radiance Beauty licensing agreement.</span></p> 254000 130000 124000 258000 107000 151000 64000 30000 34000 71000 26000 45000 318000 160000 158000 329000 133000 196000 228000 228000 288000 288000 546000 160000 386000 617000 133000 484000 3300000 72000 72000 P4Y P15Y <span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022, future amortization of intellectual property and customer lists is as follows:</span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.162%;"/> <td style="width:1.798%;"/> <td style="width:1.0%;"/> <td style="width:16.04%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Year Ending December 31,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2022 (excluding the six months ended June 30, 2022)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">26</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">53</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2024</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">53</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2025</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2026</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Thereafter</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">18</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">158</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table> 26000 53000 53000 4000 4000 18000 158000 <span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. Consolidated Joint Venture</span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In 2019, the Company and Legacy Ventures Hawaii, LLC, a Nevada limited liability company (“Legacy”), formed Archipelago Ventures Hawaii, LLC, a Delaware limited liability company and entered into a Limited Liability Company Operating Agreement (the “Operating Agreement”). The Company and Legacy formed Archipelago to develop, extract and commercialize hemp-derived products from industrial hemp grown in Hawaii.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the Operating Agreement, a joint operating committee consisting of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> individuals appointed by the Company and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> individuals appointed by Legacy will manage Archipelago</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. As of June 30, 2022, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">the Company and Legacy hold </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">50.75</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">49.25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% interests in Archipelago, respectively, and have made capital contributions to Archipelago of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,108,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,016,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, respectively, as determined by the joint operating committee. The Operating Agreement includes indemnification rights, non-competition obligations, and certain rights and obligations in connection with the transfer of membership interests, including rights of first refusal.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company consolidates Archipelago in the condensed consolidated financial statements after eliminating intercompany transactions. Net loss attributable to non-controlling interest of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">20,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">142,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> is recorded as an adjustment to net loss to arrive at net loss attributable to common stockholders for the three and six months ended June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, respectively. Net loss attributable to non-controlling interest of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">161,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">538,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> is recorded as an adjustment to net loss to arrive at net loss attributable to common stockholders for the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2021, respectively. Legacy’s equity interests are presented as non-controlling interests on the condensed consolidated balance sheets. Refer to Note 1 for basis of presentation.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In October 2021, Arcadia and Legacy mutually agreed to wind down the cultivation activities of Archipelago, due to regulatory challenges and a saturated hemp market.</span></p> 2 2 0.5075 0.4925 3108000 3016000 -20000 -142000 -161000 -538000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">9. Collaborative Arrangements</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">August 2017</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, the Company entered into a collaborative arrangement for the research, development and commercialization of an improved wheat quality trait in North America. This collaborative arrangement is a contractual agreement with Corteva AgriScience (“Corteva”) and involves a joint operating activity where both Arcadia and Corteva are active participants in the activities of the collaboration. Arcadia and Corteva participate in the research and development, and Arcadia has the primary responsibility for the intellectual property strategy while Corteva will generally lead the marketing and commercialization efforts. Both parties are exposed to significant risks and rewards of the collaboration and the agreement includes both cost sharing and profit sharing. The activities are performed with no guarantee of either technological or commercial success.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company accounts for research and development (“R&amp;D”) costs in accordance ASC 730, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Research and Development</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, which states R&amp;D costs must be charged to expense as incurred. Accordingly, internal R&amp;D costs are expensed as incurred. Third-party R&amp;D costs are expensed when the contracted work has been performed or as milestone results are achieved.</span></p> 2017-08 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">10. Leases</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:4.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Operating Leases</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2022, the Company leases office space in Davis, CA, and Chatsworth, CA, as well as additional buildings, land and equipment. Leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these short-term leases on a straight-line basis. The Company subleases a portion of the Davis office lease to a third party.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> In May 2022, the Company terminated its lease for office space in Chesterfield, MO effective August 1, 2022. The original lease term was scheduled to expire in </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">May 2024</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. As a result, the Company paid $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">47,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> in early termination fees during the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three months ended June 30, 2022. During the six months ended June 30, 2022, the Company did not enter new leases. On July 1, 2022, the Company entered into an agreement to lease office space in Dallas, TX. As of June 30, 2022, this lease had not yet commenced.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Some leases (the Davis office, a warehouse, and a copy machine) include one or more </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">options to renew</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, with renewal terms that can extend the lease term from </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_cb9a3ae5-476e-4514-b1e1-eb12d13ac958;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">one</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> to </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">six years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> The exercise of lease renewal options is at the Company’s sole discretion.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company’s lease agreements do not contain any material variable lease payments, material residual value guarantees or material restrictive covenants. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Leases consisted of the following (in thousands):</span></span></p><div style="font-size:11.0pt;font-family:Calibri;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:28.373%;"/> <td style="width:1.554%;"/> <td style="width:29.185%;"/> <td style="width:1.578%;"/> <td style="width:1.0%;"/> <td style="width:16.548000000000002%;"/> <td style="width:1.0%;"/> <td style="width:1.578%;"/> <td style="width:1.0%;"/> <td style="width:17.186%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Leases</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Classification</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Assets</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Operating lease assets</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Right of use asset</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,308</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,081</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total leased assets</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,308</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,081</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Liabilities</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Current - Operating</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Operating lease liability- current</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">994</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,074</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Noncurrent - Operating</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Operating lease liability- noncurrent</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,500</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,220</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total leased liabilities</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,494</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,294</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:19.682%;"/> <td style="width:1.102%;"/> <td style="width:20.309%;"/> <td style="width:0.939%;"/> <td style="width:1.0%;"/> <td style="width:11.93%;"/> <td style="width:1.0%;"/> <td style="width:0.939%;"/> <td style="width:1.0%;"/> <td style="width:11.767%;"/> <td style="width:1.0%;"/> <td style="width:0.939%;"/> <td style="width:1.0%;"/> <td style="width:11.686%;"/> <td style="width:1.0%;"/> <td style="width:0.939%;"/> <td style="width:1.0%;"/> <td style="width:11.767%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Lease Cost</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Classification</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">For the Three<br/>Months Ended<br/>June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">For the Three<br/>Months Ended<br/>June 30, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">For the Six<br/>Months Ended<br/>June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">For the Six<br/>Months Ended<br/>June 30, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Operating lease cost</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> SG&amp;A and R&amp;D Expenses</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">268</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">347</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">544</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">636</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Short term lease cost (1)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> R&amp;D Expenses</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">17</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">30</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Short term lease cost</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> SG&amp;A Expenses</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">15</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Sublease income (2)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> SG&amp;A and R&amp;D Expenses</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">90</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">177</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">33</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net lease cost</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">186</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">315</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">378</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">648</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p><div style="text-indent:0.0%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);transform:scale(0.67);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:10.0pt;font-family:Times New Roman;transform-origin:top left;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Short term lease cost consists of field trial lease agreements with a lease term of 12 months or less. </span></div></div><div style="text-indent:0.0%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);transform:scale(0.67);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:10.0pt;font-family:Times New Roman;transform-origin:top left;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Sublease income is recorded as a reduction to lease expense.</span></div></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:41.369%;"/> <td style="width:1.937%;"/> <td style="width:1.0%;"/> <td style="width:24.903%;"/> <td style="width:1.0%;"/> <td style="width:1.937%;"/> <td style="width:1.0%;"/> <td style="width:25.854%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Lease Term<br/>and Discount Rate</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Weighted-average remaining<br/>   lease term (years)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.3</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.7</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Weighted-average discount rate</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.4</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.0</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> </table></div> 2024-05 47000 Some leases (the Davis office, a warehouse, and a copy machine) include one or more options to renew, with renewal terms that can extend the lease term from one to six years. true P6Y <span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Leases consisted of the following (in thousands):</span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:28.373%;"/> <td style="width:1.554%;"/> <td style="width:29.185%;"/> <td style="width:1.578%;"/> <td style="width:1.0%;"/> <td style="width:16.548000000000002%;"/> <td style="width:1.0%;"/> <td style="width:1.578%;"/> <td style="width:1.0%;"/> <td style="width:17.186%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Leases</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Classification</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Assets</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Operating lease assets</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Right of use asset</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,308</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,081</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total leased assets</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,308</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,081</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Liabilities</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Current - Operating</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Operating lease liability- current</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">994</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,074</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Noncurrent - Operating</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Operating lease liability- noncurrent</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,500</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,220</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total leased liabilities</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,494</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,294</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:19.682%;"/> <td style="width:1.102%;"/> <td style="width:20.309%;"/> <td style="width:0.939%;"/> <td style="width:1.0%;"/> <td style="width:11.93%;"/> <td style="width:1.0%;"/> <td style="width:0.939%;"/> <td style="width:1.0%;"/> <td style="width:11.767%;"/> <td style="width:1.0%;"/> <td style="width:0.939%;"/> <td style="width:1.0%;"/> <td style="width:11.686%;"/> <td style="width:1.0%;"/> <td style="width:0.939%;"/> <td style="width:1.0%;"/> <td style="width:11.767%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Lease Cost</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Classification</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">For the Three<br/>Months Ended<br/>June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">For the Three<br/>Months Ended<br/>June 30, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">For the Six<br/>Months Ended<br/>June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">For the Six<br/>Months Ended<br/>June 30, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Operating lease cost</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> SG&amp;A and R&amp;D Expenses</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">268</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">347</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">544</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">636</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Short term lease cost (1)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> R&amp;D Expenses</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">17</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">30</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Short term lease cost</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> SG&amp;A Expenses</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">4</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">15</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Sublease income (2)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> SG&amp;A and R&amp;D Expenses</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">90</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">19</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">177</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">33</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Net lease cost</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">186</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">315</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">378</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">648</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p><div style="text-indent:0.0%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);transform:scale(0.67);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:10.0pt;font-family:Times New Roman;transform-origin:top left;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Short term lease cost consists of field trial lease agreements with a lease term of 12 months or less. </span></div></div><div style="text-indent:0.0%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);transform:scale(0.67);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:10.0pt;font-family:Times New Roman;transform-origin:top left;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Sublease income is recorded as a reduction to lease expense.</span></div></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:41.369%;"/> <td style="width:1.937%;"/> <td style="width:1.0%;"/> <td style="width:24.903%;"/> <td style="width:1.0%;"/> <td style="width:1.937%;"/> <td style="width:1.0%;"/> <td style="width:25.854%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Lease Term<br/>and Discount Rate</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Weighted-average remaining<br/>   lease term (years)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.3</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.7</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Weighted-average discount rate</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.4</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.0</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> </table> 2308000 3081000 2308000 3081000 994000 1074000 1500000 2220000 2494000 3294000 268000 347000 544000 636000 8000 -17000 11000 30000 4000 15000 90000 19000 177000 33000 186000 315000 378000 648000 P2Y3M18D P2Y8M12D 0.064 0.060 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11. Equity Financing</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Private Placements</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In January 2021, the Company issued in a private placement offering (the “January 2021 Private Placement”) pursuant to a securities purchase agreement (“January 2021 Purchase Agreement”) (i) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7,876,784</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of its common stock, and (ii) warrants to purchase up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3,938,392</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock at an exercise price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.13</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per share (the “January 2021 Warrants”) and raised total gross proceeds of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">25.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million. The January 2021 Warrants are exercisable at any time at the option of the holder and expire </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> years from the date of issuance. In connection with the January 2021 Private Placement, the Company granted to a placement agent warrants to purchase a total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">393,839</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of Common Stock (the “January 2021 Placement Agent Warrants”) that have an exercise price per share equal to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.99</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and a term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> years from the date of issuance.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The common stock warrants are classified as a liability within Level 3 due to a contingent cash payment feature. The Company utilized a Black Scholes Merton model on January 28, 2021 with the following assumptions: volatility of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">123.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> percent, stock price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.88</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and risk-free rate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%. The estimated fair value of the common stock warrant liability was subsequently remeasured at December 31, 2021 with the changes recorded on the Company’s consolidated statements of operations and comprehensive loss.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The January 2021 Placement Agent Warrants were issued for services performed by the placement agent as part of the January 2021 Private Placement and were treated as offering costs. The value of the January 2021 Placement Agent Warrants was determined to be $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">942,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, calculated using a Black-Scholes Model. The Company incurred additional offering costs totaling $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million that consist of direct incremental legal, advisory, accounting and filing fees relating to the January 2021 Private Placement. The offering costs, inclusive of the January 2021 Placement Agent Warrants, totaled $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million and allocated to the common stock warrant liability and the common stock using their relative fair values. A total of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">769,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> was allocated to the common stock warrant liability and expensed and the remaining $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million was allocated to the common stock and offset to additional paid in capital.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In March 2018, the Company issued in a private placement offering (the “March 2018 Private Placement”) pursuant to a securities purchase agreement (“March 2018 Purchase Agreement”) (i) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">300,752</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of its common stock and (ii) warrants to purchase up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">300,752</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock at an initial exercise price equal to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">45.75</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> (the “March 2018 Warrants”) and raised total gross proceeds of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">10.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million. The March 2018 Warrants are exercisable at any time at the option of the holder and expire </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">five years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> from the date of issuance. In connection with the March 2018 Private Placement, the Company granted to a placement agent warrants to purchase a total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">15,038</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of Common Stock (the “March 2018 Placement Agent Warrants”) that have an exercise price per share equal to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">41.5625</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and a term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">five years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> from the date of issuance.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The number of shares of common stock and the number and exercise price of the March 2018 Warrants issued in the March 2018 Private Placement were subject to adjustments as provided in the March 2018 Purchase Agreement. Following the adjustments as provided in the March 2018 Purchase Agreement, the number of shares issued to the purchasers was </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,201,634</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, the total number of shares issuable upon exercise of the March 2018 Warrants was </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,282,832</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and the per share exercise price of the March 2018 Warrants was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">10.7258</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Registered Direct Offerings</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">May 11, 2018, the Company filed a shelf Registration Statement on Form S-3 with the SEC which was declared effective on June 8, 2018 (“Shelf Registration Statement”). This shelf registration process allows the Company to sell any combination of common </span></span><span style=""/></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">stock, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">preferred stock, warrants and units consisting of such securities in one or more offerings from time to time having aggregate offering prices of up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million. This registration statement may no longer be used after June 8, 2021, the three-year anniversary of its effective date.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In December 2020, the Company entered into a securities purchase agreement (the “December 2020 Purchase Agreement”) pursuant to which it sold (i) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,618,658</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> registered shares of its common stock pursuant to the Shelf Registration Statement and (ii) unregistered warrants to purchase </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,618,658</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of its common stock (the “December 2020 Warrants”) in a private placement, for total gross proceeds of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million (the “December 2020 Registered Direct Offering”). The December 2020 Registered Direct Offering closed on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">December 22, 2020</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The December 2020 Warrants have an exercise price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per share, became exercisable upon issuance and expire </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> years after the date of issuance. In connection with the December 2020 Registered Direct Offering, the Company granted to a placement agent warrants to purchase a total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">130,933</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock (“December 2020 Placement Agent Warrants”) that have an exercise price per share equal to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.8188</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and a term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">five years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In September 2019, the Company entered into a securities purchase agreement (the “September 2019 Purchase Agreement”) pursuant to which it sold (i) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,318,828</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> registered shares of its common stock pursuant to the Shelf Registration Statement and (ii) unregistered warrants to purchase </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">659,414</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of its common stock (the “September 2019 Warrants”) in a private placement, for total gross proceeds of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">10.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million (the “September 2019 Registered Direct Offering”). The September 2019 Registered Direct Offering closed on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">September 5, 2019</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The September 2019 Warrants have an exercise price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7.52</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per share, became exercisable upon issuance and expire </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> years after the date of issuance. In connection with the September 2019 Registered Direct Offering, the Company granted to a placement agent warrants to purchase a total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">65,942</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock (“September 2019 Placement Agent Warrants”) that have an exercise price per share equal to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">9.4781</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and a term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">five years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In June 2019, the Company entered into a securities purchase agreement (the “June 2019 Purchase Agreement”) pursuant to which it sold (i) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,489,575</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> registered shares of its common stock pursuant to the Shelf Registration Statement and (ii) unregistered warrants to purchase </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,489,575</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of its common stock (the “June 2019 Warrants”) in a private placement, for total gross proceeds of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million (the “June 2019 Registered Direct Offering”). The June 2019 Registered Direct Offering closed on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 14, 2019</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The June 2019 Warrants have an exercise price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per share, became exercisable upon issuance and expire </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> years after the date of issuance. In connection with the June 2019 Registered Direct Offering, the Company granted to a placement agent warrants to purchase a total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">74,479</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock (“June 2019 Placement Agent Warrants”) that have an exercise price per share equal to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.2938</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and a term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">five years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In June 2018, the Company entered into a securities purchase agreement (the “June 2018 Purchase Agreement”) pursuant to which it sold (i) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,392,345</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> registered shares of its common stock pursuant to the Shelf Registration Statement and (ii) unregistered warrants to purchase </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,392,345</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of its common stock (the “June</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2018 Warrants”) in a private placement, for total gross proceeds of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">14.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million (the “June 2018 Registered Direct Offering”). The June 2018 Registered Direct Offering closed on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 14, 2018</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The June 2018 Warrants have an exercise price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">9.94</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per share, became exercisable upon issuance and expire </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> years after the date of issuance. In connection with the June 2018 Registered Direct Offering, the Company granted to a placement agent warrants to purchase a total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">69,617</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock (“June 2018 Placement Agent Warrants”) that have an exercise price per share equal to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12.568</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and a term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">five years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">.</span></p> 7876784 3938392 3.13 25100000 P5Y6M 393839 3.99 P5Y6M 123.8 2.88 0.5 942000 1900000 2800000 769000 2000000.0 300752 300752 45.75 10000000.0 P5Y 15038 41.5625 P5Y 1201634 1282832 10.7258 On May 11, 2018, the Company filed a shelf Registration Statement on Form S-3 with the SEC which was declared effective on June 8, 2018 (“Shelf Registration Statement”). This shelf registration process allows the Company to sell any combination of common stock, preferred stock, warrants and units consisting of such securities in one or more offerings from time to time having aggregate offering prices of up to $50 million. This registration statement may no longer be used after June 8, 2021, the three-year anniversary of its effective date. 50000000 2618658 2618658 8000000.0 2020-12-22 3.00 P5Y6M 130933 3.8188 P5Y 1318828 659414 10000000.0 2019-09-05 7.52 P5Y6M 65942 9.4781 P5Y 1489575 1489575 7500000 2019-06-14 5.00 P5Y6M 74479 6.2938 P5Y 1392345 1392345 14000000.0 2018-06-14 9.94 P5Y6M 69617 12.568 P5Y <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12. Warrants</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company issued the following warrants to purchase shares of its common stock, which are outstanding as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022 or December 31, 2021, respectively. These warrants are exercisable any time at the option of the holder until their expiration date.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:24.865%;"/> <td style="width:0.937%;"/> <td style="width:8.1%;"/> <td style="width:0.937%;"/> <td style="width:4.602%;"/> <td style="width:0.937%;"/> <td style="width:1.0%;"/> <td style="width:8.975999999999999%;"/> <td style="width:1.0%;"/> <td style="width:0.937%;"/> <td style="width:1.0%;"/> <td style="width:9.681%;"/> <td style="width:1.0%;"/> <td style="width:0.937%;"/> <td style="width:1.0%;"/> <td style="width:8.790999999999999%;"/> <td style="width:1.0%;"/> <td style="width:0.937%;"/> <td style="width:1.0%;"/> <td style="width:9.635%;"/> <td style="width:1.0%;"/> <td style="width:0.937%;"/> <td style="width:1.0%;"/> <td style="width:8.790999999999999%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:6.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;">Issuance Date</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;">Term</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;">Exercise<br/>Price Per<br/>Share</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;">Warrants<br/>Exercised<br/>during the<br/>Year Ended<br/>December 31,<br/>2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;">Warrants<br/>Outstanding at<br/>December 31,<br/>2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;">Warrants<br/>Exercised<br/>during the<br/>Six<br/>Months Ended<br/>June 30,<br/>2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;">Warrants<br/>Outstanding at<br/>June 30,<br/>2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">January 2021 Placement Agent Warrants</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">January 2021</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">3.99</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">393,839</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">393,839</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">January 2021 Service and Performance Warrants (1)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">January 2021</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">3.08</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">7,500</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">7,500</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 2020 Warrants</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 2020</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">3.00</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2,618,658</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2,618,658</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 2020 Placement Agent Warrants</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 2020</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">3.82</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">130,933</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">130,933</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">July 2020 Warrants</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">July 2020</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">3.85</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">641,416</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">641,416</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">July 2020 Placement Agent Warrants</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">July 2020</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">4.97</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">32,071</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">32,071</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">May 2020 Warrants</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">May 2020</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">4.78</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">1,392,345</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">1,392,345</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">May 2020 Placement Agent Warrants</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">May 2020</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">6.13</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">69,617</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">69,617</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 2020 Service and Performance Warrants (1)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 2020</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">3</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2.50</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">18,350</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">18,350</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">February 12, 2020 Service and Performance Warrants (1)(3)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">February 2020</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">4.71</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">150,000</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">February 3, 2020 Service and Performance Warrants (1)(3)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">February 2020</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">4.91</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">10,000</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">September 2019 Placement Agent Warrants</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">September 2019</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">9.48</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">65,942</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">65,942</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 2019 Placement Agent Warrants</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 2019</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">6.29</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">74,479</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">74,479</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">April 2019 Service and Performance Warrants (1)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">April 2019</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">6.18</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">145,154</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">145,154</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 2018 Placement Agent Warrants</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 2018</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">12.57</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">69,617</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">69,617</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 2018 Placement Agent Warrants</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 2018</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">41.56</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">15,038</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">15,038</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">January 2021 Warrants (2)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">January 2021</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">3.13</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">3,938,392</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">3,938,392</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">September 2019 Warrants (2)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">September 2019</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">7.52</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">659,414</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">659,414</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 2019 Warrants (2)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 2019</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5.00</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">435,830</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">435,830</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 2018 Warrants (2)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 2018</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">9.94</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 2018 Warrants (2)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 2018</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">10.73</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">641,416</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">641,416</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">11,510,011</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">11,350,011</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">(1)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> The Company issued service and performance warrants (“Service and Performance Warrants”) in connection with professional services agreements with non-affiliated third party entities.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">(2)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Certain warrants contain a contingent cash payment feature and therefore were accounted for as a liability at the date of issuance and were adjusted to fair value at each balance sheet date. Upon adoption of ASU No. 2020-06 on January 1, 2022, all of the common stock warrant liabilities have been reclassified to equity classified common stock warrants, due to the elimination of the contingent cash payments as criteria for liability classification.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">(3)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> These warrants expired in </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">February 2022</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">.</span></p> <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company issued the following warrants to purchase shares of its common stock, which are outstanding as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022 or December 31, 2021, respectively. These warrants are exercisable any time at the option of the holder until their expiration date.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:24.865%;"/> <td style="width:0.937%;"/> <td style="width:8.1%;"/> <td style="width:0.937%;"/> <td style="width:4.602%;"/> <td style="width:0.937%;"/> <td style="width:1.0%;"/> <td style="width:8.975999999999999%;"/> <td style="width:1.0%;"/> <td style="width:0.937%;"/> <td style="width:1.0%;"/> <td style="width:9.681%;"/> <td style="width:1.0%;"/> <td style="width:0.937%;"/> <td style="width:1.0%;"/> <td style="width:8.790999999999999%;"/> <td style="width:1.0%;"/> <td style="width:0.937%;"/> <td style="width:1.0%;"/> <td style="width:9.635%;"/> <td style="width:1.0%;"/> <td style="width:0.937%;"/> <td style="width:1.0%;"/> <td style="width:8.790999999999999%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:6.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;">Issuance Date</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;">Term</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;">Exercise<br/>Price Per<br/>Share</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;">Warrants<br/>Exercised<br/>during the<br/>Year Ended<br/>December 31,<br/>2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;">Warrants<br/>Outstanding at<br/>December 31,<br/>2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;">Warrants<br/>Exercised<br/>during the<br/>Six<br/>Months Ended<br/>June 30,<br/>2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;">Warrants<br/>Outstanding at<br/>June 30,<br/>2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">January 2021 Placement Agent Warrants</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">January 2021</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">3.99</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">393,839</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">393,839</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">January 2021 Service and Performance Warrants (1)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">January 2021</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">3.08</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">7,500</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">7,500</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 2020 Warrants</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 2020</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">3.00</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2,618,658</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2,618,658</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 2020 Placement Agent Warrants</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">December 2020</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">3.82</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">130,933</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">130,933</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">July 2020 Warrants</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">July 2020</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">3.85</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">641,416</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">641,416</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">July 2020 Placement Agent Warrants</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">July 2020</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">4.97</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">32,071</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">32,071</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">May 2020 Warrants</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">May 2020</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">4.78</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">1,392,345</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">1,392,345</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">May 2020 Placement Agent Warrants</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">May 2020</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">6.13</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">69,617</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">69,617</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 2020 Service and Performance Warrants (1)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 2020</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">3</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2.50</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">18,350</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">18,350</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">February 12, 2020 Service and Performance Warrants (1)(3)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">February 2020</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">4.71</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">150,000</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">February 3, 2020 Service and Performance Warrants (1)(3)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">February 2020</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">4.91</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">10,000</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">September 2019 Placement Agent Warrants</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">September 2019</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">9.48</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">65,942</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">65,942</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 2019 Placement Agent Warrants</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 2019</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">6.29</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">74,479</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">74,479</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">April 2019 Service and Performance Warrants (1)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">April 2019</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">6.18</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">145,154</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">145,154</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 2018 Placement Agent Warrants</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 2018</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">12.57</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">69,617</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">69,617</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 2018 Placement Agent Warrants</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 2018</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">41.56</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">15,038</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">15,038</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">January 2021 Warrants (2)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">January 2021</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">3.13</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">3,938,392</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">3,938,392</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">September 2019 Warrants (2)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">September 2019</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">7.52</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">659,414</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">659,414</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 2019 Warrants (2)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 2019</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5.00</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">435,830</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">435,830</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 2018 Warrants (2)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">June 2018</span></span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">9.94</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 2018 Warrants (2)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">March 2018</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"> years</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">10.73</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">641,416</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">641,416</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">11,510,011</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">11,350,011</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table> 2021-01 P5Y6M 3.99 393839 393839 2021-01 P2Y 3.08 7500 7500 2020-12 P5Y6M 3.00 2618658 2618658 2020-12 P5Y 3.82 130933 130933 2020-07 P5Y6M 3.85 641416 641416 2020-07 P5Y6M 4.97 32071 32071 2020-05 P5Y 4.78 1392345 1392345 2020-05 P5Y 6.13 69617 69617 2020-03 P3Y 2.50 18350 18350 2020-02 P2Y 4.71 150000 2020-02 P2Y 4.91 10000 2019-09 P5Y 9.48 65942 65942 2019-06 P5Y 6.29 74479 74479 2019-04 P5Y 6.18 145154 145154 2018-06 P5Y 12.57 69617 69617 2018-03 P5Y 41.56 15038 15038 2021-01 P5Y6M 3.13 3938392 3938392 2019-09 P5Y6M 7.52 659414 659414 2019-06 P5Y6M 5.00 435830 435830 2018-06 P5Y6M 9.94 2018-03 P5Y 10.73 641416 641416 11510011 11350011 2022-02 2022-02 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">13. Stock-Based Compensation and Employee Stock Purchase Program</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stock Incentive Plans</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company has </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> equity incentive plans: the 2006 Stock Plan (“2006 Plan”) and the 2015 Omnibus Equity Incentive Plan (“2015 Plan”).</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In 2006, the Company adopted the 2006 Plan, which provided for the granting of stock options to executives, employees, and other service providers under terms and provisions established by the Board of Directors. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company granted non-statutory stock options (“NSOs”) under the 2006 Plan until May 2015, when it was terminated as to future awards, although it continues to govern the terms of options that remain outstanding and were issued under the 2006 Plan. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The 2015 Plan became effective upon the Company’s IPO in May 2015 and all shares that were reserved, but not issued, under the 2006 Plan were assumed by the 2015 Plan. Upon effectiveness, the 2015 Plan had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">154,387</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock reserved for future issuance, which included </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">10,637</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> that were transferred to and assumed by the 2015 Plan. The 2015 Plan provides for automatic annual increases in shares available for grant. In addition, shares subject to awards under the 2006 Plan that are forfeited or canceled will be added to the 2015 Plan.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> The 2015 Plan provides for the grant of incentive stock options (“ISOs”), NSOs, restricted stock awards, stock units, stock appreciation rights, and other forms of equity compensation, all of which may be granted to employees, officers, non-employee directors, and consultants. The exercise price for ISOs and NSOs will be granted at a price per share not less than the fair value of our common stock at the date of grant. Options granted generally vest over a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">four-year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> period; however, there might be alternative vesting schedules, as approved by the Board. Options granted, once vested, are generally exercisable for up to </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">10</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> years, after grant to the extent vested.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In June 2019, the shareholders approved an amendment to the Company’s 2015 Plan for a one-time increase to the number of shares of common stock that may be issued under the 2015 Plan by </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">120,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares. On May 17, 2021, upon completion of the Arcadia Wellness transaction, the Company granted </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">248,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> inducement stock option pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. On May 28, 2021, the Company filed a registration statement on Form S-8 to register the issuance of shares upon exercise of these inducement stock options. On February 2, 2022, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Sta</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">nley Jacot, Jr. was hired as the new president and chief executive officer of the Company. The Company granted Mr. Jacot an inducement stock option to purchase </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">316,108</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company’s common</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> stock pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. The Company has not filed a registration statement on Form S-8 to register the issuance of shares upon exercise of this inducement stock option. The inducement options grants have been issued outside of the 2015 Plan, but are subject to the terms and conditions of the 2015 Plan. As of June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, a total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,484,005</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock were reserved for issuance under the 2015 Plan, of which </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">584,777</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock are available for future grant. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, a total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">7,813</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,899,228</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> options are outstanding under the 2006 and 2015 Plans, respectively. As of December 31, 2021, a total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8,240</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,345,955</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> options are outstanding under the 2006 and 2015 Plans, respectively. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> a total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">376,608</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> inducement options are outstanding.</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following is a summary of stock option information and weighted average exercise prices under the Company’s stock incentive plans (in thousands, except share data and price per share):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:81.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.303%;"/> <td style="width:1.191%;"/> <td style="width:1.0%;"/> <td style="width:10.282%;"/> <td style="width:1.0%;"/> <td style="width:1.191%;"/> <td style="width:1.0%;"/> <td style="width:11.667%;"/> <td style="width:1.0%;"/> <td style="width:1.191%;"/> <td style="width:1.0%;"/> <td style="width:11.175%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Shares<br/>Subject to<br/>Outstanding<br/>Options</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Weighted-<br/>Average<br/>Exercise<br/>Price Per<br/>Share</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Outstanding — Balance at December 31, 2021</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,422,195</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.28</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Options granted</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,030,822</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.16</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Options exercised</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Options forfeited</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">130,263</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.86</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Options expired</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">39,105</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.21</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Outstanding — Balance at June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,283,649</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.54</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">31,230</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Vested and expected to vest — June 30, 2022</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,011,343</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.82</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">24,452</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Exercisable — June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">862,726</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.76</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Aggregate intrinsic value represents the difference between the exercise price of the options and the estimated fair value of the Company’s common stock determined by our Board of Directors for each of the respective periods. The intrinsic value of options exercised was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> for both </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">quarters ended June 30, 2022 and 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">As of June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, there was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million of unrecognized compensation cost related to unvested stock-based compensation grants that will be recognized over the weighted-average remaining recognition period of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.8</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> years.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">On December 14, 2021, Matt Plavan provided notice to the Company of his resignation as Arcadia’s president, chief executive officer and director, effective as of December 31, 2021. On December 19, 2021, Arcadia and Mr. Plavan entered into a Separation and Release Agreement (the “Separation Agreement”) which provided that the vesting of all unvested options previously issued to Mr. Plavan accelerated pursuant to the terms of the Separation Agreement. In addition, the Separation Agreement extended the post-termination exercise period of the accelerated options from </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">90 days</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> to up to </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_93f39f3d-252d-40fe-8992-3ffcb46a4c30;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">two and one-half years</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The stock compensation expense</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">related </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">to the modification of Mr. Plavan’s stock options was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">154,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and it was recognized in selling, general and administrative expenses during the year ended December 31, 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In determining the fair value of the stock-based awards, the Company uses the Black-Scholes option-pricing model and assumptions discussed below. Each of these inputs is subjective and generally requires significant judgment to determine.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Expected Term—</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The expected term is the estimated period of time outstanding for stock options granted and was estimated based on a simplified method allowed by the SEC, and defines the term as the average of the contractual term of the options and the weighted-average vesting period for all open employee awards.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Expected Volatility—</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The historical volatility data was computed using the daily closing prices for the Company’s shares during the equivalent period of the calculated expected term of the stock-based awards.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Risk-Free Interest Rate—</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The risk-free interest rate is based on the interest rate of U.S. Treasuries of comparable maturities on the date the options were granted.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Expected Dividend—</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The expected dividend yield is based on the Company’s expectation of future dividend payouts to common stockholders.</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The fair value of stock option awards was estimated at the date of grant using a Black-Scholes option-pricing model with the following weighted-average assumption:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:49.015%;"/> <td style="width:1.176%;"/> <td style="width:1.0%;"/> <td style="width:10.127999999999998%;"/> <td style="width:1.0%;"/> <td style="width:1.176%;"/> <td style="width:1.0%;"/> <td style="width:9.014%;"/> <td style="width:1.0%;"/> <td style="width:1.176%;"/> <td style="width:1.0%;"/> <td style="width:10.127999999999998%;"/> <td style="width:1.0%;"/> <td style="width:1.176%;"/> <td style="width:1.0%;"/> <td style="width:9.014%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Three Months Ended June 30,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Six Months Ended June 30,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected term (years)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.85</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.84</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.61</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.37</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">123</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">122</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">122</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">122</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.85</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.06</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.48</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.81</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Dividend yield</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company recognized </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">323,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">583,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> of compensation expense for stock options awards for the three and six months ended June 30, 2022, respectively. The Company recognized </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">356,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">681,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> of compensation expense for stock options awards for the three and six months ended June 30, 2021, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Employee Stock Purchase Plan</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company’s 2015 Employee Stock Purchase Plan (“ESPP”) became effective on May 14, 2015. The ESPP allows eligible employees to purchase shares of the Company’s common stock at a discount of up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">15</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% of their eligible compensation through payroll deductions, subject to any plan limitations. After the first offering period, which began on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">May 14, 2015</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and ended on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">February 1, 2016</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, the ESPP provides for </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">six-month</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> offering periods, and at the end of each offering period, employees are able to purchase shares at </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">85</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% of the lower of the fair market value of the Company’s common stock on the first trading day of the offering period or on the last day of the offering period. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, the number of shares of common stock reserved for future issuance under the ESPP is </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">128,914</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The ESPP provides for automatic annual increases in the shares available for purchase beginning on January 1, 2016. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">54,928</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares had been issued under the ESPP. The Company recorded $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> of ESPP related compensation expense for the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, respectively. The Company recorded $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">8,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">13,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> of ESPP related compensation expense for the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> 2 The 2015 Plan became effective upon the Company’s IPO in May 2015 and all shares that were reserved, but not issued, under the 2006 Plan were assumed by the 2015 Plan. Upon effectiveness, the 2015 Plan had 154,387 shares of common stock reserved for future issuance, which included 10,637 that were transferred to and assumed by the 2015 Plan. The 2015 Plan provides for automatic annual increases in shares available for grant. In addition, shares subject to awards under the 2006 Plan that are forfeited or canceled will be added to the 2015 Plan. 154387 10637 P4Y P10Y 120000 248000 316108 2484005 584777 7813 1899228 8240 1345955 376608 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The following is a summary of stock option information and weighted average exercise prices under the Company’s stock incentive plans (in thousands, except share data and price per share):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:81.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:57.303%;"/> <td style="width:1.191%;"/> <td style="width:1.0%;"/> <td style="width:10.282%;"/> <td style="width:1.0%;"/> <td style="width:1.191%;"/> <td style="width:1.0%;"/> <td style="width:11.667%;"/> <td style="width:1.0%;"/> <td style="width:1.191%;"/> <td style="width:1.0%;"/> <td style="width:11.175%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Shares<br/>Subject to<br/>Outstanding<br/>Options</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Weighted-<br/>Average<br/>Exercise<br/>Price Per<br/>Share</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Outstanding — Balance at December 31, 2021</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,422,195</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.28</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Options granted</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,030,822</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.16</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Options exercised</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Options forfeited</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">130,263</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.86</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Options expired</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">39,105</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.21</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Outstanding — Balance at June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,283,649</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.54</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">31,230</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Vested and expected to vest — June 30, 2022</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,011,343</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.82</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">24,452</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Exercisable — June 30, 2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">862,726</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.76</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table> 1422195 5.28 1030822 1.16 130263 2.86 39105 6.21 2283649 3.54 31230000 2011343 3.82 24452000 862726 6.76 0 0 1400000 P2Y9M18D P90D 154000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The fair value of stock option awards was estimated at the date of grant using a Black-Scholes option-pricing model with the following weighted-average assumption:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:49.015%;"/> <td style="width:1.176%;"/> <td style="width:1.0%;"/> <td style="width:10.127999999999998%;"/> <td style="width:1.0%;"/> <td style="width:1.176%;"/> <td style="width:1.0%;"/> <td style="width:9.014%;"/> <td style="width:1.0%;"/> <td style="width:1.176%;"/> <td style="width:1.0%;"/> <td style="width:10.127999999999998%;"/> <td style="width:1.0%;"/> <td style="width:1.176%;"/> <td style="width:1.0%;"/> <td style="width:9.014%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Three Months Ended June 30,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">Six Months Ended June 30,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected term (years)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.85</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.84</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.61</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6.37</span></span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">123</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">122</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">122</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">122</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.85</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1.06</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.48</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.81</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Dividend yield</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table> P6Y10M6D P6Y10M2D P6Y7M9D P6Y4M13D 1.23 1.22 1.22 1.22 0.0285 0.0106 0.0248 0.0081 323000 583000 356000 681000 0.15 2015-05-14 2016-02-01 P6M 0.85 128914 54928 1000 2000 8000 13000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">14. Income Taxes</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Income tax expense during interim periods is based on applying an estimated annual effective income tax rate to year-to-date income, plus any significant unusual or infrequently occurring items that are recorded in the interim period. The computation of the annual estimated effective tax rate at each interim period requires certain estimates and significant judgment including, but not limited to, the expected operating income for the year, projections of the proportion of income earned and taxed in various jurisdictions, permanent and temporary differences, and the likelihood of recovering deferred tax assets generated in the current year. The accounting estimates used to compute the provision for income taxes may change as new events occur, more experience is obtained, additional information becomes known, or as the tax environment changes.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The interim financial statement provision for income taxes is different from the amounts computed by applying the United States federal statutory income tax rate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">21</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%. The Company’s effective tax rate was </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% for each of the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, and was -</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0.01</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% for each of the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The difference between the effective tax rate and the federal statutory rate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">21</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% was primarily due to the full valuation allowance recorded on the Company’s net deferred tax assets.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company experienced an ownership change under IRC Section 382 as a result of the common shares issued in connection with the January 2021 Offering. This ownership change limited the Company’s ability to utilize its net operating loss carryforwards prior to expiration and certain net operating loss carryforwards were written off as a result. The Company is currently conducting additional analysis regarding the valuation of the Company at the time of the ownership change to assess what, if any, portion of the limitation may be reversed. Any adjustment to the amount of limitation will not impact the deferred tax asset balance due to the full valuation allowance.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">During the six months ended June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, there were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> material changes to the Company’s uncertain tax positions.</span></p> 0.21 0.0000 0.0000 -0.0001 -0.0001 0.21 0 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">15. Commitments and Contingencies</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Leases</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company leases office and laboratory space, grain storage bins, warehouse space, farmland, and equipment under operating lease agreements having initial lease terms ranging from </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_62f870f7-a5f7-42d2-81af-aec7481ef3a5;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">one</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> to </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">five years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, including certain renewal options available to the Company at market rates. The Company also leases land for field trials on a short-term basis. See</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Note 10.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Legal Matters</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">From time to time, in the ordinary course of business, the Company may become involved in certain legal proceedings. The Company currently is not a party to any material litigation or other material legal proceedings.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Contingent Liability Related to the Anawah Acquisition</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In</span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_7c86ea0d-0eca-4fa6-952b-1844dc95a602;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> June 2005</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">the Company completed its agreement and plan of merger and reorganization with Anawah, to purchase the Anawah’s food and agricultural research company through a non-cash stock purchase. Pursuant to the merger with Anawah, and in accordance with the ASC 805 - Business Combinations, the Company incurred a contingent liability not to exceed $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million. This liability represents amounts to be paid to Anawah’s previous stockholders for cash collected on revenue recognized by the Company upon commercial sale of certain specific products developed using technology acquired in the purchase. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">As of December 31, 2010, the Company ceased activities relating to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> of the </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">six</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> Anawah product programs</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> thus, the contingent liability was reduced to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">3.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million. During the third quarter of 2016, one of the programs previously accrued for was abandoned and another program previously abandoned was reactivated. During the fourth quarter of 2019, the Company determined that one of the technologies was no longer active and decided to abandon the previously accrued program. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, the Company continues to pursue a total of two development programs using this technology and believes that the contingent liability is probable. As a result, $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> million remains on the condensed consolidated balance sheet as an other noncurrent liability.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Contingent Liability Related to the ISI Acquisition</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">In August 2020, the Company acquired by merger ISI. A portion of the purchase price consideration for the acquisition in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">280,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> will be recognized in </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> annual installments, each of up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">132,626</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company’s common stock, subject to the achievement of revenue milestones in 2021 and 2022. The contingent consideration was measured and recorded at fair value. As a result of a remeasurement of the contingent consideration, we recorded a decrease to the related liability of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">31,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">140,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> during the quarters ended March 31, 2022 and 2021, respectively. During the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">quarter ended June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, the remaining contingent liability of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">39,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> was written-down to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> as the probability of achievement of the 2022 revenue milestone is remote.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Contracts</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company has entered into contract research agreements with unrelated parties that require the Company to pay certain funding commitments. The initial terms of these agreements range from one to </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> in duration and in certain cases are cancelable.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company licenses certain technologies via executed agreements (“In-Licensing Agreements”) that are used to develop and advance the Company’s own technologies. The Company has entered into various In-Licensing Agreements with related and unrelated parties that require the Company to pay certain license fees, royalties, and/or milestone fees. In addition, certain royalty payments ranging from </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">15</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% of net revenue amounts as defined in the In-Licensing Agreements are or will be due.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Company could be adversely affected by certain actions by the government as it relates to government contract revenue received in prior years. Government agencies, such as the Defense Contract Audit Agency routinely audit and investigate government contractors. These agencies review a contractor’s performance under its agreements; cost structure; and compliance with applicable laws, regulations and standards. The agencies also review the adequacy of, and a contractor’s compliance with, its internal control systems and policies, including the contractor’s purchasing, property, estimating, compensation and management information systems. While the Company’s management anticipates no adverse result from an audit, should any costs be found to be improperly allocated to a government agreement, such costs will not be reimbursed, or if already reimbursed, may need to be refunded. If an audit uncovers improper or illegal activities, civil and criminal penalties and administrative sanctions, including termination of contracts, forfeiture of profits, suspension of payments or fines, and suspension or prohibition from doing business with the government could occur. In</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">addition, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">serious reputational harm or significant adverse financial effects could occur if allegations of impropriety were made against the Company. There currently are routine audits in process relating to government grant revenues.</span></p> P5Y 5000000.0 As of December 31, 2010, the Company ceased activities relating to three of the six Anawah product programs 3 6 3000000.0 2000000.0 280000 2 132626 -31000 -140000 39000 0 P3Y 0.02 0.15 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">16. Net Loss per Share</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Basic net loss per share is calculated by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period and excludes any dilutive effects of stock-based awards and warrants. Diluted net loss per share attributable to common stockholders is computed giving effect to all potentially dilutive common shares, including common stock issuable upon exercise of stock options and warrants. As the Company had net losses for the three and six months ended June 30, 2022 and 2021, all potentially dilutive common shares were determined to be anti-dilutive.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"><br/></span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in shares):</span></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:40.599%;"/> <td style="width:1.364%;"/> <td style="width:1.0%;"/> <td style="width:11.329%;"/> <td style="width:1.0%;"/> <td style="width:1.364%;"/> <td style="width:1.0%;"/> <td style="width:11.728%;"/> <td style="width:1.0%;"/> <td style="width:1.364%;"/> <td style="width:1.0%;"/> <td style="width:11.245000000000001%;"/> <td style="width:1.0%;"/> <td style="width:1.364%;"/> <td style="width:1.0%;"/> <td style="width:11.644%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">For the Three Months Ended June 30,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">For the Six Months Ended June 30,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Options to purchase common stock</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,283,649</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,711,145</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,283,649</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,711,145</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Warrants to purchase common stock</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11,350,011</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11,540,011</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11,350,011</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11,540,011</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">13,633,660</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">13,251,156</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">13,633,660</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">13,251,156</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table></div> <span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in shares):</span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:40.599%;"/> <td style="width:1.364%;"/> <td style="width:1.0%;"/> <td style="width:11.329%;"/> <td style="width:1.0%;"/> <td style="width:1.364%;"/> <td style="width:1.0%;"/> <td style="width:11.728%;"/> <td style="width:1.0%;"/> <td style="width:1.364%;"/> <td style="width:1.0%;"/> <td style="width:11.245000000000001%;"/> <td style="width:1.0%;"/> <td style="width:1.364%;"/> <td style="width:1.0%;"/> <td style="width:11.644%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">For the Three Months Ended June 30,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">For the Six Months Ended June 30,</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;min-width:fit-content;"/> </p></td> <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Options to purchase common stock</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,283,649</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,711,145</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">2,283,649</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,711,145</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Warrants to purchase common stock</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11,350,011</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11,540,011</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11,350,011</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">11,540,011</span></p></td> <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">13,633,660</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">13,251,156</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">13,633,660</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">13,251,156</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"/> </p></td> </tr> </table> 2283649 1711145 2283649 1711145 11350011 11540011 11350011 11540011 13633660 13251156 13633660 13251156 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">17. Related-Party Transactions</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company’s related parties include Moral Compass Corporation (“MCC”) and the John Sperling Foundation (“JSF”). The rights to the intellectual property owned by Blue Horse Labs, Inc. (“BHL”) were assigned to its sole shareholder, the John Sperling Revocable Trust (“JSRT”) due to BHL’s dissolution and then subsequently to the JSF. The JSF is deemed a related party of the Company because MCC, the Company’s largest stockholder, and the JSF share common officers and directors.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">JSF receives a single digit royalty from the Company when revenue has been collected on product sales or for license payments from third parties that involve certain intellectual property developed under research funding originally from BHL. Royalty fees due to JSF were </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">83,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">64,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> as of June 30, 2022 and December 31, 2021, respectively, and are included in the condensed consolidated balance sheets as amounts due to related parties.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">During the six months ended June 30, 2021, the Company leased</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> land on the island of Molokai, Hawaii from an entity owned by Kevin Comcowich, the Chair of the Company’s Board of Directors, and his wife. The Company used to grow hemp on this land to support the operations of its joint venture Archipelago Ventures Hawaii, until the expiration of the lease in February 2022. The original lease was executed in February 2019, covered </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> acres of land, had a term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">two years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and provided for rent payments of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,200</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per acre per year. In March and April 2020, the Company entered into </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> lease amendments for </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">two additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">-acre parcels</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">two additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">15</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">-acre parcels</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, at the same lease rate of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1,200</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> per acre per year, and with a term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">two years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">. The Company made lease payments in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> for each of the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, and made lease payments in the amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">6,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">42,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> during the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three and six months ended June 30, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, respectively.</span></p> 83000 64000 10 P2Y 1200 2 two additional 10-acre parcels 10 two additional 15-acre parcels 15 1200 1200 P2Y P2Y 0 0 6000 42000 <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">18. Subsequent Events</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Saavy Naturals™</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">On July 8, 2022, the Company entered an agreement to license Saavy Naturals™ to Radiance Beauty &amp; Wellness, Inc. Please refer to a discussion of the agreement in Note 6.</span></p> The gross carrying amounts included in this table reflect the effects of the impairments of intangible assets recorded during the year ended December 31, 2021, when the Company estimated an overall decrease in the sales forecast for AW products, due to an inventory item rationalization, in addition to a decrease in the sales forecast of ISI seeds, related to the saturated hemp seed market. As a result, Arcadia performed a quantitative intangible assets impairment test. The Company used a discounted cash flow approach to develop the fair value of the acquired intellectual property, customer lists, brands and trademarks. As a result of this assessment, Arcadia recorded an impairment of intangible assets in the amount of $3.3 million in the condensed consolidated statements of operations and comprehensive loss for the year ended December 31, 2021. The Company recorded an impairment of intangible assets in the amount of $72,000 during the three and six months ended June 30, 2022 related to the Radiance Beauty licensing agreement. EXCEL 78 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 79 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 80 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 81 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 320 327 1 true 106 0 false 10 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 100040 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited) Statements 3 false false R4.htm 100060 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 100070 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 100080 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 100090 - Disclosure - Description of Business and Basis of Presentation Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentation Description of Business and Basis of Presentation Notes 7 false false R8.htm 100100 - Disclosure - Recent Accounting Pronouncements Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRecentAccountingPronouncements Recent Accounting Pronouncements Notes 8 false false R9.htm 100110 - Disclosure - Inventory Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventory Inventory Notes 9 false false R10.htm 100120 - Disclosure - Property and Equipment, Net Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNet Property and Equipment, Net Notes 10 false false R11.htm 100130 - Disclosure - Investments and Fair Value Instruments Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstruments Investments and Fair Value Instruments Notes 11 false false R12.htm 100140 - Disclosure - Arcadia Wellness Acquisition Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisition Arcadia Wellness Acquisition Notes 12 false false R13.htm 100150 - Disclosure - Intangible Assets, Net Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNet Intangible Assets, Net Notes 13 false false R14.htm 100160 - Disclosure - Consolidated Joint Venture Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureConsolidatedJointVenture Consolidated Joint Venture Notes 14 false false R15.htm 100170 - Disclosure - Collaborative Arrangements Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCollaborativeArrangements Collaborative Arrangements Notes 15 false false R16.htm 100180 - Disclosure - Leases Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeases Leases Notes 16 false false R17.htm 100190 - Disclosure - Equity Financing Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancing Equity Financing Notes 17 false false R18.htm 100200 - Disclosure - Warrants Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrants Warrants Notes 18 false false R19.htm 100210 - Disclosure - Stock-Based Compensation and Employee Stock Purchase Program Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgram Stock-Based Compensation and Employee Stock Purchase Program Notes 19 false false R20.htm 100230 - Disclosure - Income Taxes Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxes Income Taxes Notes 20 false false R21.htm 100240 - Disclosure - Commitment and Contingencies Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentAndContingencies Commitment and Contingencies Notes 21 false false R22.htm 100250 - Disclosure - Net Loss per Share Sheet http://arcadiabio.com/20220630/taxonomy/role/DisclosureNetLossPerShare1 Net Loss per Share Notes 22 false false R23.htm 100260 - Disclosure - Related-Party Transactions Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactions Related-Party Transactions Notes 23 false false R24.htm 100270 - Disclosure - Subsequent Events Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureSubsequentEvents Subsequent Events Notes 24 false false R25.htm 100280 - Disclosure - Description of Business and Basis of Presentation (Policies) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies Description of Business and Basis of Presentation (Policies) Policies http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRecentAccountingPronouncements 25 false false R26.htm 100290 - Disclosure - Inventory (Tables) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventoryTables Inventory (Tables) Tables http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventory 26 false false R27.htm 100300 - Disclosure - Property and Equipment, Net (Tables) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetTables Property and Equipment, Net (Tables) Tables http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNet 27 false false R28.htm 100310 - Disclosure - Investments and Fair Value Instruments (Tables) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsTables Investments and Fair Value Instruments (Tables) Tables http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstruments 28 false false R29.htm 100320 - Disclosure - Arcadia Wellness Acquisition (Tables) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionTables Arcadia Wellness Acquisition (Tables) Tables http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisition 29 false false R30.htm 100330 - Disclosure - Intangible Assets, Net (Tables) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetTables Intangible Assets, Net (Tables) Tables http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNet 30 false false R31.htm 100340 - Disclosure - Leases (Tables) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesTables Leases (Tables) Tables http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeases 31 false false R32.htm 100350 - Disclosure - Warrants (Tables) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsTables Warrants (Tables) Tables http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrants 32 false false R33.htm 100360 - Disclosure - Stock-Based Compensation and Employee Stock Purchase Program (Tables) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramTables Stock-Based Compensation and Employee Stock Purchase Program (Tables) Tables http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgram 33 false false R34.htm 100380 - Disclosure - Net Loss per Share (Tables) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureNetLossPerShareTables Net Loss per Share (Tables) Tables http://arcadiabio.com/20220630/taxonomy/role/DisclosureNetLossPerShare1 34 false false R35.htm 100390 - Disclosure - Description of Business and Basis of Presentation - Additional Information (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail Description of Business and Basis of Presentation - Additional Information (Detail) Details 35 false false R36.htm 100400 - Disclosure - Recent Accounting Pronouncements - Additional Information (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRecentAccountingPronouncementsAdditionalInformationDetail Recent Accounting Pronouncements - Additional Information (Detail) Details 36 false false R37.htm 100410 - Disclosure - Inventory - Additional Information (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventoryAdditionalInformationDetail Inventory - Additional Information (Detail) Details 37 false false R38.htm 100420 - Disclosure - Inventory - Summary of Inventories (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventorySummaryOfInventoriesDetail Inventory - Summary of Inventories (Detail) Details 38 false false R39.htm 100430 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment, Net (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetail Property and Equipment, Net - Summary of Property and Equipment, Net (Detail) Details 39 false false R40.htm 100440 - Disclosure - Property and Equipment, Net - Additional Information (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetail Property and Equipment, Net - Additional Information (Detail) Details 40 false false R41.htm 100450 - Disclosure - Investments and Fair Value Instruments - Summary of Amortized Cost and Fair Value of Investment Securities Portfolio (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail Investments and Fair Value Instruments - Summary of Amortized Cost and Fair Value of Investment Securities Portfolio (Detail) Details 41 false false R42.htm 100460 - Disclosure - Investments and Fair Value Instruments - Additional Information (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsAdditionalInformationDetail Investments and Fair Value Instruments - Additional Information (Detail) Details 42 false false R43.htm 100470 - Disclosure - Investments and Fair Value Instruments - Summary of Fair Value of Investments Securities (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail Investments and Fair Value Instruments - Summary of Fair Value of Investments Securities (Detail) Details 43 false false R44.htm 100490 - Disclosure - Investments and Fair Value Instruments - Summary of Changes in Fair Value and Other Adjustments of Liabilities (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail Investments and Fair Value Instruments - Summary of Changes in Fair Value and Other Adjustments of Liabilities (Detail) Details 44 false false R45.htm 100500 - Disclosure - Industrial Seed Innovations Acquisition - Additional Information (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail Industrial Seed Innovations Acquisition - Additional Information (Detail) Details 45 false false R46.htm 100520 - Disclosure - Arcadia Wellness Acquisition - Additional Information (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail Arcadia Wellness Acquisition - Additional Information (Detail) Details 46 false false R47.htm 100530 - Disclosure - Arcadia Wellness Acquisition - Schedule of Allocation Purchase Price of Assets Acquired at Fair Value at Acquisition Date (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail Arcadia Wellness Acquisition - Schedule of Allocation Purchase Price of Assets Acquired at Fair Value at Acquisition Date (Detail) Details 47 false false R48.htm 100540 - Disclosure - Arcadia Wellness Acquisition - Schedule of Unaudited Pro-forma Condensed Consolidated Results of Operations (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionScheduleOfUnauditedProFormaCondensedConsolidatedResultsOfOperationsDetail Arcadia Wellness Acquisition - Schedule of Unaudited Pro-forma Condensed Consolidated Results of Operations (Detail) Details 48 false false R49.htm 100550 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets, Net (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail Intangible Assets, Net - Schedule of Intangible Assets, Net (Detail) Details 49 false false R50.htm 100560 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets, Net (Parenthetical) (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetParentheticalDetail Intangible Assets, Net - Schedule of Intangible Assets, Net (Parenthetical) (Detail) Details 50 false false R51.htm 100570 - Disclosure - Intangible Assets, Net - Additional Information (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetAdditionalInformationDetail Intangible Assets, Net - Additional Information (Detail) Details 51 false false R52.htm 100580 - Disclosure - Intangible Assets, Net - Schedule of Future Amortization of Intellectual Property and Customer Lists (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail Intangible Assets, Net - Schedule of Future Amortization of Intellectual Property and Customer Lists (Detail) Details 52 false false R53.htm 100590 - Disclosure - Consolidated Joint Venture - Additional Information (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureConsolidatedJointVentureAdditionalInformationDetail Consolidated Joint Venture - Additional Information (Detail) Details 53 false false R54.htm 100600 - Disclosure - Collaborative Arrangements - Additional Information (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCollaborativeArrangementsAdditionalInformationDetail Collaborative Arrangements - Additional Information (Detail) Details 54 false false R55.htm 100610 - Disclosure - Leases - Additional Information (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail Leases - Additional Information (Detail) Details 55 false false R56.htm 100620 - Disclosure - Leases - Schedule of Leases (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail Leases - Schedule of Leases (Detail) Details 56 false false R57.htm 100630 - Disclosure - Equity Financing - Additional Information (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail Equity Financing - Additional Information (Detail) Details 57 false false R58.htm 100640 - Disclosure - Warrants - Summary of Warrants Issued to Purchase Common Stock (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail Warrants - Summary of Warrants Issued to Purchase Common Stock (Detail) Details 58 false false R59.htm 100650 - Disclosure - Warrants - Summary of Warrants Issued to Purchase Common Stock (Parenthetical) (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockParentheticalDetail Warrants - Summary of Warrants Issued to Purchase Common Stock (Parenthetical) (Detail) Details 59 false false R60.htm 100660 - Disclosure - Stock-Based Compensation and Employee Stock Purchase Program - Additional Information (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail Stock-Based Compensation and Employee Stock Purchase Program - Additional Information (Detail) Details 60 false false R61.htm 100670 - Disclosure - Stock-Based Compensation and Employee Stock Purchase Program - Summary of Activity Under Stock Incentive Plans (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramSummaryOfActivityUnderStockIncentivePlansDetail Stock-Based Compensation and Employee Stock Purchase Program - Summary of Activity Under Stock Incentive Plans (Detail) Details 61 false false R62.htm 100680 - Disclosure - Stock-Based Compensation and Employee Stock Purchase Program - Weighted-Average Fair Value Assumption of Stock Option Awards (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramWeightedAverageFairValueAssumptionOfStockOptionAwardsDetail Stock-Based Compensation and Employee Stock Purchase Program - Weighted-Average Fair Value Assumption of Stock Option Awards (Detail) Details 62 false false R63.htm 100710 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 63 false false R64.htm 100720 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 64 false false R65.htm 100730 - Disclosure - Net Loss per Share - Summary of Securities Not Included in Diluted Per Share Calculations (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/DisclosureNetLossPerShareSummaryOfSecuritiesNotIncludedInDilutedPerShareCalculationsDetail Net Loss per Share - Summary of Securities Not Included in Diluted Per Share Calculations (Detail) Details 65 false false R66.htm 100740 - Disclosure - Related-Party Transactions - Additional Information (Detail) Sheet http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail Related-Party Transactions - Additional Information (Detail) Details 66 false false All Reports Book All Reports rkda-20220630.htm rkda-20220630.xsd rkda-20220630_cal.xml rkda-20220630_def.xml rkda-20220630_lab.xml rkda-20220630_pre.xml rkda-ex31_1.htm rkda-ex31_2.htm rkda-ex32_1.htm rkda-ex32_2.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 84 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "rkda-20220630.htm": { "axisCustom": 0, "axisStandard": 25, "contextCount": 320, "dts": { "calculationLink": { "local": [ "rkda-20220630_cal.xml" ] }, "definitionLink": { "local": [ "rkda-20220630_def.xml" ] }, "inline": { "local": [ "rkda-20220630.htm" ] }, "labelLink": { "local": [ "rkda-20220630_lab.xml" ] }, "presentationLink": { "local": [ "rkda-20220630_pre.xml" ] }, "schema": { "local": [ "rkda-20220630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 647, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 7, "http://xbrl.sec.gov/dei/2022": 4, "total": 11 }, "keyCustom": 67, "keyStandard": 260, "memberCustom": 63, "memberStandard": 37, "nsprefix": "rkda", "nsuri": "http://arcadiabio.com/20220630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100120 - Disclosure - Property and Equipment, Net", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNet", "shortName": "Property and Equipment, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:InvestmentsAndFairValueOfInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100130 - Disclosure - Investments and Fair Value Instruments", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstruments", "shortName": "Investments and Fair Value Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:InvestmentsAndFairValueOfInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_c30c3297-3f07-49b0-b650-71475f57fcb2", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100140 - Disclosure - Arcadia Wellness Acquisition", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisition", "shortName": "Arcadia Wellness Acquisition", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_c30c3297-3f07-49b0-b650-71475f57fcb2", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100150 - Disclosure - Intangible Assets, Net", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNet", "shortName": "Intangible Assets, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100160 - Disclosure - Consolidated Joint Venture", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureConsolidatedJointVenture", "shortName": "Consolidated Joint Venture", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100170 - Disclosure - Collaborative Arrangements", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCollaborativeArrangements", "shortName": "Collaborative Arrangements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100180 - Disclosure - Leases", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100190 - Disclosure - Equity Financing", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancing", "shortName": "Equity Financing", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:WarrantsAndRightsNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100200 - Disclosure - Warrants", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrants", "shortName": "Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:WarrantsAndRightsNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100210 - Disclosure - Stock-Based Compensation and Employee Stock Purchase Program", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgram", "shortName": "Stock-Based Compensation and Employee Stock Purchase Program", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited", "shortName": "Condensed Consolidated Balance Sheets (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100230 - Disclosure - Income Taxes", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100240 - Disclosure - Commitment and Contingencies", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentAndContingencies", "shortName": "Commitment and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100250 - Disclosure - Net Loss per Share", "role": "http://arcadiabio.com/20220630/taxonomy/role/DisclosureNetLossPerShare1", "shortName": "Net Loss per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100260 - Disclosure - Related-Party Transactions", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactions", "shortName": "Related-Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100270 - Disclosure - Subsequent Events", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureSubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:OrganizationPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100280 - Disclosure - Description of Business and Basis of Presentation (Policies)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies", "shortName": "Description of Business and Basis of Presentation (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:OrganizationPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:ScheduleOfInventoryCurrentAndNonCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100290 - Disclosure - Inventory (Tables)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventoryTables", "shortName": "Inventory (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:ScheduleOfInventoryCurrentAndNonCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:ScheduleOfPropertyPlantAndEquipmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100300 - Disclosure - Property and Equipment, Net (Tables)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetTables", "shortName": "Property and Equipment, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:ScheduleOfPropertyPlantAndEquipmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "rkda:InvestmentsAndFairValueOfInstrumentsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:SummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100310 - Disclosure - Investments and Fair Value Instruments (Tables)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsTables", "shortName": "Investments and Fair Value Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "rkda:InvestmentsAndFairValueOfInstrumentsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:SummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100320 - Disclosure - Arcadia Wellness Acquisition (Tables)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionTables", "shortName": "Arcadia Wellness Acquisition (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100330 - Disclosure - Intangible Assets, Net (Tables)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetTables", "shortName": "Intangible Assets, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:ScheduleOfOperatingLeaseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100340 - Disclosure - Leases (Tables)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:ScheduleOfOperatingLeaseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "rkda:WarrantsAndRightsNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100350 - Disclosure - Warrants (Tables)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsTables", "shortName": "Warrants (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "rkda:WarrantsAndRightsNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100360 - Disclosure - Stock-Based Compensation and Employee Stock Purchase Program (Tables)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramTables", "shortName": "Stock-Based Compensation and Employee Stock Purchase Program (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100380 - Disclosure - Net Loss per Share (Tables)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureNetLossPerShareTables", "shortName": "Net Loss per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "p", "rkda:OrganizationPolicyPolicyTextBlock", "div", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:EntityPlaceOfIncorporation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100390 - Disclosure - Description of Business and Basis of Presentation - Additional Information (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "shortName": "Description of Business and Basis of Presentation - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "rkda:OrganizationPolicyPolicyTextBlock", "div", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:EntityPlaceOfIncorporation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100400 - Disclosure - Recent Accounting Pronouncements - Additional Information (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRecentAccountingPronouncementsAdditionalInformationDetail", "shortName": "Recent Accounting Pronouncements - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_a508268e-bae7-4eec-9e86-57b35a1f9fc6", "decimals": "-5", "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_30d68f9e-aea3-468e-a4ea-39578ccec601", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InventoryWriteDown", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100410 - Disclosure - Inventory - Additional Information (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventoryAdditionalInformationDetail", "shortName": "Inventory - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R38": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "rkda:ScheduleOfInventoryCurrentAndNonCurrentTableTextBlock", "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "first": true, "lang": null, "name": "rkda:InventoryRawMaterialsCurrentAndNonCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100420 - Disclosure - Inventory - Summary of Inventories (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventorySummaryOfInventoriesDetail", "shortName": "Inventory - Summary of Inventories (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "rkda:ScheduleOfInventoryCurrentAndNonCurrentTableTextBlock", "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "first": true, "lang": null, "name": "rkda:InventoryRawMaterialsCurrentAndNonCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "rkda:ScheduleOfPropertyPlantAndEquipmentTableTextBlock", "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100430 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment, Net (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetail", "shortName": "Property and Equipment, Net - Summary of Property and Equipment, Net (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "rkda:ScheduleOfPropertyPlantAndEquipmentTableTextBlock", "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_30d68f9e-aea3-468e-a4ea-39578ccec601", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100060 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)", "role": "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited", "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_30d68f9e-aea3-468e-a4ea-39578ccec601", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100440 - Disclosure - Property and Equipment, Net - Additional Information (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetail", "shortName": "Property and Equipment, Net - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_30d68f9e-aea3-468e-a4ea-39578ccec601", "decimals": "0", "lang": null, "name": "us-gaap:GainLossOnSaleOfPropertyPlantEquipment", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "rkda:SummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesTableTextBlock", "div", "rkda:InvestmentsAndFairValueOfInstrumentsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "first": true, "lang": null, "name": "rkda:DebtAndEquitySecuritiesAmortizedCostBasis", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100450 - Disclosure - Investments and Fair Value Instruments - Summary of Amortized Cost and Fair Value of Investment Securities Portfolio (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail", "shortName": "Investments and Fair Value Instruments - Summary of Amortized Cost and Fair Value of Investment Securities Portfolio (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "rkda:SummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesTableTextBlock", "div", "rkda:InvestmentsAndFairValueOfInstrumentsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "first": true, "lang": null, "name": "rkda:DebtAndEquitySecuritiesAmortizedCostBasis", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "p", "rkda:InvestmentsAndFairValueOfInstrumentsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100460 - Disclosure - Investments and Fair Value Instruments - Additional Information (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsAdditionalInformationDetail", "shortName": "Investments and Fair Value Instruments - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "rkda:InvestmentsAndFairValueOfInstrumentsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_30d68f9e-aea3-468e-a4ea-39578ccec601", "decimals": "0", "lang": null, "name": "us-gaap:AssetImpairmentCharges", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "div", "rkda:InvestmentsAndFairValueOfInstrumentsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100470 - Disclosure - Investments and Fair Value Instruments - Summary of Fair Value of Investments Securities (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail", "shortName": "Investments and Fair Value Instruments - Summary of Fair Value of Investments Securities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "div", "rkda:InvestmentsAndFairValueOfInstrumentsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "div", "rkda:InvestmentsAndFairValueOfInstrumentsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_8ba9a8db-3747-4c45-bb30-274eb476ef7a", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100490 - Disclosure - Investments and Fair Value Instruments - Summary of Changes in Fair Value and Other Adjustments of Liabilities (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail", "shortName": "Investments and Fair Value Instruments - Summary of Changes in Fair Value and Other Adjustments of Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "div", "rkda:InvestmentsAndFairValueOfInstrumentsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_8ba9a8db-3747-4c45-bb30-274eb476ef7a", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_30d68f9e-aea3-468e-a4ea-39578ccec601", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100500 - Disclosure - Industrial Seed Innovations Acquisition - Additional Information (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "shortName": "Industrial Seed Innovations Acquisition - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R46": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseOptionToExtend", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100520 - Disclosure - Arcadia Wellness Acquisition - Additional Information (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "shortName": "Arcadia Wellness Acquisition - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_f03e78ca-454c-4e4a-a27f-f16e02e2d241", "decimals": "INF", "lang": null, "name": "rkda:EffectiveRateOfRoyaltyOfGrossSales", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "div", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_284fd92f-54d0-4a99-949e-790e016688d0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100530 - Disclosure - Arcadia Wellness Acquisition - Schedule of Allocation Purchase Price of Assets Acquired at Fair Value at Acquisition Date (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail", "shortName": "Arcadia Wellness Acquisition - Schedule of Allocation Purchase Price of Assets Acquired at Fair Value at Acquisition Date (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "div", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_284fd92f-54d0-4a99-949e-790e016688d0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_30d68f9e-aea3-468e-a4ea-39578ccec601", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100540 - Disclosure - Arcadia Wellness Acquisition - Schedule of Unaudited Pro-forma Condensed Consolidated Results of Operations (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionScheduleOfUnauditedProFormaCondensedConsolidatedResultsOfOperationsDetail", "shortName": "Arcadia Wellness Acquisition - Schedule of Unaudited Pro-forma Condensed Consolidated Results of Operations (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "div", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_5283b435-68ee-4a7f-906d-83d240a8239d", "decimals": "-3", "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "rkda:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock", "div", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100550 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets, Net (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail", "shortName": "Intangible Assets, Net - Schedule of Intangible Assets, Net (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "rkda:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock", "div", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_2ce78144-bae1-4410-8b43-5da9be0f0165", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100070 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited", "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_b1eb440d-8fa9-453e-9f86-58e2ff978489", "decimals": "-3", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_30d68f9e-aea3-468e-a4ea-39578ccec601", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ImpairmentOfIntangibleAssetsFinitelived", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100560 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets, Net (Parenthetical) (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetParentheticalDetail", "shortName": "Intangible Assets, Net - Schedule of Intangible Assets, Net (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R51": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_4714d1cb-41e9-4979-ac46-9aae83605297", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100570 - Disclosure - Intangible Assets, Net - Additional Information (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetAdditionalInformationDetail", "shortName": "Intangible Assets, Net - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_4714d1cb-41e9-4979-ac46-9aae83605297", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100580 - Disclosure - Intangible Assets, Net - Schedule of Future Amortization of Intellectual Property and Customer Lists (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail", "shortName": "Intangible Assets, Net - Schedule of Future Amortization of Intellectual Property and Customer Lists (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "p", "rkda:BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock", "div", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_30d68f9e-aea3-468e-a4ea-39578ccec601", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100590 - Disclosure - Consolidated Joint Venture - Additional Information (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureConsolidatedJointVentureAdditionalInformationDetail", "shortName": "Consolidated Joint Venture - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_b59ba30f-4a9a-497e-9a2d-b991652f11f0", "decimals": "INF", "lang": null, "name": "rkda:NumberOfIndividualsAppointed", "reportCount": 1, "unique": true, "unitRef": "U_Individual", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:CollaborativeArrangementDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_f4dc4d3c-b34e-41e1-bbef-821622bf5685", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:ContractualAgreementMonthAndYear", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100600 - Disclosure - Collaborative Arrangements - Additional Information (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCollaborativeArrangementsAdditionalInformationDetail", "shortName": "Collaborative Arrangements - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:CollaborativeArrangementDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_f4dc4d3c-b34e-41e1-bbef-821622bf5685", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:ContractualAgreementMonthAndYear", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_670cd883-f914-48c5-9a8d-a35bd450dd9f", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:OperatingLeaseTermExpirationMonthAndYear", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100610 - Disclosure - Leases - Additional Information (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail", "shortName": "Leases - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_670cd883-f914-48c5-9a8d-a35bd450dd9f", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:OperatingLeaseTermExpirationMonthAndYear", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100620 - Disclosure - Leases - Schedule of Leases (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail", "shortName": "Leases - Schedule of Leases (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_86b5f1b3-51c1-481e-89f3-6eca967e5e14", "decimals": "-3", "lang": null, "name": "rkda:OperatingLeaseAssets", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NoninterestExpenseOfferingCost", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100630 - Disclosure - Equity Financing - Additional Information (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "shortName": "Equity Financing - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "lang": "en-US", "name": "us-gaap:RegistrationPaymentArrangementTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "div", "rkda:WarrantsAndRightsNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100640 - Disclosure - Warrants - Summary of Warrants Issued to Purchase Common Stock (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail", "shortName": "Warrants - Summary of Warrants Issued to Purchase Common Stock (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "div", "rkda:WarrantsAndRightsNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "p", "rkda:WarrantsAndRightsNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_3c056d8c-f411-4980-b403-4caafffe4b0e", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:WarrantExpirationMonthAndYear", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100650 - Disclosure - Warrants - Summary of Warrants Issued to Purchase Common Stock (Parenthetical) (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockParentheticalDetail", "shortName": "Warrants - Summary of Warrants Issued to Purchase Common Stock (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "p", "rkda:WarrantsAndRightsNoteDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_3c056d8c-f411-4980-b403-4caafffe4b0e", "decimals": null, "first": true, "lang": "en-US", "name": "rkda:WarrantExpirationMonthAndYear", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_30d68f9e-aea3-468e-a4ea-39578ccec601", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100080 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": "-3", "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": "INF", "first": true, "lang": null, "name": "rkda:NumberOfEquityIncentivePlans", "reportCount": 1, "unique": true, "unitRef": "U_IncentivePlan", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100660 - Disclosure - Stock-Based Compensation and Employee Stock Purchase Program - Additional Information (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail", "shortName": "Stock-Based Compensation and Employee Stock Purchase Program - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": "INF", "first": true, "lang": null, "name": "rkda:NumberOfEquityIncentivePlans", "reportCount": 1, "unique": true, "unitRef": "U_IncentivePlan", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_86b5f1b3-51c1-481e-89f3-6eca967e5e14", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100670 - Disclosure - Stock-Based Compensation and Employee Stock Purchase Program - Summary of Activity Under Stock Incentive Plans (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramSummaryOfActivityUnderStockIncentivePlansDetail", "shortName": "Stock-Based Compensation and Employee Stock Purchase Program - Summary of Activity Under Stock Incentive Plans (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_70861671-93b7-4512-833d-177a02b5c868", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100680 - Disclosure - Stock-Based Compensation and Employee Stock Purchase Program - Weighted-Average Fair Value Assumption of Stock Option Awards (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramWeightedAverageFairValueAssumptionOfStockOptionAwardsDetail", "shortName": "Stock-Based Compensation and Employee Stock Purchase Program - Weighted-Average Fair Value Assumption of Stock Option Awards (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_70861671-93b7-4512-833d-177a02b5c868", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100710 - Disclosure - Income Taxes - Additional Information (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "shortName": "Income Taxes - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherLiabilitiesNoncurrent", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100720 - Disclosure - Commitments and Contingencies - Additional Information (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "shortName": "Commitments and Contingencies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_44ac7807-6acb-461d-8bd3-826cac1ac570", "decimals": "-5", "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_30d68f9e-aea3-468e-a4ea-39578ccec601", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100730 - Disclosure - Net Loss per Share - Summary of Securities Not Included in Diluted Per Share Calculations (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/DisclosureNetLossPerShareSummaryOfSecuritiesNotIncludedInDilutedPerShareCalculationsDetail", "shortName": "Net Loss per Share - Summary of Securities Not Included in Diluted Per Share Calculations (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_30d68f9e-aea3-468e-a4ea-39578ccec601", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_1b85bafc-cab4-40a0-bbef-f18de823e565", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DueToRelatedPartiesCurrent", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100740 - Disclosure - Related-Party Transactions - Additional Information (Detail)", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail", "shortName": "Related-Party Transactions - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_2ac380b0-c26a-4d98-90da-4607318e5c1b", "decimals": "INF", "lang": null, "name": "rkda:NumberOfLeaseAmendments", "reportCount": 1, "unique": true, "unitRef": "U_Lease", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100090 - Disclosure - Description of Business and Basis of Presentation", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentation", "shortName": "Description of Business and Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100100 - Disclosure - Recent Accounting Pronouncements", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRecentAccountingPronouncements", "shortName": "Recent Accounting Pronouncements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100110 - Disclosure - Inventory", "role": "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventory", "shortName": "Inventory", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rkda-20220630.htm", "contextRef": "C_27c230a2-5a13-457a-9680-e3822d5bcdf4", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 106, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r720" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r721" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "verboseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r718" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "verboseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r718" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r718" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r729" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r718" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r718" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r718" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r718" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r717" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r719" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "rkda_AccountsReceivableWrittenDown": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accounts receivable written-down.", "label": "Accounts Receivable Written-down", "terseLabel": "Accounts receivable written-down" } } }, "localname": "AccountsReceivableWrittenDown", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "rkda_AchievementOfRevenueMilestoneIn2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Achievement of Revenue Milestone in 2021.", "label": "Achievement Of Revenue Milestone In2021 [Member]", "terseLabel": "Revenue Milestone in 2021 [Member]" } } }, "localname": "AchievementOfRevenueMilestoneIn2021Member", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_AchievementOfRevenueMilestoneIn2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Achievement of Revenue Milestone in 2022.", "label": "Achievement Of Revenue Milestone In2022 [Member]", "terseLabel": "Revenue Milestone in 2022 [Member]" } } }, "localname": "AchievementOfRevenueMilestoneIn2022Member", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_AdditionalCashReceivableFromSaleOfInterestInJointVenture": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Additional cash receivable from sale of interest in joint venture.", "label": "Additional Cash Receivable From Sale Of Interest In Joint Venture", "terseLabel": "Additional cash receivable from sale of interest in joint venture" } } }, "localname": "AdditionalCashReceivableFromSaleOfInterestInJointVenture", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "rkda_AdditionalPropertiesUnderLeaseAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional properties under lease agreement.", "label": "Additional Properties Under Lease Agreement", "terseLabel": "Number of additional properties under lease agreement" } } }, "localname": "AdditionalPropertiesUnderLeaseAgreement", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "rkda_AmendmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amendment.", "label": "Amendment [Member]", "terseLabel": "Amendment [Member]" } } }, "localname": "AmendmentMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_AnawahIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Anawah Inc.", "label": "Anawah Inc [Member]", "terseLabel": "Anawah, Inc [Member]" } } }, "localname": "AnawahIncMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_April2019ServiceAndPerformanceWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "April 2019 service and performance warrants.", "label": "April2019 Service And Performance Warrants [Member]", "terseLabel": "April 2019 Service and Performance Warrants [Member]" } } }, "localname": "April2019ServiceAndPerformanceWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_ArcadiaBiosciencesIncorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arcadia Biosciences incorporation.", "label": "Arcadia Biosciences Incorporation [Member]", "terseLabel": "Arcadia Biosciences, Inc [Member]" } } }, "localname": "ArcadiaBiosciencesIncorporationMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureConsolidatedJointVentureAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_ArcadiaWellnessAcquisitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arcadia Wellness Acquisition.", "label": "Arcadia Wellness Acquisition [Member]" } } }, "localname": "ArcadiaWellnessAcquisitionMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisition" ], "xbrltype": "domainItemType" }, "rkda_ArcadiaWellnessLimitedLiabilityCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arcadia Wellness limited liability company.", "label": "Arcadia Wellness Limited Liability Company [Member]", "terseLabel": "Arcadia Wellness [Member]" } } }, "localname": "ArcadiaWellnessLimitedLiabilityCompanyMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionScheduleOfUnauditedProFormaCondensedConsolidatedResultsOfOperationsDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "rkda_ArcadiaWellnessTransactionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arcadia wellness transaction.", "label": "Arcadia Wellness Transaction [Member]" } } }, "localname": "ArcadiaWellnessTransactionMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "domainItemType" }, "rkda_ArchipelagoVenturesHawaiiLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Archipelago Ventures Hawaii, LLC.", "label": "Archipelago Ventures Hawaii L L C [Member]", "terseLabel": "Archipelago Ventures Hawaii, LLC [Member]" } } }, "localname": "ArchipelagoVenturesHawaiiLLCMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureConsolidatedJointVentureAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_August2019ServiceAndPerformanceWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "August 2019 service and performance warrants.", "label": "August2019 Service And Performance Warrants [Member]", "terseLabel": "August 2019 Service and Performance Warrants [Member]" } } }, "localname": "August2019ServiceAndPerformanceWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basis of presentation and principles of consolidation.", "label": "Basis Of Presentation And Principles Of Consolidation Policy Policy [Text Block]", "terseLabel": "Basis of Presentation and Principles of Consolidation" } } }, "localname": "BasisOfPresentationAndPrinciplesOfConsolidationPolicyPolicyTextBlock", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "rkda_BioceresCropSolutionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bioceres Crop Solutions.", "label": "Bioceres Crop Solutions [Member]", "terseLabel": "Bioceres Crop Solutions [Member]" } } }, "localname": "BioceresCropSolutionsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_BusinessAcquisitionNetIncomeLossAttributableToCommonStockholders": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business acquisition net income loss attributable to common stockholders.", "label": "Business Acquisition Net Income Loss Attributable To Common Stockholders", "terseLabel": "Net (loss) income attributable to common stockholders", "verboseLabel": "Net loss attributable to common stockholders" } } }, "localname": "BusinessAcquisitionNetIncomeLossAttributableToCommonStockholders", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionScheduleOfUnauditedProFormaCondensedConsolidatedResultsOfOperationsDetail" ], "xbrltype": "monetaryItemType" }, "rkda_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business acquisition pro forma earnings per share basic and diluted.", "label": "Business Acquisition Pro Forma Earnings Per Share Basic And Diluted", "terseLabel": "Basic and diluted" } } }, "localname": "BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionScheduleOfUnauditedProFormaCondensedConsolidatedResultsOfOperationsDetail" ], "xbrltype": "perShareItemType" }, "rkda_BusinessCombinationConsiderationTransferredRemainingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination consideration transferred remaining amount.", "label": "Business Combination Consideration Transferred Remaining Amount", "terseLabel": "Remaining amount paid in multiple installments" } } }, "localname": "BusinessCombinationConsiderationTransferredRemainingAmount", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "rkda_BusinessCombinationEquityInterestIssuableUponAchievementOfRevenueMilestoneShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business combination, equity interest issuable upon achievement of revenue milestone share.", "label": "Business Combination Equity Interest Issuable Upon Achievement Of Revenue Milestone Share", "terseLabel": "Business combination, equity interest issuable upon achievement of revenue milestone" } } }, "localname": "BusinessCombinationEquityInterestIssuableUponAchievementOfRevenueMilestoneShare", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "rkda_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerList": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed customer list.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Customer List", "terseLabel": "Customer list" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerList", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail" ], "xbrltype": "monetaryItemType" }, "rkda_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeposits": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed deposits.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deposits", "terseLabel": "Deposits" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeposits", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail" ], "xbrltype": "monetaryItemType" }, "rkda_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFormulations": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed formulations.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Formulations", "terseLabel": "Formulations" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFormulations", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail" ], "xbrltype": "monetaryItemType" }, "rkda_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeNamesAndTrademarks": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed trade names and trademarks.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Trade Names And Trademarks", "terseLabel": "Trade names and trademarks" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradeNamesAndTrademarks", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail" ], "xbrltype": "monetaryItemType" }, "rkda_BusinessCombinationRemainingContingentLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, remaining contingent liability.", "label": "Business Combination, remaining Contingent Liability", "terseLabel": "Remaining contingent liability" } } }, "localname": "BusinessCombinationRemainingContingentLiability", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "rkda_BusinessCombinationRemainingContingentLiabilityWrittenDown": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination remaining contingent liability written-down.", "label": "Business Combination Remaining Contingent Liability Written-down", "terseLabel": "Business combination remaining contingent liability written-down" } } }, "localname": "BusinessCombinationRemainingContingentLiabilityWrittenDown", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "rkda_CashSharesAndRoyaltyReceivableFromSaleOfInterestInJointVenture": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "cash shares and royalty receivable from sale of interest in joint venture", "label": "cash shares and royalty receivable from sale of interest in joint venture", "terseLabel": "Cash shares and royalty receivable" } } }, "localname": "CashSharesAndRoyaltyReceivableFromSaleOfInterestInJointVenture", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "rkda_ChesterfieldAndChatsworthMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chesterfield and Chatsworth.", "label": "Chesterfield And Chatsworth [Member]", "terseLabel": "Chesterfield, MO And Chatsworth, CA [Member]" } } }, "localname": "ChesterfieldAndChatsworthMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_ClassOfWarrantOrRightExercisableTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right exercisable term.", "label": "Class Of Warrant Or Right Exercisable Term", "terseLabel": "Warrant, exercisable term" } } }, "localname": "ClassOfWarrantOrRightExercisableTerm", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "rkda_ClassOfWarrantsOrRightsIssuanceMonthAndYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants or rights issuance month and year.", "label": "Class Of Warrants Or Rights Issuance Month And Year", "terseLabel": "Issuance Date" } } }, "localname": "ClassOfWarrantsOrRightsIssuanceMonthAndYear", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "gYearMonthItemType" }, "rkda_CollaborativeArrangementsCopromotionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangements, copromotion.", "label": "Collaborative Arrangements Copromotion [Member]", "terseLabel": "Collaborative Arrangements [Member]" } } }, "localname": "CollaborativeArrangementsCopromotionMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCollaborativeArrangementsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_CommitmentsAndContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitments and contingencies line items.", "label": "Commitments And Contingencies [Line Items]", "terseLabel": "Commitments And Contingencies [Line Items]" } } }, "localname": "CommitmentsAndContingenciesLineItems", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "rkda_CommitmentsAndContingenciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitments and contingencies table.", "label": "Commitments And Contingencies [Table]", "terseLabel": "Commitments And Contingencies [Table]" } } }, "localname": "CommitmentsAndContingenciesTable", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "rkda_CommonStockWarrantLiabilities": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common stock warrant liabilities.", "label": "Common Stock Warrant Liabilities", "terseLabel": "Common stock warrant liabilities" } } }, "localname": "CommonStockWarrantLiabilities", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRecentAccountingPronouncementsAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "rkda_CommonStockWarrantLiabilitiesReclassifiedToEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common stock warrant liabilities reclassified to equity.", "label": "Common stock warrant liabilities reclassified to equity" } } }, "localname": "CommonStockWarrantLiabilitiesReclassifiedToEquity", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "rkda_CommonStockWarrantLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock warrant liability.", "label": "Common Stock Warrant Liability [Member]", "terseLabel": "Common Stock Warrant Liability [Member]" } } }, "localname": "CommonStockWarrantLiabilityMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail" ], "xbrltype": "domainItemType" }, "rkda_ContingentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contingent liabilities.", "label": "Contingent Liabilities [Member]", "terseLabel": "Contingent Liabilities [Member]" } } }, "localname": "ContingentLiabilitiesMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "rkda_ContractualAgreementMonthAndYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual agreement month and year.", "label": "Contractual Agreement Month And Year", "terseLabel": "Contractual agreement month and year" } } }, "localname": "ContractualAgreementMonthAndYear", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCollaborativeArrangementsAdditionalInformationDetail" ], "xbrltype": "gYearMonthItemType" }, "rkda_DebtAndEquitySecurities": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail": { "order": 1.0, "parentTag": "rkda_DebtAndEquitySecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt and equity securities.", "label": "Debt And Equity Securities", "terseLabel": "Estimated Fair Value" } } }, "localname": "DebtAndEquitySecurities", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail" ], "xbrltype": "monetaryItemType" }, "rkda_DebtAndEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail": { "order": 0.0, "parentTag": "rkda_DebtAndEquitySecuritiesAmortizedCostBasis", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt and equity securities accumulated gross unrealized gain before tax.", "label": "Debt And Equity Securities Accumulated Gross Unrealized Gain Before Tax", "terseLabel": "Unrealized Gains" } } }, "localname": "DebtAndEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail" ], "xbrltype": "monetaryItemType" }, "rkda_DebtAndEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt and equity securities accumulated gross unrealized loss before tax.", "label": "Debt And Equity Securities Accumulated Gross Unrealized Loss Before Tax", "negatedLabel": "Unrealized Losses" } } }, "localname": "DebtAndEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail" ], "xbrltype": "monetaryItemType" }, "rkda_DebtAndEquitySecuritiesAmortizedCostBasis": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt and equity securities amortized cost basis.", "label": "Debt And Equity Securities Amortized Cost Basis", "totalLabel": "Amortized Cost" } } }, "localname": "DebtAndEquitySecuritiesAmortizedCostBasis", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail" ], "xbrltype": "monetaryItemType" }, "rkda_DebtAndEquitySecuritiesCurrent": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail": { "order": 1.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt and equity securities current.", "label": "Debt And Equity Securities Current", "terseLabel": "Short-term investments" } } }, "localname": "DebtAndEquitySecuritiesCurrent", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail" ], "xbrltype": "monetaryItemType" }, "rkda_DebtInstrumentMaturityYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument maturity year.", "label": "Debt Instrument Maturity Year", "terseLabel": "Debt instrument maturity year" } } }, "localname": "DebtInstrumentMaturityYear", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "gYearListItemType" }, "rkda_DecemberTwoThousandAndTwentyPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "December two thousand and twenty purchase agreement.", "label": "December Two Thousand And Twenty Purchase Agreement [Member]", "terseLabel": "December 2020 Purchase Agreement [Member]" } } }, "localname": "DecemberTwoThousandAndTwentyPurchaseAgreementMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_DecemberTwoThousandTwentyPlacementAgentWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "December 2020 placement agent warrants.", "label": "December Two Thousand Twenty Placement Agent Warrants [Member]", "terseLabel": "December 2020 Placement Agent Warrants [Member]" } } }, "localname": "DecemberTwoThousandTwentyPlacementAgentWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_DecemberTwoThousandTwentyWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "December 2020 warrants.", "label": "December Two Thousand Twenty Warrants [Member]", "terseLabel": "December 2020 Warrants [Member]" } } }, "localname": "DecemberTwoThousandTwentyWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_DecreaseInCommonStockWarrantLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Decrease in common stock warrant liabilities.", "label": "Decrease in Common Stock Warrant Liabilities", "terseLabel": "Decrease in common stock warrant liabilities" } } }, "localname": "DecreaseInCommonStockWarrantLiabilities", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRecentAccountingPronouncementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "rkda_DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndWarrantsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of compensation related costs share based payments and warrants.", "label": "Disclosure Of Compensation Related Costs Share Based Payments And Warrants [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndWarrantsAbstract", "nsuri": "http://arcadiabio.com/20220630", "xbrltype": "stringItemType" }, "rkda_EffectiveRateOfRoyaltyOfGrossSales": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effective rate of royalty of gross sales", "label": "Effective rate of royalty of gross sales" } } }, "localname": "EffectiveRateOfRoyaltyOfGrossSales", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "rkda_EmployeeStockPurchasePlanOfferingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee stock purchase plan offering period.", "label": "Employee Stock Purchase Plan Offering Period", "terseLabel": "Purchase plan offering period" } } }, "localname": "EmployeeStockPurchasePlanOfferingPeriod", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "rkda_EntityIncorporationYearOfIncorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Entity incorporation year of incorporation.", "label": "Entity Incorporation Year Of Incorporation", "terseLabel": "Year of incorporation" } } }, "localname": "EntityIncorporationYearOfIncorporation", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "gYearItemType" }, "rkda_EntityPlaceOfIncorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Entity place of incorporation.", "label": "Entity Place Of Incorporation", "terseLabel": "Place of incorporation" } } }, "localname": "EntityPlaceOfIncorporation", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "rkda_EntityReincorporationDateOfReincorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Entity reincorporation date of reincorporation.", "label": "Entity Reincorporation Date Of Reincorporation", "terseLabel": "Date of reincorporation" } } }, "localname": "EntityReincorporationDateOfReincorporation", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "gYearMonthItemType" }, "rkda_EntityReincorporationStateCountryName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "State or Country Name where an entity is re-incorporated.", "label": "Entity Reincorporation State Country Name", "terseLabel": "Place of reincorporation" } } }, "localname": "EntityReincorporationStateCountryName", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "rkda_FairValueMeasurementInitialRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair Value Measurement Initial Recognition.", "label": "Fair Value Measurement Initial Recognition", "terseLabel": "Initial recognition" } } }, "localname": "FairValueMeasurementInitialRecognition", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "rkda_February122020ServiceAndPerformanceWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February 12, 2020 service and performance warrants.", "label": "February122020 Service And Performance Warrants [Member]", "terseLabel": "February 12, 2020 Service and Performance Warrants [Member]" } } }, "localname": "February122020ServiceAndPerformanceWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockParentheticalDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_February32020ServiceAndPerformanceWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February 3, 2020 service and performance warrants.", "label": "February32020 Service And Performance Warrants [Member]", "terseLabel": "February 3, 2020 Service and Performance Warrants [Member]" } } }, "localname": "February32020ServiceAndPerformanceWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockParentheticalDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_FiniteAndIndefiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Finite and indefinite lived intangible assets.", "label": "Finite And Indefinite Lived Intangible Assets [Line Items]", "terseLabel": "Finite And Indefinite Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteAndIndefiniteLivedIntangibleAssetsLineItems", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail" ], "xbrltype": "stringItemType" }, "rkda_FiniteAndIndefiniteLivedIntangibleAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Finite and indefinite lived intangible assets.", "label": "Finite And Indefinite Lived Intangible Assets [Table]", "terseLabel": "Finite And Indefinite Lived Intangible Assets [Table]" } } }, "localname": "FiniteAndIndefiniteLivedIntangibleAssetsTable", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail" ], "xbrltype": "stringItemType" }, "rkda_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finite lived intangible assets amortization expense after year four.", "label": "Finite Lived Intangible Assets Amortization Expense After Year Four", "terseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail" ], "xbrltype": "monetaryItemType" }, "rkda_FirstOfferingPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First offering period end date.", "label": "First Offering Period End Date", "terseLabel": "First offering period, end date" } } }, "localname": "FirstOfferingPeriodEndDate", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "rkda_FirstOfferingPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First offering period start date.", "label": "First Offering Period Start Date", "terseLabel": "First offering period, start date" } } }, "localname": "FirstOfferingPeriodStartDate", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "rkda_FormulationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Formulations.", "label": "Formulations [Member]", "terseLabel": "Formulations [Member]" } } }, "localname": "FormulationsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_IncreaseDecreaseInOperatingLeasePayments": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 36.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase Decrease in Operating Lease Payments.", "label": "Increase Decrease In Operating Lease Payments", "terseLabel": "Operating lease payments" } } }, "localname": "IncreaseDecreaseInOperatingLeasePayments", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "rkda_IndefiniteLivedIntangibleAssetsAccumulatedAmortizationAndImpairment": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail": { "order": 1.0, "parentTag": "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Indefinite lived intangible assets accumulated amortization and impairment.", "label": "Indefinite Lived Intangible Assets Accumulated Amortization And Impairment", "terseLabel": "Indefinite-lived intangible assets, Accumulated Amortization and Impairment" } } }, "localname": "IndefiniteLivedIntangibleAssetsAccumulatedAmortizationAndImpairment", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail" ], "xbrltype": "monetaryItemType" }, "rkda_IndefiniteLivedIntangibleAssetsExcludingGoodwillGross": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail": { "order": 0.0, "parentTag": "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Indefinite lived intangible assets excluding goodwill gross.", "label": "Indefinite Lived Intangible Assets Excluding Goodwill Gross", "terseLabel": "Indefinite-lived intangible assets, Gross Carrying Amount" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillGross", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail" ], "xbrltype": "monetaryItemType" }, "rkda_InducementStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inducement stock option.", "label": "Inducement Stock Option [Member]", "terseLabel": "Inducement Stock Option [Member]" } } }, "localname": "InducementStockOptionMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_IndustrialSeedInnovationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Industrial seed innovations.", "label": "Industrial Seed Innovations [Member]", "terseLabel": "Industrial Seed Innovations [Member]" } } }, "localname": "IndustrialSeedInnovationsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionScheduleOfPreliminaryAllocationOfPurchasePriceOfISIAssetsAcquiredBasedOnFairValuesDetail" ], "xbrltype": "domainItemType" }, "rkda_IntellectualPropertyAndCustomerListsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intellectual property and customer lists.", "label": "Intellectual Property And Customer Lists [Member]", "terseLabel": "Intellectual Property and Customer Lists [Member]" } } }, "localname": "IntellectualPropertyAndCustomerListsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail" ], "xbrltype": "domainItemType" }, "rkda_InventoryCurrentAndNonCurrentNet": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventorySummaryOfInventoriesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventory current and non current net.", "label": "Inventory Current And Non Current Net", "totalLabel": "Inventories" } } }, "localname": "InventoryCurrentAndNonCurrentNet", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventorySummaryOfInventoriesDetail" ], "xbrltype": "monetaryItemType" }, "rkda_InventoryFinishedGoodsCurrentAndNonCurrent": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventorySummaryOfInventoriesDetail": { "order": 2.0, "parentTag": "rkda_InventoryCurrentAndNonCurrentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventory finished goods current and non-current.", "label": "Inventory Finished Goods Current And Non Current", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsCurrentAndNonCurrent", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventorySummaryOfInventoriesDetail" ], "xbrltype": "monetaryItemType" }, "rkda_InventoryGoodsInProcessCurrentAndNonCurrent": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventorySummaryOfInventoriesDetail": { "order": 1.0, "parentTag": "rkda_InventoryCurrentAndNonCurrentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventory goods ion process current and non current.", "label": "Inventory Goods In Process Current And Non Current", "terseLabel": "Goods in process" } } }, "localname": "InventoryGoodsInProcessCurrentAndNonCurrent", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventorySummaryOfInventoriesDetail" ], "xbrltype": "monetaryItemType" }, "rkda_InventoryRawMaterialsCurrentAndNonCurrent": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventorySummaryOfInventoriesDetail": { "order": 0.0, "parentTag": "rkda_InventoryCurrentAndNonCurrentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventory raw materials current and non-current.", "label": "Inventory Raw Materials Current And Non Current", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsCurrentAndNonCurrent", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventorySummaryOfInventoriesDetail" ], "xbrltype": "monetaryItemType" }, "rkda_InvestmentsAndFairValueInstrumentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments and fair value instruments.", "label": "Investments And Fair Value Instruments [Abstract]" } } }, "localname": "InvestmentsAndFairValueInstrumentsAbstract", "nsuri": "http://arcadiabio.com/20220630", "xbrltype": "stringItemType" }, "rkda_InvestmentsAndFairValueOfInstrumentsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments and fair value of instruments disclosure.", "label": "Investments And Fair Value Of Instruments Disclosure [Text Block]", "terseLabel": "Investments and Fair Value Instruments" } } }, "localname": "InvestmentsAndFairValueOfInstrumentsDisclosureTextBlock", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstruments" ], "xbrltype": "textBlockItemType" }, "rkda_JanuaryTwoThousandAndTwentyOneOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "January two thousand and twenty one offering.", "label": "January Two Thousand And Twenty One Offering [Member]", "terseLabel": "January 2021 Offering [Member]" } } }, "localname": "JanuaryTwoThousandAndTwentyOneOfferingMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail" ], "xbrltype": "domainItemType" }, "rkda_JanuaryTwoThousandAndTwentyOnePIPEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "January two thousand and twenty one PIPE.", "label": "January Two Thousand And Twenty One P I P E [Member]", "terseLabel": "January 2021 PIPE [Member]" } } }, "localname": "JanuaryTwoThousandAndTwentyOnePIPEMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "rkda_JanuaryTwoThousandAndTwentyOnePIPESecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "January two thousand and twenty one PIPE securities purchase agreement.", "label": "January Two Thousand And Twenty One P I P E Securities Purchase Agreement [Member]", "terseLabel": "January 2021 PIPE Purchase Agreement [Member]" } } }, "localname": "JanuaryTwoThousandAndTwentyOnePIPESecuritiesPurchaseAgreementMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "domainItemType" }, "rkda_JanuaryTwoThousandTwentyOnePlacementAgentWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "January two thousand twenty one placement agent warrants.", "label": "January Two Thousand Twenty One Placement Agent Warrants [Member]", "terseLabel": "January 2021 Placement Agent Warrants [Member]" } } }, "localname": "JanuaryTwoThousandTwentyOnePlacementAgentWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_JanuaryTwoThousandTwentyOnePrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "January two thousand twenty one private placement.", "label": "January Two Thousand Twenty One Private Placement [Member]", "terseLabel": "January 2021 Private Placement [Member]" } } }, "localname": "JanuaryTwoThousandTwentyOnePrivatePlacementMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "January two thousand twenty one securities purchase purchase agreement.", "label": "January Two Thousand Twenty One Securities Purchase Purchase Agreement [Member]", "terseLabel": "January 2021 Purchase Agreement [Member]" } } }, "localname": "JanuaryTwoThousandTwentyOneSecuritiesPurchasePurchaseAgreementMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_JanuaryTwoThousandTwentyOneServiceAndPerformanceWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "January two thousand twenty one service and performance warrants.", "label": "January Two Thousand Twenty One Service And Performance Warrants [Member]", "terseLabel": "January 2021 Service and Performance Warrants [Member]" } } }, "localname": "JanuaryTwoThousandTwentyOneServiceAndPerformanceWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_JanuaryTwoThousandTwentyOneWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "January two thousand twenty one warrants.", "label": "January Two Thousand Twenty One Warrants [Member]", "terseLabel": "January 2021 Warrants [Member]" } } }, "localname": "JanuaryTwoThousandTwentyOneWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_JohnSperlingFoundationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "John sperling foundation.", "label": "John Sperling Foundation [Member]", "terseLabel": "John Sperling Foundation [Member]" } } }, "localname": "JohnSperlingFoundationMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_July2019ServiceAndPerformanceWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "July 2019 service and performance warrants.", "label": "July2019 Service And Performance Warrants [Member]", "terseLabel": "July 2019 Service and Performance Warrants [Member]" } } }, "localname": "July2019ServiceAndPerformanceWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_July2020PlacementAgentWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "July 2020 placement agent warrants.", "label": "July2020 Placement Agent Warrants [Member]", "terseLabel": "July 2020 Placement Agent Warrants [Member]" } } }, "localname": "July2020PlacementAgentWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_July2020WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "July 2020 warrants.", "label": "July2020 Warrants [Member]", "terseLabel": "July 2020 Warrants [Member]" } } }, "localname": "July2020WarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_JulyTwoThousandAndTwentyWarrantsTransactionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "July two thousand and twenty warrants transaction.", "label": "July Two Thousand And Twenty Warrants Transaction Member", "terseLabel": "July 2020 Warrants Transaction [Member]" } } }, "localname": "JulyTwoThousandAndTwentyWarrantsTransactionMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "rkda_JulyTwoThousandTwentyWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "July two thousand twenty warrants.", "label": "July Two Thousand Twenty Warrants [Member]", "terseLabel": "July 2020 Warrants [Member]" } } }, "localname": "JulyTwoThousandTwentyWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "rkda_June2019PlacementAgentWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June 2019 placement agent warrants.", "label": "June2019 Placement Agent Warrants [Member]", "terseLabel": "June 2019 Placement Agent Warrants [Member]" } } }, "localname": "June2019PlacementAgentWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_JuneTwoThousandAndNineteenOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June two thousand and nineteen offering.", "label": "June Two Thousand And Nineteen Offering [Member]", "terseLabel": "June 2019 Offering [Member]" } } }, "localname": "JuneTwoThousandAndNineteenOfferingMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail" ], "xbrltype": "domainItemType" }, "rkda_JuneTwoThousandEighteenPlacementAgentWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June two thousand eighteen placement agent warrants.", "label": "June Two Thousand Eighteen Placement Agent Warrants [Member]", "terseLabel": "June 2018 Placement Agent Warrants [Member]" } } }, "localname": "JuneTwoThousandEighteenPlacementAgentWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_JuneTwoThousandEighteenPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June two thousand eighteen purchase agreement.", "label": "June Two Thousand Eighteen Purchase Agreement [Member]", "terseLabel": "June 2018 Purchase Agreement [Member]" } } }, "localname": "JuneTwoThousandEighteenPurchaseAgreementMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_JuneTwoThousandEighteenWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June two thousand eighteen warrants.", "label": "June Two Thousand Eighteen Warrants [Member]", "terseLabel": "June 2018 Warrants [Member]" } } }, "localname": "JuneTwoThousandEighteenWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "rkda_JuneTwoThousandNineteenPlacementAgentWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June two thousand nineteen placement agent warrants.", "label": "June Two Thousand Nineteen Placement Agent Warrants [Member]", "terseLabel": "June 2019 Placement Agent Warrants [Member]" } } }, "localname": "JuneTwoThousandNineteenPlacementAgentWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_JuneTwoThousandNineteenSecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June two thousand nineteen securities purchase agreement.", "label": "June Two Thousand Nineteen Securities Purchase Agreement [Member]", "terseLabel": "June 2019 Purchase Agreement [Member]" } } }, "localname": "JuneTwoThousandNineteenSecuritiesPurchaseAgreementMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_JuneTwoThousandNineteenWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June 2019 warrants.", "label": "June Two Thousand Nineteen Warrants [Member]", "terseLabel": "June 2019 Warrants [Member]" } } }, "localname": "JuneTwoThousandNineteenWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_LaboratoryEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Laboratory equipment.", "label": "Laboratory Equipment [Member]", "terseLabel": "Laboratory equipment [Member]" } } }, "localname": "LaboratoryEquipmentMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "rkda_LegacyVenturesHawaiiLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legacy Ventures Hawaii, LLC.", "label": "Legacy Ventures Hawaii L L C [Member]", "terseLabel": "Legacy Ventures Hawaii, LLC [Member]" } } }, "localname": "LegacyVenturesHawaiiLLCMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureConsolidatedJointVentureAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_LineOfCreditFacilityAgreementDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of credit facility agreement date.", "label": "Line Of Credit Facility Agreement Date", "terseLabel": "Line of credit facility agreement date" } } }, "localname": "LineOfCreditFacilityAgreementDate", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "rkda_LiquidityCapitalResourcesAndGoingConcernPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liquidity capital resources and going concern.", "label": "Liquidity Capital Resources And Going Concern Policy Policy [Text Block]", "terseLabel": "Liquidity, Capital Resources, and Going Concern" } } }, "localname": "LiquidityCapitalResourcesAndGoingConcernPolicyPolicyTextBlock", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "rkda_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtScheduleOfMaturitiesOfCurrentAndNoncurrentDebtDetail": { "order": 5.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long term debt maturities repayments of principal after year four.", "label": "Long Term Debt Maturities Repayments Of Principal After Year Four", "terseLabel": "Thereafter" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtScheduleOfMaturitiesOfCurrentAndNoncurrentDebtDetail" ], "xbrltype": "monetaryItemType" }, "rkda_March2018PlacementAgentWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March 2018 placement agent warrants.", "label": "March2018 Placement Agent Warrants [Member]", "terseLabel": "March 2018 Placement Agent Warrants [Member]" } } }, "localname": "March2018PlacementAgentWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_March2020ServiceAndPerformanceWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March 2020 service and performance warrants.", "label": "March2020 Service And Performance Warrants [Member]", "terseLabel": "March 2020 Service and Performance Warrants [Member]" } } }, "localname": "March2020ServiceAndPerformanceWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_MarchTwoThousandEighteenOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March two thousand eighteen offering.", "label": "March Two Thousand Eighteen Offering [Member]", "terseLabel": "March 2018 Offering [Member]" } } }, "localname": "MarchTwoThousandEighteenOfferingMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail" ], "xbrltype": "domainItemType" }, "rkda_MarchTwoThousandEighteenPIPEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March two thousand eighteen P I P E.", "label": "March Two Thousand Eighteen P I P E Member", "terseLabel": "March 2018 PIPE [Member]" } } }, "localname": "MarchTwoThousandEighteenPIPEMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "rkda_MarchTwoThousandEighteenPlacementAgentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March two thousand eighteen placement agent.", "label": "March Two Thousand Eighteen Placement Agent [Member]", "terseLabel": "March 2018 Placement Agent Warrants [Member]" } } }, "localname": "MarchTwoThousandEighteenPlacementAgentMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_MarchTwoThousandEighteenPrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March two thousand eighteen private placement.", "label": "March Two Thousand Eighteen Private Placement [Member]", "terseLabel": "March 2018 Private Placement [Member]" } } }, "localname": "MarchTwoThousandEighteenPrivatePlacementMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_MarchTwoThousandEighteenSecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March two thousand eighteen securities purchase agreement.", "label": "March Two Thousand Eighteen Securities Purchase Agreement [Member]", "terseLabel": "March 2018 Purchase Agreement [Member]" } } }, "localname": "MarchTwoThousandEighteenSecuritiesPurchaseAgreementMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_MarchTwoThousandEighteenWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March 2018 warrants.", "label": "March Two Thousand Eighteen Warrants [Member]", "terseLabel": "March 2018 Warrants [Member]" } } }, "localname": "MarchTwoThousandEighteenWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_May2020PlacementAgentWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "May 2020 placement agent warrants.", "label": "May2020 Placement Agent Warrants [Member]", "terseLabel": "May 2020 Placement Agent Warrants [Member]" } } }, "localname": "May2020PlacementAgentWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_May2020WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "May 2020 warrants.", "label": "May2020 Warrants [Member]", "terseLabel": "May 2020 Warrants [Member]" } } }, "localname": "May2020WarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_MayTwoThousandAndTwentyWarrantTransactionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "May two thousand and twenty warrant transaction.", "label": "May Two Thousand And Twenty Warrant Transaction [Member]", "terseLabel": "May 2020 Warrant Transaction [Member]" } } }, "localname": "MayTwoThousandAndTwentyWarrantTransactionMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "rkda_MayTwoThousandTwentyWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "May two thousand twenty warrants.", "label": "May Two Thousand Twenty Warrants [Member]", "terseLabel": "May 2020 Warrants [Member]" } } }, "localname": "MayTwoThousandTwentyWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "rkda_MidFirstBankMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "MidFirst Bank.", "label": "Mid First Bank [Member]", "terseLabel": "MidFirst Bank [Member]" } } }, "localname": "MidFirstBankMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_NumberOfAnnualInstallmentOfCommonStockSharesPayable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of annual installment of common stock, shares payable.", "label": "Number Of Annual Installment Of Common Stock Shares Payable", "terseLabel": "Number of annual installment of common stock shares payable", "verboseLabel": "Number of annual installment of common stock shares payable" } } }, "localname": "NumberOfAnnualInstallmentOfCommonStockSharesPayable", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "rkda_NumberOfEquityIncentivePlans": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of equity incentive plans.", "label": "Number Of Equity Incentive Plans", "terseLabel": "Number of equity incentive plans" } } }, "localname": "NumberOfEquityIncentivePlans", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "rkda_NumberOfIndividualsAppointed": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of individuals appointed.", "label": "Number Of Individuals Appointed", "terseLabel": "Number of individuals appointed" } } }, "localname": "NumberOfIndividualsAppointed", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureConsolidatedJointVentureAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "rkda_NumberOfInstallmentBecomeDueWithinTwelveMonthsAsFullAmountContingentConsiderationIncludedInOtherNoncurrentLiabilities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of installment become due within twelve months as full amount contingent consideration included in other noncurrent liabilities.", "label": "Number Of Installment Become Due Within Twelve Months As Full Amount Contingent Consideration Included In Other Noncurrent Liabilities", "terseLabel": "Number of installment become due within 12 months as full amount contingent consideration included in other noncurrent liabilities" } } }, "localname": "NumberOfInstallmentBecomeDueWithinTwelveMonthsAsFullAmountContingentConsiderationIncludedInOtherNoncurrentLiabilities", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "rkda_NumberOfLeaseAmendments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of lease amendments.", "label": "Number Of Lease Amendments", "terseLabel": "Number of lease amendments" } } }, "localname": "NumberOfLeaseAmendments", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "rkda_NumberOfLeaseRenewalTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of lease renewal term.", "label": "Number Of Lease Renewal Term", "terseLabel": "Number of lease renewal term" } } }, "localname": "NumberOfLeaseRenewalTerm", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "rkda_NumberOfTechnologyDevelopmentPrograms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of technology development programs.", "label": "Number Of Technology Development Programs", "terseLabel": "Number of development programs" } } }, "localname": "NumberOfTechnologyDevelopmentPrograms", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "rkda_NumberOfTechnologyDevelopmentProgramsCeased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of technology development programs ceased.", "label": "Number Of Technology Development Programs Ceased", "terseLabel": "Number of development programs ceased" } } }, "localname": "NumberOfTechnologyDevelopmentProgramsCeased", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "rkda_OfferingClosingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Offering closing period.", "label": "Offering Closing Period", "terseLabel": "Offering closing period" } } }, "localname": "OfferingClosingPeriod", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "rkda_OperatingLeaseAssets": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating lease assets.", "label": "Operating Lease Assets", "totalLabel": "Total leased assets" } } }, "localname": "OperatingLeaseAssets", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail" ], "xbrltype": "monetaryItemType" }, "rkda_OperatingLeaseAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating lease assets.", "label": "Operating Lease Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "OperatingLeaseAssetsAbstract", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail" ], "xbrltype": "stringItemType" }, "rkda_OperatingLeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating lease liabilities.", "label": "Operating Lease Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "OperatingLeaseLiabilitiesAbstract", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail" ], "xbrltype": "stringItemType" }, "rkda_OperatingLeaseTermAndDiscountRateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating lease term and discount rate.", "label": "Operating Lease Term And Discount Rate [Abstract]", "terseLabel": "Lease Term and Discount Rate" } } }, "localname": "OperatingLeaseTermAndDiscountRateAbstract", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail" ], "xbrltype": "stringItemType" }, "rkda_OperatingLeaseTermExpirationMonthAndYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating lease term expiration month and year.", "label": "Operating Lease Term Expiration Month and Year", "terseLabel": "Operating lease term, expiration" } } }, "localname": "OperatingLeaseTermExpirationMonthAndYear", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail" ], "xbrltype": "gYearMonthItemType" }, "rkda_OrganizationPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization policy.", "label": "Organization Policy Policy [Text Block]", "terseLabel": "Organization" } } }, "localname": "OrganizationPolicyPolicyTextBlock", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "rkda_PaycheckProtectionProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Paycheck protection program.", "label": "Paycheck Protection Program [Member]", "terseLabel": "Paycheck Protection Program [Member]" } } }, "localname": "PaycheckProtectionProgramMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_PaymentsForTerminationFees": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments for termination fees.", "label": "Payments for Termination Fees", "terseLabel": "Early termination fees" } } }, "localname": "PaymentsForTerminationFees", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "rkda_PaymentsOfOfferingCosts": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments of offering costs.", "label": "Payments Of Offering Costs", "negatedLabel": "Payments of offering costs" } } }, "localname": "PaymentsOfOfferingCosts", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "rkda_PresidentAndChiefExecutiveOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "President and Chief Executive Officer [Member]", "label": "President and Chief Executive Officer [Member]", "terseLabel": "Stanley Jacot, Jr. [Member]" } } }, "localname": "PresidentAndChiefExecutiveOfficerMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_ProceedsFromIssuanceOfCommonStockAndWarrantsFromOffering": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of common stock and warrants from Offering.", "label": "Proceeds From Issuance Of Common Stock And Warrants From Offering", "terseLabel": "Proceeds from issuance of common stock and warrants from offering" } } }, "localname": "ProceedsFromIssuanceOfCommonStockAndWarrantsFromOffering", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "rkda_ProceedsFromIssuanceOfCommonStockAndWarrantsGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of common stock and warrants gross.", "label": "Proceeds From Issuance Of Common Stock And Warrants Gross", "terseLabel": "Proceeds from issuance of common stock and warrants gross" } } }, "localname": "ProceedsFromIssuanceOfCommonStockAndWarrantsGross", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "rkda_ProceedsFromSaleOfPropertyAndEquipmentInAccountsReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from sale of property and equipment in accounts receivable.", "label": "Proceeds from Sale of Property and Equipment in Accounts Receivable", "terseLabel": "Proceeds from sale of property and equipment in accounts receivable" } } }, "localname": "ProceedsFromSaleOfPropertyAndEquipmentInAccountsReceivable", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "rkda_PromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note.", "label": "Promissory Note [Member]", "terseLabel": "Promissory Notes [Member[" } } }, "localname": "PromissoryNoteMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_RadianceBeautyLicensingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Radiance beauty licensing agreement.", "label": "Radiance Beauty Licensing Agreement [Member]", "terseLabel": "Radiance Beauty Licensing Agreement [Member]" } } }, "localname": "RadianceBeautyLicensingAgreementMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetParentheticalDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventoryAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_RemainingContingentLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Remaining contingent liability", "label": "Remaining Contingent Liability", "terseLabel": "Remaining contingent" } } }, "localname": "RemainingContingentLiability", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "rkda_RentMaintenanceAndUtilitiesCurrentAndNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Rent maintenance and utilities current and noncurrent.", "label": "Rent Maintenance and Utilities Current and Noncurrent", "terseLabel": "Accrued rent, maintenance and utilities" } } }, "localname": "RentMaintenanceAndUtilitiesCurrentAndNoncurrent", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "rkda_RestrictedCashMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted cash.", "label": "Restricted Cash [Member]", "terseLabel": "Restricted Cash [Member]" } } }, "localname": "RestrictedCashMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_RoyaltyPaymentsDuePercentageOfNetRevenueAsDefinedInAgreements": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Royalty Payments Due, Percentage Of Net Revenue As Defined In Agreements", "label": "Royalty Payments Due Percentage Of Net Revenue As Defined In Agreements", "terseLabel": "Royalty payments due, percentage of net revenue as defined in the In-Licensing agreements" } } }, "localname": "RoyaltyPaymentsDuePercentageOfNetRevenueAsDefinedInAgreements", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "rkda_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of finite and indefinite lived intangible assets.", "label": "Schedule Of Finite And Indefinite Lived Intangible Assets Table [Text Block]", "terseLabel": "Schedule of Intangible Assets, Net" } } }, "localname": "ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "rkda_ScheduleOfInventoryCurrentAndNonCurrentTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process. Includes current and non-current inventory balances.", "label": "Schedule Of Inventory Current And Non Current Table [Text Block]", "terseLabel": "Summary of Inventories" } } }, "localname": "ScheduleOfInventoryCurrentAndNonCurrentTableTextBlock", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventoryTables" ], "xbrltype": "textBlockItemType" }, "rkda_ScheduleOfOperatingLeaseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of operating lease.", "label": "Schedule Of Operating Lease Table [Text Block]", "terseLabel": "Schedule of Leases" } } }, "localname": "ScheduleOfOperatingLeaseTableTextBlock", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "rkda_ScheduleOfPropertyPlantAndEquipmentTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of property plant and equipment.", "label": "Schedule Of Property Plant And Equipment Table [Text Block]", "terseLabel": "Summary of Property and Equipment, Net" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTableTextBlock", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetTables" ], "xbrltype": "textBlockItemType" }, "rkda_SellingGeneralAndAdministrativeAndResearchAndDevelopmentExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Selling, general and administrative and research and development expenses.", "label": "Selling General And Administrative And Research And Development Expenses [Member]", "terseLabel": "SG&A and R&D Expenses [Member]" } } }, "localname": "SellingGeneralAndAdministrativeAndResearchAndDevelopmentExpensesMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail" ], "xbrltype": "domainItemType" }, "rkda_SeparationAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Separation agreement.", "label": "Separation Agreement [Member]", "terseLabel": "Separation Agreement [Member]" } } }, "localname": "SeparationAgreementMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_September2019PlacementAgentWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September 2019 placement agent warrants.", "label": "September2019 Placement Agent Warrants [Member]", "terseLabel": "September 2019 Placement Agent Warrants [Member]" } } }, "localname": "September2019PlacementAgentWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_SeptemberTwoThousandAndNineteenOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September two thousand and nineteen offering.", "label": "September Two Thousand And Nineteen Offering [Member]", "terseLabel": "September 2019 Offering [Member]" } } }, "localname": "SeptemberTwoThousandAndNineteenOfferingMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail" ], "xbrltype": "domainItemType" }, "rkda_SeptemberTwoThousandNineteenPlacementAgentWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September Two Thousand Nineteen Placement Agent Warrant.", "label": "September Two Thousand Nineteen Placement Agent Warrant [Member]", "terseLabel": "September 2019 Placement Agent Warrants [Member]" } } }, "localname": "SeptemberTwoThousandNineteenPlacementAgentWarrantMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_SeptemberTwoThousandNineteenPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September 2019 purchase agreement.", "label": "September Two Thousand Nineteen Purchase Agreement [Member]", "terseLabel": "September 2019 Purchase Agreement [Member]" } } }, "localname": "SeptemberTwoThousandNineteenPurchaseAgreementMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_SeptemberTwoThousandNineteenWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September 2019 warrants.", "label": "September Two Thousand Nineteen Warrants [Member]", "terseLabel": "September 2019 Warrants [Member]" } } }, "localname": "SeptemberTwoThousandNineteenWarrantsMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "rkda_ShortTermLeaseCostAndCostReclassifications": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureLeasesScheduleOfLeasesDetail3": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Short term lease cost and cost (reclassifications).", "label": "Short Term Lease Cost And Cost Reclassifications", "negatedTerseLabel": "Short term lease cost", "terseLabel": "Short term lease cost" } } }, "localname": "ShortTermLeaseCostAndCostReclassifications", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail" ], "xbrltype": "monetaryItemType" }, "rkda_SoftwareAndComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Software and computer equipment.", "label": "Software And Computer Equipment [Member]", "terseLabel": "Software and computer equipment [Member]" } } }, "localname": "SoftwareAndComputerEquipmentMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "rkda_StockIssuedDuringPeriodSharesRelatedToExerciseOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares related to exercise of warrants.", "label": "Stock Issued During Period Shares Related To Exercise Of Warrants", "terseLabel": "Warrants Exercised during the Year", "verboseLabel": "Investors exercised warrants and purchase shares of common stock" } } }, "localname": "StockIssuedDuringPeriodSharesRelatedToExerciseOfWarrants", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "sharesItemType" }, "rkda_SummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of amortized cost and fair value of investment securities.", "label": "Summary Of Amortized Cost And Fair Value Of Investment Securities Table [Text Block]", "terseLabel": "Summary of Amortized Cost and Fair Value of Investment Securities Portfolio" } } }, "localname": "SummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesTableTextBlock", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "rkda_TwoThousandFifteenOmnibusEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand fifteen omnibus equity incentive plan.", "label": "Two Thousand Fifteen Omnibus Equity Incentive Plan [Member]", "terseLabel": "2015 Omnibus Equity Incentive Plan [Member]" } } }, "localname": "TwoThousandFifteenOmnibusEquityIncentivePlanMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_TwoThousandSixStockIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand six stock incentive plan.", "label": "Two Thousand Six Stock Incentive Plan [Member]", "terseLabel": "2006 Stock Incentive Plan [Member]" } } }, "localname": "TwoThousandSixStockIncentivePlanMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_VerdecaLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Verdeca LLC.", "label": "Verdeca L L C [Member]", "terseLabel": "Verdeca LLC [Member]" } } }, "localname": "VerdecaLLCMember", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "rkda_WarrantExpirationMonthAndYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant expiration month and year.", "label": "Warrant Expiration Month and Year", "terseLabel": "Warrant expiration month and year" } } }, "localname": "WarrantExpirationMonthAndYear", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockParentheticalDetail" ], "xbrltype": "gYearMonthItemType" }, "rkda_WarrantIssuedIncludedInOfferingCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrant issued included in offering costs.", "label": "Warrant Issued Included In Offering Costs", "terseLabel": "Common stock warrants issued to placement agent and included in offering costs related to purchase agreement" } } }, "localname": "WarrantIssuedIncludedInOfferingCosts", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "rkda_WarrantLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrant liabilities.", "label": "Warrant Liabilities", "terseLabel": "Warrant liabilities" } } }, "localname": "WarrantLiabilities", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "rkda_WarrantsAndRightsNoteDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants and rights note disclosure.", "label": "Warrants And Rights Note Disclosure [Text Block]", "terseLabel": "Warrants" } } }, "localname": "WarrantsAndRightsNoteDisclosureTextBlock", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrants" ], "xbrltype": "textBlockItemType" }, "rkda_WarrantsExpirationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants expiration period.", "label": "Warrants Expiration Period", "terseLabel": "Warrants expiration period" } } }, "localname": "WarrantsExpirationPeriod", "nsuri": "http://arcadiabio.com/20220630", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "srt_BoardOfDirectorsChairmanMember": { "auth_ref": [ "r170" ], "lang": { "en-us": { "role": { "label": "Board of Directors Chairman [Member]", "terseLabel": "Mr. Kevin Comcowich [Member]" } } }, "localname": "BoardOfDirectorsChairmanMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r170" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]", "terseLabel": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r48", "r50", "r106", "r107", "r283", "r316" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureConsolidatedJointVentureAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r258", "r259", "r260", "r261", "r282", "r315", "r353", "r355", "r584", "r585", "r586", "r587", "r588", "r589", "r608", "r668", "r671", "r714", "r715" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]", "verboseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r258", "r259", "r260", "r261", "r282", "r315", "r353", "r355", "r584", "r585", "r586", "r587", "r588", "r589", "r608", "r668", "r671", "r714", "r715" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": { "auth_ref": [ "r700", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713" ], "lang": { "en-us": { "role": { "label": "Real Estate, Type of Property [Axis]", "terseLabel": "Real Estate, Type of Property" } } }, "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": { "auth_ref": [ "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713" ], "lang": { "en-us": { "role": { "label": "Real Estate [Domain]", "terseLabel": "Real Estate" } } }, "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_OfficeBuildingMember": { "auth_ref": [ "r700", "r713" ], "lang": { "en-us": { "role": { "label": "Office Building [Member]", "terseLabel": "Office Space [Member]" } } }, "localname": "OfficeBuildingMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]", "terseLabel": "Ownership" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureConsolidatedJointVentureAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "terseLabel": "Ownership" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureConsolidatedJointVentureAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r166", "r259", "r260", "r339", "r340", "r611", "r667", "r669" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r166", "r259", "r260", "r339", "r340", "r611", "r667", "r669" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r251", "r258", "r259", "r260", "r261", "r282", "r315", "r342", "r353", "r355", "r387", "r388", "r389", "r584", "r585", "r586", "r587", "r588", "r589", "r608", "r668", "r671", "r714", "r715" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r251", "r258", "r259", "r260", "r261", "r282", "r315", "r342", "r353", "r355", "r387", "r388", "r389", "r584", "r585", "r586", "r587", "r588", "r589", "r608", "r668", "r671", "r714", "r715" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r49", "r50", "r106", "r107", "r283", "r316" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureConsolidatedJointVentureAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r3", "r110", "r111", "r112", "r116", "r117", "r122", "r123", "r124", "r125", "r127", "r128", "r129", "r130", "r131", "r133", "r146", "r204", "r205", "r413", "r484", "r489", "r490", "r491", "r538", "r561", "r562", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r3", "r110", "r111", "r112", "r116", "r117", "r122", "r123", "r124", "r125", "r127", "r128", "r129", "r130", "r131", "r133", "r146", "r204", "r205", "r413", "r484", "r489", "r490", "r491", "r538", "r561", "r562", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember": { "auth_ref": [ "r3", "r116", "r117", "r125", "r133", "r204", "r205", "r413", "r484", "r491", "r538", "r561", "r562", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period, Accounting Standards Update, Adjustment [Member]", "terseLabel": "Reclassification upon Adoption [Member]" } } }, "localname": "RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r167", "r168", "r339", "r341", "r670", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r167", "r168", "r339", "r341", "r670", "r700", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r170", "r569" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]", "terseLabel": "Title of Individual" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]", "terseLabel": "Title of Individual" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Changes and Error Corrections [Abstract]" } } }, "localname": "AccountingChangesAndErrorCorrectionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201602Member": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).", "label": "Accounting Standards Update 2016-02 [Member]", "terseLabel": "ASU 2016-02" } } }, "localname": "AccountingStandardsUpdate201602Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate202006Member": { "auth_ref": [ "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r488", "r489", "r490", "r491" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.", "label": "Accounting Standards Update 2020-06 [Member]", "terseLabel": "ASU 2020-06 [Member]" } } }, "localname": "AccountingStandardsUpdate202006Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRecentAccountingPronouncementsAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate202006RetrospectiveMember": { "auth_ref": [ "r484", "r488" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity applied using retrospective transition method.", "label": "Accounting Standards Update 2020-06 Retrospective [Member]", "terseLabel": "Accounting Standards Update 2020-06 [Member]" } } }, "localname": "AccountingStandardsUpdate202006RetrospectiveMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate202104Member": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2021-04 Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40): Issuer's Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force).", "label": "Accounting Standards Update 2021-04 [Member]" } } }, "localname": "AccountingStandardsUpdate202104Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRecentAccountingPronouncementsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdateExtensibleList": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r116", "r117", "r118", "r120", "r175", "r176", "r198", "r199", "r200", "r201", "r204", "r205", "r396", "r397", "r398", "r412", "r413", "r442", "r443", "r444", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r488", "r489", "r490", "r491", "r492", "r506", "r507", "r509", "r510", "r511", "r512", "r516", "r517", "r527", "r528", "r535", "r536", "r537", "r556", "r558", "r559", "r560", "r561", "r562", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683" ], "lang": { "en-us": { "role": { "documentation": "Indicates amendment to accounting standards.", "label": "Accounting Standards Update [Extensible Enumeration]" } } }, "localname": "AccountingStandardsUpdateExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r36" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable and accrued expenses", "totalLabel": "Accounts Payable and Accrued Liabilities, Current, Total" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r171", "r172" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net of allowance for doubtful accounts of $89 and $76 as of June 30, 2022 and December 31, 2021, respectively", "totalLabel": "Accounts Receivable, after Allowance for Credit Loss, Current, Total" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalariesCurrentAndNoncurrent": { "auth_ref": [ "r638", "r661" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided.", "label": "Accrued Salaries", "terseLabel": "Accrued salaries" } } }, "localname": "AccruedSalariesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r15", "r246" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetail": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less accumulated depreciation and amortization", "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance", "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance", "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r27", "r53", "r54", "r55", "r655", "r679", "r683" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive income", "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r52", "r55", "r62", "r63", "r64", "r110", "r111", "r112", "r469", "r562", "r674", "r675" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Loss [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r228" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Weighted average useful life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r25" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "periodEndLabel": "Additional Paid in Capital, Common Stock, Ending Balance", "periodStartLabel": "Additional Paid in Capital, Common Stock, Beginning Balance", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRecentAccountingPronouncementsAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r110", "r111", "r112", "r396", "r397", "r398", "r489" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r116", "r117", "r118", "r120", "r133", "r175", "r176", "r198", "r199", "r200", "r201", "r204", "r205", "r396", "r397", "r398", "r410", "r411", "r412", "r413", "r442", "r443", "r444", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r488", "r489", "r490", "r491", "r492", "r506", "r507", "r509", "r510", "r511", "r512", "r516", "r517", "r527", "r528", "r535", "r536", "r537", "r538", "r556", "r558", "r559", "r560", "r561", "r562", "r613", "r614", "r615", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRecentAccountingPronouncementsAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r357", "r399", "r400" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation", "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "auth_ref": [ "r329", "r334" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs", "negatedLabel": "Offering costs", "verboseLabel": "Remaining offering costs allocated to common stock and offset to additional paid in capital" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "auth_ref": [ "r278", "r329", "r334" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.", "label": "Adjustments to Additional Paid in Capital, Warrant Issued", "terseLabel": "Issuance of placement agent warrants" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r31", "r173", "r206" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r91", "r226", "r234" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of intangible assets", "totalLabel": "Amortization of Intangible Assets, Total" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r143" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities not included in the diluted per share calculations, amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureNetLossPerShareSummaryOfSecuritiesNotIncludedInDilutedPerShareCalculationsDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r143" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureNetLossPerShareSummaryOfSecuritiesNotIncludedInDilutedPerShareCalculationsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureNetLossPerShareSummaryOfSecuritiesNotIncludedInDilutedPerShareCalculationsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r143" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureNetLossPerShareSummaryOfSecuritiesNotIncludedInDilutedPerShareCalculationsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AreaOfLand": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of land held.", "label": "Area of Land", "terseLabel": "Acres of land" } } }, "localname": "AreaOfLand", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "areaItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetParentheticalDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCollaborativeArrangementsAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventoryAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r91", "r242" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "terseLabel": "Impairment charges", "totalLabel": "Asset Impairment Charges, Total" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r19", "r102", "r154", "r158", "r164", "r193", "r265", "r266", "r267", "r269", "r270", "r271", "r272", "r273", "r274", "r276", "r277", "r463", "r470", "r505", "r573", "r575", "r633", "r653" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r10", "r33", "r102", "r193", "r265", "r266", "r267", "r269", "r270", "r271", "r272", "r273", "r274", "r276", "r277", "r463", "r470", "r505", "r573", "r575" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r496" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "totalLabel": "Total Assets at Fair Value" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets at Fair Value" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure": { "auth_ref": [ "r496" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of assets classified as held for sale.", "label": "Property and equipment classified as assets held for sale, fair value" } } }, "localname": "AssetsHeldForSaleLongLivedFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup": { "auth_ref": [ "r240" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets held-for-sale that are not part of a disposal group.", "label": "Assets Held-for-sale, Not Part of Disposal Group", "terseLabel": "Assets held for sale", "totalLabel": "Assets Held-for-sale, Not Part of Disposal Group, Total" } } }, "localname": "AssetsHeldForSaleNotPartOfDisposalGroup", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent": { "auth_ref": [ "r240", "r575" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.", "label": "Assets Held-for-sale, Not Part of Disposal Group, Current", "terseLabel": "Assets held for sale", "totalLabel": "Assets Held-for-sale, Not Part of Disposal Group, Current, Total" } } }, "localname": "AssetsHeldForSaleNotPartOfDisposalGroupCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AutomobileLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan to finance the purchase of a vehicle.", "label": "Automobile Loan [Member]", "terseLabel": "Vehicle Loans [Member]" } } }, "localname": "AutomobileLoanMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r361", "r362", "r363", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r380", "r381", "r383", "r384", "r386", "r387", "r388", "r389", "r390" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramWeightedAverageFairValueAssumptionOfStockOptionAwardsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r475", "r476" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r352", "r354", "r436" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisition", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionScheduleOfUnauditedProFormaCondensedConsolidatedResultsOfOperationsDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionScheduleOfPreliminaryAllocationOfPurchasePriceOfISIAssetsAcquiredBasedOnFairValuesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r352", "r354", "r431", "r432", "r436" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisition", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionScheduleOfUnauditedProFormaCondensedConsolidatedResultsOfOperationsDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionScheduleOfPreliminaryAllocationOfPurchasePriceOfISIAssetsAcquiredBasedOnFairValuesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1": { "auth_ref": [ "r426", "r427", "r428" ], "lang": { "en-us": { "role": { "documentation": "Date when the acquirer obtains control of the acquiree, in YYYY-MM-DD format.", "label": "Business Acquisition, Effective Date of Acquisition", "terseLabel": "Date of merger and reorganization" } } }, "localname": "BusinessAcquisitionEffectiveDateOfAcquisition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r451" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "terseLabel": "Business combination, equity interest issuable, shares" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisition", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionScheduleOfUnauditedProFormaCondensedConsolidatedResultsOfOperationsDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionScheduleOfPreliminaryAllocationOfPurchasePriceOfISIAssetsAcquiredBasedOnFairValuesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r429", "r430" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "terseLabel": "Schedule of Unaudited Pro-forma Condensed Consolidated Results of Operations" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r429", "r430" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Net Income (Loss)", "terseLabel": "Net (loss) income", "verboseLabel": "Net loss" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionScheduleOfUnauditedProFormaCondensedConsolidatedResultsOfOperationsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r429", "r430" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisition, Pro Forma Revenue", "terseLabel": "Total revenues" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionScheduleOfUnauditedProFormaCondensedConsolidatedResultsOfOperationsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r425" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Acquisition related costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r446", "r447", "r449" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Purchase price consideration", "totalLabel": "Business Combination, Consideration Transferred, Total" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "auth_ref": [ "r446", "r447" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.", "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable", "terseLabel": "Business combination, equity interest issuable, value" } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "auth_ref": [ "r90", "r453" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "terseLabel": "Change in fair value of contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r445", "r448", "r452" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability", "terseLabel": "Contingent liability", "totalLabel": "Business Combination, Contingent Consideration, Liability, Total" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r437", "r454" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Industrial Seed Innovations Acquisition", "verboseLabel": "Arcadia Wellness Acquisition" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisition" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r434" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets", "terseLabel": "Prepaid and other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r434" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionScheduleOfPreliminaryAllocationOfPurchasePriceOfISIAssetsAcquiredBasedOnFairValuesDetail": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "negatedLabel": "Deferred tax liability", "terseLabel": "Deferred tax liability" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionScheduleOfPreliminaryAllocationOfPurchasePriceOfISIAssetsAcquiredBasedOnFairValuesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r434" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionScheduleOfPreliminaryAllocationOfPurchasePriceOfISIAssetsAcquiredBasedOnFairValuesDetail": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Intangible assets, net", "totalLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionScheduleOfPreliminaryAllocationOfPurchasePriceOfISIAssetsAcquiredBasedOnFairValuesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r433", "r434" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail": { "order": 0.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 }, "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionScheduleOfPreliminaryAllocationOfPurchasePriceOfISIAssetsAcquiredBasedOnFairValuesDetail": { "order": 0.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventory" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionScheduleOfPreliminaryAllocationOfPurchasePriceOfISIAssetsAcquiredBasedOnFairValuesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": { "auth_ref": [ "r434" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets", "terseLabel": "Fixed assets", "totalLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets, Total" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r434" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionScheduleOfPreliminaryAllocationOfPurchasePriceOfISIAssetsAcquiredBasedOnFairValuesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "totalLabel": "Total consideration allocated" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionScheduleOfPreliminaryAllocationOfPurchasePriceOfISIAssetsAcquiredBasedOnFairValuesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r7", "r109", "r150" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description and Basis of Presentation [Text Block]", "terseLabel": "Description of Business and Basis of Presentation" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r95", "r96", "r97" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Purchases of property and equipment included in accounts payable and accrued expenses" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r8", "r12", "r93" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance", "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance", "terseLabel": "Cash and cash equivalents", "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail": { "order": 0.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r85", "r93", "r98" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash and cash equivalents - end of period", "periodStartLabel": "Cash and cash equivalents - beginning of period", "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r85", "r519" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net (decrease) increase in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsMember": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Equivalents [Member]", "terseLabel": "Cash Equivalents [Member]" } } }, "localname": "CashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": { "auth_ref": [ "r0", "r1", "r114", "r175", "r176", "r195", "r196", "r197", "r198", "r199", "r410", "r442", "r443", "r477", "r480", "r481", "r492", "r506", "r508", "r509", "r510", "r516", "r517", "r527", "r534", "r535", "r536", "r537", "r556", "r558", "r613", "r614", "r672", "r673" ], "lang": { "en-us": { "role": { "documentation": "Indicates (true false) whether accounting standards update was adopted.", "label": "Change in Accounting Principle, Accounting Standards Update, Adopted [true false]", "terseLabel": "Change in accounting principle, accounting standards update, adopted [true false]" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRecentAccountingPronouncementsAdditionalInformationDetail" ], "xbrltype": "booleanItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": { "auth_ref": [ "r0", "r1", "r125", "r175", "r176", "r195", "r196", "r197", "r198", "r199", "r410", "r442", "r443", "r444", "r477", "r480", "r481", "r482", "r485", "r492", "r506", "r508", "r509", "r510", "r516", "r517", "r527", "r534", "r535", "r536", "r537", "r556", "r558", "r613", "r614", "r672", "r673" ], "lang": { "en-us": { "role": { "documentation": "Date accounting standards update was adopted, in YYYY-MM-DD format.", "label": "Change in Accounting Principle, Accounting Standards Update, Adoption Date", "terseLabel": "Change in accounting principle, accounting standards update, adoption date" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRecentAccountingPronouncementsAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect": { "auth_ref": [ "r116", "r132", "r177", "r202", "r416" ], "lang": { "en-us": { "role": { "documentation": "Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.", "label": "Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]", "terseLabel": "Change in accounting principle, accounting standards update, immaterial effect [true false]" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRecentAccountingPronouncementsAdditionalInformationDetail" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r336", "r359" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]", "terseLabel": "Class of Warrant or Right" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockParentheticalDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]", "terseLabel": "Class of Warrant or Right" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockParentheticalDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Warrants issued, exercise price", "verboseLabel": "Exercise Price Per Share" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]", "terseLabel": "Class Of Warrant Or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockParentheticalDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Warrant issued, shares of common stock called by warrant" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Warrants Outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r336", "r359" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]", "terseLabel": "Class Of Warrant Or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockParentheticalDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CollaborativeArrangementDisclosureTextBlock": { "auth_ref": [ "r455", "r456", "r458" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.", "label": "Collaborative Arrangement Disclosure [Text Block]", "terseLabel": "Collaborative Arrangements" } } }, "localname": "CollaborativeArrangementDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCollaborativeArrangements" ], "xbrltype": "textBlockItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "terseLabel": "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCollaborativeArrangementsAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r44", "r639", "r660" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 17)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r255", "r256", "r257", "r262", "r701" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "terseLabel": "Total number of shares reserved for issuance under plan" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r110", "r111", "r489" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, issued", "totalLabel": "Common Stock, Shares, Issued, Total" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r24", "r329" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance", "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance", "terseLabel": "Common stock, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r24", "r575" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "periodEndLabel": "Common Stock, Value, Issued, Ending Balance", "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance", "terseLabel": "Common stock, $0.001 par value - 150,000,000 shares authorized as of June 30, 2022 and December 31, 2021; 22,188,918 and 22,184,235 shares issued and outstanding as of March 31,2022 and December 31, 2021, respectively", "totalLabel": "Common Stock, Value, Issued, Total" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r58", "r60", "r61", "r68", "r642", "r664" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "terseLabel": "Comprehensive loss attributable to common stockholders", "totalLabel": "Comprehensive loss attributable to common stockholders" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]", "terseLabel": "Construction in Progress [Member]" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateDebtSecuritiesMember": { "auth_ref": [ "r343", "r351", "r684" ], "lang": { "en-us": { "role": { "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.", "label": "Corporate Debt Securities [Member]", "terseLabel": "Corporate Securities [Member]" } } }, "localname": "CorporateDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r74", "r611" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of revenues", "totalLabel": "Cost of Goods and Services Sold, Total" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r73" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerListsMember": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information.", "label": "Customer Lists [Member]", "terseLabel": "Customer Lists [Member]" } } }, "localname": "CustomerListsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r440" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer List [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtAndEquitySecuritiesRealizedGainLoss": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment in debt and equity securities.", "label": "Debt and Equity Securities, Realized Gain (Loss)", "negatedLabel": "Realized gain on corporate securities", "terseLabel": "Realized gain on corporate securities", "totalLabel": "Debt and Equity Securities, Realized Gain (Loss), Total" } } }, "localname": "DebtAndEquitySecuritiesRealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r99", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r296", "r303", "r304", "r306", "r312" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r20", "r21", "r22", "r101", "r108", "r279", "r280", "r281", "r282", "r283", "r284", "r286", "r292", "r293", "r294", "r295", "r297", "r298", "r299", "r300", "r301", "r302", "r308", "r309", "r310", "r311", "r531", "r634", "r635", "r652" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r279", "r308", "r309", "r530", "r531", "r532" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt instrument, face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r40", "r280" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateTerms": { "auth_ref": [ "r40" ], "lang": { "en-us": { "role": { "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.", "label": "Debt Instrument, Interest Rate Terms", "terseLabel": "Debt instrument interest rate terms" } } }, "localname": "DebtInstrumentInterestRateTerms", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r41", "r282", "r500" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date", "terseLabel": "Debt instrument maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r42", "r101", "r108", "r279", "r280", "r281", "r282", "r283", "r284", "r286", "r292", "r293", "r294", "r295", "r297", "r298", "r299", "r300", "r301", "r302", "r308", "r309", "r310", "r311", "r531" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r42", "r101", "r108", "r279", "r280", "r281", "r282", "r283", "r284", "r286", "r292", "r293", "r294", "r295", "r297", "r298", "r299", "r300", "r301", "r302", "r305", "r308", "r309", "r310", "r311", "r330", "r331", "r332", "r333", "r529", "r530", "r531", "r532", "r650" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Debt Instrument [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": { "auth_ref": [ "r184", "r214" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss", "terseLabel": "Investment in continuous unrealized loss position for more than twelve months" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredOfferingCosts": { "auth_ref": [ "r220" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.", "label": "Deferred Offering Costs", "terseLabel": "Offering costs" } } }, "localname": "DeferredOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsAssets": { "auth_ref": [ "r18" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.", "label": "Deposits Assets", "terseLabel": "Deposit account" } } }, "localname": "DepositsAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r91", "r244" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation", "totalLabel": "Depreciation, Total", "verboseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r360", "r361", "r391", "r392", "r394", "r401" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]", "terseLabel": "Stock-Based Compensation and Employee Stock Purchase Program" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgram" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r34", "r105", "r268", "r270", "r271", "r275", "r276", "r277", "r567" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "terseLabel": "Amounts due to related parties", "totalLabel": "Due to Related Parties, Current, Total", "verboseLabel": "Royalty fees due" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]", "verboseLabel": "Net loss per share attributable to common stockholders:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r69", "r122", "r123", "r125", "r126", "r127", "r136", "r138", "r140", "r141", "r142", "r146", "r147", "r490", "r491", "r643", "r665" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic net loss per share attributable to common stockholders:", "totalLabel": "Earnings Per Share, Basic, Total" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r69", "r122", "r123", "r125", "r126", "r127", "r138", "r140", "r141", "r142", "r146", "r147", "r490", "r491", "r643", "r665" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted net loss per share attributable to common stockholders:", "totalLabel": "Earnings Per Share, Diluted, Total" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share Reconciliation [Abstract]", "terseLabel": "Net loss per share attributable to common stockholders:" } } }, "localname": "EarningsPerShareReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r143", "r144", "r145", "r148" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net (Loss) Income per Share", "verboseLabel": "Net Loss per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureNetLossPerShare1" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r519" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 0.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "terseLabel": "Effects of foreign currency translation on cash and cash equivalents", "totalLabel": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective tax rate", "totalLabel": "Effective Income Tax Rate Reconciliation, Percent, Total" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r103", "r405", "r419" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "verboseLabel": "Federal statutory tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r393" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized compensation cost related to unvested stock-based compensation grants", "totalLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r393" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted-average remaining recognition period" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "2015 Employee Stock Purchase Plan [Member]" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]", "terseLabel": "Employee Stock Option [Member]", "verboseLabel": "Option to Purchase Common Stock [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureNetLossPerShareSummaryOfSecuritiesNotIncludedInDilutedPerShareCalculationsDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramWeightedAverageFairValueAssumptionOfStockOptionAwardsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r2", "r62", "r63", "r64", "r110", "r111", "r112", "r117", "r128", "r131", "r149", "r201", "r329", "r334", "r396", "r397", "r398", "r412", "r413", "r489", "r520", "r521", "r522", "r523", "r524", "r526", "r562", "r674", "r675", "r676" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r191" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Joint venture interest percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureConsolidatedJointVentureAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": { "auth_ref": [ "r71", "r72", "r91" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.", "label": "Equity Method Investment, Realized Gain (Loss) on Disposal", "negatedLabel": "Gain on sale of Verdeca", "terseLabel": "Gain on sale of Verdeca" } } }, "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r13", "r155", "r190" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Capital contributions" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureConsolidatedJointVentureAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r194" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]", "terseLabel": "Consolidated Joint Venture" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureConsolidatedJointVenture" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r91", "r313" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "negatedLabel": "Change in fair value of common stock warrant liabilities", "terseLabel": "Change in fair value of common stock warrant liabilities" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r496", "r497", "r504" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r496", "r497", "r498", "r503", "r504" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "terseLabel": "Summary of Fair Value of Investment Securities" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Summary of Warrant Liabilities Measured and Recorded on Recurring Basis using Black-Scholes Model" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r501" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]", "terseLabel": "Asset Class" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r496", "r504" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]", "terseLabel": "Asset Class" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r294", "r308", "r309", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r351", "r497", "r581", "r582", "r583" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r502", "r504" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]", "terseLabel": "Liability Class" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r294", "r343", "r344", "r349", "r351", "r497", "r581" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r294", "r308", "r309", "r343", "r344", "r349", "r351", "r497", "r582" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r294", "r308", "r309", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r351", "r497", "r583" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r501" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]", "terseLabel": "Fair Value by Liability Class" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "terseLabel": "Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r501", "r504" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "terseLabel": "Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r501", "r504" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of Changes in Fair Value and Other Adjustments of Liabilities" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": { "auth_ref": [ "r501" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)", "terseLabel": "Change in fair value of contingent consideration", "totalLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease), Total" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r501" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r294", "r308", "r309", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r351", "r581", "r582", "r583" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r181", "r182", "r187", "r188", "r189", "r207", "r209", "r210", "r211", "r212", "r213", "r215", "r216", "r217", "r305", "r327", "r478", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r722", "r723", "r724", "r725", "r726", "r727", "r728" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Useful life", "verboseLabel": "Useful life of intangible assets amortized" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r17", "r233" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail2": { "order": 0.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0 }, "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail": { "order": 0.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "terseLabel": "Amortized intangible assets, Accumulated Amortization", "verboseLabel": "Total intangible asset, Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r235" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail": { "order": 0.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "terseLabel": "2022 (excluding the six months ended June 30, 2022)" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r235" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r235" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r235" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r227", "r230", "r233", "r237", "r612", "r619" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r233", "r619" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Amortized intangible assets, Gross Carrying Amount", "totalLabel": "Finite-Lived Intangible Assets, Gross, Total" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetParentheticalDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r227", "r232" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r233", "r612" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "periodEndLabel": "Finite-Lived Intangible Assets, Net, Ending Balance", "periodStartLabel": "Finite-Lived Intangible Assets, Net, Beginning Balance", "totalLabel": "Finite-Lived Intangible Assets, Net, Total" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture and fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets": { "auth_ref": [ "r91", "r243", "r248" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 6.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property", "negatedLabel": "(Gain) loss on disposal of property and equipment" } } }, "localname": "GainLossOnDispositionOfAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r91" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "terseLabel": "Gain on sale of property and equipment", "totalLabel": "Gain (Loss) on Disposition of Property Plant Equipment, Total" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r16", "r221", "r222", "r223", "r224", "r575", "r632" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 }, "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionScheduleOfPreliminaryAllocationOfPurchasePriceOfISIAssetsAcquiredBasedOnFairValuesDetail": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Goodwill, Ending Balance", "periodStartLabel": "Goodwill, Beginning Balance", "terseLabel": "Goodwill", "totalLabel": "Goodwill, Total" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionScheduleOfPreliminaryAllocationOfPurchasePriceOfISIAssetsAcquiredBasedOnFairValuesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "auth_ref": [ "r91", "r238" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.", "label": "Impairment of Intangible Assets, Finite-Lived", "terseLabel": "Impairment of intangible asset", "verboseLabel": "Impairment of intangible assets" } } }, "localname": "ImpairmentOfIntangibleAssetsFinitelived", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetParentheticalDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": { "auth_ref": [ "r91", "r241" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 5.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.", "label": "Impairment of Long-Lived Assets to be Disposed of", "terseLabel": "Impairment of property and equipment" } } }, "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).", "label": "Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net", "totalLabel": "Net loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r249", "r253" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r253" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r103", "r406", "r408", "r409", "r417", "r420", "r422", "r423", "r424" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r104", "r130", "r131", "r153", "r404", "r418", "r421", "r666" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax provision", "totalLabel": "Income Tax Expense (Benefit), Total" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r87", "r94" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r90" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 31.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses", "totalLabel": "Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r90" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 27.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r90", "r609" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 33.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Unearned revenue" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "auth_ref": [ "r90" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 32.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.", "label": "Increase (Decrease) in Due to Related Parties", "totalLabel": "Increase (Decrease) in Due to Related Parties, Total", "verboseLabel": "Amounts due to related parties" } } }, "localname": "IncreaseDecreaseInDueToRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r90" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 28.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories", "totalLabel": "Increase (Decrease) in Inventories, Total" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": { "auth_ref": [ "r90" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 34.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current liabilities classified as other.", "label": "Increase (Decrease) in Other Current Liabilities", "terseLabel": "Other current liabilities" } } }, "localname": "IncreaseDecreaseInOtherCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "auth_ref": [ "r90" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 30.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.", "label": "Increase (Decrease) in Other Noncurrent Assets", "negatedLabel": "Other noncurrent assets" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "auth_ref": [], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 25.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "terseLabel": "Other noncurrent liabilities" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r90" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 29.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets", "totalLabel": "Increase (Decrease) in Prepaid Expense and Other Assets, Total" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r229", "r236" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r236" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "periodEndLabel": "Indefinite-lived Intangible Assets (Excluding Goodwill), Ending Balance", "periodStartLabel": "Indefinite-lived Intangible Assets (Excluding Goodwill), Beginning Balance", "totalLabel": "Indefinite-lived intangible assets, Net Carrying Amount" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r229", "r236" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r239" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "terseLabel": "Intangible Assets, Net" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [ "r16" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail2": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "terseLabel": "Total intangible asset, Gross Carrying Amount", "totalLabel": "Intangible Assets, Gross (Excluding Goodwill), Total" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r225", "r231" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail2": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net", "totalLabel": "Total intangible asset, Net Carrying Amount" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntellectualPropertyMember": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.", "label": "Intellectual Property [Member]", "terseLabel": "Intellectual Property [Member]" } } }, "localname": "IntellectualPropertyMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r644" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income (Expense), Net", "terseLabel": "Interest income (expense)", "totalLabel": "Interest Income (Expense), Net, Total" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r83", "r86", "r94" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryCurrentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.", "label": "Inventory, Current [Table]" } } }, "localname": "InventoryCurrentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventoryAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventory" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventory" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Inventory [Line Items]" } } }, "localname": "InventoryLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventoryAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r9", "r32", "r575" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories, net \u2014 current", "totalLabel": "Inventory, Net, Total" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNoncurrent": { "auth_ref": [ "r18" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.", "label": "Inventory, Noncurrent", "terseLabel": "Inventories, net \u2014 noncurrent", "totalLabel": "Inventory, Noncurrent, Total" } } }, "localname": "InventoryNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r218" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write-down", "terseLabel": "Inventories written down", "verboseLabel": "Write-down of inventory" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventoryAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]", "terseLabel": "Investments" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r553", "r554" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureLeasesScheduleOfLeasesDetail3": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "negatedTotalLabel": "Net lease cost", "totalLabel": "Net lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease, Cost [Abstract]", "terseLabel": "Lease Cost" } } }, "localname": "LeaseCostAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r245" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee Disclosure [Abstract]" } } }, "localname": "LesseeDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee Lease Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r545" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee Lease Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend": { "auth_ref": [ "r544" ], "lang": { "en-us": { "role": { "documentation": "Indicates (true false) whether lessee has option to extend operating lease.", "label": "Lessee, Operating Lease, Existence of Option to Extend [true false]", "terseLabel": "Existence of option to extend" } } }, "localname": "LesseeOperatingLeaseExistenceOfOptionToExtend", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail" ], "xbrltype": "booleanItemType" }, "us-gaap_LesseeOperatingLeaseOptionToExtend": { "auth_ref": [ "r544" ], "lang": { "en-us": { "role": { "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.", "label": "Lessee, Operating Lease, Option to Extend", "terseLabel": "Lease option to extend, description" } } }, "localname": "LesseeOperatingLeaseOptionToExtend", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r544" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Renewal Term", "terseLabel": "Option to extend lease, term" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r544" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Operating leases, term of contract" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r555" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r37", "r102", "r159", "r193", "r265", "r266", "r267", "r270", "r271", "r272", "r273", "r274", "r276", "r277", "r464", "r470", "r471", "r505", "r573", "r574" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r30", "r102", "r193", "r505", "r575", "r637", "r658" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r11", "r39", "r102", "r193", "r265", "r266", "r267", "r270", "r271", "r272", "r273", "r274", "r276", "r277", "r464", "r470", "r471", "r505", "r573", "r574", "r575" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_LicenseMember": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.", "label": "License [Member]", "terseLabel": "License" } } }, "localname": "LicenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r22", "r635", "r652" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-Term Line of Credit", "terseLabel": "Debt instrument outstanding amount", "totalLabel": "Long-term Line of Credit, Total" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r35", "r101" ], "lang": { "en-us": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]", "terseLabel": "Lender Name" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityInitiationDate1": { "auth_ref": [ "r35" ], "lang": { "en-us": { "role": { "documentation": "Date the credit facility first became available, in YYYY-MM-DD format.", "label": "Line of Credit Facility, Initiation Date", "terseLabel": "Line of credit facility initiation date" } } }, "localname": "LineOfCreditFacilityInitiationDate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r35", "r101" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line of Credit Facility, Lender [Domain]", "terseLabel": "Line of Credit Facility, Lender" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r35" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Line of credit facility maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansInsuredOrGuaranteedByGovernmentAuthoritiesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by US and non-US government sponsored enterprise, authority, agency and program guarantees for government insured loans.", "label": "Loans Insured or Guaranteed by Government Authorities [Axis]", "terseLabel": "Loans Insured or Guaranteed by Government Authorities" } } }, "localname": "LoansInsuredOrGuaranteedByGovernmentAuthoritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LoansInsuredOrGuaranteedByGovernmentAuthoritiesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Guarantee by US and non-US government sponsored enterprises, authorities, agencies and programs for government insured loans.", "label": "Loans Insured or Guaranteed by Government Authorities [Domain]", "terseLabel": "Loans Insured or Guaranteed by Government Authorities" } } }, "localname": "LoansInsuredOrGuaranteedByGovernmentAuthoritiesDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LoansPayable": { "auth_ref": [ "r22", "r635", "r651" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Loans Payable", "terseLabel": "Loans", "totalLabel": "Loans Payable, Total" } } }, "localname": "LoansPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r22", "r293", "r307", "r308", "r309", "r635", "r654" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtScheduleOfMaturitiesOfCurrentAndNoncurrentDebtDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "totalLabel": "Total" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtScheduleOfMaturitiesOfCurrentAndNoncurrentDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r108", "r263", "r298" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtScheduleOfMaturitiesOfCurrentAndNoncurrentDebtDetail": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtScheduleOfMaturitiesOfCurrentAndNoncurrentDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r108", "r263", "r298" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtScheduleOfMaturitiesOfCurrentAndNoncurrentDebtDetail": { "order": 4.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Four", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtScheduleOfMaturitiesOfCurrentAndNoncurrentDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r108", "r263", "r298" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtScheduleOfMaturitiesOfCurrentAndNoncurrentDebtDetail": { "order": 3.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Three", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtScheduleOfMaturitiesOfCurrentAndNoncurrentDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r108", "r263", "r298" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtScheduleOfMaturitiesOfCurrentAndNoncurrentDebtDetail": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtScheduleOfMaturitiesOfCurrentAndNoncurrentDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "auth_ref": [ "r108" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtScheduleOfMaturitiesOfCurrentAndNoncurrentDebtDetail": { "order": 0.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.", "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "terseLabel": "Remainder of 2021" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtScheduleOfMaturitiesOfCurrentAndNoncurrentDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r42", "r264" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Measurement Input, Expected Dividend Rate [Member]", "terseLabel": "Expected Dividend Yield [Member]" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input, Expected Term [Member]", "terseLabel": "Remaining Term [Member]" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]", "terseLabel": "Expected Volatility [Member]", "verboseLabel": "Expected Volatility [Member]" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input, Risk Free Interest Rate [Member]", "terseLabel": "Risk-Free Interest Rate [Member]", "verboseLabel": "Risk-Free Interest Rate [Member]" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputSharePriceMember": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using share price of saleable stock.", "label": "Measurement Input, Share Price [Member]", "terseLabel": "Stock Price [Member]" } } }, "localname": "MeasurementInputSharePriceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]", "terseLabel": "Measurement Input Type" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]", "terseLabel": "Measurement Input Type" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r47", "r102", "r193", "r265", "r270", "r271", "r272", "r276", "r277", "r505", "r636", "r657" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "periodEndLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance", "periodStartLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance", "terseLabel": "Non-controlling interest", "totalLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Total" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r343" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Money Market Funds [Member]" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfFairValueOfInvestmentsSecuritiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r85" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r85" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r85", "r89", "r92" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "terseLabel": "Net cash used in operations", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r6", "r56", "r59", "r64", "r66", "r92", "r102", "r116", "r122", "r123", "r125", "r126", "r130", "r131", "r139", "r154", "r157", "r160", "r163", "r165", "r193", "r265", "r266", "r267", "r270", "r271", "r272", "r273", "r274", "r276", "r277", "r491", "r505", "r640", "r662" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "negatedLabel": "Net loss attributable to common stockholders", "terseLabel": "Net income attributable to common stockholders", "totalLabel": "Net loss attributable to common stockholders" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r56", "r59", "r64", "r130", "r131", "r466", "r473" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedLabel": "Net loss attributable to noncontrolling interest", "terseLabel": "Net loss attributable to non-controlling interest", "totalLabel": "Net Income (Loss) Attributable to Noncontrolling Interest, Total" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureConsolidatedJointVentureAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Basic, Operations [Abstract]", "terseLabel": "Net loss per share attributable to common stockholders:" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersOperationsBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionScheduleOfUnauditedProFormaCondensedConsolidatedResultsOfOperationsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r5", "r114", "r115", "r118", "r119", "r133", "r134", "r135", "r177", "r178", "r202", "r203", "r414", "r415", "r416", "r487", "r493", "r494", "r495", "r513", "r514", "r515", "r539", "r540", "r557", "r563", "r616", "r617", "r618", "r678", "r679", "r680", "r681", "r683" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.", "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRecentAccountingPronouncements" ], "xbrltype": "textBlockItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "terseLabel": "New Accounting Pronouncements Or Change In Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRecentAccountingPronouncementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r113", "r116", "r117", "r118", "r120", "r121", "r125", "r133", "r146", "r175", "r176", "r198", "r199", "r200", "r201", "r204", "r205", "r396", "r397", "r398", "r410", "r411", "r412", "r413", "r442", "r443", "r444", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r488", "r489", "r490", "r491", "r492", "r506", "r507", "r509", "r510", "r511", "r512", "r516", "r517", "r527", "r528", "r535", "r536", "r537", "r538", "r556", "r558", "r559", "r560", "r561", "r562", "r613", "r614", "r615", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683" ], "lang": { "en-us": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "Accounting Standards Update and Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRecentAccountingPronouncementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "NONCASH INVESTING AND FINANCING ACTIVITIES:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": { "auth_ref": [ "r335", "r462", "r468" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.", "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest", "terseLabel": "Non-controlling interest capital contribution" } } }, "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": { "auth_ref": [ "r335", "r462", "r468" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.", "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance", "terseLabel": "Non-controlling interest contributions" } } }, "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r110", "r111", "r112", "r334", "r459" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-Controlling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_NoninterestExpenseOfferingCost": { "auth_ref": [ "r645" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Includes offering costs of open-end investment companies, and closed-end funds with a continuous offering period.", "label": "Noninterest Expense Offering Cost", "negatedLabel": "Issuance and offering costs", "terseLabel": "Issuance and offering costs", "verboseLabel": "Offering costs allocated to common stock warrant liability and expensed" } } }, "localname": "NoninterestExpenseOfferingCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r154", "r157", "r160", "r163", "r165" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Income (Loss) [Abstract]", "terseLabel": "Operating expenses (income):" } } }, "localname": "OperatingIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r546", "r554" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureLeasesScheduleOfLeasesDetail3": { "order": 0.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "negatedTerseLabel": "Operating lease cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r542" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureLeasesScheduleOfLeasesDetail2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Decrease in operating lease liability", "totalLabel": "Total leased liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r542" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureLeasesScheduleOfLeasesDetail2": { "order": 0.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Current - Operating", "verboseLabel": "Operating lease liability \u2014 current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r542" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureLeasesScheduleOfLeasesDetail2": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Noncurrent - Operating", "verboseLabel": "Operating lease liability \u2014 noncurrent" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r543", "r549" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Lease payments" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r541" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail": { "order": 0.0, "parentTag": "rkda_OperatingLeaseAssets", "weight": 1.0 }, "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease assets", "verboseLabel": "Right of use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r91" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Operating Lease, Right-of-Use Asset, Amortization Expense", "terseLabel": "Lease amortization" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r552", "r554" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted-average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r551", "r554" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted-average remaining lease term (years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail" ], "xbrltype": "durationItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r18" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other noncurrent assets", "totalLabel": "Other Assets, Noncurrent, Total" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r51" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Foreign currency translation adjustment", "totalLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r57", "r60", "r62", "r63", "r65", "r67", "r329", "r520", "r525", "r526", "r641", "r663" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Other comprehensive loss", "totalLabel": "Other Comprehensive loss" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r38", "r575" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "terseLabel": "Other current liabilities", "totalLabel": "Other Liabilities, Current, Total" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r43" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other noncurrent liabilities", "totalLabel": "Other Liabilities, Noncurrent, Total", "verboseLabel": "Other noncurrent liability" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r76" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other (expense) income, net", "totalLabel": "Other Nonoperating Income (Expense), Total" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r88" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Payments for Rent", "terseLabel": "Rent payments" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r79", "r450" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Cash paid for Acquisition" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r79" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedTerseLabel": "Acquisitions, net of cash acquired", "totalLabel": "Payments to Acquire Businesses, Net of Cash Acquired, Total" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r80" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment", "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r361", "r362", "r363", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r380", "r381", "r383", "r384", "r386", "r387", "r388", "r389", "r390" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r361", "r362", "r363", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r380", "r381", "r383", "r384", "r386", "r387", "r388", "r389", "r390" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r33" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Purchase Agreement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromContributedCapital": { "auth_ref": [ "r81" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received by a corporation from a shareholder during the period.", "label": "Proceeds from Contributed Capital", "terseLabel": "Capital contributions received from non-controlling interest" } } }, "localname": "ProceedsFromContributedCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r81" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "terseLabel": "Proceeds from issuance, aggregate offering prices" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": { "auth_ref": [ "r78" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.", "label": "Proceeds from Sale, Maturity and Collection of Investments", "terseLabel": "Proceeds from sales and maturities of investments", "totalLabel": "Proceeds from Sale, Maturity and Collection of Investments, Total" } } }, "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r77" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from Sale of Property, Plant, and Equipment", "terseLabel": "Proceeds from sale of property and equipment", "totalLabel": "Proceeds from Sale of Property, Plant, and Equipment, Total" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockPlans": { "auth_ref": [ "r81" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the stock plan during the period.", "label": "Proceeds from Stock Plans", "terseLabel": "Proceeds from ESPP purchases" } } }, "localname": "ProceedsFromStockPlans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]", "terseLabel": "Product" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r6", "r56", "r59", "r64", "r84", "r102", "r116", "r130", "r131", "r154", "r157", "r160", "r163", "r165", "r193", "r265", "r266", "r267", "r270", "r271", "r272", "r273", "r274", "r276", "r277", "r461", "r465", "r467", "r473", "r474", "r491", "r505", "r646" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net income (loss)", "terseLabel": "Net (loss) income", "totalLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r247" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r250", "r702", "r703", "r704" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r14", "r245" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetail": { "order": 0.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance", "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance", "terseLabel": "Property and equipment, gross", "totalLabel": "Property, Plant and Equipment, Gross, Total" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property Plant And Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r247", "r575", "r649", "r659" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance", "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance", "terseLabel": "Property and equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r245" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r70", "r208" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Bad debt expense" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RegistrationPaymentArrangementTerm": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Describes the term of the registration payment arrangement.", "label": "Registration Payment Arrangement, Term", "terseLabel": "Registration statement expiration term" } } }, "localname": "RegistrationPaymentArrangementTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r350", "r566", "r567" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r350", "r566", "r570", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r564", "r565", "r567", "r571", "r572" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related-Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLinesOfCredit": { "auth_ref": [ "r82", "r101" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Repayments of Lines of Credit", "terseLabel": "Repayments of line of credit" } } }, "localname": "RepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r82" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of Notes Payable", "negatedLabel": "Principal payments on debt" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r402", "r610", "r716" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development", "totalLabel": "Research and Development Expense, Total" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "R&D Expenses [Member]" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDescription": { "auth_ref": [ "r252", "r254" ], "lang": { "en-us": { "role": { "documentation": "Description of a specific restructuring plan and related activities including the facts and circumstances leading to the restructuring or decision to exit an activity, and the expected completion date. This concept and related items would be utilized for each plan if multiple exit plans have been implemented in the period.", "label": "Restructuring and Related Activities, Description", "terseLabel": "Restructuring activities, description" } } }, "localname": "RestructuringAndRelatedActivitiesDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r26", "r334", "r575", "r656", "r678", "r683" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance", "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance", "terseLabel": "Accumulated deficit", "totalLabel": "Retained Earnings (Accumulated Deficit), Total" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRecentAccountingPronouncementsAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r2", "r110", "r111", "r112", "r117", "r128", "r131", "r201", "r396", "r397", "r398", "r412", "r413", "r489", "r674", "r676" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r151", "r152", "r156", "r161", "r162", "r166", "r167", "r169", "r338", "r339", "r611" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 0.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Total revenues", "totalLabel": "Revenue from Contract with Customer, Excluding Assessed Tax, Total", "verboseLabel": "License revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenues:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r550", "r554" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Right of use assets obtained in exchange for new operating lease liabilities" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RoyaltyMember": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "Money for usage-based right to asset.", "label": "Royalty [Member]", "terseLabel": "Royalty" } } }, "localname": "RoyaltyMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r143" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureNetLossPerShareSummaryOfSecuritiesNotIncludedInDilutedPerShareCalculationsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r143" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of Securities Not Included in Diluted per Share Calculations" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureNetLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Securities, Available-for-Sale [Line Items]", "terseLabel": "Schedule Of Available For Sale Securities [Line Items]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": { "auth_ref": [ "r179", "r180", "r183", "r184", "r185", "r186", "r647", "r648" ], "lang": { "en-us": { "role": { "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.", "label": "Schedule of Available-for-Sale Securities [Table]", "terseLabel": "Schedule Of Available For Sale Securities [Table]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r431", "r432", "r436" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureArcadiaWellnessAcquisitionScheduleOfAllocationPurchasePriceOfAssetsAcquiredAtFairValueAtAcquisitionDateDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisition", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionScheduleOfUnauditedProFormaCondensedConsolidatedResultsOfOperationsDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionScheduleOfPreliminaryAllocationOfPurchasePriceOfISIAssetsAcquiredBasedOnFairValuesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r457" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "terseLabel": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCollaborativeArrangementsAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDescriptionOfBusinessAndBasisOfPresentationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]", "terseLabel": "Schedule Of Equity Method Investments [Line Items]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureConsolidatedJointVentureAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r6", "r102", "r192", "r193", "r505" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]", "terseLabel": "Schedule Of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureConsolidatedJointVentureAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r227", "r232", "r612" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule Of Finite Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetParentheticalDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfFutureAmortizationOfIntellectualPropertyAndCustomerListsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "terseLabel": "Schedule of Maturities of Current and Noncurrent Debt" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r247" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Schedule Of Property Plant And Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r435" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of Allocation Purchase Price of Assets Acquired at Fair Value at Acquisition Date" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r568", "r570" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r356", "r358", "r361", "r362", "r363", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r380", "r381", "r383", "r384", "r386", "r387", "r388", "r389", "r390" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramWeightedAverageFairValueAssumptionOfStockOptionAwardsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r364", "r379", "r382" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Summary of Activity Under Stock Incentive Plans" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Weighted-Average Fair Value Assumption of Stock Option Awards" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r336", "r359" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "terseLabel": "Summary of Warrants Issued to Purchase Common Stock" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r232" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Future Amortization of Intellectual Property and Customer Lists" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r75" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "order": 7.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative", "totalLabel": "Selling, General and Administrative Expense, Total" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, General and Administrative Expenses [Member]", "verboseLabel": "SG&A Expenses [Member]" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r90" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation", "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r361" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Options vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r388" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramWeightedAverageFairValueAssumptionOfStockOptionAwardsDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r387" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramWeightedAverageFairValueAssumptionOfStockOptionAwardsDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramWeightedAverageFairValueAssumptionOfStockOptionAwardsDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramWeightedAverageFairValueAssumptionOfStockOptionAwardsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate", "terseLabel": "Percentage in payroll deductions to acquire shares of common stock" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized", "terseLabel": "Additional shares authorized for issuance under the plan" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "terseLabel": "Common stock available for future grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "terseLabel": "Shares Subject to Outstanding, Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramSummaryOfActivityUnderStockIncentivePlansDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price Per Share, Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramSummaryOfActivityUnderStockIncentivePlansDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r381" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value", "terseLabel": "Intrinsic value of options exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period", "negatedLabel": "Shares Subject to Outstanding, Options Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramSummaryOfActivityUnderStockIncentivePlansDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r371" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Shares Subject to Outstanding, Options Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramSummaryOfActivityUnderStockIncentivePlansDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Shares Subject to Outstanding, Options granted", "verboseLabel": "Options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramSummaryOfActivityUnderStockIncentivePlansDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r395" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value, Outstanding Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramSummaryOfActivityUnderStockIncentivePlansDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r365", "r366" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Shares Subject to Outstanding, Ending Balance", "periodStartLabel": "Shares Subject to Outstanding, Beginning Balance", "terseLabel": "Total number of options outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramSummaryOfActivityUnderStockIncentivePlansDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r365", "r366" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price Per Share, Outstanding Ending Balance", "periodStartLabel": "Weighted-Average Exercise Price Per Share, Outstanding Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramSummaryOfActivityUnderStockIncentivePlansDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [ "r383" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value, Vested and expected to vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramSummaryOfActivityUnderStockIncentivePlansDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [ "r383" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "terseLabel": "Shares Subject to Outstanding, Vested and expected to vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramSummaryOfActivityUnderStockIncentivePlansDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r383" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price Per Share, Vested and expected to vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramSummaryOfActivityUnderStockIncentivePlansDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward": { "auth_ref": [ "r360" ], "lang": { "en-us": { "role": { "documentation": "Description of terms of award under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award", "terseLabel": "Terms under the plan" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r361", "r362", "r363", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r380", "r381", "r383", "r384", "r386", "r387", "r388", "r389", "r390" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramWeightedAverageFairValueAssumptionOfStockOptionAwardsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r370" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Weighted-Average Exercise Price Per Share, Options exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramSummaryOfActivityUnderStockIncentivePlansDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Weighted-Average Exercise Price Per Share, Options expired" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramSummaryOfActivityUnderStockIncentivePlansDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r371" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Weighted-Average Exercise Price Per Share, Options forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramSummaryOfActivityUnderStockIncentivePlansDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Weighted-Average Exercise Price Per Share, Options granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramSummaryOfActivityUnderStockIncentivePlansDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r362" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "terseLabel": "Options exercisable period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r386" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected term (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramWeightedAverageFairValueAssumptionOfStockOptionAwardsDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r395" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value, Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramSummaryOfActivityUnderStockIncentivePlansDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent", "terseLabel": "Employees are able to purchase company's common stock on first trading day of offering period, percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Stockholders Equity, Ending Balance, Shares", "periodStartLabel": "Stockholders Equity, Beginning Balance, Shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermInvestmentsMember": { "auth_ref": [ "r696", "r697", "r698", "r699" ], "lang": { "en-us": { "role": { "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.", "label": "Short-Term Investments [Member]", "terseLabel": "Short-term Investments [Member]" } } }, "localname": "ShortTermInvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r547", "r554" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureLeasesScheduleOfLeasesDetail3": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-Term Lease, Cost", "negatedLabel": "Short term lease cost", "terseLabel": "Short term lease cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r2", "r46", "r62", "r63", "r64", "r110", "r111", "r112", "r117", "r128", "r131", "r149", "r201", "r329", "r334", "r396", "r397", "r398", "r412", "r413", "r489", "r520", "r521", "r522", "r523", "r524", "r526", "r562", "r674", "r675", "r676" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Additional Paid-In Capital [Member]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r110", "r111", "r112", "r149", "r611" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r95", "r96", "r97" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Stock Issued", "terseLabel": "Shares of common stock issued at closing of Arcadia Wellness transaction" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r23", "r24", "r334" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Issuance of common stock at closing of acquisition transaction, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r23", "r24", "r329", "r334" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "Issuance of common stock pursuant to employee stock purchase plan", "verboseLabel": "Issuance of shares related to employee stock purchase plan, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r23", "r24", "r329", "r334" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of shares, Shares", "verboseLabel": "Shares of common stock issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r23", "r24", "r329", "r334", "r370" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "negatedLabel": "Shares Subject to Outstanding, Options exercised", "terseLabel": "Issuance of shares related to employee stock option exercises, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramSummaryOfActivityUnderStockIncentivePlansDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r46", "r329", "r334" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Issuance of common stock at closing of acquisition transaction" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r23", "r24", "r329", "r334" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "terseLabel": "Issuance of shares related to employee stock purchase plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r23", "r24", "r329", "r334" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of shares" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r24", "r28", "r29", "r102", "r174", "r193", "r505", "r575" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 0.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Stockholders' Equity Attributable to Parent, Ending Balance", "periodStartLabel": "Stockholders' Equity Attributable to Parent, Beginning Balance", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r2", "r3", "r63", "r102", "r110", "r111", "r112", "r117", "r128", "r193", "r201", "r334", "r396", "r397", "r398", "r412", "r413", "r459", "r460", "r472", "r489", "r505", "r520", "r521", "r526", "r562", "r675", "r676" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Stockholders Equity, Ending Balance", "periodStartLabel": "Stockholders Equity, Beginning Balance", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r100", "r314", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r328", "r334", "r337", "r479" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Equity Financing" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancing" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubleaseIncome": { "auth_ref": [ "r548", "r554" ], "calculation": { "http://arcadiabio.com/20220630/taxonomy/role/DisclosureLeasesScheduleOfLeasesDetail3": { "order": 3.0, "parentTag": "us-gaap_LeaseCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sublease income excluding finance and operating lease expense.", "label": "Sublease Income", "negatedLabel": "Sublease income" } } }, "localname": "SubleaseIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r576", "r577" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureSubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_TrademarksAndTradeNamesMember": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trademarks and Trade Names [Member]", "terseLabel": "Trademarks and Trade Names", "verboseLabel": "Brands and Trademarks [Member]" } } }, "localname": "TrademarksAndTradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r181", "r182", "r187", "r188", "r189", "r305", "r327", "r478", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r722", "r723", "r724", "r725", "r726", "r727", "r728" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfAmortizedCostAndFairValueOfInvestmentSecuritiesPortfolioDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r116", "r117", "r118", "r120", "r133", "r175", "r176", "r198", "r199", "r200", "r201", "r204", "r205", "r396", "r397", "r398", "r410", "r411", "r412", "r413", "r442", "r443", "r444", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r488", "r489", "r490", "r491", "r492", "r506", "r507", "r509", "r510", "r511", "r512", "r516", "r517", "r527", "r528", "r535", "r536", "r537", "r538", "r556", "r558", "r559", "r560", "r561", "r562", "r613", "r614", "r615", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Accounting Standards Update [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfChangesInFairValueAndOtherAdjustmentsOfLiabilitiesDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRecentAccountingPronouncementsAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r457" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetParentheticalDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCollaborativeArrangementsAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIndustrialSeedInnovationsAcquisitionAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInventoryAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAndEmployeeStockPurchaseProgramAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://arcadiabio.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfStockholdersEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_UnrealizedGainLossOnSecurities": { "auth_ref": [ "r91" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) recognized in the income statement on unsold other securities.", "label": "Unrealized Gain (Loss) on Securities", "verboseLabel": "Unrealized gains on corporate securities" } } }, "localname": "UnrealizedGainLossOnSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r403", "r407" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Unrecognized Tax Benefits, Ending Balance", "periodStartLabel": "Unrecognized Tax Benefits, Beginning Balance", "terseLabel": "Uncertain tax positions" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]", "terseLabel": "Vehicles [Member]" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetSummaryOfPropertyAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrants [Member]", "verboseLabel": "Warrants to Purchase Common Stock [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/DisclosureNetLossPerShareSummaryOfSecuritiesNotIncludedInDilutedPerShareCalculationsDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants and Rights Note Disclosure [Abstract]" } } }, "localname": "WarrantsAndRightsNoteDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.", "label": "Warrants and Rights Outstanding, Measurement Input", "terseLabel": "Warrants and rights outstanding, measurement input" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureEquityFinancingAdditionalInformationDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail" ], "xbrltype": "decimalItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Remaining term (in years)", "verboseLabel": "Term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureInvestmentsAndFairValueInstrumentsSummaryOfWarrantLiabilitiesMeasuredAndRecordedOnRecurringBasisUsingBlackScholesModelDetail", "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureWarrantsSummaryOfWarrantsIssuedToPurchaseCommonStockDetail" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r137", "r142" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted average shares - Diluted", "terseLabel": "Weighted average number of common shares outstanding - diluted", "totalLabel": "Weighted average number of common shares outstanding - diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionScheduleOfUnauditedProFormaCondensedConsolidatedResultsOfOperationsDetail", "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Denominator:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r136", "r142" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average shares - Basic", "terseLabel": "Weighted average number of common shares outstanding", "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total", "verboseLabel": "Weighted average number of common shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://arcadiabio.com/20220630/taxonomy/role/Role_DisclosureArcadiaWellnessAcquisitionScheduleOfUnauditedProFormaCondensedConsolidatedResultsOfOperationsDetail", "http://arcadiabio.com/20220630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "xbrltype": "sharesItemType" } }, "unitCount": 10 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r109": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31010-122693" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693" }, "r135": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org/topic&trid=2122394" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r148": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(1)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)(2)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27340-111563" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(b)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r194": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "https://asc.fasb.org/topic&trid=2196965" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL120254519-210437" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314" }, "r219": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.A)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r239": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126982154&loc=d3e400-110220" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(a))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r257": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r262": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r312": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r337": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907" }, "r401": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r424": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e845-128460" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e848-128460" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "44", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5558-128473" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479" }, "r454": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r458": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "808", "URI": "https://asc.fasb.org/topic&trid=5833765" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121483254&loc=SL120254523-199619" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=99383193&loc=d3e16207-108621" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL77916155-209984" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL120154346-209984" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r555": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r572": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r577": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(1)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(2)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(3)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.14)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r7": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r717": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r718": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r719": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r720": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r721": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r722": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r723": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r724": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r725": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r726": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r727": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r728": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r729": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" } }, "version": "2.1" } ZIP 85 0000950170-22-016942-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-22-016942-xbrl.zip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�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�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Ə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�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end